<SEC-DOCUMENT>0001641172-25-021187.txt : 20250728
<SEC-HEADER>0001641172-25-021187.hdr.sgml : 20250728
<ACCEPTANCE-DATETIME>20250728171742
ACCESSION NUMBER:		0001641172-25-021187
CONFORMED SUBMISSION TYPE:	PRE 14A
PUBLIC DOCUMENT COUNT:		11
CONFORMED PERIOD OF REPORT:	20250728
FILED AS OF DATE:		20250728
DATE AS OF CHANGE:		20250728

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ProPhase Labs, Inc.
		CENTRAL INDEX KEY:			0000868278
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				232577138
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PRE 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-21617
		FILM NUMBER:		251156659

	BUSINESS ADDRESS:	
		STREET 1:		711 STEWART AVE, SUITE 200
		STREET 2:		GARDEN CITY
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			11530
		BUSINESS PHONE:		(215) 345-0919

	MAIL ADDRESS:	
		STREET 1:		711 STEWART AVE, SUITE 200
		STREET 2:		GARDEN CITY
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			11530

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	QUIGLEY CORP
		DATE OF NAME CHANGE:	19930328
</SEC-HEADER>
<DOCUMENT>
<TYPE>PRE 14A
<SEQUENCE>1
<FILENAME>formpre14a.htm
<DESCRIPTION>PRE 14A
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Washington,
DC 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SCHEDULE
PRE 14A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Rule
14a-101)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proxy
Statement Pursuant to Section 14(a)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>of
the Securities Exchange Act of 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
    by the Registrant</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 8%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
    by a Party other than the Registrant</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preliminary
    Proxy Statement</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9744;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Confidential,
    for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive
    Proxy Statement</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive
    Additional Materials</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    Material Pursuant to &sect;240.14a-12</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>PROPHASE
LABS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
of Registrant as Specified in Its Charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
of Person(s) Filing Proxy Statement, if other than the Registrant)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
of Filing Fee (Check all boxes that apply):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    fee required.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
    paid previously with preliminary materials:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
    computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; color: Red"><IMG SRC="formpre14a_001.jpg" ALT="" STYLE="width: 250px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
28, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Stockholder:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ProPhase Labs, Inc. Special Meeting of Stockholders (the &ldquo;Special Meeting&rdquo;) will be held on Friday, August 29, 2025, at 4:00
p.m. Eastern Time, at 273 Merrick Road, Lynbrook, NY 11563. The meeting will start promptly at 4:00 p.m., Eastern Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
are invited to attend the Special Meeting. Whether or not you plan to attend the Special Meeting in person, your vote is important. Please
vote your shares by proxy in advance of the Special Meeting as instructed in the enclosed proxy card if you are a record holder or, for
shares held in street name, the voting instruction form provided by your bank, broker or nominee. Even if you have voted by proxy, you
may still vote in person if you attend the Special Meeting. Please note, however, that if your shares are held of record by a bank, broker
or similar institution and you wish to vote at the Special Meeting, you must obtain a proxy issued in your name from that record holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details
of the business to be conducted at the Special Meeting are included in the attached Notice of Special Meeting and Proxy Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Ted Karkus</I></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ted
    Karkus</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Chairman
    of the Board of Directors </I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>and
    Chief Executive Officer</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ProPhase
Labs, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>626
RXR Plaza, 6th Floor</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Uniondale,
New York 11556</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF SPECIAL MEETING OF STOCKHOLDERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>to
be held Friday, August 29, 2025</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TO
THE STOCKHOLDERS OF PROPHASE LABS, INC.:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE
IS HEREBY GIVEN that a Special Meeting of Stockholders (the &ldquo;Special Meeting&rdquo;) of ProPhase Labs, Inc. (the &ldquo;Company&rdquo;),
a Delaware corporation, will be held at 273 Merrick Road, Lynbrook, NY 11563, on Friday, August 29, 2025, at 4:00 p.m., Eastern Time,
for the following purposes:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    approve, for purposes of complying with Nasdaq Listing Rule 5635(c), (i) an amendment to the Company&rsquo;s Amended and Restated
    2022 Equity Compensation Plan to increase the number of shares authorized for issuance thereunder by 3,000,000 shares, and (ii) the
    adoption of the Company&rsquo;s Amended and Restated 2025 Equity Compensation Plan, as approved by the Board of Directors, to supersede
    the 2022 Plan, contingent on the approval of Proposal 3. (Proposal 1);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    approve, for purposes of complying with Nasdaq Listing Rule 5635(c), (i) an amendment to the Company&rsquo;s Amended and Restated
    2022 Directors&rsquo; Equity Compensation Plan to increase the number of shares authorized for issuance thereunder by 500,000 shares,
    and (ii) the adoption of the Company&rsquo;s Amended and Restated 2025 Directors&rsquo; Equity Compensation Plan, as approved by
    the Board of Directors, to supersede the 2022 Directors&rsquo; Plan, contingent on the approval of Proposal 3. (Proposal 2); </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    approve an amendment to Article FOURTH of the Company&rsquo;s Certificate of Incorporation, as amended, to increase the number of
    authorized shares of common stock from 50,000,000 to 1,000,000,000 shares, as recommended by the Board of Directors to transform
    the structure of the Company to have the flexibility to attract and execute on the optimal crypto treasury strategy. (Proposal 3);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    approve, on a non-binding, advisory basis, the Board of Directors&rsquo; adoption of a share repurchase program authorizing the Company,
    in its discretion, to repurchase up to $15 million of its outstanding common stock from time to time in the open market or through
    privately negotiated transactions, subject to applicable law and the Company&rsquo;s financial condition. (Proposal 4); </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance by the Company of shares of its common stock (and/or
    securities convertible into or exercisable for common stock), in one or more non-public offerings, in an aggregate amount that may
    exceed 20% of the total number of shares of the Company&rsquo;s common stock outstanding as of the date of issuance, at a price that
    may be less than the greater of book value or market value of the common stock, as determined in accordance with Nasdaq rules. (Proposal
    5)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    approve an amendment to the Company&rsquo;s By-Laws to add the address of its principal executive offices to 626 RXR Plaza, 6<SUP>th</SUP>
    Floor, Uniondale, NY 11556 (this proposal is considered a routine matter for which brokers may exercise discretionary voting authority).
    (Proposal 6);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    transact such other business as may properly come before the Special Meeting and any adjournments or postponements thereof.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
items of business are more fully described in the proxy statement accompanying this Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YOUR
BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE IN FAVOR OF PROPOSALS 1 THROUGH 6.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
record date for the Special Meeting is Friday, August 1, 2025. Only stockholders of record at the close of business on that date may
vote at the Special Meeting or any adjournment or postponement thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Order of the Board of Directors</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Ted Karkus</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ted
    Karkus</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    of the Board of Directors</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
    Chief Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Uniondale,
New York</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
28, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 100%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMPORTANT
                                            NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE STOCKHOLDERS&rsquo; MEETING
                                            TO BE HELD ON AUGUST 29, 2025</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 7.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Notice of Special Meeting of Stockholders and Proxy Statement are available at:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>www.proxyvote.com</I></FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ProPhase
Labs, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>626
RXR Plaza, 6th Floor</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Uniondale,
New York 11556</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROXY
STATEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SPECIAL
MEETING OF STOCKHOLDERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>to
be held August 29, 2025</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>TABLE
OF CONTENTS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.5in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#sl_001">QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND THE ANNUAL MEETING</A>&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#sl_002">PROPOSAL 1 - ELECTION OF BOARD OF DIRECTORS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#sl_003">Required Vote</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#sl_004">Recommendation of the Board of Directors</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#sl_012">EXECUTIVE OFFICERS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#sl_005">EXECUTIVE AND DIRECTOR COMPENSATION</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#sl_006">Summary Compensation Table (2024 and 2023)</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#o_001">Outstanding Equity Awards at 2024 Fiscal Year End</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">10<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#o_002">Director Compensation for 2024</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>11</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#sl_008">EQUITY COMPENSATION PLAN INFORMATION</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#sl_009">SECURITY OWNERSHIP</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#sl_010">PROPOSAL 2 - RATIFICATION OF THE APPOINTMENT OF INDEPENDENT AUDITORS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#sl_013">Required Vote</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">26<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#sl_014">Recommendation of the Board of Directors</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>27</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_009">PROPOSAL 3 - ADVISORY VOTE ON EXECUTIVE COMPENSATION</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_007">Required Vote</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_006">Recommendation of the Board of Directors</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_008">PROPOSAL 4 &ndash; ADVISORY VOTE ON THE FREQUENCY OF FUTURE ADVISORY VOTES ON EXECUTIVE COMPENSATION</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#sl_011">Required Vote</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_010">Recommendation of the Board of Directors</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_001">OTHER INFORMATION</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_002">Attending the Annual Meeting</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_003">Expenses and Solicitation</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_004">Householding of Proxy Materials</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_005">Other Business</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ProPhase
Labs, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>626
RXR Plaza, 6th Floor</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Uniondale,
New York 11556</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROXY
STATEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="sl_001"></A>QUESTIONS
AND ANSWERS ABOUT THESE PROXY MATERIALS AND THE SPECIAL MEETING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Q:
    </I></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Why
    am I receiving these materials? </I></B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Board of Directors (the &ldquo;Board&rdquo;) of ProPhase Labs, Inc. (the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;our,&rdquo;
    or &ldquo;us,&rdquo; as the context requires) is providing this proxy statement (this &ldquo;Proxy Statement&rdquo;) to solicit your
    proxy in connection with a Special Meeting of Stockholders (the &ldquo;Special Meeting&rdquo;), which will be held at 273 Merrick
    Road, Lynbrook, NY 11563, on Friday, August 29, 2025, at 4:00 p.m., Eastern Time. The Board is requesting your vote on the proposals
    described in this Proxy Statement. This Proxy Statement and the Notice of Special Meeting, along with the accompanying proxy card,
    or voting instruction form, as applicable, are being mailed to stockholders on or about August 7, 2025.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Q:
    </I></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Who
    is soliciting the proxies? </I></B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    are soliciting proxies in the form enclosed on behalf of the Board. Our Board has selected Ted Karkus and Lance Bisesar (the &ldquo;Named
    Proxies&rdquo;) to vote all shares for which the Company has been appointed to act as proxy at the Special Meeting. The Named Proxies
    will vote any properly executed proxy, if received in time and not revoked, at the Special Meeting in accordance with your directions.
    The Named Proxies will vote any signed proxy that fails to specify a choice on any proposal to be acted upon at the Special Meeting
    in accordance with the Board&rsquo;s voting recommendations (as described below in <I>&ldquo;What are the Board&rsquo;s voting recommendations?&rdquo;</I>),
    and, in the Named Proxies&rsquo; discretion, FOR or AGAINST such other business as may properly come before the Special Meeting or
    any adjournment or postponement thereof.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Q:
    </I></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>What
    information is contained in these materials? </I></B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    Proxy Statement contains information related to the proposals to be voted on at the Special Meeting, the voting process, the compensation
    of the Company&rsquo;s executive officers and directors, and other required information. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Q:
    </I></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>What
    proposals will be voted on at the Special Meeting? </I></B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
    are six matters on which a vote is scheduled at the Special Meeting:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 97%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    approve, for purposes of complying with Nasdaq Listing Rule 5635(c), (i) an amendment to the Company&rsquo;s Amended and Restated
    2022 Equity Compensation Plan to increase the number of shares authorized for issuance thereunder by 3,000,000 shares, and (ii) the
    adoption of the Company&rsquo;s Amended and Restated 2025 Equity Compensation Plan, as approved by the Board of Directors, to supersede
    the 2022 Plan, contingent on the approval of Proposal 3. (Proposal 1);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    approve, for purposes of complying with Nasdaq Listing Rule 5635(c), (i) an amendment to the Company&rsquo;s Amended and Restated
    2022 Directors&rsquo; Equity Compensation Plan to increase the number of shares authorized for issuance thereunder by 500,000 shares,
    and (ii) the adoption of the Company&rsquo;s Amended and Restated 2025 Directors&rsquo; Equity Compensation Plan, as approved by
    the Board of Directors, to supersede the 2022 Directors&rsquo; Plan, contingent on the approval of Proposal 3. (Proposal 2); </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    approve an amendment to Article FOURTH of the Company&rsquo;s Certificate of Incorporation, as amended, to increase the number of
    authorized shares of common stock from 50,000,000 to 1,000,000,000 shares, as recommended by the Board of Directors to transform
    the structure of the Company to have the flexibility to attract and execute on the optimal crypto treasury strategy. (Proposal 3);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    approve, on a non-binding, advisory basis, the Board of Directors&rsquo; adoption of a share repurchase program authorizing the Company,
    in its discretion, to repurchase up to $15 million of its outstanding common stock from time to time in the open market or through
    privately negotiated transactions, subject to applicable law and the Company&rsquo;s financial condition. (Proposal 4);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance by the
                                            Company of shares of its common stock (and/or securities convertible into or exercisable
                                            for common stock), in one or more non-public offerings, in an aggregate amount that may exceed
                                            20% of the total number of shares of the Company&rsquo;s common stock outstanding as of the
                                            date of issuance, at a price that may be less than the greater of book value or market value
                                            of the common stock, as determined in accordance with Nasdaq rules. (Proposal 5)</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    approve an amendment to the Company&rsquo;s By-Laws to add the address of its principal executive offices to 626 RXR Plaza, 6<SUP>th</SUP>
    Floor, Uniondale, NY 11556 (this proposal is considered a routine matter for which brokers may exercise discretionary voting authority).
    (Proposal 6)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will also consider and vote upon any other business properly brought before the Special Meeting, or any adjournment or postponement thereof.
However, our Secretary has not received timely and proper notice from any stockholder of any other matter to be presented at the meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Q:
    </I></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>What
    are the Board&rsquo;s voting recommendations? </I></B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Board recommends that you vote your shares:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
    (i) an amendment to the Company&rsquo;s Amended and Restated 2022 Equity Compensation Plan to increase the number of shares authorized
    for issuance thereunder by 3,000,000 shares, and (ii) the adoption of the Company&rsquo;s Amended and Restated 2025 Equity Compensation
    Plan, as approved by the Board of Directors, to supersede the 2022 Plan, contingent on the approval of Proposal 3. (Proposal
    1); </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
    (i) an amendment to the Company&rsquo;s Amended and Restated 2022 Directors&rsquo; Equity Compensation Plan to increase the number
    of shares authorized for issuance thereunder by 500,000 shares, and (ii) the adoption of the Company&rsquo;s Amended and Restated
    2025 Directors&rsquo; Equity Compensation Plan, as approved by the Board of Directors, to supersede the 2022 Directors&rsquo; Plan,
    contingent on the approval of Proposal 3. (Proposal 2);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
    an amendment to Article FOURTH of the Company&rsquo;s Certificate of Incorporation, as amended, to increase the number of authorized
    shares of common stock from 50,000,000 to 1,000,000,000 shares, as recommended by the Board of Directors to transform the structure
    of the Company to have the flexibility to attract and execute on the optimal crypto treasury strategy. (Proposal 3); </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
    the approval of, on a non-binding, advisory basis, the Board of Directors&rsquo; adoption of a share repurchase program authorizing
    the Company, in its discretion, to repurchase up to $15 million of its outstanding common stock from time to time in the open market
    or through privately negotiated transactions, subject to applicable law and the Company&rsquo;s financial condition. (Proposal 4);
    and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
                                            the approval of the issuance by the Company of shares of its common stock (and/or securities
                                            convertible into or exercisable for common stock), in one or more non-public offerings, in
                                            an aggregate amount that may exceed 20% of the total number of shares of the Company&rsquo;s
                                            common stock outstanding as of the date of issuance, at a price that may be less than the
                                            greater of book value or market value of the common stock, as determined in accordance with
                                            Nasdaq rules. (Proposal 5).</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
the approval of an amendment to the Company&rsquo;s By-Laws to add the address of its principal executive offices to 626 RXR Plaza,
6<SUP>th</SUP> Floor, Uniondale, NY 11556 (this proposal is considered a routine matter for which brokers may exercise discretionary
voting authority). (Proposal 6)</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Q:
    </I></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>What
    shares may I vote?</I></B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
    may vote all shares of the Company&rsquo;s common stock, par value $0.0005 per share, that you own as of the close of business on
    August 1, 2025 (the &ldquo;Record Date&rdquo;). These shares include:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">those
    held directly in your name as the stockholder of record; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">those
    held for you as the beneficial owner through a bank, broker, or similar institution at the close of business on the Record Date.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
share of common stock is entitled to one vote.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors has fixed the close of business on August 1, 2025 as the record date for determining stockholders entitled to notice
of, and to vote at, the Special Meeting. Only stockholders of record at the close of business on that date will be entitled to vote at
the Special Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this preliminary proxy statement, the Company does not yet know the number of shares of common stock that will be outstanding
on the record date. The exact number of shares entitled to vote will be provided in the definitive proxy statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Q:
    </I></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>What
    is the difference between holding shares as a stockholder of record and as a beneficial owner? </I></B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Most
                                            Company stockholders hold their shares through a bank, broker or similar institution rather
                                            than directly in their own name. As summarized below, there are some distinctions between
                                            shares held of record and those owned beneficially.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Stockholder
    of Record</I></B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    your shares are registered directly in your name with the Company&rsquo;s transfer agent, Equiniti Trust Company LLC, you are considered,
    with respect to those shares, the stockholder of record and we are sending these proxy materials directly to you. As the stockholder
    of record, you have the right to vote your shares in person at the Special Meeting or to grant a proxy to vote your shares to the
    Company or any other person who will appear in person at the Special Meeting, and any adjournment or postponement thereof, and vote
    your shares on your behalf.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Beneficial
    Owner</I></B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    you hold shares in a stock brokerage account or through a bank or similar institution, you are considered the beneficial owner of
    shares held in street name, and your bank, broker or nominee is forwarding these proxy materials to you. Your bank, broker, or nominee
    is considered, with respect to those shares, the stockholder of record. As the beneficial owner, you have the right to direct your
    bank, broker, or other nominee on how to vote your shares, but because you are not the stockholder of record, you may not vote these
    shares in person at the Special Meeting unless you obtain a signed proxy from the record holder giving you the right to vote the
    shares. Your bank, broker, or nominee has enclosed a voting instruction form for you to use.</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Q:
    </I></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>May
    I attend the Special Meeting in person? </I></B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            you are a stockholder of record, you are invited to attend the Special Meeting and vote your
                                            shares in person at the Special Meeting.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    you are a beneficial owner, you may not vote your shares in person at the Special Meeting unless you obtain a signed proxy from your
    bank, broker or other nominee giving you the right to vote the shares in person at the Special Meeting.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    stockholders attending the Special Meeting will be asked to present a form of photo identification, such as a driver&rsquo;s license,
    in order to be admitted to the meeting. By attending the Special Meeting, stockholders agree to abide by the agenda and procedures
    for the Special Meeting, copies of which will be distributed to attendees at the meeting.</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Q:
    </I></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>How
    can I vote my shares in person at the Special Meeting? </I></B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            you are a stockholder of record, you may vote shares you hold directly in your name at the
                                            Special Meeting. If you choose to attend the Special Meeting, please bring the enclosed proxy
                                            card. Voting in person at the Special Meeting will revoke any proxy you submitted earlier.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    you are the beneficial owner of shares held in street name and your bank, broker, or nominee is forwarding these proxy materials
    to you, you may vote the shares in person at the Special Meeting only if you have obtained a signed proxy from your bank, broker,
    or nominee (<I>i.e</I>., the record holder) giving you the right to vote the shares.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
    if you plan to attend the Special Meeting, we recommend that you also submit your proxy as described below so that your vote will
    be counted if you later decide not to attend the Special Meeting. Submitting your proxy now will not prevent you from voting your
    shares in person at the Special Meeting if you desire to do so, as your proxy is revocable at your option.</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Q:
    </I></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>How
    can I vote my shares without attending the Special Meeting? </I></B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whether
                                            you hold shares directly as the stockholder of record or beneficially in street name, you
                                            may direct your vote without attending the Special Meeting. If you hold your shares directly,
                                            you may vote by granting a proxy. If you hold your shares in street name, you may submit
                                            voting instructions to your bank, broker, or other nominee. Please refer to the summary instructions
                                            below and those included on your proxy card or, for shares held in street name, the voting
                                            instruction form provided by your bank, broker or nominee.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>By
    Mail</I></B>&mdash; If you hold your shares directly in your name as the stockholder of record, you may vote by mail by following
    the instructions provided on your proxy card and mailing the proxy card in the enclosed, postage prepaid and addressed envelope.
    If you hold your shares in street name, you may vote by mail by following the voting instruction form provided by your bank, broker
    or nominee and mailing the proxy card in the enclosed, postage prepaid and addressed envelope. If you provide specific voting instructions
    on your proxy card or voting instruction form, your shares will be voted as you instruct at the Special Meeting. If you sign but
    do not provide instructions, your shares will be voted as described below in &ldquo;<I>How are votes counted?</I>&rdquo;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>On
    the Internet</I></B>&mdash; If you hold your shares directly in your name as the stockholder of record you may vote online at <I>www.proxyvote.com
    </I>by following the online instructions (have your proxy card available when you access the website). If you hold your shares in
    street name and the firm that holds your shares offers online voting, your broker voting instruction form will contain instructions
    on how to vote online. If you vote online, you do not need to mail in your proxy card.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>By
    Telephone</I></B>&mdash; If you hold your shares directly in your name as the stockholder of record you may vote by telephone by
    following the instructions on your proxy card (have your proxy card available when you call). If you hold your shares in street name
    and the firm that holds your shares offers voting by telephone, your broker voting instruction form will contain instructions on
    how to vote by telephone. If you vote by telephone, you do not need to mail in your proxy card.</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Q:
    </I></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>May
    I change or revoke my vote? </I></B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes,
                                            you may change or revoke your proxy instructions at any time prior to the vote at the Special
                                            Meeting.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    you hold your shares directly and returned your proxy by mail, you must (a) provide written notice of revocation to the Secretary
    of the Company, (b) timely deliver a valid, later-dated proxy, or (c) vote in person at the Special Meeting. Your attendance at the
    Special Meeting will not by itself revoke your previously granted proxy unless you give written notice of revocation to the Secretary
    of the Company before the Special Meeting or you vote at the Special Meeting. Any proxy submitted by a stockholder of record may
    be revoked at any time prior to its exercise at the Special Meeting.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    shares you own beneficially, you may change your vote by submitting new voting instructions to your bank, broker or nominee. If you
    voted on the Internet or by telephone, you may change your vote by following the instructions for voting by either method until the
    cut-off time stated in the proxy instructions.</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Q:
    </I></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>How
    are votes counted? </I></B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                            Proposal 1 (amending the Company&rsquo;s Equity Compensation Plan to increase its number
                                            of shares authorized for issuance by 3,000,000 and adopting the new Amended and Restated
                                            2025 Equity Compensation Plan), you may vote &ldquo;FOR&rdquo;, &ldquo;AGAINST&rdquo; or
                                            &ldquo;ABSTAIN.&rdquo; For abstentions, see &ldquo;<I>What happens if I abstain from voting?</I>&rdquo;
                                            below.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    Proposal 2 (amending the Director&rsquo;s Equity Compensation Plan to increase the number of its shares authorized for issuance by
    500,000 and adopting the new Amended and Restated 2025 Directors&rsquo; Equity Compensation Plan), you may vote &ldquo;FOR&rdquo;,
    &ldquo;AGAINST&rdquo; or &ldquo;ABSTAIN.&rdquo; For abstentions, see &ldquo;<I>What happens if I abstain from voting?</I>&rdquo;
    below.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    Proposal 3 (increasing the number of authorized shares of common stock from 50,000,000 to 1,000,000,000 shares), you may vote &ldquo;FOR&rdquo;,
    &ldquo;AGAINST&rdquo; or &ldquo;ABSTAIN.&rdquo; For abstentions, see &ldquo;<I>What happens if I abstain from voting?</I>&rdquo;
    below.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    Proposal 4 (approving the adoption of a share repurchase program authorizing the Company to repurchase up to $15 million of its outstanding
    common stock), you may vote &ldquo;FOR&rdquo;, &ldquo;AGAINST&rdquo; or &ldquo;ABSTAIN.&rdquo; For abstentions, see &ldquo;<I>What
    happens if I abstain from voting?</I>&rdquo; below.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    Proposal 5 (approving the issuance by the Company of shares of common stock in one or more non-public offerings in an aggregate amount
    that may exceed 20% of the total number of shares of the Company&rsquo;s common stock outstanding as of the date of the issuance),
    you may vote &ldquo;FOR&rdquo;, &ldquo;AGAINST&rdquo; or &ldquo;ABSTAIN.&rdquo; For abstentions, see &ldquo;<I>What happens if I
    abstain from voting?</I>&rdquo; below.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    Proposal 6 (approving the amendment of the Bylaws to add the Company&rsquo;s corporate address), you may vote &ldquo;FOR&rdquo;,
    &ldquo;AGAINST&rdquo; or &ldquo;ABSTAIN.&rdquo; For abstentions, see &ldquo;<I>What happens if I abstain from voting?</I>&rdquo;
    below.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    you specify a voting choice, the shares will be voted in accordance with that choice. If you vote your shares, but do not indicate
    your voting preferences, the Named Proxies will vote your shares in accordance with the recommendations of the Board.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    you are a beneficial owner and you have not provided voting instructions to your bank, broker or nominee, your bank, broker or nominee
    may not exercise discretionary authority to vote your shares with respect to any of Proposals 1 to 5, which are considered non-routine matters. As a result, your shares will be treated as &ldquo;broker non-votes&rdquo;
with respect to these proposals. See &ldquo;<I>What is a broker non-vote?</I>&rdquo; for more information. Proposal 6 is a routine
    matter and broker non-votes and abstentions (described below) will be counted as present and entitled to vote for
    purposes of determining a quorum at the Special Meeting.</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Q:
    </I></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>What
    is the quorum requirement for the Special Meeting? </I></B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    quorum requirement for holding a Special Meeting and transacting business is a majority of the outstanding shares of common stock
    entitled to vote. The shares may be present in person or represented by proxy at the Special Meeting. Abstentions and &ldquo;broker
    non-votes&rdquo; (described below) will be counted as present and entitled to vote for purposes of determining a quorum at the Special
    Meeting.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Q:
    </I></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>What
    is the voting requirement to approve each of the proposals? </I></B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amending
    the Company&rsquo;s Equity Compensation Plan to increase its number of shares authorized for issuance by 3,000,000 and adopting the
    new Restated 2025 Equity Compensation Plan (Proposal 1), amending the Director&rsquo;s Equity Compensation Plan to increase the number
    of its shares authorized for issuance by 500,000 and adopting the new Amended and Restated 2025 Directors&rsquo; Equity Compensation
    Plan (Proposal 2), increasing the number of authorized shares of common stock from 50,000,000 to 1,000,000,000 (Proposal 3), approving
    the adoption of a share repurchase program authorizing the Company to repurchase up to $15 million of its outstanding common stock
    (Proposal 4), approving the issuance by the Company of shares of common stock in one or more non-public offerings in an aggregate
    amount that may exceed 20% of the total number of shares of the Company&rsquo;s common stock outstanding as of the date of the issuance
    (Proposal 5), will each require the affirmative vote of a majority of the votes cast on such proposal by the shares present in person
    or represented by proxy at the Special Meeting and entitled to vote thereon. Approving the amendment of the Bylaws to add the corporate
    address (Proposal 6) will require 66 2/3% affirmative vote of all shareholders. See Proposal 6 below. In each case, a quorum
    must be present at the Special Meeting for a valid vote.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Q:
    </I></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>What
    happens if I abstain from voting? </I></B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    an executed proxy card or voting instruction form is returned and the stockholder has explicitly abstained from voting on any proposal,
    the shares represented by the proxy will be considered present at the Special Meeting for the purpose of determining a quorum. Abstentions
    will not be counted as votes cast and therefore they will have no effect on the outcome of any proposal.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Q:
    </I></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>What
    is a &ldquo;broker non-vote&rdquo;? </I></B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    &ldquo;broker non-vote&rdquo; occurs when a broker submits a proxy that does not indicate a vote for one or more of the proposals
    because the broker has not received instructions from the beneficial owner on how to vote on such proposal and does not have discretionary
    authority to vote in the absence of instructions. Brokers have discretionary authority to vote on matters that are deemed &ldquo;routine.&rdquo;
    One of the proposals considered in this Special Meeting, Proposal 6, is routine. Brokers do not have discretionary authority to vote
    on matters that are deemed &ldquo;non-routine,&rdquo; such as Amending the Company&rsquo;s Equity Compensation Plan to increase its
    number of shares authorized for issuance by 3,000,000 and adopting the new Restated 2025 Equity Compensation Plan (Proposal 1), amending
    the Director&rsquo;s Equity Compensation Plan to increase the number of its shares authorized for issuance by 500,000 and adopting
    the new Amended and Restated 2025 Directors&rsquo; Equity Compensation Plan (Proposal 2), increasing the number of authorized shares
    of common stock from 50,000,000 to 1,000,000,000 (Proposal 3), approving the adoption of a share repurchase program authorizing the
    Company to repurchase up to $15 million of its outstanding common stock (Proposal 4), and approving the issuance by the Company of
    shares of common stock in one or more non-public offerings in an aggregate amount that may exceed 20% of the total number of shares
    of the Company&rsquo;s common stock outstanding as of the date of the issuance (Proposal 5). Broker non-votes will be counted for
    the purposes of determining whether a quorum exists at the Special Meeting, but because they are not votes that are cast, they will
    have no effect on the outcome of Proposal 1, Proposal 2, Proposal 3, Proposal 4, or Proposal 5.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Q:
    </I></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Will
    I have dissenters&rsquo; rights? </I></B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    dissenters&rsquo; rights are available under the General Corporation Law of the State of Delaware, our certificate of incorporation,
    or our bylaws to any stockholder with respect to any of the proposals.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Q:
    </I></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>What
    does it mean if I receive more than one proxy card or voting instruction form? </I></B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
    means your shares are registered differently or are held in more than one account. Please provide voting instructions for all proxy
    cards and voting instruction forms you receive.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Q:
    </I></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Where
    can I find the voting results of the Special Meeting? </I></B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    will announce preliminary voting results at the Special Meeting and publish final results in a Current Report on Form 8-K following
    the Special Meeting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="o_001"></A><B>Outstanding
Equity Awards at 2024 Fiscal Year End</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information concerning outstanding equity awards held by each of our named executive officers for the last
completed fiscal year of December 31, 2024, as of December 31, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Option Awards</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Name</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
                                            of Securities</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Underlying
                                            Unexercised</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Options
                                            (#) Exercisable</B></FONT></P></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
                                            of Securities</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Underlying
                                            Unexercised</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Options
                                            (#) Unexercisable</B></FONT></P></TD><TD STYLE="padding-bottom: 1pt"><SUP>&nbsp;</SUP></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Option Exercise Price ($)</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Option Expiration Date</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 32%; text-align: left">Ted Karkus</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">100,000</TD><TD STYLE="width: 3%; text-align: left"><SUP>(1)</SUP></TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">400,000</TD><TD STYLE="width: 3%; text-align: left"><SUP>(1)</SUP></TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">9.00</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/4/2030
                                            </FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100,000</TD><TD STYLE="text-align: left"><SUP>(2)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">300,000</TD><TD STYLE="text-align: left"><SUP>(2)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.00</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/16/2031
                                            </FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Jed Latkin</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,500</TD><TD STYLE="text-align: left"><SUP>(3)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">40,000</TD><TD STYLE="text-align: left"><SUP>(3)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.84</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/12/2030
                                            </FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">125,000</TD><TD STYLE="text-align: left"><SUP>(4)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">375,000</TD><TD STYLE="text-align: left"><SUP>(4)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.00</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2030
                                            </FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Robert Morse</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left"><SUP>(5)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left"><SUP>(5)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Award
    of 500,000 options was granted on April 4, 2024 was scheduled to vest in 5 equal annual installments beginning on April 4, 2024,
    subject to Mr. Karkus continued service through each vesting date.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Award
    of 400,000 options was granted on March 17, 2024 was scheduled to vest in 4 equal annual installments beginning on March 17, 2024,
    subject to Mr. Karkus continued service through each vesting date.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Award
    of 35,000 options was granted on March 13, 2023 was scheduled to vest in 4 equal annual installments beginning on March 13, 2023,
    subject to Mr. Latkin continued service through each vesting date.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Award
    of 125,000 options was granted on January 1, 2024 was scheduled to vest in 4 equal annual installments beginning on January 1, 2024,
    subject to Mr. Latkin continued service through each vesting date.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of December 31, 2024, Mr. Morse had no outstanding or exercisable options.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="o_002"></A>Director
Compensation for 2024-2026</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
setting director compensation, the Board considers the significant amount of time that directors expend in fulfilling their duties to
the Company. Only non-employee directors are entitled to compensation for Board service.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the period beginning July 1, 2024 and ending June 30, 2025 (the &ldquo;2024 Director Period&rdquo;), our non-employee directors are entitled
to receive:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    $35,000 annual cash service retainer (to be paid in quarterly installments beginning September 30, 2024); and </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    stock option to purchase 70,000 shares of the Company&rsquo;s common stock with an exercise price of $6.00 per share (the closing
    price of the Company&rsquo;s common stock on the grant date); vesting in four equal quarterly installments of 17,500 shares over
    one year, with the first quarterly installment vesting on September 30, 2024 and each additional installment vesting quarterly thereafter,
    subject to the director&rsquo;s continued service with the Company on each such vesting date. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the period beginning July 1, 2025 and ending June 30, 2026 (the &ldquo;2025 Director Period&rdquo;), our non-employee directors were
entitled to receive, at their election, either:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    $48,000 annual cash service retainer (to be paid in quarterly installments beginning September 30, 2025); and </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    stock option to purchase shares of the Company&rsquo;s common stock to be determined upon shareholder approval of Proposal 2 and
    Proposal 3 with an exercise price per share to be determined (the closing price of the Company&rsquo;s common stock on
    the grant date); vesting in four equal quarterly installments over one year, with the first quarterly installment
    vesting on September 30, 2023 and each additional installment vesting quarterly thereafter, subject to the director&rsquo;s continued
    service with the Company on each such vesting date and approval of Proposal 2 and Proposal 3.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
options granted under the director compensation program are granted under the Company&rsquo;s Amended and Restated 2022 Directors&rsquo;
Equity Compensation Plan (the &ldquo;2022 Directors&rsquo; Plan&rdquo;) with an exercise price equal to the Fair Market Value (as such
term is defined in the 2022 Directors&rsquo; Plan) of our common stock on the date of grant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
reimburse each non-employee member of our Board for out-of-pocket expenses incurred in connection with attending Board and committee
meetings. Non-employee directors do not participate in any nonqualified deferred compensation plan and we do not pay any life insurance
policies for the directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name
    <SUP>(1)</SUP></B></FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Fees Earned or<BR> Paid in Cash <BR>
    ($)</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Awards
                                            <SUP>(2)<BR> </SUP>($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Total <BR> ($)</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 46%; text-align: left">Jason Barr</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">17,500</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">163,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">180,500</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Louis Gleckel, MD</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">26,250</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">163,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">189,250</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Warren Hirsch</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">26,250</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">163,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">189,250</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    employee directors do not receive director fees. Accordingly, Mr. Ted Karkus is not entitled to, and did not receive, any compensation
    for his service on the Board in 2024.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    each of the non-employee directors, this amount relates to a stock option to purchase 70,000 shares of the Company&rsquo;s common
    stock granted to each of the non-employee directors on March 17, 2024 for the 2024 Director Period. The amounts reported represent
    the aggregate grant date fair value of the option awards granted to the non-employee directors in March 2024, determined in accordance
    with FASB ASC Topic 718. For a discussion of the assumptions and methodologies used to value the option award granted, see Note 7
    &ldquo;Stockholders&rsquo; Equity&rdquo; to the financial statements included in our 2024 Annual Report.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2024, Dr. Gleckel held options to purchase an aggregate of 350,000 shares of common stock and Mr. Hirsch held options
to purchase an aggregate of 250,000 shares of common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="sl_008"></A>EQUITY
COMPENSATION PLAN INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below sets forth information with respect to shares of common stock that may be issued under our equity compensation plans issued
as of December 31, 2024:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Plan Category</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number of Securities<BR> to be Issued
    Upon<BR> Exercise of<BR> Outstanding<BR> Options, Warrants<BR> and Rights</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Weighted-Average<BR> Exercise Price
    of<BR> Outstanding<BR> Options, Warrants<BR> and Rights</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number of Securities<BR> Remaining
    Available<BR> for Future Issuance<BR> Under Equity<BR> Compensation Plans<BR> (Excluding<BR> Securities Reflected<BR> in Column (a))</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">(a)</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">(b)</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">(c)</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 46%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity compensation
    plans approved by security holders<SUP>(1)(2)(3)</SUP></FONT></TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">3,330,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">6.74</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">705,785</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
    compensation plans not approved by security holders<SUP>(4)</SUP></FONT></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">550,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">6.02</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Total</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2024, there were 2,286,124 shares of our common stock issuable pursuant to stock options outstanding under the 2022
    Plan. At December 31, 2024, there were 1,093,285 shares of common stock that were available for issuance pursuant to the 2022 Plan.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2024, there were 665,126 shares of our common stock issuable pursuant to stock options outstanding under the 2022 Directors&rsquo;
    Plan. At December 31, 2024, there were 210,000 shares of common stock that were available for issuance pursuant to the 2022 Directors
    Plan.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2024, no stock options were outstanding under the 2018 Stock Incentive Plan. At December 31, 2024, there were no shares
    of common stock that were available for issuance pursuant to the 2018 Stock Incentive Plan.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    the number of shares of our common stock underlying stock option awards granted as inducements material to employees entering into
    employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4) and outstanding as of December 31, 2024.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="sl_009"></A>SECURITY
OWNERSHIP</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information regarding ownership of our common stock as of April 29, 2025 by (a) each person known to the Company
to own more than 5% of the outstanding shares of our common stock, (b) each director and nominee for director of the Company, (c) the
named executive officers for the last completed fiscal year of December 31, 2024 and (d) all directors, nominees, and current executive
officers as a group as of April 29, 2025. Unless otherwise indicated, the address of each person or entity listed below is the Company&rsquo;s
principal executive office.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid">Name of Beneficial Owners</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stock<BR> Beneficially<BR> Owned<SUP>(1)</SUP></FONT></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Percent
    of Class (%)<SUP>(2)</SUP></FONT></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Officers and Directors</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ted Karkus<SUP>(3)</SUP></FONT></TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">3,215,329</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">7.6</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Jed Latkin</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Louis Gleckel, MD<SUP>(4)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">436,340</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.0</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warren Hirsch<SUP>(5)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">232,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All Current Directors and
    Executive Officers (4 persons)<SUP>(6)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,109,169</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9.6</TD><TD STYLE="text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
Less than 1%</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
    ownership has been determined in accordance with Rule 13d-3 (&ldquo;Rule 13d-3&rdquo;) under the Exchange Act, and unless otherwise
    indicated, represents shares for which the beneficial owner has sole voting and investment power.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    percentage of class is calculated in accordance with Rule 13d-3 based on 41,879,017 shares outstanding on April 29, 2025. Shares
    of common stock that a person has the right to acquire within 60 calendar days of April 29, 2025 are deemed outstanding for purposes
    of computing the percentage ownership of the person holding such rights, but are not deemed outstanding for purposes of computing
    the percentage ownership of any other person, except with respect to the percentage ownership of all executive officers and directors
    as a group.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    138,600 shares held by Mr. Karkus&rsquo; son who resides with him and for which Mr. Karkus may be deemed the beneficial owner. Does
    not include the Unvested Warrants. <I>See</I> Related Party Transactions.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    options to purchase 332,5000 shares that are vested or will vest within 60 days of April 29, 2025.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    options to purchase 232,500 shares that are vested or will vest within 60 days of April 29, 2025.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    options to purchase 990,000 shares that are vested or will vest within 60 days of April 29, 2025.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Comparison
Chart: 2022 Plans vs. Proposed 2025 Plans</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Feature</B></FONT></TD>
    <TD STYLE="text-align: left; padding-bottom: 1pt; width: 2%; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2022
    Equity Plan</B></FONT></TD>
    <TD STYLE="text-align: left; padding-bottom: 1pt; width: 2%; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2025
    Equity Plan (Proposal 1)</B></FONT></TD>
    <TD STYLE="text-align: left; padding-bottom: 1pt; width: 2%; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2022
    Directors&rsquo; Plan</B></FONT></TD>
    <TD STYLE="text-align: left; padding-bottom: 1pt; width: 2%; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: left; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2025
    Directors&rsquo; Plan (Proposal 2)</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
    Reserve</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,750
    shares</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">+3,000,000
    shares</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000
    shares</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">+500,000
    shares</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;Term</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    years</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    years</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    years</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
    years</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eligible
    Participants</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employees,
    consultants</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Same</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-employee
    directors</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Same</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholder
    Approval</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approved
    2022</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seeking
    approval 2025</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approved
    2022</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seeking
    approval 2025</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plan
    Status</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Active</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Will
    supersede 2022 Equity Plan</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Active</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Will
    supersede 2022 Directors&rsquo; Equity Plan</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="sl_002"></A>PROPOSAL
1 &ndash; APPROVAL OF THE AMENDED AND RESTATED 2025 EQUITY COMPENSATION PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">On June 16, 2023, Company
shareholders approved the Amended and Restated 2022 Equity Compensation Plan (the &ldquo;Amended and Restated 2022 Plan&rdquo;). As of
July 25, 2025, there remained 33,750 shares available for future issuance under the Amended and Restated 2022 Plan, which our Board has
determined to be insufficient for the Company&rsquo;s growth. The Amended and Restated 2022 Plan is attached hereto as Exhibit 2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The Board recommends that
shareholders replace the Amended and Restated 2022 Plan by adopting the 2025 Equity Compensation Plan (&ldquo;2025 Plan&rdquo;) which
will increase the number of shares reserved for issuance under the Company&rsquo;s employee equity compensation plan by 3,000,000 shares.
The 2025 Plan is attached as Exhibit 3 to this Proxy Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
grants under the 2025 Plan will be within the discretion of the Compensation Committee at various future dates,
it is not possible as of the date of this Proxy Statement to accurately determine future benefits that will be received by our executive
officers and other plan participants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
setting the amount of shares proposed to be added to the 2025 Plan, our Compensation Committee and the Board considered the total amount
of awards outstanding under existing grants and available for new awards, as well as anticipated stock award grants over the next year.
Our Compensation Committee believes that 3,000,000 additional shares is appropriate at this time to allow us to grant awards over at
least the next year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company believes that it has a strong business model and that it will continue to achieve improved financial operations and results in
future years. In order to achieve this future success, the Company will need to attract, retain and motivate key personnel and potential
hires. The Board believes that equity-based compensation will continue to be essential to permit the Company to successfully continue
the pursuit of these objectives. Accordingly, the Board is proposing the 2025 Plan to permit the continued issuance by the Company
of equity-based compensation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">The 2025 Plan as proposed is otherwise unchanged from the Amended and Restated
2022 Plan as approved by the stockholders, except for the increase in the total authorized shares thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
principal features of the 2025 Plan include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>No
    Discount Stock Options</I>: The 2025 Plan prohibits the grant of a stock option with an exercise price less
    than the fair market value of the Company&rsquo;s stock on the date of grant.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>No
    Repricing of Stock Options</I>: The 2025 Plan prohibits the repricing of stock options without stockholder approval.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Independent
    Committee Administration</I>: The 2025 Plan will be administered by the Compensation Committee of the Board,
    whose members satisfy the independence requirements of Rule 10A-3(b)(1) of the Exchange Act, and are &ldquo;non-employee directors&rdquo;
    as defined in Rule 16b-3 of the Exchange Act, and &ldquo;independent directors&rdquo; as required by Nasdaq.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>No
    Evergreen Feature</I>: The 2025 Plan does not contain an &ldquo;evergreen&rdquo; provision that automatically
    increases the number of shares authorized for issuance under the 2025 Plan.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>No
    Transfer for Value</I>: Participants are not permitted to transfer awards for value under the 2025 Plan.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Material
    Amendments to the Plan Require Stockholder Approval</I>: The 2025 Plan provides that a material amendment to
    the 2025 Plan will not be effective unless approved by the Company&rsquo;s stockholders.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 49.7pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
description of the 2025 Plan is included below. It is not a complete statement of the 2025 Plan. The full text of the 2025 Plan,
which has been marked to show changes from the existing Amended and Restated 2022 Plan, is attached as Exhibit 3 to this
Proxy Statement. The 2025 Plan will become effective on September 1, 2025, pending stockholder approval of this
Proposal 1 at the Special Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Purpose</I>.
The purpose of the 2025 Plan is to aid us and our affiliates in recruiting and retaining key employees of outstanding
ability and to motivate those employees to exert their best efforts on our behalf and the behalf of our affiliates by providing incentives
through the granting of options, restricted stock awards, restricted stock units (&ldquo;RSUs&rdquo;), and stock-based compensation,
to relate employees&rsquo; compensation more closely to the Company&rsquo;s performance and its stockholders&rsquo; interests, and to
increase employees&rsquo; stock ownership in the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Eligibility</I>.
All of the Company&rsquo;s employees, including employees who are officers, and our directors are eligible to participate in the 2025 Plan. Consultants and advisors who perform services for the Company are also eligible to participate in the 2025 Plan. As of July 25, 2025, the Company had three non-employee directors and 20 employees (including those at the subsidiary
level), which include two executive officers, who were eligible to participate in the 2022 Amended and Restated Plan. In addition, the
Company routinely utilizes varying levels of consultants and advisors to conduct its normal business operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Shares
Subject to the Plan</I>. The 2022 Amended and Restated Plan currently authorizes the issuance of 1,975,785 shares (subject to the counting,
adjustment and substitution provisions of the predecessor plan). Shares that are subject to awards under the 2022 Amended and
Restated Plan which terminate, expire, forfeit or lapse without the payment of consideration (or awards settled in cash in lieu of shares)
may be granted again under the 2025 Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">If the 2025 Plan is approved by our stockholders, the number of shares
authorized for issuance will be (i) 3,000,000, plus (ii) the number of shares available under the 2022 Amended and Restated Plan immediately
prior to stockholder approval of the 2025 Plan (as of July 25, 2025, 33,750 shares were available under the 2022 Amended and Restated
Plan, subject to the counting, adjustment and substitution provisions of the Plan), plus (iii) that number of shares that are represented
by awards which previously have been granted and are outstanding under the 2022 Amended and Restated Plan (including those granted under
the predecessor Equity Compensation Plans) on the date the 2025 Plan is approved by stockholders of the Company and which subsequently
expire or otherwise lapse, are terminated or forfeited, are settled in cash, or exchanged with the Administrator&rsquo;s permission, prior
to the issuance of shares, for awards not involving shares of common stock, without the issuance of the underlying shares, all of which
may be issued as ISOs to the extent approved or by prior stockholder approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Administration</I>.
The 2025 Plan will be administered by the &ldquo;Committee,&rdquo; which is the Compensation Committee or such other
committee of our Board to which the Board has delegated power. The Committee is authorized to interpret the 2025
Plan to establish, amend and rescind any rules and policies relating to the 2025 Plan and to make any other determinations
that it deems necessary or advisable for the administration of the 2025 Plan. The Committee may correct any defect
or supply any omission or reconcile any inconsistency in the 2025 Plan in the manner and to the extent the Committee
deems necessary or advisable. The Committee will have the full power and authority to establish the terms and conditions of any award
consistent with the provisions of the 2025 Plan and, except with respect to the provisions prohibiting repricing
of any award granted under the 2025 Plan, to waive any such terms and conditions at any time (including, without
limitation, accelerating or waiving any vesting conditions). Determinations made by the Committee need not be uniform and may be made
selectively among participants in the 2025 Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Performance-Based
Awards and Metrics<B>.</B></I> Under the 2025 Plan, the Compensation Committee may grant performance-based equity
awards that are earned or vest upon the achievement of specified performance goals. These performance goals may be based on <B>company-wide</B>
financial or strategic objectives, <B>individual performance criteria</B>, or a combination of both.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
performance metrics may include, but are not limited to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
                                            growth</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EBITDA
                                            or adjusted EBITDA</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
                                            income</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnings
                                            per share (EPS)</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
                                            shareholder return (TSR)</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Return
                                            on equity (ROE)</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Strategic
                                            initiatives, such as product development milestones, operational efficiency goals, or M&amp;A
                                            integration success</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Individual
performance metrics may include, but are not limited to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Achievement
                                            of role-specific objectives</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Individual,
                                            leadership, and team development</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Execution
                                            of strategic initiatives</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cross-functional
                                            collaboration</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operational
                                            or departmental efficiency improvements</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Performance
goals may be set on an absolute or relative basis and are determined by the Compensation Committee at the time of grant. The Committee
may exercise discretion to adjust or modify goals to reflect extraordinary events or changed circumstances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Limitations</I>.
No award may be granted under the 2025 Plan after the tenth anniversary of the effective date (as defined therein),
but awards theretofore granted may extend beyond that date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Options</I>.
The Committee may grant non-qualified stock options and incentive stock options, which will be subject to the terms and conditions as
set forth in the 2025 Plan, the related option agreement and any other terms, not inconsistent therewith, as determined
by the Committee; provided that all stock options granted under the 2025 Plan are required to have a per share exercise
price that is not less than 100% of the fair market value of our common stock underlying such stock options on the date an option is
granted (other than in the case of options granted in substitution of previously granted options), and all stock options that are intended
to qualify as incentive stock options will be subject to the terms and conditions that comply with the rules as may be prescribed by
Section 422 of the Internal Revenue Code of 1986, as amended (the &ldquo;Code&rdquo;). The maximum term for stock options granted under
the 2025 Plan will be seven years from the initial date of grant. The purchase price for the shares as to which
a stock option is exercised will be paid to us, to the extent permitted by law (i) in cash or its equivalent at the time the stock option
is exercised, (ii) in shares having a fair market value equal to the aggregate exercise price for the shares being purchased and satisfying
any requirements that may be imposed by the Committee, so long as the shares have been held for no less than six months (or such other
period established by the Committee in order to avoid adverse accounting treatment), (iii) partly in cash and partly in shares (as described
above), (iv) if there is a public market for the shares at such time, through the delivery of irrevocable instructions to a broker to
sell the shares being acquired upon the exercise of the stock option and to deliver to us the amount of the proceeds of such sale equal
to the aggregate exercise price for the shares being purchased, or (v) to the extent the Committee provides in the option agreement or
otherwise, through net settlement in shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Restricted
Stock</I>. Restricted stock awards may be granted under the 2025 Plan. Restricted stock awards are grants of shares that vest in accordance
with terms and conditions established by the Committee. The Committee will determine the number of restricted stock granted to any employee,
director or consultant and, subject to the provisions of the 2025 Plan, will determine the terms and conditions of such awards.
The Committee may impose whatever conditions to vesting it determines to be appropriate (for example, the Committee may set restrictions
based on the achievement of specific performance goals or continued service to us); provided, however, that the Committee, in its sole
discretion, may accelerate the time at which any restrictions will lapse or be removed. Recipients of restricted stock awards generally
will have voting and dividend rights with respect to such shares upon grant without regard to vesting, unless the Committee provides
otherwise. Shares of restricted stock that do not vest are subject to the Company&rsquo;s right of repurchase or forfeiture.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Restricted
Stock Units</I>. Awards of RSUs may be granted under the 2025 Plan. A RSU is the right to receive shares at a future
date. The Committee determines the terms and conditions of RSUs, including the vesting criteria (which may include accomplishing specified
performance criteria or continued service to us) and the form and timing of payment. Notwithstanding the foregoing, the Committee, in
its sole discretion, may accelerate the time at which RSUs will vest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Other
Stock-Based Awards</I>. In addition to stock options, restricted stock and RSUs, the Committee may grant or sell awards of shares, including
performance-based awards. Prior to the payment of any performance-based award, the Committee, or its delegate, will certify that the
applicable performance goals have been met. In connection with such certification, the Committee, or its delegate, may decide to pay
amounts, which are less than the award otherwise payable for achievement of the applicable performance goals; provided that the Committee
has the authority to waive any applicable performance goal. In the event the applicable performance goals are not waived by the Committee,
payment of an award to a participant will occur only after certification and will be made as determined by our Committee in its sole
discretion after the end of the applicable performance period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Clawback.</I>
Awards under the 2025 Plan are subject to the Company&rsquo;s clawback policy as may be in effect from time to time,
including any policy adopted pursuant to Rule 10D-1 under the Securities Exchange Act of 1934 and applicable listing standards of The
Nasdaq Stock Market. In addition, the Compensation Committee retains the discretion to impose additional clawback, forfeiture, or repayment
provisions in individual award agreements, including in the event of a participant&rsquo;s misconduct or a restatement of the Company&rsquo;s
financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Effect
of Certain Events on the 2025 Plan</I>. In the event of any change in the outstanding shares of our common stock
by reason of any stock dividend or split, reorganization, recapitalization, merger, consolidation, spin-off, combination or exchange
of shares or other corporate exchange or change in capital structure, any distribution or special dividend to stockholders of shares,
cash or other property (other than regular cash dividends) or any similar event, the Committee without liability to any person will make
such substitution or adjustment, if any, as it deems to be equitable, as to the number or kind of shares or other securities issued or
reserved for issuance as set forth in the 2025 Plan or pursuant to outstanding awards and the per share exercise
price thereof, as applicable; provided that the Committee determines in its sole discretion the manner in which such substitution or
adjustment will be made. Except as otherwise provided in an award agreement or otherwise determined by the Committee, in the event of
a Change of Control (as defined below) or similar corporate transaction (whether or not involving a permitted holder), with respect to
any outstanding award then held by participants which are unexercisable or otherwise unvested or subject to lapse restrictions, the Committee
will accelerate, vest, or cause the restrictions to lapse with all or any portion of an award, and may (i) cancel award for fair value
(as determined in the sole discretion of the Committee), which, in the case of stock options, may equal the excess, if any, of the value
of the consideration to be paid in the Change of Control transaction to holders of the same number of shares subject to such stock options
over the aggregate exercise price of such stock options, (ii) provide for the issuance of substitute awards, or (iii) provide that the
stock options will be exercisable for all shares subject thereto for a period of at least 10 days prior to the Change of Control and
that upon the occurrence of the Change of Control, the stock options will terminate and be of no further force or effect. For the avoidance
of doubt, the Committee may cancel stock options for no consideration if the fair market value of the shares subject to such options
is less than or equal to the aggregate exercise price of such stock options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of the 2025 Plan, a Change of Control means the occurrence of any one of the following events:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
A change in the ownership of the Company that occurs on the date that any one person, or more than one person acting as a group (for
purposes of SEC Rule 13d) (&ldquo;Person&rdquo;), acquires ownership of the shares that, together with the shares held by such Person,
constitutes more than 50% of the total voting power of the shares of the Company. No Change of Control will have occurred in the event
Ted Karkus (the &ldquo;Executive&rdquo;) or a group which includes Executive acquires more than 50% of the voting control of the Company.
The acquisition of additional shares by any one Person, who is considered to own more than 50% of the total voting power of the shares
of the Company will not be considered an additional Change of Control; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
A change in the effective control of the Company that occurs on the date that a majority of members of the Board is replaced during any
12 month period by directors whose appointment or election is not endorsed by one of either the Executive or a majority of the members
of the Board prior to the date of the appointment or election; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
A change in the ownership of a &ldquo;substantial portion of the Company&rsquo;s assets&rdquo;, as defined herein. For this purpose,
a &ldquo;substantial portion of the Company&rsquo;s assets&rdquo; will mean assets of the Company having a total gross fair market value
equal to or more than 50% of the total gross fair market value of all of the assets of the Company immediately prior to such change in
ownership. For purposes of this subsection (iii), a change in ownership of a substantial portion of the Company&rsquo;s assets occurs
on the date that any Person acquires (or has acquired during the 12 month period ending on the date of the most recent acquisition by
such Person or Persons) assets from the Company that constitute a &ldquo;substantial portion of the Company&rsquo;s assets.&rdquo; For
purposes of this subsection (iii), the following will not constitute a change in the ownership of a substantial portion of the Company&rsquo;s
assets: (a) a transfer to an entity that is controlled by the Company&rsquo;s stockholders immediately after the transfer, or (b) a transfer
of assets by the Company to: (1) a stockholder of the Company (immediately before the asset transfer) in exchange for or with respect
to the Company&rsquo;s stock, (2) an entity, 50% or more of the total value or voting power of which is owned, directly or indirectly,
by the Company, (3) a Person, that owns, directly or indirectly, 50% or more of the total value or voting power of all the outstanding
stock of the Company, or (4) an entity, at least 50% of the total value or voting power of which is owned, directly or indirectly, by
a Person described in this subsection (iii). For purposes of this subsection (iii), gross fair market value means the value of the assets
of the Company, or the value of the assets being disposed of, determined without regard to any liabilities associated with such assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this definition, Persons will be considered to be acting as a group if they are owners of a corporation that enters into
a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, a transaction will not be deemed a Change of Control unless the transaction qualifies as a change of control event within
the meaning of Section 409A of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Nontransferability
of Awards</I>. Unless otherwise determined by the Committee, an award will not be transferable or assignable by a participant otherwise
than by will or by the laws of descent and distribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Federal
Income Tax Consequences</I>. The current United States federal income tax treatment of awards under the 2025 Plan is generally described
below. This description of tax consequences is not a complete description. There may be different income tax consequences under certain
circumstances, and there may be gift and estate tax consequences. Local, state and other taxing authorities may also tax grants under
the 2025 Plan. Tax laws are subject to change. Each award holder should consult with his or her personal tax advisor concerning
the application of the general principles discussed below to his or her own situation and the application of other tax laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Nonqualified
Stock Options.&nbsp;</I>There generally are no federal income tax consequences upon the grant of a nonqualified stock option. Upon the
exercise of a nonqualified stock option, the recipient recognizes ordinary income in an amount equal to the difference between the fair
market value of the underlying stock on the date of exercise and the exercise price. Any gain or loss realized on disposition of shares
purchased upon exercise of a nonstatutory stock option is treated as a capital gain or loss for federal income tax purposes. The capital
gain tax rate will depend on the length of time the participant holds the shares and other factors. The Company generally is entitled
to a corresponding federal income tax deduction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a participant surrenders shares underlying a nonqualified stock option to pay the exercise price, such person recognizes no gain or loss
on the surrendered shares, and his or her basis and holding period for the surrendered shares continues to apply to that number of new
shares equal to the surrendered shares. To the extent that the number of shares received upon the exercise of the option exceeds the
number surrendered, the fair market value of the excess shares on the date of exercise, reduced by any cash paid by the participant upon
exercise, is includible in gross income. The basis in the excess shares equals the sum of the cash paid upon the exercise of the stock
option plus any amount included in the exercising person&rsquo;s gross income as a result of the exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Incentive
Stock Options.&nbsp;</I>There generally are no federal income tax consequences upon the grant of an incentive stock option. A recipient
does not recognize income for purposes of the regular federal income tax upon the exercise of an incentive stock option. However, for
purposes of the alternative minimum tax, in the year in which an incentive stock option is exercised, the amount by which the fair market
value of the shares acquired upon exercise exceeds the exercise price is included in alternative minimum taxable income.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
is recognized upon the sale of stock acquired upon exercise of an incentive stock option. If the shares acquired upon exercise of an
incentive stock option are disposed after two years from the date the option was granted and after one year from the date the shares
were transferred upon the exercise of the option, the person recognizes long-term capital gain or loss in the amount of the difference
between the amount realized on the sale and the exercise price. The Company is not entitled to any corresponding tax deduction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a participant disposes of shares acquired upon exercise of an incentive stock option before satisfying both holding period requirements
(a disqualifying disposition), the gain recognized on the disposition is taxed as ordinary income to the extent of the difference between
the fair market value of the shares on the date of exercise (or the amount realized on the disposition, if less) and the exercise price,
and, generally, the Company is entitled to a deduction in that amount. The gain, if any, in excess of the amount recognized as ordinary
income is long-term or short-term capital gain, depending upon the length of time the participant held the shares before the disposition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a participant surrenders shares received upon the exercise of a prior incentive stock option to pay the exercise price of any option
within either the two-year or one-year holding periods described above, the disqualifying disposition of the shares used to pay the exercise
price results in income (or loss) to the participant and, to the extent of recognized income, a tax deduction for the Company. If a participant
surrenders the shares after the holding period requirements are met, or if a participant surrenders shares that were not received upon
the exercise of an incentive stock option, the participant recognizes no gain or loss on the surrendered shares, and the basis and the
holding period for the surrendered shares continues to apply to that number of new shares that is equal to the surrendered shares. The
holding period for purposes of determining whether a participant has a disqualifying disposition for the new shares when the participant
sells the shares begins on the date the shares were exercised. To the extent that the number of shares received exceeds the number of
shares surrendered, the basis in the excess shares equals the amount of cash, if any, paid for such excess shares and the holding period
with respect to the excess shares begins on the date the shares were exercised.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Restricted
Stock.</I>&nbsp;A participant will not recognize income at the time a restricted stock award is granted. When the restrictions lapse
with regard to any installment of restricted stock, the participant will recognize ordinary income in an amount equal to the fair market
value of the shares with respect to which the restrictions lapse, unless the participant elected to realize ordinary income in the year
the award is granted in an amount equal to the fair market value of the restricted stock awarded, determined without regard to the restrictions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>RSUs</I>.
A participant will not recognize income at the time RSUs are granted. The participant will recognize ordinary income at the time the
RSUs vest, in an amount equal to the fair market value of the shares delivered. The amount of ordinary income recognized by the participant
is subject to payroll taxes. The Company is entitled to a deduction at the same time and in the same amount as the participant recognizes
ordinary income.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Tax
Withholding.&nbsp;</I>The Company has the right to deduct from all grants or other compensation payable to a participant any taxes required
to be withheld with respect to grants under the 2025 Plan. The Company may require that a participant pay to it the amount of
any required withholding. The Committee may permit a participant to satisfy the Company&rsquo;s tax withholding obligation with respect
to a grant by having shares withheld. However, the value of shares withheld may not exceed the minimum required tax withholding amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Method
of Valuation.</I> For purposes of determining the exercise price of stock options and the valuation of other equity awards under the
2025 Plan, the &ldquo;fair market value&rdquo; of the Company&rsquo;s common stock on a given date will generally be equal to
the closing sales price per share of the Company&rsquo;s common stock as reported on the Nasdaq Capital Market (or such other national
securities exchange on which the shares are then listed) on the date of grant. If the shares are not traded on such date, fair market
value will be determined based on the closing price on the last preceding trading date, or by such other reasonable method as determined
by the Compensation Committee in accordance with applicable law. For financial reporting purposes, the Company expects to determine the
grant-date fair value of awards in accordance with ASC Topic 718 using commonly accepted valuation methodologies, such as the Black-Scholes
option-pricing model for stock options. The valuation assumptions may include the stock price on the date of grant, expected stock price
volatility, expected term of the award, risk-free interest rate, and expected dividend yield, among other factors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Amendment
and Termination</I>. The Committee may amend, alter or discontinue the 2025 Plan, but no amendment, alteration or discontinuation
will be made which, (i) without the approval of our stockholders, would (except as provided in the 2025 Plan in connection with
adjustments in certain corporate events), increase the total number of shares reserved for the purposes of the 2025 Plan or change
the maximum number of shares of common stock for which awards may be granted to any participant, or (ii) without the consent of a participant,
would materially adversely impair any of the rights or obligations under any award theretofore granted to the participant under the 2025
Plan; provided, however, that the Committee may amend the 2025 Plan in such manner as it deems necessary to permit the granting
of award meeting the requirements of the Code or other applicable laws, including, without limitation, to avoid adverse tax consequences
to us or any participant. In no event may the Committee or any other entity reprice any option or substitute any outstanding option for
a new option with a lower exercise price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Nasdaq
Listing Rule 5635(c) Shareholder Approval Requirement.</I> Nasdaq Listing Rule 5635(c) requires shareholder approval of equity compensation
plans or material amendments thereto when such plans provide for the issuance of equity securities to the Company&rsquo;s officers, directors,
employees, or consultants. Because the proposed 2025 Plan would supersede the Company&rsquo;s existing equity compensation plan
and authorize the issuance of additional shares of common stock to eligible participants, and because the proposed amendment to the Company&rsquo;s
Amended and Restated 2022 Plan would materially increase the number of shares available for issuance thereunder, shareholder approval
of this proposal is required under Rule 5635(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amounts of future awards under the Amended and Restated 2025 Equity Compensation Plan are not determinable at this time, as awards under
the plan will be made at the discretion of the Committee. No awards have been approved or granted under the Amended and Restated 2025
Equity Compensation Plan that are contingent upon stockholder approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="sl_003"></A>Required
Vote</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval
of the 2025 Plan will require the affirmative vote of a majority of the votes cast on such proposal by the Shares present in person
or represented by proxy at the Special Meeting and entitled to vote thereon. A quorum must be present at the Special Meeting for a valid
vote.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="sl_004"></A>Recommendation
of the Board of Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
BOARD OF DIRECTORS OF THE COMPANY RECOMMENDS THAT STOCKHOLDERS VOTE FOR THE APPROVAL OF THE SECOND AMENDED AND RESTATED 2022 PLAN.
PROXIES SOLICITED BY THE BOARD WILL BE VOTED &ldquo;FOR&rdquo; THE APPROVAL OF THE AMENDED AND RESTATED 2025 PLAN UNLESS
STOCKHOLDERS SPECIFY A CONTRARY VOTE.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
Appraisal or Dissenters&rsquo; Rights</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Delaware law and our Certificate of Incorporation and Bylaws, stockholders are not entitled to appraisal or dissenters&rsquo; rights
with respect to the approval of the 2025 Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="sl_010"></A>PROPOSAL
2 -APPROVAL OF 2025 DIRECTORS&rsquo; EQUITY COMPENSATION PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 15pt">On June 16, 2023,
Company shareholders approved the Amended and Restated 2022 Directors&rsquo; Equity Compensation Plan (the &ldquo;Amended and Restated
2022 Directors&rsquo; Plan&rdquo;). As of July 25, 2025, there were 100,000 shares available for future issuance under the Amended and
Restated 2022 Directors&rsquo; Plan, which our Board has determined to be insufficient for the Company&rsquo;s growth. The Amended and
Restated 2022 Directors&rsquo; Plan is attached hereto as Exhibit 4.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">The Board recommends
that shareholders approve the adoption of the new 2025 Directors&rsquo; Equity Compensation Plan (&ldquo;2025 Directors&rsquo; Plan&rdquo;)
which will increase the number of shares reserved for issuance under the Company&rsquo;s director equity compensation plan by 500,000
shares. The 2025 Directors&rsquo; Plan is attached as Exhibit 5 to this Proxy Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Interests
of Directors.</I> Our non-employee directors have a direct interest in this proposal because they are eligible to receive awards under
the 2025 Directors&rsquo; Plan. The Board was aware of these interests when it approved the 2025 Directors&rsquo; Plan and recommended that stockholders vote in favor of this proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
setting the amount of shares proposed to be added to the Amended and Restated 2022 Directors&rsquo; Plan, our Compensation Committee
and the Board considered the total amount of awards outstanding under existing grants and available for new awards, as well as
anticipated stock award grants to directors in future years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The 2025 Directors&rsquo; Plan as proposed is otherwise unchanged from the Amended and Restated 2022 Directors&rsquo;
Plan as approved by the stockholders, except for the increase in the total authorized shares thereunder and a provision providing for
the adjustment of the per share exercise price of stock options granted under the Amended and Restated 2025 Directors&rsquo; Plan in
the event of any change in the outstanding shares of common stock of the Company as a result of, among other things, any distribution
or special dividend to stockholders of shares, cash or other property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
principal features of the Amended and Restated 2025 Directors&rsquo; Plan include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 49.7pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>No
    Discount Stock Options</I>: The Amended and Restated 2025 Directors&rsquo; Plan prohibits the grant of a stock option with an exercise
    price less than the fair market value of the Company&rsquo;s stock on the date of grant.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>No
    Repricing of Stock Options</I>: The Amended and Restated 2025 Directors&rsquo; Plan prohibits the repricing of stock options without
    stockholder approval.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Independent
    Committee Administration</I>: The Amended and Restated 2025 Directors&rsquo; Plan will be administered by the Compensation Committee
    of the Board, whose members satisfy the independence requirements of Rule 10A-3(b)(1) of the Exchange Act, and are &ldquo;outside
    directors&rdquo; as defined under Section 162(m) of the Code, &ldquo;non-employee directors&rdquo; as defined in Rule 16b-3 of the
    Exchange Act, and &ldquo;independent directors&rdquo; as required by Nasdaq.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>No
    Evergreen Feature</I>: The Amended and Restated 2025 Directors&rsquo; Plan does not contain an &ldquo;evergreen&rdquo; provision
    that automatically increases the number of shares authorized for issuance under the Amended and Restated 2025 Directors&rsquo; Plan.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>No
    Transfer for Value</I>: Participants are not permitted to transfer awards for value under the Amended and Restated 2025 Directors&rsquo;
    Plan.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Material
    Amendments to the Plan Require Stockholder Approval</I>: The Amended and Restated 2025 Directors&rsquo; Plan provides that a material
    amendment to the Amended and Restated 2025 Directors&rsquo; Plan will not be effective unless approved by the Company&rsquo;s stockholders.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 49.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
description of the Amended and Restated 2025 Directors&rsquo; Plan is included below. It is not a complete statement of the Amended
and Restated 2025 Directors&rsquo; Plan. The full text of the Amended and Restated 2025 Directors&rsquo; Plan, which has been marked
to show changes to the existing 2025 Directors&rsquo; Plan, is attached as Appendix B to this Proxy Statement. The Amended and
Restated 2022 Directors&rsquo; Plan will become effective immediately upon stockholder approval of this Proposal 2 at the
Special Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Purpose</I>.
The purpose of the Second Amended and Restated 2022 Directors&rsquo; Plan is to attract and retain highly qualified individuals to
serve on the Board, to relate Directors&rsquo; compensation more closely to the Company&rsquo;s performance and its
stockholders&rsquo; interests, and to increase Directors&rsquo; stock ownership in the Company. A primary purpose of the plan is to
provide the Company with the ability to pay all or a portion of the fees of Directors in restricted stock instead of cash, thereby
strengthening the cash flow position of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Eligibility</I>.
All of the Company&rsquo;s directors are eligible to participate in the Amended and Restated 2025 Directors&rsquo; Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amounts of future awards under the Amended and Restated 2025 Directors&rsquo; Equity Compensation Plan are not determinable at this time,
as awards under the plan will be made at the discretion of the Committee. No awards have been approved or granted under the Amended and
Restated 2025 Directors&rsquo; Equity Compensation Plan that are contingent upon stockholder approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Shares
Subject to the Plan</I>. The 2025 Directors&rsquo; Plan currently authorizes the issuance of (i) 300,000 shares. Shares that are subject
to awards under the 2025 Directors&rsquo; Plan which terminate, expire, forfeit or lapse without the payment of consideration (or awards
settled in cash in lieu of shares) may be granted again under the 2025 Directors&rsquo; Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Amended and Restated 2025 Directors&rsquo; Plan is approved by our stockholders, the number of shares authorized for issuance will
be (i) 500,000, plus (ii) the number of shares available under the Amended and Restated 2022 Directors&rsquo; Plan immediately prior
to stockholder approval of the Amended and Restated 2025 Directors&rsquo; Plan (as of July 25, 2025, 100,000 shares were available under
the 2022 Directors&rsquo; Plan, subject to the counting, adjustment and substitution provisions of the Plan), plus (iii) , that number
of shares that are represented by awards which previously have been granted and are outstanding under the Amended and Restated 2022 Directors&rsquo;
Plan (including those granted under the predecessor Equity Compensation Plans) on the date the Amended and Restated 2025 Directors&rsquo;
Plan is approved by stockholders of the Company and which subsequently expire or otherwise lapse, are terminated or forfeited, are settled
in cash, or exchanged with the Administrator&rsquo;s permission, prior to the issuance of shares, for awards not involving shares of
common stock, without the issuance of the underlying shares, all of which may be issued as ISOs to the extent approved or by prior stockholder
approval.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Administration</I>.
The Amended and Restated 2025 Directors&rsquo; Plan is administered by the &ldquo;Committee,&rdquo; which is the Compensation Committee
or such other committee of our Board to which the Board has delegated power. The Committee is authorized to interpret the Amended and
Restated 2025 Directors&rsquo; Plan to establish, amend and rescind any rules and policies relating to the Amended and Restated 2025
Directors&rsquo; Plan and to make any other determinations that it deems necessary or advisable for the administration of the Amended
and Restated 2025 Directors&rsquo; Plan. The Committee may correct any defect or supply any omission or reconcile any inconsistency in
the Amended and Restated 2025 Directors&rsquo; Plan in the manner and to the extent the Committee deems necessary or advisable. The Committee
will have the full power and authority to establish the terms and conditions of any award consistent with the provisions of the Amended
and Restated 2025 Directors&rsquo; Plan and, except with respect to the provisions prohibiting repricing of any award granted under the
Amended and Restated 2025 Directors&rsquo; Plan, to waive any such terms and conditions at any time (including, without limitation, accelerating
or waiving any vesting conditions). Determinations made by the Committee need not be uniform and may be made selectively among participants
in the Amended and Restated 2025 Directors&rsquo; Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Performance-Based
Awards and Metrics<B>.</B></I> Under the Amended and Restated 2025 Directors&rsquo; Plan, the Compensation Committee may grant performance-based
equity awards that are earned or vest upon the achievement of specified performance goals. These performance goals may be based on <B>company-wide</B>
financial or strategic objectives, <B>individual performance criteria</B>, or a combination of both.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
performance metrics may include, but are not limited to:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
                                            growth</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EBITDA
                                            or adjusted EBITDA</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
                                            income</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnings
                                            per share (EPS)</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
                                            shareholder return (TSR)</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Return
                                            on equity (ROE)</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Strategic
                                            initiatives, such as product development milestones, operational efficiency goals, or M&amp;A
                                            integration success</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Individual
performance metrics may include, but are not limited to:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Achievement
                                            of role-specific objectives</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Individual,
                                            leadership, and team development</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Execution
                                            of strategic initiatives</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cross-functional
                                            collaboration</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operational
                                            or departmental efficiency improvements</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Performance
goals may be set on an absolute or relative basis and are determined by the Compensation Committee at the time of grant. The Committee
may exercise discretion to adjust or modify goals to reflect extraordinary events or changed circumstances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Limitations</I>.
No award may be granted under the Amended and Restated 2025 Directors&rsquo; Plan after the tenth anniversary of the effective date (as
defined therein), but awards theretofore granted may extend beyond that date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Options</I>.
The Committee may grant non-qualified stock options, which will be subject to the terms and conditions as set forth in the Amended and
Restated 2025 Directors&rsquo; Plan, the related option agreement and any other terms, not inconsistent therewith, as determined by the
Committee; provided that all stock options granted under the Amended and Restated 2025 Directors&rsquo; Plan are required to have a per
share exercise price that is not less than 100% of the fair market value of our common stock underlying such stock options on the date
an option is granted (other than in the case of options granted in substitution of previously granted options). The maximum term for
stock options granted under the Amended and Restated 2025 Directors&rsquo; Plan will be seven years from the initial date of grant. The
purchase price for the shares as to which a stock option is exercised will be paid to us, to the extent permitted by law (i) in cash
or its equivalent at the time the stock option is exercised, (ii) in shares having a fair market value equal to the aggregate exercise
price for the shares being purchased and satisfying any requirements that may be imposed by the Committee, so long as the shares have
been held for no less than six months (or such other period established by the Committee in order to avoid adverse accounting treatment),
(iii) partly in cash and partly in shares (as described above), (iv) if there is a public market for the shares at such time, through
the delivery of irrevocable instructions to a broker to sell the shares being acquired upon the exercise of the stock option and to deliver
to us the amount of the proceeds of such sale equal to the aggregate exercise price for the shares being purchased, or (v) to the extent
the Committee has provided in the option agreement or otherwise, through net settlement in shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Restricted
Stock</I>. Restricted stock awards may be granted under the Amended and Restated 2025 Directors&rsquo; Plan. Restricted stock awards
are grants of shares that vest in accordance with terms and conditions established by the Committee. The Committee will determine the
number of restricted stock granted to a director and, subject to the provisions of the Amended and Restated 2025 Directors&rsquo; Plan,
will determine the terms and conditions of such awards. The Committee, in its sole discretion, may accelerate the time at which any restrictions
will lapse or be removed. Recipients of restricted stock awards generally will have voting and dividend rights with respect to such shares
upon grant without regard to vesting, unless the Committee provides otherwise. Shares of restricted stock that do not vest are subject
to the Company&rsquo;s right of repurchase or forfeiture.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Restricted
Stock Units</I>. Awards of RSUs may be granted under the Amended and Restated 2025 Directors&rsquo; Plan. An RSU is the right to receive
shares at a future date. The Committee determines the terms and conditions of RSUs, including the vesting criteria (which may include
accomplishing specified performance criteria or continued service to us) and the form and timing of payment. Notwithstanding the foregoing,
the Committee, in its sole discretion, may accelerate the time at which RSUs will vest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Other
Stock-Based Awards</I>. In addition to stock options, restricted stock and RSUs, the Committee may grant or sell awards of shares, including
performance-based awards. Prior to the payment of any performance-based award, the Committee, or its delegate, will certify that the
applicable performance goals have been met. In connection with such certification, the Committee, or its delegate, may decide to pay
amounts, which are less than the award otherwise payable for achievement of the applicable performance goals; provided that the Committee
will have the authority to waive any applicable performance goal. In the event the applicable performance goals are not waived by the
Committee, payment of an award to a participant will occur only after certification and will be made as determined by our Committee in
its sole discretion after the end of the applicable performance period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Clawback.</I>
Awards under the Amended and Restated 2025 Directors&rsquo; Plan are subject to the Company&rsquo;s clawback policy as may be in effect
from time to time, including any policy adopted pursuant to Rule 10D-1 under the Securities Exchange Act of 1934 and applicable listing
standards of The Nasdaq Stock Market. In addition, the Compensation Committee retains the discretion to impose additional clawback, forfeiture,
or repayment provisions in individual award agreements, including in the event of a participant&rsquo;s misconduct or a restatement of
the Company&rsquo;s financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Effect
of Certain Events on Amended and Restated 2025 Directors&rsquo; Plan</I>. In the event of any change in the outstanding shares of our
common stock by reason of any stock dividend or split, reorganization, recapitalization, merger, consolidation, spin-off, combination
or exchange of shares or other corporate exchange or change in capital structure, any distribution or special dividend to stockholders
of shares, cash or other property (other than regular cash dividends) or any similar event, the Committee without liability to any person
will make such substitution or adjustment, if any, as it deems to be equitable, as to the number or kind of shares or other securities
that may be issued as set forth in the Amended and Restated 2025 Directors&rsquo; Plan or pursuant to outstanding awards; provided that
the Committee will determine in its sole discretion the manner in which such substitution or adjustment will be made. Except as otherwise
provided in an award agreement or otherwise determined by the Committee, in the event of a Change of Control (as defined below) or similar
corporate transaction (whether or not involving a permitted holder), with respect to any outstanding award then held by participants
which are unexercisable or otherwise unvested or subject to lapse restrictions, the Committee will accelerate, vest, or cause the restrictions
to lapse with all or any portion of an award, and may (i) cancel award for fair value (as determined in the sole discretion of the Committee),
which, in the case of stock options, may equal the excess, if any, of the value of the consideration to be paid in the Change of Control
transaction to holders of the same number of shares subject to such stock options over the aggregate exercise price of such stock options,
(ii) provide for the issuance of substitute awards, or (iii) provide that the stock options will be exercisable for all shares subject
thereto for a period of at least 10 days prior to the Change of Control and that upon the occurrence of the Change of Control, the stock
options will terminate and be of no further force or effect. For the avoidance of doubt, the Committee may cancel stock options for no
consideration if the fair market value of the shares subject to such options is less than or equal to the aggregate exercise price of
such stock options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of the Amended and Restated 2025 Directors&rsquo; Plan, a Change of Control means the occurrence of any one of the following
events:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) A change in the ownership of the Company that occurs on the date that any one person, or more than one person acting as a group (for
purposes of SEC Rule 13d) (&ldquo;Person&rdquo;), acquires ownership of the shares that, together with the shares held by such Person,
constitutes more than 50% of the total voting power of the shares of the Company. No Change of Control will have occurred in the event
Ted Karkus (the &ldquo;Executive&rdquo;) or a group which includes Executive acquires more than 50% of the voting control of the Company.
The acquisition of additional shares by any one Person, who is considered to own more than 50% of the total voting power of the shares
of the Company will not be considered an additional Change of Control; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) A change in the effective control of the Company that occurs on the date that a majority of members of the Board is replaced during
any 12 month period by directors whose appointment or election is not endorsed by one of either the Executive or a majority of the members
of the Board prior to the date of the appointment or election; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
A change in the ownership of a &ldquo;substantial portion of the Company&rsquo;s assets&rdquo;, as defined herein. For this purpose,
a &ldquo;substantial portion of the Company&rsquo;s assets&rdquo; will mean assets of the Company having a total gross fair market value
equal to or more than 50% of the total gross fair market value of all of the assets of the Company immediately prior to such change in
ownership. For purposes of this subsection (iii), a change in ownership of a substantial portion of the Company&rsquo;s assets occurs
on the date that any Person acquires (or has acquired during the 12 month period ending on the date of the most recent acquisition by
such Person or Persons) assets from the Company that constitute a &ldquo;substantial portion of the Company&rsquo;s assets.&rdquo; For
purposes of this subsection (iii), the following will not constitute a change in the ownership of a substantial portion of the Company&rsquo;s
assets: (a) a transfer to an entity that is controlled by the Company&rsquo;s stockholders immediately after the transfer, or (b) a transfer
of assets by the Company to: (1) a stockholder of the Company (immediately before the asset transfer) in exchange for or with respect
to the Company&rsquo;s stock, (2) an entity, 50% or more of the total value or voting power of which is owned, directly or indirectly,
by the Company, (3) a Person, that owns, directly or indirectly, 50% or more of the total value or voting power of all the outstanding
stock of the Company, or (4) an entity, at least 50% of the total value or voting power of which is owned, directly or indirectly, by
a Person described in this subsection (iii). For purposes of this subsection (iii), gross fair market value means the value of the assets
of the Company, or the value of the assets being disposed of, determined without regard to any liabilities associated with such assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this definition, persons will be considered to be acting as a group if they are owners of a corporation that enters into
a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, a transaction will not be deemed a Change of Control unless the transaction qualifies as a change of control event within
the meaning of Section 409A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Nontransferability
of Awards</I>. Unless otherwise determined by the Committee, an award will not be transferable or assignable by a participant otherwise
than by will or by the laws of descent and distribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Federal
Income Tax Consequences</I>. The current United States federal income tax treatment of awards under the Amended and Restated 2025 Directors&rsquo;
Plan is generally described below. This description of tax consequences is not a complete description. There may be different income
tax consequences under certain circumstances, and there may be gift and estate tax consequences. Local, state and other taxing authorities
may also tax grants under the Amended and Restated 2025 Directors&rsquo; Plan. Tax laws are subject to change. Each award holder should
consult with his or her personal tax advisor concerning the application of the general principles discussed below to his or her own situation
and the application of other tax laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Nonqualified
Stock Options. </I>There generally are no federal income tax consequences upon the grant of a nonqualified stock option. Upon the exercise
of a nonqualified stock option, the recipient recognizes ordinary income in an amount equal to the difference between the fair market
value of the underlying stock on the date of exercise and the exercise price. Any gain or loss realized on disposition of shares purchased
upon exercise of a nonstatutory stock option is treated as a capital gain or loss for federal income tax purposes. The capital gain tax
rate will depend on the length of time the participant holds the shares and other factors. The Company generally is entitled to a corresponding
federal income tax deduction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a participant surrenders shares underlying a nonqualified stock option to pay the exercise price, such person recognizes no gain or loss
on the surrendered shares, and his or her basis and holding period for the surrendered shares continues to apply to that number of new
shares equal to the surrendered shares. To the extent that the number of shares received upon the exercise of the option exceeds the
number surrendered, the fair market value of the excess shares on the date of exercise, reduced by any cash paid by the participant upon
exercise, is includible in gross income. The basis in the excess shares equals the sum of the cash paid upon the exercise of the stock
option plus any amount included in the exercising person&rsquo;s gross income as a result of the exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Restricted
Stock.</I> A participant will not recognize income at the time a restricted stock award is granted. When the restrictions lapse with
regard to any installment of restricted stock, the participant will recognize ordinary income in an amount equal to the fair market value
of the shares with respect to which the restrictions lapse, unless the participant elected to realize ordinary income in the year the
award is granted in an amount equal to the fair market value of the restricted stock awarded, determined without regard to the restrictions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>RSUs</I>.
A participant will not recognize income at the time RSUs are granted. The participant will recognize ordinary income at the time the
RSUs vest, in an amount equal to the fair market value of the shares delivered. The amount of ordinary income recognized by the participant
is subject to payroll taxes. The Company is entitled to a deduction at the same time and in the same amount as the participant recognizes
ordinary income.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Tax
Withholding. </I>The Company has the right to deduct from all grants or other compensation payable to a participant any taxes required
to be withheld with respect to grants under the Amended and Restated 2025 Directors&rsquo; Plan. The Company may require that a participant
pay to it the amount of any required withholding. The Committee may permit a participant to satisfy the Company&rsquo;s tax withholding
obligation with respect to a grant by having shares withheld. However, the value of shares withheld may not exceed the minimum required
tax withholding amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Method
of Valuation.</I> For purposes of determining the exercise price of stock options and the valuation of other equity awards under the
Amended and Restated 2025 Directors&rsquo; Plan, the &ldquo;fair market value&rdquo; of the Company&rsquo;s common stock on a given date
will generally be equal to the closing sales price per share of the Company&rsquo;s common stock as reported on the Nasdaq Capital Market
(or such other national securities exchange on which the shares are then listed) on the date of grant. If the shares are not traded on
such date, fair market value will be determined based on the closing price on the last preceding trading date, or by such other reasonable
method as determined by the Compensation Committee in accordance with applicable law. For financial reporting purposes, the Company expects
to determine the grant-date fair value of awards in accordance with ASC Topic 718 using commonly accepted valuation methodologies, such
as the Black-Scholes option-pricing model for stock options. The valuation assumptions may include the stock price on the date of grant,
expected stock price volatility, expected term of the award, risk-free interest rate, and expected dividend yield, among other factors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Amendment
and Termination</I>. The Committee may amend, alter or discontinue the Amended and Restated 2025 Directors&rsquo; Plan, but no amendment,
alteration or discontinuation will be made which, (i) without the approval of our stockholders, would (except as provided in the Amended
and Restated 2025 Directors&rsquo; Plan in connection with adjustments in certain corporate events), increase the total number of shares
of our common stock reserved for the purposes of the Amended and Restated 2025 Directors&rsquo; Plan or change the maximum number of
shares for which awards may be granted to any participant, or (ii) without the consent of a participant, would materially adversely impair
any of the rights or obligations under any award theretofore granted to the participant under the Amended and Restated 2025 Directors&rsquo;
Plan; provided, however, that the Committee may amend the Amended and Restated 2025 Directors&rsquo; Plan in such manner as it deems
necessary to permit the granting of award meeting the requirements of the Code or other applicable laws, including, without limitation,
to avoid adverse tax consequences to us or any participant. In no event may the Committee or any other entity reprice any option or substitute
and outstanding option for a new option with a lower exercise price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Nasdaq
Listing Rule 5635(c) Shareholder Approval Requirement.</I> Nasdaq Listing Rule 5635(c) requires shareholder approval of equity compensation
plans or material amendments thereto when such plans provide for the issuance of equity securities to the Company&rsquo;s officers, directors,
employees, or consultants. Because the proposed Amended and Restated 2025 Directors&rsquo; Plan would supersede the Company&rsquo;s existing
equity compensation plan and authorize the issuance of additional shares of common stock to eligible participants, and because the proposed
amendment to the Company&rsquo;s Amended and Restated 2022 Equity Directors&rsquo; Plan would materially increase the number of shares
available for issuance thereunder, shareholder approval of this proposal is required under Rule 5635(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
Appraisal or Dissenters&rsquo; Rights</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Delaware law, stockholders are not entitled to appraisal or dissenters&rsquo; rights in connection with the approval of the Second
Amended and Restated 2022 Directors&rsquo; Equity Compensation Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
copy of the full text of the Second Amended and Restated 2022 Directors&rsquo; Equity Compensation Plan is attached as Appendix B to
this Proxy Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
this time, no specific grants under the Second Amended and Restated 2022 Directors&rsquo; Equity Compensation Plan have been made or
determined for the
current fiscal year or any future fiscal years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
future benefits or amounts that would be received under the Second Amended and Restated 2022 Directors&rsquo; Equity Compensation
Plan by executive officers, non-executive officer employees, and non-employee directors are discretionary and are therefore not
determinable at this time. The following table provides information with respect to benefits under the plan:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="sl_013"></A>Required
Vote</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval
of the Second Amended and Restated 2022 Directors&rsquo; Plan will require the affirmative vote of a majority of the votes cast on
such proposal by the Shares present in person or represented by proxy at the Special Meeting and entitled to vote thereon. A quorum
must be present at the Special Meeting for a valid vote.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="sl_014"></A>Recommendation
of the Board of Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
BOARD OF DIRECTORS OF THE COMPANY RECOMMENDS THAT STOCKHOLDERS VOTE FOR THE APPROVAL OF THE SECOND AMENDED AND RESTATED 2023
DIRECTORS&rsquo; PLAN. PROXIES SOLICITED BY THE BOARD WILL BE VOTED &ldquo;FOR&rdquo; THE APPROVAL OF THE AMENDED AND RESTATED 2025
DIRECTORS&rsquo; PLAN UNLESS STOCKHOLDERS SPECIFY A CONTRARY VOTE.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_009"></A>PROPOSAL
3 &ndash; AMEND THE CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Introduction</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company Certificate of Incorporation, as amended, currently authorizes the issuance of up to 50,000,000 shares of common stock. Proposal
3 would increase the number of authorized shares of common stock from 50,000,000 to 1,000,000,000 shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
proposed form of Certificate of Amendment to the Certificate of Incorporation to effect the increase in our authorized common stock is
attached as <U>Exhibit 4</U> to this Proxy Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the increase in authorized shares as contemplated in the Certificate of Amendment to the Certificate of Incorporation (the &ldquo;Certificate
of Amendment&rdquo;), 1,000,000,000 shares of common stock will be authorized. There will be no changes to the issued and outstanding
shares of common stock or preferred stock as a result of the amendment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Reasons
for the Increase in Authorized Shares of Common Stock in the Certificate of Amendment</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has determined that the increase in our authorized shares of Common Stock is in the best interests of the Company and unanimously
recommends approval by the stockholders. First, the Board has determined that it is in the best interest of the Company to explore
the adoption and execution of a crypto treasury strategy, positioning the Company as a pioneer in the intersection between life sciences
and financial innovation. An increase in the authorized shares of common stock will provide the Company with the necessary flexibility
in capital structure to effectively implement such a strategy. By increasing the authorized shares to 1 billion shares, it transforms
the structure of the Company to have the flexibility to attract and execute on the optimal crypto treasury strategy. The Company
is currently working with a team of expert crypto treasury advisors to execute on such a strategy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Formulation
and execution of an effective crypto treasury strategy will bolster Company efforts to diversify its treasury assets and leverage the
potential of blockchain-based digital currencies. The Company&rsquo;s crypto treasury strategy may include the acquisition and long-term
holding of select digital assets, including Bitcoin, giving Company investors regulated access to the rapidly evolving digital asset
landscape.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may also evaluate acquisitions, asset purchases, or business combinations involving digital-asset focused operating companies.
The increased availability of authorized shares of common stock will allow the Company to respond quickly to such opportunities through
equity consideration, joint ventures, or minority investments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">As previously
disclosed in the Company&rsquo;s Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;)
on July 28, 2025 (the &ldquo;8-K&rdquo;), the Company entered into a Securities Purchase Agreement (the &ldquo;Purchase Agreement&rdquo;)
dated July 22, 2025 with certain institutional investors, pursuant to which the Company agreed to seek stockholder approval to increase
its authorized shares of common stock to allow for the issuance of shares upon conversion or exercise of securities issued in the financing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">The full text
of the 8-K, including the Purchase Agreement and related transaction documents, is incorporated by reference into this proxy statement
and is available without charge on the SEC&rsquo;s website at https://www.sec.gov/Archives/edgar/data/868278/000164117225021109/0001641172-25-021109-index.html</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
proposed increase in authorized shares of common stock will also preserve headroom to support the Company&rsquo;s equity compensation
plans, satisfy equity reserve requirements under Nasdaq Listing Rule 5635(c), and ensure compliance with potential equity issuance requirements
associated with debt or warrant instruments issued in connection with any future financing transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board also believes that the availability of additional authorized shares of common stock is required for additional flexibility to issue
common stock for a variety of general corporate purposes as the Board may determine to be desirable including, without limitation, future
financings, investment opportunities, acquisitions, or other distributions and stock splits (including splits effected through the declaration
of stock dividends).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the Record Date 41,541,205 shares of our Common Stock were outstanding out of the 50,000,000 shares that we are authorized to issue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company issues additional shares of common stock or other securities convertible into shares of our common stock in the future, it
could dilute the voting rights of existing stockholders and could also dilute earnings per share and book value per share of existing
stockholders. The increase in authorized number of common stock could also discourage or hinder efforts by other parties to obtain control
of the Company, thereby having an anti-takeover effect. The increase in authorized number of common stock is not being proposed in response
to any known threat to acquire control of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company remains committed to prudent financial management while exploring innovative avenues to drive stockholder value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, pursuant to the terms of certain convertible notes and warrants issued by the Company, the Company is required to maintain
a sufficient number of authorized but unissued shares of common stock to satisfy potential conversion and exercise requirements of these
instruments. The proposed increase in authorized shares is necessary to comply with these obligations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
increase in the authorized common shares would also be necessary to allow for the issuance of shares of our common stock pursuant to
the offerings described below in Proposal 5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
CEO, Ted Karkus, and an additional investor, both will be issued warrants in connection with a loan they made to the Company, as previously
disclosed by the Company on <U>sec.gov</U>. The full text of the 8-K, including the Purchase Agreement and related transaction documents,
is incorporated by reference into this proxy statement and is available without charge on the SEC&rsquo;s website at https://www.sec.gov/Archives/edgar/data/868278/000164117225016815/0001641172-25-016815-index.html</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">In addition, Proposal 1 and
Proposal 2 herein are both contingent upon approval of Proposal 3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than as set forth herein, the Company has no current plans, proposals or arrangements, written or oral, to issue any of the additional
authorized shares of common stock that would become available as a result of the filing of the Certificate of Incorporation, as amended
and restated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, following the approval and filing of the amendment, the Company may explore additional financing opportunities or strategic
transactions that would require the issuance of additional shares of common stock, but no such plans are currently in existence and the
Company has not begun any negotiations with any party related thereto. If we issue additional shares, the ownership interest of holders
of our capital stock will be diluted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Effects
of the Increase in Authorized Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the filing of the Certificate of Amendment with the Secretary of State of the State of Delaware, we will have the authority to issue
up to an additional 950,000,000 shares of common stock. These shares may be issued without stockholder approval at any time, in the sole
discretion of the Board. The authorized and unissued shares may be issued for cash or for any other purpose that is deemed in the best
interests of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
increase in our authorized common stock could have a number of effects on the Company&rsquo;s stockholders depending upon the exact nature
and circumstances of any actual issuances of authorized but unissued shares. If we issue additional shares of common stock or other securities
convertible into shares of our common stock in the future, it could dilute the voting rights of existing stockholders and could also
dilute earnings per share and book value per share of existing stockholders. The increase in authorized number of common stock could
also discourage or hinder efforts by other parties to obtain control of the Company, thereby having an anti-takeover effect. The increase
in authorized number of common stock is not being proposed in response to any known threat to acquire control of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
increase in our authorized common stock will not change the number of shares of common stock issued and outstanding, nor will it have
any immediate dilutive effect or change the rights of current holders of our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Advantages
and Disadvantages of Increasing Authorized Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are certain advantages and disadvantages of increasing the Company&rsquo;s authorized common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
advantages include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    ability to raise capital by issuing capital stock under future financing transactions, if any.</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Having
    shares of common stock available to pursue business expansion opportunities, if any.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 48pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
disadvantages include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    the event that additional shares of common stock are issued, dilution to the existing stockholders, including a decrease in our net
    income per share in future periods. This could cause the per-share market price of our stock to decline.</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    issuance of authorized but unissued stock could be used to deter a potential takeover of the Company that may otherwise be beneficial
    to stockholders by diluting the shares held by a potential suitor or issuing shares to a stockholder that will vote in accordance
    with the desires of the Board, at that time. A takeover may be beneficial to independent stockholders because, among other reasons,
    a potential suitor may offer such stockholders a premium for their shares of stock compared to the then-existing market price. The
    Company does not have any plans or proposals to adopt provisions or enter into agreements that may have material anti-takeover consequences.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 48pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Procedure
for Implementing the Amendment</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
increase in the number of shares of our authorized common stock will become effective upon the filing of the Certificate of Amendment
or such later time as specified in the filing with the Secretary of State of the State of Delaware. The form of the Certificate of Amendment
is attached hereto as <U>Appendix C</U>. The exact timing of the filing of the Certificate of Amendment will be determined by the Board
based on its evaluation as to when such action will be the most advantageous to the Company and its stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Interests
of Officers and Directors in this Proposal</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than as disclosed above, the</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> officers and directors
of the Company do not have any substantial interest, direct or indirect, in this proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
Appraisal or Dissenters&rsquo; Rights</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Delaware law, stockholders are not entitled to appraisal or dissenters&rsquo; rights in connection with the amendment to the Certificate
of Incorporation to increase the number of authorized shares of common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_007"></A>Required
Vote</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval
of the Amendment to the Certificate of Incorporation to increase the number of authorized common stock shares to 1,000,000,000 will require
the affirmative vote of a majority of the votes cast on such proposal by the Shares present in person or represented by proxy at the
Special Meeting and entitled to vote thereon. A quorum must be present at the Special Meeting for a valid vote.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_006"></A>Recommendation
of the Board of Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
BOARD OF DIRECTORS OF THE COMPANY RECOMMENDS THAT STOCKHOLDERS VOTE FOR THE APPROVAL TO AMEND THE CERTIFICATE OF INCORPORATION TO INCREASE
THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK TO 1,000,000,000 SHARES. PROXIES SOLICITED BY THE BOARD WILL BE VOTED &ldquo;FOR&rdquo;
THE APPROVAL OF THE AMENDMENT TO INCREASE THE NUMBER OF AUTHORIZED SHARES UNLESS STOCKHOLDERS SPECIFY A CONTRARY VOTE.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_008"></A>PROPOSAL
4 - ADVISORY VOTE TO APPROVE SHARE REPURCHASE PROGRAM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Background
and Purpose</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board believes a share repurchase authorization will enable the Company to utilize excess capital to return value to shareholders, offset
dilution from equity compensation, and enhance stockholder value over time by taking advantage of attractive market opportunities when
available.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description
of the Program</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the proposed program, the Company would be authorized to repurchase, in its discretion, up to $15&#8239;million of its outstanding common
stock at prevailing market prices or via privately negotiated transactions at times deemed appropriate by the Board, subject to compliance
with all applicable securities laws, stock exchange requirements, and consideration of the Company&rsquo;s financial condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Methods
of Repurchase</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repurchases
under the program may be made from time to time through a variety of methods, including open market purchases, privately negotiated transactions,
block trades, accelerated share repurchase programs, or pursuant to plans adopted in accordance with Rule 10b5-1 under the Securities
Exchange Act of 1934, as amended. The timing and manner of any repurchases will be subject to market conditions, trading restrictions,
and other factors, including compliance with Rule 10b-18 under the Exchange Act, which provides a non-exclusive safe harbor from liability
for market manipulation in connection with certain repurchases. The Company is not obligated to repurchase any specific number of shares,
and the program may be suspended or discontinued at any time at the Company&rsquo;s discretion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Timeframe
and Duration</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
share repurchase program does not obligate the Company to repurchase any specific number of shares and does not have a fixed expiration
date. The timing, amount, and pace of repurchases, if any, will be determined by the Company&rsquo;s management in its discretion and
may be influenced by general business and market conditions, the trading price of the Company&rsquo;s common stock, alternative investment
opportunities, and other factors. The program may be suspended, modified, or terminated at any time without prior notice and without
further action by the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Factors
Considered in Determining Repurchase Timing</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
determining whether, when, and in what amounts to repurchase shares under the program, the Board of Directors and the Company&rsquo;s
management may consider a variety of factors, including the current and projected financial condition of the Company, the market price
of the Company&rsquo;s common stock, general economic and market conditions, the availability and cost of capital, the potential return
on investment from repurchases relative to other strategic opportunities, and applicable legal and regulatory requirements. The Board
and management may also consider the impact of repurchases on the Company&rsquo;s capital structure, earnings per share, and overall
shareholder value. In particular, the Board may evaluate the timing of repurchases in light of anticipated corporate developments, including
any potential mergers the Board believes could enhance the long-term value of the Company&rsquo;s common stock. Any decisions regarding
the timing or amount of share repurchases will be made in compliance with applicable securities laws, including those relating to the
use of material nonpublic information, and may be effected pursuant to a Rule 10b5-1 trading plan to help ensure compliance with insider
trading restrictions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Regulatory
and Financial Limitations.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s ability to repurchase shares under the program is subject to a number of regulatory and financial limitations. All repurchases
will be made in compliance with applicable federal securities laws, including Regulation M and Rule 10b-18 under the Securities Exchange
Act of 1934, as amended, which provides a non-exclusive safe harbor for issuers engaged in repurchases. In addition, the Company must
comply with any applicable state corporate law restrictions, including limitations on the use of capital for share repurchases and requirements
that the Company remain solvent after giving effect to any repurchase. The Company&rsquo;s ability to repurchase shares may also be constrained
by covenants or restrictions in its existing or future financing arrangements, capital needs for operational or strategic initiatives,
and the availability of cash on hand or other sources of liquidity. The Board and management will assess these factors in determining
the scope and timing of any repurchases.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
and Limitations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
the share repurchase program is intended to enhance long-term shareholder value, there can be no assurance as to the actual number of
shares that will be repurchased or the timing of any such repurchases. The program is entirely discretionary and may be suspended, modified,
or terminated by the Company at any time without prior notice. In addition, repurchases may be limited or delayed due to market conditions,
applicable legal requirements, or other corporate considerations. The program may also impact the Company&rsquo;s liquidity or capital
allocation flexibility and may reduce the funds available for other purposes, such as reinvestment in the business, strategic acquisitions,
or the payment of dividends. Shareholders should also be aware that repurchases will not guarantee any particular outcome with respect
to the market price of the Company&rsquo;s common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Tax
and Accounting Treatment</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
repurchased shares would be retired (or held as treasury shares) under the Company&rsquo;s Certificate of Incorporation and repurchases
would be reflected within the Company&rsquo;s financial statements as a reduction to shareholders&rsquo; equity and cash.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
Appraisal or Dissenters&rsquo; Rights</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Delaware law, stockholders are not entitled to appraisal or dissenters&rsquo; rights in connection with the approval of the share repurchase
program.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Interests
of Directors and Officers in this Proposal</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
executive officers and directors may be deemed to have an interest in this proposal to the extent they own shares of our common stock
that could potentially increase in value as a result of the share repurchase program. The Board was aware of these interests and considered
them, among other matters, when approving this proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="sl_011"></A>Required
Vote</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notices
of intention to present proposals at the 2026 Annual Meeting should be addressed to the Secretary, ProPhase Labs, Inc., 626 RXR Plaza,
6th Floor, Uniondale, New York 11556.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transactions
with Related Persons</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Certain
Relationships and Related Party Transactions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the terms of the charter of our Audit Committee, the Audit Committee must review and approve the terms and conditions
of all related party transactions. &ldquo;Related party transactions,&rdquo; as described in Item 404(a) of Regulation S-K promulgated
by the SEC generally refer to any transaction, arrangement or other relationship, or any series of similar transactions, arrangements
or relationships in which we were or are to be a participant, where the amount involved exceeds the lesser of (i) $120,000 and (ii) one
percent (1%) of the average of our total assets at year-end for the prior two fiscal years (which was approximately $77.6 million), and
in which any director, executive officer or holder of more than five percent (5%) of our voting securities (or affiliates or immediate
family members of such persons) had or will have a material interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
January 1, 2024, there have been no related party transactions except as described below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jason
Karkus, President of Nebula Genomics, a wholly-owned subsidiary of the Company, since January 2024, and prior to that Executive Vice
President and Co-Chief Operations Officer of ProPhase Diagnostics, Inc., a wholly-owned subsidiary of the Company, is the son of Ted
Karkus, our Chairman and Chief Executive Officer. For 2024, Mr. Jason Karkus received an annual base salary of $320,000, a bonus of $100,000
for his significant contributions related to the growth of ProPhase Diagnostics, Inc., a $7,800 vehicle allowance, and a $16,800 matching
contribution in the Company&rsquo;s 401(k) defined contribution plan. He also received stock options with a value of $1,220,000 in 2024
that vest in four equal installments starting on the grant date. The compensation paid to Mr. Karkus was approved by the Company&rsquo;s
compensation committee and audit committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ted
Karkus, the Company&rsquo;s Chief Executive Officer and the Chairman of the Board of Directors, entered into a loan agreement with the
Company on June 22, 2025 (the &ldquo;Loan Agreement&rdquo;) for a $500,000 cash investment, with a 20% original issue discount (OID).
The loan bears interest at a rate of 10% per annum and matures twelve (12) months from the execution date. The loan is secured by the
Company but subordinate to other potential lenders up to $6,000,000 and may be prepaid by the Company at any time without penalty. The
Company entered into agreements with identical terms with one other investor (&ldquo;Lender&rdquo;) for a total of $500,000 additional
invested cash. The loans are not convertible.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Loan Agreement, the Company also issued 500,000 warrants to purchase shares of the Company&rsquo;s common stock as
a term of the Loan Agreement for Mr. Karkus, as well as issued warrants on the same terms to the Lender, all of which such warrants do
not vest until a future shareholders&rsquo; approval of an increase in the Company&rsquo;s authorized shares of common stock (the &ldquo;Unvested
Warrants&rdquo;). The Unvested Warrants have an exercise price of $0.60 and are underwater as of the closing of the common stock on the
last market trading day prior to the issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this Proxy Statement, the Unvested Warrants have not vested or become exercisable. The vesting of these warrants is subject
to a condition outside of the holder&rsquo;s control and will not occur within 60 days, thus, the underlying shares are not deemed beneficially
owned for purposes of this Schedule DEF 14A in accordance with Rule 13d-3(d)(1) under the Securities Exchange Act of 1934. The Company
has not reserved any shares for this purpose at this time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Loan Agreement and the terms of the transaction were reviewed and approved by the disinterested members of the Board of Directors, in
accordance with the Company&rsquo;s policies for related party transactions and Item 404(a) of Regulation S-K. The Board determined that
the terms of the transaction were fair and reasonable to the Company and on terms no less favorable than those that could have been obtained
from an unaffiliated third party under similar circumstances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INFORMATION
ABOUT DIRECTORS AND EXECUTIVE OFFICERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Biographical
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DIRECTORS
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table and the paragraphs following the table set forth information regarding the current ages, positions, and business experience
of the directors of the Company as of the date of this Proxy Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 31pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Name</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Position</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Age</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Initial Year in Office</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ted Karkus<SUP>(1)</SUP></FONT></TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: left">Chairman of the Board and Chief Executive Officer</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 15%; text-align: center">66</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 15%; text-align: center">2009</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Louis Gleckel, MD<SUP>(1)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD>Director</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">69</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">2009</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warren Hirsch<SUP>(1)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD>Director</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">67</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">2019</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carolina Abenante, Esq.<SUP>(1)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD>Director</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">55</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">2025</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
Director nominee</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TED
KARKUS</B> has been the Chairman of the Board and the Chief Executive Officer of the Company since June 2009. Mr. Karkus was instrumental
in assisting the turnaround of ID Biomedical, an influenza vaccine manufacturer, which in 2005 was sold to GlaxoSmithKline plc for over
$1.4 billion. Mr. Karkus has twenty-five years of experience in securities and capital markets including two years with Fahnestock &amp;
Co. Inc., a full-service brokerage firm, where he was Senior Vice President, Director of Institutional Equities, and four years at S.G.
Warburg, an investment bank, where he was an institutional equity salesman and developed a large network of institutional investors.
Mr. Karkus graduated with an MBA from Columbia University Graduate School of Business in 1984 where he received Beta Gamma Sigma honors.
He graduated Magna Cum Laude from Tufts University in 1981.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Karkus brings extensive financial structuring as well as operational and marketing strategy experience to our Board, including successful
restructuring and turn-around scenarios in the pharmaceutical industry. Among his accomplishments, in 2010/2011 he led the restructuring
and streamlining of our operations, which resulted in improved sales and margins of our Cold-EEZE brand, and in 2017 succeeded in selling
the Cold-EEZE brand for $50 million to Mylan, a multibillion-dollar pharmaceutical company. These skills, as well as Mr. Karkus&rsquo;
experience as our Chairman and Chief Executive Officer, along with his deep knowledge of and genuine interest in our Company, management
skills and business savvy, and his performance as a Board member of the Company, led the Board to conclude that he should be nominated
to serve another term as a director.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LOUIS
GLECKEL, MD,</B> has been a member of our Board since June 2009 and currently serves as a member of the Audit Committee, Compensation
Committee, and as chairman of the Nominating and Corporate Governance Committee. In 1997, Dr. Gleckel co-founded ProHealth Care Associates,
a comprehensive state of the art multi-specialty physician group practice with offices in Long Island and Bronx, New York. At ProHealth,
he is the Division Chief of Cardiology and Internal Medicine specializing in Preventative Cardiology, Metabolic Syndrome and Internal
Medicine with particular emphasis on high-risk patients with complications from diabetes and heart disease. He was named to New York
Magazine&rsquo;s Best Doctors list for three years, New York Metro Area Best Doctors list for 14 years and the 2008 Nassau County Best
Doctors list. For over ten years Dr. Gleckel has been a team physician for the New York Jets and New York Islanders as well as for the
tennis players at the US Open. Dr. Gleckel also served as Chairman of the Board of Invicta Corporation, a development stage company that
designed, manufactured and marketed photochromic eyeglass lenses, for approximately four years until his resignation in February 2005.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Gleckel brings to the Board extensive knowledge of the medical, pharmaceutical and related industries as a distinguished doctor, as well
as experience in successful business development and board service. This experience, as well as his independence and his performance
as a Board member, member of our Compensation Committee, and chairman of our Nominating and Corporate Governance Committee, led the Board
to conclude that he should be nominated to serve another term as a director. Dr. Gleckel has also been determined by the Board to be
independent under the applicable rules of the Nasdaq and the Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WARREN
HIRSCH</B> has been a member of our Board since 2019 and currently serves as a member of the Compensation Committee, Nominating and Corporate
Governance Committee, and as chairman of the Audit Committee. Mr. Hirsch has over 35 years of experience as a Certified Public Accountant.
Mr. Hirsch owns and operates Hirsch and Hirsch CPA PLLC, which offers a full range of accounting, tax and small business consulting services.
From 2000 to May 2019, Mr. Hirsch served as a registered representative of Royal Alliance, a national financial advisory firm. Mr. Hirsch
graduated with a bachelor&rsquo;s degree in accounting from Hofstra University in 1980.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Hirsch has extensive knowledge and background related to accounting and financial reporting rules and regulations as well as the evaluation
of financial results, internal controls and business processes. Based on these qualifications, our Board has determined that Mr. Hirsch
should be nominated to serve another term as a director. Mr. Hirsch has also been determined by the Board to be independent under the
applicable rules of the Nasdaq and the Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CAROLINA
ABENANTE, ESQ. </B>was appointed to our Board as of June 20, 2025 to fill a vacancy and currently serves as a member of our Nominating
and Corporate Governance Committee and Chair of the Compensation Committee. In 2012, Ms. Abenante founded NYIAX, Inc., a financial and
advertising technology company. At NYIAX, Inc. she serves as Vice Chairperson since 2016 and prior to the time she served as the sole
director NYIAX from 2011 to 2016. Ms. Abenante served as President of NYIAX from June 2012 to April 2018 and later became NYIAX&rsquo;s
Chief Strategy Officer and General Counsel in April 2018. Starting from May 23, 2022, Ms. Abenante has served as Chief Evangelist and
Chief Strategy Officer of NYIAX, and at the same time ceased to be General Counsel. She has been in the New York City technology and
advertising industry since 1999, when she was the Director of Corporate Development for Juno Online Services, Inc. from 1999 to 2000,
focusing on corporate development, mergers and acquisitions and domestic and international strategic partnerships. In 2001-2005, she
became the Senior Director of Business Development and was part of the digital advertising tech and advertising team for Reed Elsevier
Ltd (Reed Business Information), in the U.S. (NYSE and LSE listed) working with creating and developing partnership for business-to-business
publishing through the Reed Elsevier family of digital publications and bringing Reed Business Publications to foreign markets. In 2005-2009,
she held the position of Vice President/Sr. Director of Business Development, Legal and Policy for Phorm Inc. (AIM: PHRM), developing
strategy and legal framework in US and foreign jurisdictions, namely the United Kingdom, Brazil, Italy, Spain, and China, and made inroads
into internationalization of its brand and products for behavioral advertising collaborating with companies such as British Telecom.
Ms. Abenante later became a consultant and legal counsel in strategy and business development from 2009 to 2015 for US and International
start-ups and traditional publishers seeking to develop new strategies for the development and creation of Programmatic advertising platforms,
advertisement operation and compliance, e-commerce, and privacy. Ms. Abenante holds a Bachelor of Science degree in Management and Finance
from Seton Hall University in May 1992, a J.D. from New York Law School in May 1997, an M.B.A. in General Management with a concentration
in financial management from SDA Bocconi School of Management, Universita Luigi Bocconi in Milan, Italy in December 1998, an LLM in Corporate
Taxation from New York Law School in May 2007, and an LLM in Commercial Real Estate Financing from New York Law School in May 2009. She
is a practicing attorney and a member of the Bar of the State of New Jersey. She sits on various New Jersey Bar and committees of the
New Jersey Bar Association (Tax and Media) and is a member of the American Bar Association. She has been a featured speaker at Imperial
College London, England, Web Summit in Lisbon, Portugal, IAB Blockchain and other forums multiple times in the area of advertising, blockchain
as a technology for compliance in advertising, and the intersection of AdTech to FinTech. She has spoken multiple times as a featured
speaker for TechUpForWomen on advertising, hiring, crypto currency and blockchain. Additionally, she is one of the inventors of the series
of NYIAX/Nasdaq AB US patents on &ldquo;Systems and Methods for Electronic Continuous Trading of Variant Inventories&rdquo; (Patent No.
10,607,291).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on Ms. Abenante&rsquo;s tax, finance, and legal qualifications as well as her extensive knowledge and experience relating to accounting
and financial reporting rules and regulations and internal controls, our Board has determined that Ms. Abenante should be nominated to
serve as director of the Company. Ms. Abenante has also been determined by the Board to be independent under the applicable rules of
the Nasdaq and the Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="sl_012"></A>EXECUTIVE
OFFICERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table and the paragraphs following the table set forth information regarding the current ages, positions, and business experience
of the current executive officers of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">Name</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">Position</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center">Age</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 26%; text-align: left">Ted Karkus</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 58%; text-align: left">Chairman of the Board and Chief Executive Officer</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 10%; text-align: center">66</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Stuart Hollenshead</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Chief Operating Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">41</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
&ldquo;<I>Proposal 1 &ndash; Election of Board of Directors</I>&rdquo; for Mr. Karkus&rsquo; biography.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>STUART
HOLLENSHEAD</B> is a seasoned C-level executive with 15+ years of experience in media, e-commerce, marketing, and technology. Mr. Hollenshead
has led growth, monetization, and audience engagement for top digital brands. At TheStreet, Mr. Hollenshead scaled DTC subscriptions
to $30M and pioneered AI-driven content automation. At Business Insider, he drove audience growth, contributing to its $442M acquisition
by Axel Springer. At WWE, Mr. Hollenshead helped WWE Network reach nearly 2M subscribers. As COO &amp; CBO of Barstool Sports, Mr. Hollenshead
led record-breaking expansion, culminating in its $551M acquisition by Penn Entertainment. Now simultaneously CEO of 10PM Curfew, a female-centric
platform with an audience of 70M+, Mr. Hollenshead continues to build and scale high-growth businesses each and every day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="sl_005"></A>EXECUTIVE
AND DIRECTOR COMPENSATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="sl_006"></A>Summary
Compensation Table (2024 and 2023)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summary compensation table sets forth the total compensation paid or accrued for the years ended December 31, 2024 and 2023
to our Chief Executive Officer, our former Chief Accounting Officer and our former Chief Financial Officers. We refer to these officers
as our &ldquo;named executive officers&rdquo; for 2024 and 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
REGARDING VALUATION OF OPTION AWARDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amounts reported in the &ldquo;Option Awards&rdquo; column represent the aggregate grant-date fair value of stock option awards calculated
in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 718, &ldquo;Compensation&mdash;Stock
Compensation.&rdquo; The fair value of each option award is based on the Black-Scholes option pricing model and reflects accounting assumptions
required under U.S. generally accepted accounting principles (GAAP), not the actual economic value realized by the executive. These accounting-based
values are intended to reflect the estimated cost to the Company at the time of grant and are not necessarily indicative of any value
the executive has received or will ultimately receive. Importantly, the stock options granted to our named executive officers, including
our Chief Executive Officer, have consistently had exercise prices equal to or greater than the market price of our common stock on the
date of grant. As of the date of this filing, all such options remain underwater, meaning the current market price of our stock is below
the exercise price of the options. Accordingly, these options have no intrinsic value and provide no economic benefit to the executives
unless and until the Company&rsquo;s stock price increases materially above the grant price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following stock option grants were made in 2023 and 2024 and are included in the compensation valuation disclosures:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ted
    Karkus (CEO): 400,000 options granted on March 17, 2024, with an exercise price of $6.00 per share.</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ted
    Karkus (CEO): 400,000 options granted on April 4, 2023, with an exercise price of $9.00 per share.</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    Morse (CFO): 50,000 options granted on April 4, 2023, with an exercise price of $9.00 per share.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
values disclosed in the compensation tables should be interpreted as accounting estimates&mdash;not as current or guaranteed compensation
to the executive officers. These options currently have no intrinsic value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name and Principal </B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Position</B></FONT></P></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Year</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Salary</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Bonus</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>($)<SUP>(1)</SUP></B></FONT></P></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Awards</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>All Other</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Compensation</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>($)<SUP>(2)</SUP></B></FONT></P></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total </B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>($)</B></FONT></P></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: left">Ted Karkus</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 8%; text-align: center">2024</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; text-align: right">675,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; text-align: right">200,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; text-align: right">1,220,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; text-align: right">28,200</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; text-align: right">2,123,200</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: left; padding-left: 10pt">Chief Executive Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">675,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">200,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,465,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">27,200</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,367,200</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jed Latkin<SUP>(3)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2024</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">350,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">80,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,315,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">27,200</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,772,200</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: left; padding-left: 10pt">Former Chief Operating Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert Morse<SUP>(4)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2024</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">126,827</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: left; padding-left: 10pt">Former Chief Financial Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">275,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,890</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">246,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">541,390</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monica Brady<SUP>(5)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2024</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: left; padding-left: 10pt">Former Chief Accounting Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">200,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,680</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">210,680</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                            Mr. Karkus, the amount reported for 2024 consists of a $200,000 discretionary bonus awarded
                                            to Mr. Karkus in April 2024 for his 2023 contributions to the Company and for 2023 consists
                                            of a $200,000 discretionary bonus awarded to Mr. Karkus in March 2023 for his 2022 contributions
                                            to the Company.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;For
Mr. Latkin, the amount reported for 2024 consists of a $80,000 sign-on bonus awarded to Mr. Latkin in January 2024, which was in conjunction
with his employment agreement.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    Mr. Morse, the amount reported for 2023 consists of a $19,890 discretionary bonus awarded to Mr. Morse in March 2023 for his 2022
    contributions to the Company.</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                            Mr. Karkus, the amounts reported for 2024 2023 consists of a $15,000 vehicle allowance and
                                            a $13,200 matching contribution to the Company&rsquo;s 401(k) defined contribution plan and
                                            2023 consists of a $15,000 vehicle allowance and a $12,200 matching contribution to the Company&rsquo;s
                                            401(k) defined contribution plan.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    Mr. Latkin, the amount reported for 2024 consists of a $10,800 vehicle allowance and a $16,400 matching contribution to the Company&rsquo;s
    401(k) defined contribution plan.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    Ms. Brady, the amount reported for 2023 consists of a $5,000 vehicle allowance and a $5,680 matching contribution in the Company&rsquo;s
    401(k) defined contribution plan.</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Latkin served as Chief Operating Officer effective January 1, 2024. Mr. Latkin resigned as Chief Operating Officer effective February
    14, 2025.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Morse resigned as Chief Financial Officer and resumed his role as Controller, effective January 1, 2024. Although Mr. Morse continues
    to work for the Company, he is no longer the principal financial officer and principal accounting officer of the Company.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Brady resigned as Chief Accounting Officer effective January 13, 2023.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval
of the Amended and Restated 2025 Directors&rsquo; Plan will require the affirmative vote of a majority of the votes cast on such proposal
by the Shares present in person or represented by proxy at the Special Meeting and entitled to vote thereon. A quorum must be present
at the Special Meeting for a valid vote.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vote
Required for Non-Binding Advisory Vote</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
advisory vote is not binding on the Board. However, the Board intends to consider the outcome of this vote in determining whether to
proceed with the program in accordance with corporate governance best practices and responsiveness to stockholder sentiment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval
of the Amended and Restated 2025 Directors&rsquo; Plan will require the affirmative vote of a majority of the votes cast on such proposal
by the Shares present in person or represented by proxy at the Special Meeting and entitled to vote thereon. A quorum must be present
at the Special Meeting for a valid vote.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Recommendation
of the Board of Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
BOARD OF DIRECTORS OF THE COMPANY RECOMMENDS THAT STOCKHOLDERS VOTE FOR THE APPROVAL OF THE SHARE REPURCHASE PROGRAM. PROXIES SOLICITED
BY THE BOARD WILL BE VOTED &ldquo;FOR&rdquo; THE APPROVAL OF THE SHARE REPURCHASE PROGRAM UNLESS STOCKHOLDERS SPECIFY A CONTRARY VOTE.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROPOSAL
5 &ndash; ISSUANCE OF SHARES OF COMMON STOCK IN NON-PUBLIC OFFERINGS (NASDAQ RULE 5635(d) PROPOSAL)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>What
am I voting on and how should I vote?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
are being asked to approve the issuance of in excess of 20% of our common stock that may be issuable upon conversion or exercise of notes
and warrants in a convertible note offering that could result in shares of common stock being deemed sold at a price below the &ldquo;Minimum
Price&rdquo; as defined under Nasdaq Listing Rule 5635(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company raised $3 million in senior secured convertible notes with accompanying warrants issued at a 20% original issue discount secured
by Company assets. The notes cannot be converted for the first four months, and the warrants are exercisable at $0.50 per share; the
agreement at issue also allows for an additional $3 million in future investment. Proceeds will be used for working capital, general
purposes, and debt repayment, with transaction documents to be filed in a Form 8-K. The transaction includes customary investor protections
and penalties and is designed to align long-term interests including providing the Company with flexible capital to support its strategic
objectives. The Board believes that this
capital raise, coupled with the Company&rsquo;s forward-looking digital asset strategy, positions the Company to unlock significant shareholder
value by gaining early exposure to blockchain-based financial infrastructure. In executing this strategy, the Company intends to become
a unique public market vehicle for investors seeking regulated access to both life sciences innovation and the growth potential of digital
assets. Nasdaq Listing Rule 5635(d) requires shareholder approval. At this time, the Company reserved 1,000,000 shares. By agreement
of the Company and the investors, an additional 226,310,704 shares, or 400% of the maximum aggregate number of Underlying Shares based
on the OID face amount of $3,750,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors believes voting For this Proposal 5 is in the best interests of the Company as it will allow the Company to comply
with the contractual obligations described herein and potentially also raise additional capital, and thus provide us with the necessary
capital to support the Company&rsquo;s Crypto Treasury Strategy and existing business lines and initiatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
Board of Directors therefore recommends you vote &ldquo;FOR&rdquo; the approval of the issuance in excess of 20% of the Company&rsquo;s
common stock.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are seeking stockholder approval for the issuance of in excess of 20% of the Company&rsquo;s common stock either the sale and issuance
of common stock at a price less than the &ldquo;Minimum Price&rdquo; or upon sale and subsequent conversion of convertible notes and
exercise of warrants stock. The Company requires such approval in order to ensure that we will be able to successfully obtain funding
through a private placement of our securities in light of current market conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Potential
Effects on Current Stockholders</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuance of shares of common stock (and/or securities convertible into or exercisable for common stock) pursuant to this Proposal could
have a dilutive effect on the ownership interests and voting power of existing stockholders. Depending on the number of shares issued
and the price at which they are issued, current stockholders may experience a significant reduction in their relative ownership and earnings
per share. This could cause dilution of both the intrinsic value of shares and relative voting power.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to dilution, the issuance of a substantial number of new shares could also adversely affect the market price of the Company&rsquo;s
common stock. Any such decline could occur regardless of the Company&rsquo;s actual operating performance or prospects. Further, if securities
are issued to one or more large investors, those investors may obtain rights, preferences, or privileges not available to existing stockholders
and could gain a measure of influence or control over Company matters, particularly if the Company issues a number of shares sufficient
to constitute a significant percentage of its outstanding stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is not assured that any capital raised will result in the intended financial or strategic benefits. Moreover, any future capital raised
through non-public offerings may be perceived by the market as a sign of liquidity pressure or a lack of access to public markets, which
could negatively affect investor sentiment and the Company&rsquo;s stock price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Interest
of Certain Persons in Matter to Be Acted Upon</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
director or executive officer has any substantial interest, direct or indirect, by security holdings or otherwise, in this Proposal that
is not shared by all of our other stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Vote
Required</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval
of this Proposal 5 requires the affirmative vote of the majority of the votes cast on this proposal. Abstentions and broker non-votes
are not considered votes cast and will have no effect on the outcome of Proposal  5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
BOARD RECOMMENDS A VOTE &ldquo;FOR&rdquo; APPROVAL, FOR PURPOSES OF COMPLYING WITH NASDAQ LISTING RULE 5635(D) IN CONNECTION WITH THE
COMPANY&rsquo;S NOTE AND WARRANT OFFERING DESCRIBED HEREIN THAT MAY BE CONVERTIBLE INTO COMMON STOCK IN EXCESS OF 20% OF
OUR COMMON STOCK PRESENTLY OUTSTANDING (OR OUTSTANDING AT THE TIME SUCH OFFERING OCCURS) AND ANY OTHER POTENTIAL OFFERING THAT COULD
HAVE A SIMILAR EFFECT.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Background
and Rationale</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq
Listing Rule&#8239;5635(d) requires the Company to obtain stockholder approval before issuing, in a transaction other than a public offering,
shares (or securities convertible into shares) representing 20% or more of our outstanding common stock at a price less than the &ldquo;Minimum
Price&rdquo; &mdash; defined as the greater of book value or market value per share, based on Nasdaq rules</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
proposal seeks that approval in advance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description
of the Proposal</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
approved, the Company may issue, in one or more private offerings, shares of common stock and/or securities convertible into or exercisable
for common stock, in an aggregate amount that may exceed 20% of the common stock outstanding as of each issuance. The securities may
be sold at a price per share below the greater of book or market value, all in accordance with Nasdaq Listing Rule&#8239;5635(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
actual terms of any issuance&mdash;including price, timing, investor(s), and amount&mdash;will be determined by the Board and management
based on market conditions, the Company&rsquo;s capital needs, and other strategic objectives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Why
Your Vote Matters</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compliance:
Obtaining shareholder approval in advance enables the Company to proceed with future non-public financings without risking Nasdaq listing
status.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
flexibility: Approval ensures the Board can act swiftly and efficiently in future capital markets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dilution
disclosure: The Company will fully disclose dilution impact and pricing details when such offerings occur.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Voting
Mechanics</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vote
required: This proposal must be approved by a majority of votes cast at the meeting. Abstentions and broker non-votes will have no effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Board
Recommendation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
BOARD OF DIRECTORS OF THE COMPANY RECOMMENDS THAT STOCKHOLDERS VOTE FOR THE APPROVAL OF THE ISSUANCE OF COMMON STOCK IN NON-PUBLIC OFFERINGS
IN AN AMOUNT THAT MAY EXCEED 20% OF OUTSTANDING COMMON STOCK. PROXIES SOLICITED BY THE BOARD WILL BE VOTED &ldquo;FOR&rdquo; THE APPROVAL
OF THE ISSUANCE OF COMMON STOCK IN NON-PUBLIC OFFERINGS UNLESS STOCKHOLDERS SPECIFY A CONTRARY VOTE.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
Appraisal or Dissenters&rsquo; Rights</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Delaware law, stockholders are not entitled to appraisal or dissenters&rsquo; rights in connection with this proposal to approve the
issuance of shares of common stock in non-public offerings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROPOSAL
6 - APPROVAL OF AMENDMENT TO COMPANY&rsquo;S BYLAWS TO DESIGNATE THE ADDRESS OF ITS PRINCIPAL EXECUTIVE OFFICES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
approve an amendment to the Company&rsquo;s By-Laws to change the address of its principal executive offices to 626 RXR Plaza, 6th Floor,
Uniondale, NY 11556 (this proposal is considered a routine matter for which brokers may exercise discretionary voting authority).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Background
and Rationale</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors has determined that relocating the Company&rsquo;s principal executive offices to 626 RXR Plaza, 6th Floor, Uniondale,
NY 11556 is in the best interests of the Company and its shareholders. The new location will better support the Company&rsquo;s ongoing
operations and future growth objectives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
amendment may be effected by shareholder approval. The proposed change to the Bylaws solely designates the address of the principal executive
offices and does not affect other provisions of the Bylaws or the rights of shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Text
of the Proposed Amendment</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
Bylaws do not designate the address of the principal executive offices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
proposed amendment would therefore add the following language to the end of Article I:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
3. The Company&rsquo;s principal executive offices are located at 626 RXR Plaza, 6th Floor, Uniondale, NY 11556.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Effect
of the Amendment</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
approved, the amendment will take effect immediately following the Special Meeting, and the Company will update its records with the
Delaware Secretary of State and other relevant authorities as required. The designation of address is administrative in nature and will
not impact the Company&rsquo;s operations, financial position, or shareholder rights. This amendment does not affect any governance provisions
of the By-Laws. The Company will update its filings with the Securities and Exchange Commission to reflect the new address of its principal
executive offices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_011"></A>Vote
Required</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Article XIII of the Company&rsquo;s Bylaws, amendment of the Bylaws of the Company by shareholder vote, requires the affirmative vote
of at least 66 2/3% of the Company&rsquo;s outstanding voting stock. Because this proposal contemplates an amendment of the Bylaws, its
approval requires the affirmative vote of at least 66 2/3% of the Company&rsquo;s outstanding voting stock for approval. Abstentions
will have the same effect as a vote against the proposal. Because this proposal regards a matter that is deemed &ldquo;routine,&rdquo;
broker non-votes will have the effect of giving pertinent brokers discretionary authority to vote on this matter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The presence, in person or by proxy, of the holders of a majority of the
Company&rsquo;s outstanding shares entitled to vote at the Special Meeting will constitute a quorum for the transaction of business. This
quorum requirement is set forth in Section 8 of the Company&rsquo;s By-Laws and applies to all matters presented at the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">However, Proposal 6 seeks shareholder approval to amend the Company&rsquo;s
By-Laws. Pursuant to Section 1 of the By-Laws, such an amendment requires the affirmative vote of at least 66 2/3% of the Company&rsquo;s
outstanding voting stock, not merely a majority of votes cast. As a result, abstentions and broker non-votes will have the same effect
as votes against the proposal. The quorum requirement governs whether the meeting may proceed; the supermajority vote requirement governs
whether this specific proposal may be approved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">If this proposal is not approved by the requisite vote of the Company&rsquo;s
shareholders, the Company&rsquo;s By-Laws will not be amended to reflect the address of its principal executive offices. However, this
will have no effect on the Company&rsquo;s ability to operate from its current location or to reflect that address in public filings,
correspondence, or other business records. The amendment is administrative in nature and intended to provide consistency and clarity within
the Company&rsquo;s governing documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_010"></A>Board
Recommendation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
BOARD OF DIRECTORS OF THE COMPANY RECOMMENDS THAT STOCKHOLDERS VOTE FOR APPROVAL TO AMEND THE BYLAWS TO DESIGNATE 626 RXR PLAZA, 6TH
FLOOR, UNIONDALE, NY 11556, AS THE COMPANY&rsquo;S PRINCIPAL EXECUTIVE OFFICE.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_001"></A>OTHER
INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_002"></A>Attending
the Special Meeting</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Special Meeting will take place at 273 Merrick Road, Lynbrook, NY 11563, on Friday, August 29, 2025, at 4:00 p.m., Eastern Time. If you
have questions about attending the Annual Meeting, please contact the Company by phone at (516) 464-6121.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_003"></A>Expenses
and Solicitation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
expenses in connection with this solicitation will be borne by the Company. In addition to the use of the mail, proxy solicitation may
be made by telephone, telegraph and personal interview by officers, directors and employees of the Company. The Company will, upon request,
reimburse brokerage houses and persons holding shares in the names of their nominees for their reasonable expenses in sending soliciting
material to their principals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_004"></A>Householding
of Proxy Materials</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
some cases, only one copy of this Proxy Statement is being delivered to multiple stockholders sharing an address. However, this delivery
method, called &ldquo;householding,&rdquo; is not being used if the Company has received contrary instructions from one or more of the
stockholders. The Company will deliver promptly, upon written or oral request, a separate copy of this Proxy Statement to a stockholder
at a shared address to which a single copy of the documents were delivered. To obtain a separate copy of our Proxy Statement and our
2024 Annual Report, send such request to Lance Bisesar, Controller, at our offices located at 626 RXR Plaza, 6th Floor, Uniondale, New
York 11556.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_005"></A>Other
Business</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board knows of no business that will be presented for consideration at the Special Meeting other than those items stated above. If any
other business should come before the Special Meeting, votes may be cast pursuant to Proxies in respect to any such business in the best
judgment of the person or persons acting under the Proxies. The final results of the balloting at the Special Meeting will appear in
the Company&rsquo;s Current Report on Form 8-K within four business days of the meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Proxy Statement and the Notice of Special Meeting are available online at: www.proxyvote.com<I>.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>YOUR
VOTE IS IMPORTANT!</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>You
are cordially invited to attend the Special Meeting. However, to ensure that your shares are represented at the meeting, please submit
your proxy card or voting instructions by mail. Please see the instructions on the proxy card and voting instruction card. Submitting
a proxy card or voting instructions will not prevent you from attending the Special Meeting and voting in person, if you so desire, but
will help the Company secure a quorum and reduce the expense of additional proxy solicitation.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNATURES</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Ted Karkus</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and Chairman of the Board of Directors </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    28, 2025</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
    No.</FONT></TD>
    <TD STYLE="width: 0.1in">&nbsp;</TD>
    <TD STYLE="text-align: justify; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="ex1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proxy Card</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="ex2.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated 2025 Employee Equity Compensation Plan (Proposal 1)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">3</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="ex3.htm">2025 Employee Equity Plan (redlined to show changes from Amended and Restated 2022 Employee Equity Plan) (Proposal 1)</A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="ex4.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated 2025 Directors&rsquo; Equity Compensation Plan (Proposal 2)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">5</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="ex5.htm">2025 Directors' Equity Plan (redlined to show changes from Amended and Restated 2022 Directors' Equity Plan) (Proposal 2)</A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="ex6.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Amendment to the Certificate of Incorporation (Proposal 3)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="ex7.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated Bylaws (reflecting change of principal executive office address) (Proposal 6)</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 43; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="aaa_001"></A></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>





</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1
<SEQUENCE>2
<FILENAME>ex1.htm
<DESCRIPTION>EX-1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="D_001"></A><B>Exhibit
1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT>&nbsp;<IMG SRC="proxy_001.jpg" ALT="" STYLE="height: 1100px; width: 850px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="proxy_002.jpg" ALT="" STYLE="height: 1100px; width: 850px"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2
<SEQUENCE>3
<FILENAME>ex2.htm
<DESCRIPTION>EX-2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><B><A NAME="ex_001"></A>Exhibit 2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
PROPHASE LABS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMENDED
AND RESTATED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2022
EQUITY COMPENSATION PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.
PURPOSE OF THE PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the Plan is to aid ProPhase Labs, Inc. (the &ldquo;Company&rdquo;) and its Affiliates in recruiting and retaining employees,
consultants and advisors of outstanding ability and to motivate them to exert their best efforts on behalf of the Company and its stockholders
by providing incentives through the granting of Awards. The Company expects that it and the Company&rsquo;s stockholders will benefit
from the added interest which such employees, consultants and advisors will have in the welfare of the Company as a result of their proprietary
interest in the Company&rsquo;s success.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.
AMENDMENT AND RESTATEMENT; EFFECTIVE DATE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan, originally titled&nbsp;<I>The Quigley Corporation 2010 Equity Compensation Plan</I>, was ratified by the Company&rsquo;s stockholders
at the Company&rsquo;s Annual Meeting of Stockholders on May 5, 2010. The Plan was subsequently amended by the Board, titled the Amended
and Restated 2010 Equity Compensation Plan, and ratified by the Company&rsquo;s stockholders at the Company&rsquo;s Annual Meeting of
Stockholders on May 6, 2013, May 24, 2016, May 23, 2018, and May 20, 2021. As renamed, the Amended and Restated 2022 Equity Compensation
Plan became effective on April 11, 2022 and, as further amended and restated herein, this Amended and Restated 2022 Equity Compensation
Plan became effective on the Effective Date, subject to approval of the Company&rsquo;s stockholders, and amends and restates the 2022
Equity Compensation Plan in its entirety.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.
DEFINITIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following capitalized terms used in the Plan have the respective meanings set forth in this Section:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Affiliate</U>:
With respect to the Company, any entity directly or indirectly controlling, controlled by or under common control with the Company or
any other entity designated by the Board in which the Company or an Affiliate has an interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Award</U>:
An Option, Restricted Stock, Restricted Stock Unit, or Other Stock Based Award granted pursuant to the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Beneficial
Owner</U>: A &ldquo;beneficial owner,&rdquo; as such term is defined in Rule 13(d)(3) of the Exchange Act (or any successor rule thereto).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Board</U>:
The Board of Directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Change
of Control</U>: The occurrence of any one of the following events:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
A change in the ownership of the Company that occurs on the date that any one person, or more than one person acting as a group (for
purposes of SEC Rule 13d) (&ldquo;Person&rdquo;), acquires ownership of the Shares that, together with the Shares held by such Person,
constitutes more than 50% of the total voting power of the Shares of the Company. No Change of Control shall have occurred in the event
Ted Karkus (the &ldquo;Executive&rdquo;) or a group which includes Executive acquires more than 50% of the voting control of the Company.
The acquisition of additional Shares by any one Person, who is considered to own more than 50% of the total voting power of the Shares
of the Company will not be considered an additional Change of Control; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
A change in the effective control of the Company that occurs on the date that a majority of members of the Board is replaced during any
12 month period by directors whose appointment or election is not endorsed by one of either the Executive or a majority of the members
of the Board prior to the date of the appointment or election; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
A change in the ownership of a &ldquo;substantial portion of the Company&rsquo;s assets&rdquo;, as defined herein. For this purpose,
a &ldquo;substantial portion of the Company&rsquo;s assets&rdquo; shall mean assets of the Company having a total gross fair market value
equal to or more than 50% of the total gross fair market value of all of the assets of the Company immediately prior to such change in
ownership. For purposes of this subsection (iii), a change in ownership of a substantial portion of the Company&rsquo;s assets occurs
on the date that any Person acquires (or has acquired during the 12 month period ending on the date of the most recent acquisition by
such Person or Persons) assets from the Company that constitute a &ldquo;substantial portion of the Company&rsquo;s assets.&rdquo; For
purposes of this subsection (iii), the following will not constitute a change in the ownership of a substantial portion of the Company&rsquo;s
assets: (a) a transfer to an entity that is controlled by the Company&rsquo;s stockholders immediately after the transfer, or (b) a transfer
of assets by the Company to: (1) a stockholder of the Company (immediately before the asset transfer) in exchange for or with respect
to the Company&rsquo;s stock, (2) an entity, 50% or more of the total value or voting power of which is owned, directly or indirectly,
by the Company, (3) a Person, that owns, directly or indirectly, 50% or more of the total value or voting power of all the outstanding
stock of the Company, or (4) an entity, at least 50% of the total value or voting power of which is owned, directly or indirectly, by
a Person described in this subsection (iii). For purposes of this subsection (iii), gross fair market value means the value of the assets
of the Company, or the value of the assets being disposed of, determined without regard to any liabilities associated with such assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this definition, persons will be considered to be acting as a group if they are owners of a corporation that enters into
a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, a transaction will not be deemed a Change of Control unless the transaction qualifies as a change in control event within
the meaning of Section 409A of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further
and for the avoidance of doubt, a transaction will not constitute a Change of Control if its primary purpose is to: (1) change the state
of the Company&rsquo;s incorporation, or (2) create a holding company that will be owned in substantially the same proportions by the
persons who held the Company&rsquo;s securities immediately before such transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f) <U>Code</U>:
The Internal Revenue Code of 1986, as amended, or any successor thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g) <U>Committee</U>:
The Compensation Committee of the Board (or a subcommittee thereof as provided under Section 5), or such other committee of the Board
(including, without limitation, the full Board) to which the Board has delegated power to act under or pursuant to the provisions of
the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h) <U>Company</U>:
ProPhase Labs, Inc., a Delaware corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i) <U>Director</U>:
A non-employee member of the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j) <U>Disability</U>:
Inability of a Participant to perform in all material respects his duties and responsibilities to the Company or any Subsidiary of the
Company, by reason of a physical or mental disability or infirmity which inability is reasonably expected to be permanent and has continued
(i) for a period of six consecutive months or (ii) such shorter period as the Committee may reasonably determine in good faith. The Disability
determination shall be in the sole discretion of the Committee and a Participant (or his representative) shall furnish the Committee
with medical evidence documenting the Participant&rsquo;s disability or infirmity which is satisfactory to the Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k) <U>Effective
Date</U>: April 23, 2023, subject to the approval of the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l) <U>Employment</U>:
The term &ldquo;Employment&rdquo; as used herein shall be deemed to refer to (i) a Participant&rsquo;s employment if the Participant
is an employee of the Company or any of its Affiliates, (ii) a Participant&rsquo;s services as a consultant, advisor or other service
provider, if the Participant is a consultant, advisor or other service provider to the Company or its Affiliates, and (iii) a Participant&rsquo;s
services as a non-employee director, if the Participant is a non-employee member of the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m) <U>Exchange
Act</U>: The Securities Exchange Act of 1934, as amended, or any successor thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n) <U>Fair
Market Value</U>: On a given date, (i) if there should be a public market for the Shares on such date, the closing price of the Shares
as reported on such date on the composite tape of the principal national securities exchange on which such Shares are listed or admitted
to trading or, if no composite tape exists for such national securities exchange on such date, then the closing price on the principal
national securities exchange on which such Shares are listed or admitted to trading, (ii) if the Shares are not listed or admitted on
a national securities exchange, the arithmetic mean of the per Share closing bid price and per Share closing asked price on such date
as quoted on the National Association of Securities Dealers Automated Quotation System (or such other market in which such prices for
the Shares are regularly quoted) or (iii) if there is no market on which the Shares are regularly quoted, the Fair Market Value shall
be the value established by the Committee in good faith and consistent with Section 409A of the Code; provided, however that in determining
the Fair Market value, the Committee shall not apply a discount for any minority interest. With respect to (i) and (ii) above, if no
sale of Shares shall have been reported on such composite tape or such national securities exchange on such date or quoted on the National
Association of Securities Dealer Automated Quotation System or other applicable market on such date, then the immediately preceding date
on which sales of the Shares have been so reported or quoted shall be used.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o) <U>ISO</U>:
An Option that is also an incentive stock option granted pursuant to Section 7(d) of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">p) <U>Option</U>:
A stock option granted pursuant to Section 7 of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">q) <U>Option
Price</U>: The purchase price per Share of an Option, as determined pursuant to Section 7(a) of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">r) <U>Participant</U>:
An employee, director, consultant, advisor or other service provider of the Company or any of its Affiliates who is selected by the Committee
to participate in the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">s) <U>Permitted
Holder(s)</U>: &ldquo;Permitted Holder&rdquo; means, as of the date of determination, any and all of (i) an employee benefit plan (or
trust forming a part thereof) maintained by (A) the Company or (B) any corporation or other Person of which a majority of its voting
power of its voting equity securities or equity interest is owned, directly or indirectly, by the Company or (ii) any stockholder of
the Company who, together with its affiliates, owns 50% or more of the total voting power of all classes of voting stock of the Company
as of the Effective Date, or any affiliate(s) of such stockholder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">t) <U>Person</U>:
A &ldquo;person,&rdquo; as such term is used for purposes of Section 13(d) or 14(d) of the Exchange Act (or any successor section thereto).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">u) <U>Plan</U>:
The ProPhase Labs, Inc. Amended and Restated 2022 Equity Compensation Plan as set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v) <U>Restricted
Stock:</U>&nbsp;An Award granted pursuant to Section 8(b) of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">w) <U>Restricted
Stock Unit</U>: An Award granted pursuant to Section 8(b) of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">x) <U>Shares</U>:
Shares of common stock of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">y) <U>Subsidiary</U>:
A subsidiary corporation, as defined in Section 424(f) of the Code (or any successor section thereto).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.
SHARES SUBJECT TO THE PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to this Section 4 and Section 9 of the Plan, the total number of Shares which may be issued under the Plan is the sum of (i) the number
of Shares available under the Plan immediately prior to stockholder approval of this Plan (as of April 23, 2023, 3,285 Shares were available
under this Plan, subject to the counting, adjustment and substitution provisions of the Plan) and (ii) 700,000 Shares, plus (iii) that
number of Shares that are represented by awards which previously have been granted and are outstanding under the Plan (including those
granted under the predecessor 2010 Equity Compensation Plan) on the date the Plan, as amended and restated, is approved by stockholders
of the Company and which subsequently expire or otherwise lapse, are terminated or forfeited, are settled in cash, or exchanged with
the Committee&rsquo;s permission, prior to the issuance of Shares, for Awards not involving shares of Common Stock, without the issuance
of the underlying Shares, all of which may be issued as ISOs to the extent approved hereunder or by prior shareholder approval. The Shares
may consist, in whole or in part, of unissued Shares or treasury Shares. The issuance of Shares or in consideration of the cancellation
or termination of an Award shall reduce the total number of Shares available under the Plan, as applicable. Shares which are subject
to Awards under this Plan which terminate, expire, forfeit or lapse without the payment of consideration (or Awards settled in cash in
lieu of Shares) may be granted again under the Plan. If the exercise price of an Award is paid by delivering to the Company Shares previously
owned by the Participant or if Shares are delivered or withheld for purposes of satisfying a tax withholding obligation, the number of
Shares covered by the Award equal to the number of Shares so delivered or withheld shall, however, be counted against the number of Shares
granted and shall not again be available for Awards under the Plan. Stock Appreciation Rights to be settled in Shares shall be counted
in full against the number of Shares available for award under the Plan regardless of the number of Shares issued upon settlement of
the Stock Appreciation Right. All of the Options that are available for issuance under the Plan may be issued as ISOs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.
ADMINISTRATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan shall be administered by the Committee. The Committee is authorized to interpret the Plan, to establish, amend and rescind any rules
and regulations relating to the Plan, and to make any other determinations that it deems necessary or advisable for the administration
of the Plan. The Committee may correct any defect or supply any omission or reconcile any inconsistency in the Plan in the manner and
to the extent the Committee deems necessary or advisable. Any decision of the Committee in the interpretation and administration of the
Plan, as described herein, shall lie within its sole and absolute discretion and shall be final, conclusive and binding on all parties
concerned (including, but not limited to, Participants and their beneficiaries or successors). The Committee shall have the full power
and authority to establish the terms and conditions of any Award consistent with the provisions of the Plan and to waive any such terms
and conditions at any time (including, without limitation, accelerating or waiving any vesting conditions). Determinations made by the
Committee under the Plan need not be uniform and may be made selectively among Participants, whether or not such Participants are similarly
situated. Awards may, in the discretion of the Committee, be granted under the Plan in assumption of, or in substitution for, outstanding
Awards previously granted by the Company, any of its Affiliates or any of their respective predecessors, or any entity acquired by the
Company or with which the Company combines. The number of Shares underlying such substitute Awards shall be counted against the aggregate
number of Shares available for Awards under the Plan. The Committee shall require payment of any minimum amount it may determine to be
necessary to withhold for federal, state, local or other, taxes as a result of the exercise, vesting or grant of an Award. Unless the
Committee specifies otherwise, the Participant may elect to pay a portion or all of such withholding taxes by (a) delivery in Shares
or (b) having Shares withheld by the Company from any Shares that would have otherwise been received by the Participant. The number of
Shares so delivered or withheld shall have an aggregate Fair Market Value sufficient to satisfy the applicable withholding taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.
LIMITATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
Award may be granted under the Plan after the tenth anniversary of the Effective Date, but Awards theretofore granted may extend beyond
that date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.
TERMS AND CONDITIONS OF OPTIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
granted under the Plan shall be, as determined by the Committee, non-qualified or incentive stock options for federal income tax purposes,
as evidenced by the related Option agreements, and shall be subject to the foregoing and the following terms and conditions and to such
other terms and conditions, not inconsistent therewith, as the Committee shall determine:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Option
Price</U>. The Option Price per Share shall be determined by the Committee, but shall not be less than 100% of the Fair Market Value
of a Share on the date an Option is granted (other than in the case of Options granted in substitution of previously granted Options,
as described in Section 5).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Exercisability</U>.
Options granted under the Plan shall be exercisable at such time and upon such terms and conditions as may be determined by the Committee,
but in no event shall an Option be exercisable more than seven years after the date it is granted. Each Option agreement shall set forth
the extent to which the Participant shall have the right to exercise the Option following termination of the Participant&rsquo;s employment
or service with the Company or its Affiliates. Such provisions shall be determined in the sole discretion of the Committee, shall be
included in the applicable Option agreements, need not be uniform among all Options issued pursuant to the Plan, and may reflect distinctions
based on the reasons for termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Exercise
of Options</U>. Except as otherwise provided in the Plan or in an Option agreement, an Option may be exercised for all, or from time
to time any part, of the Shares for which it is then exercisable. For purposes of Section 7 of the Plan, the exercise date of an Option
shall be the later of the date a notice of exercise is received by the Company and, if applicable, the date payment is received by the
Company pursuant to clauses (i), (ii), (iii) or (iv) in the following sentence. The purchase price for the Shares as to which an Option
is exercised shall be paid to the Company to the extent permitted by law, (i) in cash or its equivalent (e.g., by personal check) at
the time the Option is exercised, (ii) in Shares having a Fair Market Value equal to the aggregate Option Price for the Shares being
purchased and satisfying such other requirements as may be imposed by the Committee; provided that such Shares have been held by the
Participant for no less than six months (or such other period as established from time to time by the Committee in order to avoid adverse
accounting treatment applying generally accepted accounting principles), (iii) partly in cash and partly in Shares (as described in (ii)
above), (iv) if there is a public market for the Shares at such time, and provided that a sale of Shares by the Participant is permitted
at such time under the Company&rsquo;s insider trading policy then in effect, through the delivery of irrevocable instructions to a broker
to sell Shares obtained upon the exercise of the Option and to deliver promptly to the Company an amount out of the proceeds of such
Sale equal to the aggregate Option Price for the Shares being purchased or (v) to the extent the Committee shall approve in the Option
agreement or otherwise, through &ldquo;net settlement&rdquo; in Shares. In the case of a &ldquo;net settlement&rdquo; of an Option, the
Company will not require a cash payment of the Option Price of the Option set forth in the Option agreement, but will reduce the number
of Shares issued upon the exercise by the largest number of whole Shares that have a Fair Market Value that does not exceed the aggregate
Option Price set forth in the Option agreement. With respect to any remaining balance of the aggregate Option Price, the Company shall
accept a cash payment. No Participant shall have any rights to dividends or other rights of a stockholder with respect to Shares subject
to an Option until the Participant has given written notice of exercise of the Option, paid in full for such Shares and, if applicable,
has satisfied any other conditions imposed by the Committee pursuant to the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>ISOs</U>.
The Committee may grant Options under the Plan that are intended to be ISOs. Such ISOs shall comply with the requirements of Section
422 of the Code (or any successor section thereto). No ISO may be granted to any Participant who at the time of such grant owns more
than 10% of the total combined voting power of all classes of stock of the Company or of any Subsidiary, unless (i) the Option Price
for such ISO is at least 110% of the Fair Market Value of a Share on the date the ISO is granted and (ii) the date on which such ISO
terminates is a date not later than the day preceding the fifth anniversary of the date on which the ISO is granted. Any Participant
who disposes of Shares acquired upon the exercise of an ISO either (i) within two years after the date of grant of such ISO or (ii) within
one year after the transfer of such Shares to the Participant, shall notify the Company of such disposition and of the amount realized
upon such disposition. All Options granted under the Plan are intended to be nonqualified stock options unless the applicable Option
agreement expressly states that the Option is intended to be an ISO. If an Option is intended to be an ISO, and if for any reason such
Option (or portion thereof) shall not qualify as an ISO, then, to the extent of such nonqualification, such Option (or portion thereof)
shall be regarded as a nonqualified stock option granted under the Plan; provided that such Option (or portion thereof) otherwise complies
with the Plan&rsquo;s requirements relating to nonqualified stock options. In no event shall any member of the Committee, the Company
or any of its Affiliates (or their respective employees, officers or directors) have any liability to any Participant (or any other Person)
due to the failure of an Option to qualify for any reason as an ISO.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Attestation</U>.
Wherever in this Plan or in any agreement evidencing an Option a Participant is permitted to pay the exercise price of an Option or taxes
relating to the exercise of an Option by delivering Shares, the Participant may, subject to procedures satisfactory to the Committee,
satisfy such delivery requirement by presenting proof of beneficial ownership of such Shares, in which case the Company shall, as appropriate,
(i) treat the Option as exercised without further payment and/or (ii) withhold such number of Shares from the Shares acquired by the
exercise of the Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.
OTHER STOCK BASED AWARDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Generally</U>.
The Committee, in its sole discretion, may grant or sell Awards of Shares, Awards of restricted Shares and Awards that are valued in
whole or in part by reference to, or are otherwise based on the Fair Market Value of, Shares (&ldquo;Other Stock Based Awards&rdquo;).
Such Other Stock Based Awards shall be in such form, and dependent on such conditions, as the Committee shall determine, including, without
limitation, the right to receive one or more Shares (or the equivalent cash value of such Shares) upon the completion of a specified
period of service, the occurrence of an event and/or the attainment of performance objectives. Other Stock Based Awards may be granted
alone or in addition to any other Awards granted under the Plan. Subject to the provisions of the Plan, the Committee shall determine
to whom and when Other Stock Based Awards will be made, the number of Shares to be awarded under (or otherwise related to) such Other
Stock Based Awards; whether such Other Stock Based Awards shall be settled in cash, Shares or a combination of cash and Shares; and all
other terms and conditions of such Awards (including, without limitation, the vesting provisions thereof and provisions ensuring that
all Shares so awarded and issued shall be fully paid and non-assessable).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Restricted
Stock Awards and Restricted Stock Units</U>. The Committee may grant Restricted Stock or Restricted Stock Units at any time and from
time to time prior to the expiration of the Plan to eligible Participants selected by the Committee. A Participant shall have rights
as a stockholder with respect to any Shares subject to a Restricted Stock award hereunder only to the extent specified in the Restricted
Stock agreement evidencing such Award. Awards of Restricted Stock or Restricted Stock Units shall be evidenced only by such agreements,
notices and/or terms or conditions documented in such form (including by electronic communications) as may be approved by the Committee.
Awards of Restricted Stock or Restricted Stock Units granted pursuant to the Plan need not be identical but each must contain or be subject
to the following terms and conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <I>Terms
and Conditions</I>. Each Restricted Stock agreement and each Restricted Stock Unit agreement shall contain provisions regarding (a) the
number of Shares subject to such Award or a formula for determining such, (b) the purchase price of the Shares, if any, and the means
of payment for the Shares, (c) the performance criteria, if any, and level of achievement versus these criteria that shall determine
the number of Shares granted, issued, retainable and/or vested, (d) such terms and conditions on the grant, issuance, vesting and/or
forfeiture of the Shares as may be determined from time to time by the Committee, (e) restrictions on the transferability of the Shares
and (f) such further terms and conditions as may be determined from time to time by the Committee, in each case not inconsistent with
this Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) <I>Restricted
Stock Units</I>. Except to the extent this Plan or the Committee specifies otherwise, Restricted Stock Units represent an unfunded and
unsecured obligation of the Company and do not confer any of the rights of a stockholder until Shares are issued thereunder. Settlement
of Restricted Stock Units upon expiration of the deferral or vesting period shall be made in Shares or otherwise as determined by the
Committee. Dividends or dividend equivalent rights shall be payable in cash or in additional shares with respect to Restricted Stock
Units only to the extent specifically provided for by the Committee. Until a Restricted Stock Unit is settled, the number of Shares represented
by a Restricted Stock Unit shall be subject to adjustment pursuant to Section 9. Any Restricted Stock Units that are settled after the
Participant&rsquo;s death shall be distributed to the Participant&rsquo;s designated beneficiary(ies) or, if none was designated, the
Participant&rsquo;s estate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) <I>Share
Vesting</I>. The grant, issuance, retention and/or vesting of Shares under Restricted Stock or Restricted Stock Unit Awards shall be
at such time and in such installments as determined by the Committee or under criteria established by the Committee. The Committee shall
have the right to make the timing of the grant and/or the issuance, ability to retain and/or vesting of Shares under Restricted Stock
or Restricted Stock Unit Awards subject to continued employment, passage of time and/or such performance criteria (as described in more
detail in Section 8(c) below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Performance
Based Awards</U>. Notwithstanding anything to the contrary herein, certain Other Stock Based Awards granted under this Section 8 may
be based on the attainment of written performance goals approved by the Committee for a performance period established by the Committee
(&ldquo;Performance Based Awards&rdquo;). The Committee shall determine whether, with respect to a performance period, the applicable
performance goals have been met with respect to a given participant and, if they have, shall so certify. In connection with such certification,
the Committee, or its delegate, may decide that the amount of the Performance Based Award actually paid to a given Participant may be
less than the amount determined by the applicable performance goal formula; provided that the Committee shall have the authority to waive
any applicable performance goals. In the event the applicable performance goals are not waived by the Committee, payment of a Performance
Based Award will occur only after certification and will be made as determined by the Committee in its sole discretion after the end
of the applicable performance period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.
ADJUSTMENTS UPON CERTAIN EVENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
any other provisions in the Plan to the contrary, the following provisions shall apply to all Awards granted under the Plan:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Generally</U>.
In the event of any change in the outstanding Shares after the Effective Date by reason of any Share dividend or split, reorganization,
recapitalization, merger, consolidation, spin-off, combination or exchange of Shares or other corporate exchange or change in capital
structure, any distribution or special dividend to stockholders of Shares, cash or other property (other than regular cash dividends)
or any similar event, the Committee without liability to any person shall make such substitution or adjustment, if any, as it deems to
be equitable (subject to Section 17), as to the number or kind of Shares or other securities issued or reserved for issuance as set forth
in Section 4 of the Plan or pursuant to outstanding Awards and the per share exercise price thereof, as applicable; provided that the
Committee shall determine in its sole discretion the manner in which such substitution or adjustment shall be made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Change
of Control</U>. In the event of a Change of Control (or similar corporate transaction, whether or not including any Permitted Holder)
after the Effective Date, the Committee shall accelerate, vest or cause the restrictions to lapse with respect to all or any portion
of an Award. With respect to any Awards that are vested pursuant to the preceding sentence, the Committee may (A) cancel such Awards
for fair value (as determined in the sole discretion of the Committee) which, in the case of Awards, may equal the excess, if any, of
value of the consideration to be paid in the Change of Control transaction to holders of the same number of Shares subject to such Awards
(or, if no consideration is paid in any such transaction, the Fair Market Value of the Shares subject to such Awards) over the aggregate
exercise price of such Awards, (B) provide for the issuance of substitute Awards that will substantially preserve the otherwise applicable
terms of any affected Awards previously granted hereunder as determined by the Committee in its sole discretion or (C) provide that for
a period of at least 10 days prior to the Change of Control, such Awards shall be exercisable as to all shares subject thereto and that
upon the occurrence of the Change of Control, such Awards shall terminate and be of no further force or effect. For the avoidance of
doubt, pursuant to (A) above, the Committee may cancel Awards for no consideration if the aggregate Fair Market Value of the Shares subject
to such Awards is less than or equal to the aggregate Award Price of such Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.
NO RIGHT TO EMPLOYMENT OR AWARDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
granting of an Award under the Plan shall impose no obligation on the Company or any of its Affiliates to continue the Employment of
a Participant and shall not lessen or affect the Company&rsquo;s or any Affiliate&rsquo;s right to terminate the Employment of such Participant.
No Participant or other Person shall have any claim to be granted any Award and there is no obligation for uniformity of treatment of
Participants, holders or beneficiaries of Awards. The terms and conditions of Awards and the Committee&rsquo;s determinations and interpretations
with respect thereto need not be the same with respect to each Participant (whether or not such Participants are similarly situated).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11.
SUCCESSORS AND ASSIGNS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan shall be binding on all successors and assigns of the Company and the Participants, including, without limitation, the estate of
each such Participant and the executor, administrator or trustee of such estate, and any receiver or trustee in bankruptcy or any other
representative of the Participant&rsquo;s creditors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12.
NONTRANSFERABILITY OF AWARDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise determined by the Committee, an Award shall not be transferable or assignable by the Participant otherwise than by will or
by the laws of descent and distribution. An Award exercisable after the death of a Participant may be exercised by the legatees, personal
representatives or distributees of the Participant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>13.
AMENDMENTS OR TERMINATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may amend, alter or discontinue the Plan, but no amendment, alteration or discontinuation shall be made which (a) without the
approval of the stockholders of the Company, would (except as is provided in Section 11 of the Plan) increase the total number of Shares
reserved for the purposes of the Plan or change the maximum number of Shares for which Awards may be granted to any Participant or (b)
without the consent of a Participant, would materially adversely impair any of the rights under any Award theretofore granted to such
Participant under the Plan; provided, however, that the Committee may amend the Plan in such manner as it deems necessary to permit the
granting of Awards meeting the requirements of the Code or other applicable laws (including, without limitation, to avoid adverse tax
consequences to the Company or any Participant). Except as set forth in Section 9 hereof, in no event may the Committee or any other
entity reprice any Award or substitute an outstanding Award for a new Award with a lower exercise price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
limiting the generality of the foregoing, to the extent applicable, notwithstanding anything herein to the contrary, this Plan and Awards
issued hereunder shall be interpreted in accordance with Section 409A of the Code and Department of Treasury regulations and other interpretative
guidance issued thereunder, including without limitation any such regulations or other guidance that may be issued after the Effective
Date. Notwithstanding any provision of the Plan to the contrary, in the event that the Committee determines that any amounts payable
hereunder will be taxable to a Participant under Section 409A of the Code and related Department of Treasury guidance prior to payment
to such Participant of such amount, the Company may (a) adopt such amendments to the Plan and Awards and adopt such appropriate policies
and procedures, including amendments and policies or procedures with retroactive effect, that the Committee determines necessary or appropriate
to preserve the intended tax treatment of the benefits provided by the Plan and Awards hereunder and/or (b) take such other actions as
the Committee determines necessary or appropriate to avoid the imposition of an additional tax under Section 409A of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>14.
INTERNATIONAL PARTICIPANTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to Participants who reside or work outside the United States of America, the Committee may, in its sole discretion, amend the
terms of the Plan or Awards with respect to such Participants in order to conform such terms with the requirements of local law or to
obtain more favorable tax or other treatment for a Participant, the Company or an Affiliate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>15.
CHOICE OF LAW</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan shall be governed by and construed in accordance with the laws of the State of Delaware without regard to conflicts of laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>16.
EFFECTIVENESS OF THE PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan shall be effective as of the Effective Date, subject to the approval of the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>17.
SECTION 409A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
other provisions of the Plan or any Award agreements thereunder, no Award shall be granted, deferred, accelerated, extended, paid out
or modified under this Plan in a manner that would result in the imposition of an additional tax under Section 409A of the Code upon
a Participant. In the event that it is reasonably determined by the Committee that, as a result of Section 409A of the Code, any payment
or delivery of Shares in respect of any Award under the Plan may not be made at the time contemplated by the terms of the Plan or the
relevant Award agreement, as the case may be, without causing the Participant holding such Award to be subject to taxation under Section
409A of the Code, the Company will make such payment or delivery of Shares on the first day that would not result in the Participant
incurring any tax liability under Section 409A of the Code. In the case of a Participant who is a &ldquo;specified employee&rdquo; (within
the meaning of Section 409A(a)(2)(B)(i) of the Code), any payment and/or delivery of Shares in respect of any Award subject to Section
409A of the Code that are linked to the date of the Participant&rsquo;s separation from service shall not be made prior to the date which
is six (6) months after the date of such Participant&rsquo;s separation from service from the Company and its affiliates, determined
in accordance with Section 409A of the Code and the regulations promulgated thereunder. The Company shall use commercially reasonable
efforts to implement the provisions of this Section 17 in good faith; provided that neither the Company, the Committee nor any of the
Company&rsquo;s employees, directors or representatives shall have any liability to Participants with respect to this Section 17.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 9; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>












</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3
<SEQUENCE>4
<FILENAME>ex3.htm
<DESCRIPTION>EX-3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><B><A NAME="ex_002"></A>Exhibit 3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
PROPHASE LABS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMENDED
AND RESTATED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2025</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>
EQUITY COMPENSATION PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.
PURPOSE OF THE PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the Plan is to aid ProPhase Labs, Inc. (the &ldquo;Company&rdquo;) and its Affiliates in recruiting and retaining employees,
consultants and advisors of outstanding ability and to motivate them to exert their best efforts on behalf of the Company and its stockholders
by providing incentives through the granting of Awards. The Company expects that it and the Company&rsquo;s stockholders will benefit
from the added interest which such employees, consultants and advisors will have in the welfare of the Company as a result of their proprietary
interest in the Company&rsquo;s success.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.
AMENDMENT AND RESTATEMENT; EFFECTIVE DATE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan, originally titled&nbsp;<I>The Quigley Corporation 2010 Equity Compensation Plan</I>, was ratified by the Company&rsquo;s
stockholders at the Company&rsquo;s Annual Meeting of Stockholders on May 5, 2010. The Plan was subsequently amended by the Board,
titled the Amended and Restated 2010 Equity Compensation Plan, and ratified by the Company&rsquo;s stockholders at the
Company&rsquo;s Annual Meeting of Stockholders on May 6, 2013, May 24, 2016, May 23, 2018, May 20, 2021, and June 16, 2023 (the
&ldquo;Amended and Restated 2022 Equity Compensation Plan&rdquo;). As renamed, the Amended and Restated 2025 Equity
Compensation Plan became effective immediately upon stockholder approval at the August 29, 2025, Special Meeting; and amends
and restates the Amended and Restated 2022 Equity Compensation Plan in its entirety.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.
DEFINITIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following capitalized terms used in the Plan have the respective meanings set forth in this Section:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Affiliate</U>:
With respect to the Company, any entity directly or indirectly controlling, controlled by or under common control with the Company or
any other entity designated by the Board in which the Company or an Affiliate has an interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Award</U>:
An Option, Restricted Stock, Restricted Stock Unit, or Other Stock Based Award granted pursuant to the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Beneficial
Owner</U>: A &ldquo;beneficial owner,&rdquo; as such term is defined in Rule 13(d)(3) of the Exchange Act (or any successor rule thereto).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Board</U>:
The Board of Directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Change
of Control</U>: The occurrence of any one of the following events:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
A change in the ownership of the Company that occurs on the date that any one person, or more than one person acting as a group (for
purposes of SEC Rule 13d) (&ldquo;Person&rdquo;), acquires ownership of the Shares that, together with the Shares held by such Person,
constitutes more than 50% of the total voting power of the Shares of the Company. No Change of Control shall have occurred in the event
Ted Karkus (the &ldquo;Executive&rdquo;) or a group which includes Executive acquires more than 50% of the voting control of the Company.
The acquisition of additional Shares by any one Person, who is considered to own more than 50% of the total voting power of the Shares
of the Company will not be considered an additional Change of Control; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
A change in the effective control of the Company that occurs on the date that a majority of members of the Board is replaced during any
12 month period by directors whose appointment or election is not endorsed by one of either the Executive or a majority of the members
of the Board prior to the date of the appointment or election; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
A change in the ownership of a &ldquo;substantial portion of the Company&rsquo;s assets&rdquo;, as defined herein. For this purpose,
a &ldquo;substantial portion of the Company&rsquo;s assets&rdquo; shall mean assets of the Company having a total gross fair market value
equal to or more than 50% of the total gross fair market value of all of the assets of the Company immediately prior to such change in
ownership. For purposes of this subsection (iii), a change in ownership of a substantial portion of the Company&rsquo;s assets occurs
on the date that any Person acquires (or has acquired during the 12 month period ending on the date of the most recent acquisition by
such Person or Persons) assets from the Company that constitute a &ldquo;substantial portion of the Company&rsquo;s assets.&rdquo; For
purposes of this subsection (iii), the following will not constitute a change in the ownership of a substantial portion of the Company&rsquo;s
assets: (a) a transfer to an entity that is controlled by the Company&rsquo;s stockholders immediately after the transfer, or (b) a transfer
of assets by the Company to: (1) a stockholder of the Company (immediately before the asset transfer) in exchange for or with respect
to the Company&rsquo;s stock, (2) an entity, 50% or more of the total value or voting power of which is owned, directly or indirectly,
by the Company, (3) a Person, that owns, directly or indirectly, 50% or more of the total value or voting power of all the outstanding
stock of the Company, or (4) an entity, at least 50% of the total value or voting power of which is owned, directly or indirectly, by
a Person described in this subsection (iii). For purposes of this subsection (iii), gross fair market value means the value of the assets
of the Company, or the value of the assets being disposed of, determined without regard to any liabilities associated with such assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this definition, persons will be considered to be acting as a group if they are owners of a corporation that enters into
a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, a transaction will not be deemed a Change of Control unless the transaction qualifies as a change in control event within
the meaning of Section 409A of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further
and for the avoidance of doubt, a transaction will not constitute a Change of Control if its primary purpose is to: (1) change the state
of the Company&rsquo;s incorporation, or (2) create a holding company that will be owned in substantially the same proportions by the
persons who held the Company&rsquo;s securities immediately before such transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f) <U>Code</U>:
The Internal Revenue Code of 1986, as amended, or any successor thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g) <U>Committee</U>:
The Compensation Committee of the Board (or a subcommittee thereof as provided under Section 5), or such other committee of the Board
(including, without limitation, the full Board) to which the Board has delegated power to act under or pursuant to the provisions of
the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h) <U>Company</U>:
ProPhase Labs, Inc., a Delaware corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i) <U>Director</U>:
A non-employee member of the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j) <U>Disability</U>:
Inability of a Participant to perform in all material respects his duties and responsibilities to the Company or any Subsidiary of the
Company, by reason of a physical or mental disability or infirmity which inability is reasonably expected to be permanent and has continued
(i) for a period of six consecutive months or (ii) such shorter period as the Committee may reasonably determine in good faith. The Disability
determination shall be in the sole discretion of the Committee and a Participant (or his representative) shall furnish the Committee
with medical evidence documenting the Participant&rsquo;s disability or infirmity which is satisfactory to the Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Effective Date</U>: August 29, 2025, subject to the approval of the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l) <U>Employment</U>:
The term &ldquo;Employment&rdquo; as used herein shall be deemed to refer to (i) a Participant&rsquo;s employment if the Participant
is an employee of the Company or any of its Affiliates, (ii) a Participant&rsquo;s services as a consultant, advisor or other service
provider, if the Participant is a consultant, advisor or other service provider to the Company or its Affiliates, and (iii) a Participant&rsquo;s
services as a non-employee director, if the Participant is a non-employee member of the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m) <U>Exchange
Act</U>: The Securities Exchange Act of 1934, as amended, or any successor thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n) <U>Fair
Market Value</U>: On a given date, (i) if there should be a public market for the Shares on such date, the closing price of the Shares
as reported on such date on the composite tape of the principal national securities exchange on which such Shares are listed or admitted
to trading or, if no composite tape exists for such national securities exchange on such date, then the closing price on the principal
national securities exchange on which such Shares are listed or admitted to trading, (ii) if the Shares are not listed or admitted on
a national securities exchange, the arithmetic mean of the per Share closing bid price and per Share closing asked price on such date
as quoted on the National Association of Securities Dealers Automated Quotation System (or such other market in which such prices for
the Shares are regularly quoted) or (iii) if there is no market on which the Shares are regularly quoted, the Fair Market Value shall
be the value established by the Committee in good faith and consistent with Section 409A of the Code; provided, however that in determining
the Fair Market value, the Committee shall not apply a discount for any minority interest. With respect to (i) and (ii) above, if no
sale of Shares shall have been reported on such composite tape or such national securities exchange on such date or quoted on the National
Association of Securities Dealer Automated Quotation System or other applicable market on such date, then the immediately preceding date
on which sales of the Shares have been so reported or quoted shall be used.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o) <U>ISO</U>:
An Option that is also an incentive stock option granted pursuant to Section 7(d) of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">p) <U>Option</U>:
A stock option granted pursuant to Section 7 of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">q) <U>Option
Price</U>: The purchase price per Share of an Option, as determined pursuant to Section 7(a) of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">r) <U>Participant</U>:
An employee, director, consultant, advisor or other service provider of the Company or any of its Affiliates who is selected by the Committee
to participate in the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">s) <U>Permitted
Holder(s)</U>: &ldquo;Permitted Holder&rdquo; means, as of the date of determination, any and all of (i) an employee benefit plan (or
trust forming a part thereof) maintained by (A) the Company or (B) any corporation or other Person of which a majority of its voting
power of its voting equity securities or equity interest is owned, directly or indirectly, by the Company or (ii) any stockholder of
the Company who, together with its affiliates, owns 50% or more of the total voting power of all classes of voting stock of the Company
as of the Effective Date, or any affiliate(s) of such stockholder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">t) <U>Person</U>:
A &ldquo;person,&rdquo; as such term is used for purposes of Section 13(d) or 14(d) of the Exchange Act (or any successor section thereto).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">u)
<U>Plan</U>: The ProPhase Labs, Inc. Amended and Restated 2025 Equity Compensation Plan as set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v) <U>Restricted
Stock:</U>&nbsp;An Award granted pursuant to Section 8(b) of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">w) <U>Restricted
Stock Unit</U>: An Award granted pursuant to Section 8(b) of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">x) <U>Shares</U>:
Shares of common stock of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">y) <U>Subsidiary</U>:
A subsidiary corporation, as defined in Section 424(f) of the Code (or any successor section thereto).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.
SHARES SUBJECT TO THE PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to this Section 4 and Section 9 of the Plan, the total number of Shares which may be issued under the Plan is the sum of (i) the number
of Shares available under the Plan immediately prior to stockholder approval of this Plan (as of July 25, 2025, 33,750 Shares
were available under this Plan, subject to the counting, adjustment and substitution provisions of the Plan) and (ii) 3,000,000
Shares, plus (iii) that number of Shares that are represented by awards which previously have been granted and are outstanding under
the Plan (including those granted under the predecessor Equity Compensation Plans) on the date the Plan, as amended and restated,
is approved by stockholders of the Company and which subsequently expire or otherwise lapse, are terminated or forfeited, are settled
in cash, or exchanged with the Committee&rsquo;s permission, prior to the issuance of Shares, for Awards not involving shares of Common
Stock, without the issuance of the underlying Shares, all of which may be issued as ISOs to the extent approved hereunder or by prior
shareholder approval. The Shares may consist, in whole or in part, of unissued Shares or treasury Shares. The issuance of Shares or in
consideration of the cancellation or termination of an Award shall reduce the total number of Shares available under the Plan, as applicable.
Shares which are subject to Awards under this Plan which terminate, expire, forfeit or lapse without the payment of consideration (or
Awards settled in cash in lieu of Shares) may be granted again under the Plan. If the exercise price of an Award is paid by delivering
to the Company Shares previously owned by the Participant or if Shares are delivered or withheld for purposes of satisfying a tax withholding
obligation, the number of Shares covered by the Award equal to the number of Shares so delivered or withheld shall, however, be counted
against the number of Shares granted and shall not again be available for Awards under the Plan. Stock Appreciation Rights to be settled
in Shares shall be counted in full against the number of Shares available for award under the Plan regardless of the number of Shares
issued upon settlement of the Stock Appreciation Right. All of the Options that are available for issuance under the Plan may be issued
as ISOs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.
ADMINISTRATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan shall be administered by the Committee. The Committee is authorized to interpret the Plan, to establish, amend and rescind any rules
and regulations relating to the Plan, and to make any other determinations that it deems necessary or advisable for the administration
of the Plan. The Committee may correct any defect or supply any omission or reconcile any inconsistency in the Plan in the manner and
to the extent the Committee deems necessary or advisable. Any decision of the Committee in the interpretation and administration of the
Plan, as described herein, shall lie within its sole and absolute discretion and shall be final, conclusive and binding on all parties
concerned (including, but not limited to, Participants and their beneficiaries or successors). The Committee shall have the full power
and authority to establish the terms and conditions of any Award consistent with the provisions of the Plan and to waive any such terms
and conditions at any time (including, without limitation, accelerating or waiving any vesting conditions). Determinations made by the
Committee under the Plan need not be uniform and may be made selectively among Participants, whether or not such Participants are similarly
situated. Awards may, in the discretion of the Committee, be granted under the Plan in assumption of, or in substitution for, outstanding
Awards previously granted by the Company, any of its Affiliates or any of their respective predecessors, or any entity acquired by the
Company or with which the Company combines. The number of Shares underlying such substitute Awards shall be counted against the aggregate
number of Shares available for Awards under the Plan. The Committee shall require payment of any minimum amount it may determine to be
necessary to withhold for federal, state, local or other, taxes as a result of the exercise, vesting or grant of an Award. Unless the
Committee specifies otherwise, the Participant may elect to pay a portion or all of such withholding taxes by (a) delivery in Shares
or (b) having Shares withheld by the Company from any Shares that would have otherwise been received by the Participant. The number of
Shares so delivered or withheld shall have an aggregate Fair Market Value sufficient to satisfy the applicable withholding taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.
LIMITATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
Award may be granted under the Plan after the tenth anniversary of the Effective Date, but Awards theretofore granted may extend beyond
that date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.
TERMS AND CONDITIONS OF OPTIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
granted under the Plan shall be, as determined by the Committee, non-qualified or incentive stock options for federal income tax purposes,
as evidenced by the related Option agreements, and shall be subject to the foregoing and the following terms and conditions and to such
other terms and conditions, not inconsistent therewith, as the Committee shall determine:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Option
Price</U>. The Option Price per Share shall be determined by the Committee, but shall not be less than 100% of the Fair Market Value
of a Share on the date an Option is granted (other than in the case of Options granted in substitution of previously granted Options,
as described in Section 5).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Exercisability</U>.
Options granted under the Plan shall be exercisable at such time and upon such terms and conditions as may be determined by the Committee,
but in no event shall an Option be exercisable more than seven years after the date it is granted. Each Option agreement shall set forth
the extent to which the Participant shall have the right to exercise the Option following termination of the Participant&rsquo;s employment
or service with the Company or its Affiliates. Such provisions shall be determined in the sole discretion of the Committee, shall be
included in the applicable Option agreements, need not be uniform among all Options issued pursuant to the Plan, and may reflect distinctions
based on the reasons for termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Exercise
of Options</U>. Except as otherwise provided in the Plan or in an Option agreement, an Option may be exercised for all, or from time
to time any part, of the Shares for which it is then exercisable. For purposes of Section 7 of the Plan, the exercise date of an Option
shall be the later of the date a notice of exercise is received by the Company and, if applicable, the date payment is received by the
Company pursuant to clauses (i), (ii), (iii) or (iv) in the following sentence. The purchase price for the Shares as to which an Option
is exercised shall be paid to the Company to the extent permitted by law, (i) in cash or its equivalent (e.g., by personal check) at
the time the Option is exercised, (ii) in Shares having a Fair Market Value equal to the aggregate Option Price for the Shares being
purchased and satisfying such other requirements as may be imposed by the Committee; provided that such Shares have been held by the
Participant for no less than six months (or such other period as established from time to time by the Committee in order to avoid adverse
accounting treatment applying generally accepted accounting principles), (iii) partly in cash and partly in Shares (as described in (ii)
above), (iv) if there is a public market for the Shares at such time, and provided that a sale of Shares by the Participant is permitted
at such time under the Company&rsquo;s insider trading policy then in effect, through the delivery of irrevocable instructions to a broker
to sell Shares obtained upon the exercise of the Option and to deliver promptly to the Company an amount out of the proceeds of such
Sale equal to the aggregate Option Price for the Shares being purchased or (v) to the extent the Committee shall approve in the Option
agreement or otherwise, through &ldquo;net settlement&rdquo; in Shares. In the case of a &ldquo;net settlement&rdquo; of an Option, the
Company will not require a cash payment of the Option Price of the Option set forth in the Option agreement, but will reduce the number
of Shares issued upon the exercise by the largest number of whole Shares that have a Fair Market Value that does not exceed the aggregate
Option Price set forth in the Option agreement. With respect to any remaining balance of the aggregate Option Price, the Company shall
accept a cash payment. No Participant shall have any rights to dividends or other rights of a stockholder with respect to Shares subject
to an Option until the Participant has given written notice of exercise of the Option, paid in full for such Shares and, if applicable,
has satisfied any other conditions imposed by the Committee pursuant to the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>ISOs</U>.
The Committee may grant Options under the Plan that are intended to be ISOs. Such ISOs shall comply with the requirements of Section
422 of the Code (or any successor section thereto). No ISO may be granted to any Participant who at the time of such grant owns more
than 10% of the total combined voting power of all classes of stock of the Company or of any Subsidiary, unless (i) the Option Price
for such ISO is at least 110% of the Fair Market Value of a Share on the date the ISO is granted and (ii) the date on which such ISO
terminates is a date not later than the day preceding the fifth anniversary of the date on which the ISO is granted. Any Participant
who disposes of Shares acquired upon the exercise of an ISO either (i) within two years after the date of grant of such ISO or (ii) within
one year after the transfer of such Shares to the Participant, shall notify the Company of such disposition and of the amount realized
upon such disposition. All Options granted under the Plan are intended to be nonqualified stock options unless the applicable Option
agreement expressly states that the Option is intended to be an ISO. If an Option is intended to be an ISO, and if for any reason such
Option (or portion thereof) shall not qualify as an ISO, then, to the extent of such nonqualification, such Option (or portion thereof)
shall be regarded as a nonqualified stock option granted under the Plan; provided that such Option (or portion thereof) otherwise complies
with the Plan&rsquo;s requirements relating to nonqualified stock options. In no event shall any member of the Committee, the Company
or any of its Affiliates (or their respective employees, officers or directors) have any liability to any Participant (or any other Person)
due to the failure of an Option to qualify for any reason as an ISO.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Attestation</U>.
Wherever in this Plan or in any agreement evidencing an Option a Participant is permitted to pay the exercise price of an Option or taxes
relating to the exercise of an Option by delivering Shares, the Participant may, subject to procedures satisfactory to the Committee,
satisfy such delivery requirement by presenting proof of beneficial ownership of such Shares, in which case the Company shall, as appropriate,
(i) treat the Option as exercised without further payment and/or (ii) withhold such number of Shares from the Shares acquired by the
exercise of the Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.
OTHER STOCK BASED AWARDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Generally</U>.
The Committee, in its sole discretion, may grant or sell Awards of Shares, Awards of restricted Shares and Awards that are valued in
whole or in part by reference to, or are otherwise based on the Fair Market Value of, Shares (&ldquo;Other Stock Based Awards&rdquo;).
Such Other Stock Based Awards shall be in such form, and dependent on such conditions, as the Committee shall determine, including, without
limitation, the right to receive one or more Shares (or the equivalent cash value of such Shares) upon the completion of a specified
period of service, the occurrence of an event and/or the attainment of performance objectives. Other Stock Based Awards may be granted
alone or in addition to any other Awards granted under the Plan. Subject to the provisions of the Plan, the Committee shall determine
to whom and when Other Stock Based Awards will be made, the number of Shares to be awarded under (or otherwise related to) such Other
Stock Based Awards; whether such Other Stock Based Awards shall be settled in cash, Shares or a combination of cash and Shares; and all
other terms and conditions of such Awards (including, without limitation, the vesting provisions thereof and provisions ensuring that
all Shares so awarded and issued shall be fully paid and non-assessable).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Restricted
Stock Awards and Restricted Stock Units</U>. The Committee may grant Restricted Stock or Restricted Stock Units at any time and from
time to time prior to the expiration of the Plan to eligible Participants selected by the Committee. A Participant shall have rights
as a stockholder with respect to any Shares subject to a Restricted Stock award hereunder only to the extent specified in the Restricted
Stock agreement evidencing such Award. Awards of Restricted Stock or Restricted Stock Units shall be evidenced only by such agreements,
notices and/or terms or conditions documented in such form (including by electronic communications) as may be approved by the Committee.
Awards of Restricted Stock or Restricted Stock Units granted pursuant to the Plan need not be identical but each must contain or be subject
to the following terms and conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <I>Terms
and Conditions</I>. Each Restricted Stock agreement and each Restricted Stock Unit agreement shall contain provisions regarding (a) the
number of Shares subject to such Award or a formula for determining such, (b) the purchase price of the Shares, if any, and the means
of payment for the Shares, (c) the performance criteria, if any, and level of achievement versus these criteria that shall determine
the number of Shares granted, issued, retainable and/or vested, (d) such terms and conditions on the grant, issuance, vesting and/or
forfeiture of the Shares as may be determined from time to time by the Committee, (e) restrictions on the transferability of the Shares
and (f) such further terms and conditions as may be determined from time to time by the Committee, in each case not inconsistent with
this Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) <I>Restricted
Stock Units</I>. Except to the extent this Plan or the Committee specifies otherwise, Restricted Stock Units represent an unfunded and
unsecured obligation of the Company and do not confer any of the rights of a stockholder until Shares are issued thereunder. Settlement
of Restricted Stock Units upon expiration of the deferral or vesting period shall be made in Shares or otherwise as determined by the
Committee. Dividends or dividend equivalent rights shall be payable in cash or in additional shares with respect to Restricted Stock
Units only to the extent specifically provided for by the Committee. Until a Restricted Stock Unit is settled, the number of Shares represented
by a Restricted Stock Unit shall be subject to adjustment pursuant to Section 9. Any Restricted Stock Units that are settled after the
Participant&rsquo;s death shall be distributed to the Participant&rsquo;s designated beneficiary(ies) or, if none was designated, the
Participant&rsquo;s estate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) <I>Share
Vesting</I>. The grant, issuance, retention and/or vesting of Shares under Restricted Stock or Restricted Stock Unit Awards shall be
at such time and in such installments as determined by the Committee or under criteria established by the Committee. The Committee shall
have the right to make the timing of the grant and/or the issuance, ability to retain and/or vesting of Shares under Restricted Stock
or Restricted Stock Unit Awards subject to continued employment, passage of time and/or such performance criteria (as described in more
detail in Section 8(c) below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Performance
Based Awards</U>. Notwithstanding anything to the contrary herein, certain Other Stock Based Awards granted under this Section 8 may
be based on the attainment of written performance goals approved by the Committee for a performance period established by the Committee
(&ldquo;Performance Based Awards&rdquo;). The Committee shall determine whether, with respect to a performance period, the applicable
performance goals have been met with respect to a given participant and, if they have, shall so certify. In connection with such certification,
the Committee, or its delegate, may decide that the amount of the Performance Based Award actually paid to a given Participant may be
less than the amount determined by the applicable performance goal formula; provided that the Committee shall have the authority to waive
any applicable performance goals. In the event the applicable performance goals are not waived by the Committee, payment of a Performance
Based Award will occur only after certification and will be made as determined by the Committee in its sole discretion after the end
of the applicable performance period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.
ADJUSTMENTS UPON CERTAIN EVENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
any other provisions in the Plan to the contrary, the following provisions shall apply to all Awards granted under the Plan:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Generally</U>.
In the event of any change in the outstanding Shares after the Effective Date by reason of any Share dividend or split, reorganization,
recapitalization, merger, consolidation, spin-off, combination or exchange of Shares or other corporate exchange or change in capital
structure, any distribution or special dividend to stockholders of Shares, cash or other property (other than regular cash dividends)
or any similar event, the Committee without liability to any person shall make such substitution or adjustment, if any, as it deems to
be equitable (subject to Section 17), as to the number or kind of Shares or other securities issued or reserved for issuance as set forth
in Section 4 of the Plan or pursuant to outstanding Awards and the per share exercise price thereof, as applicable; provided that the
Committee shall determine in its sole discretion the manner in which such substitution or adjustment shall be made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Change
of Control</U>. In the event of a Change of Control (or similar corporate transaction, whether or not including any Permitted Holder)
after the Effective Date, the Committee shall accelerate, vest or cause the restrictions to lapse with respect to all or any portion
of an Award. With respect to any Awards that are vested pursuant to the preceding sentence, the Committee may (A) cancel such Awards
for fair value (as determined in the sole discretion of the Committee) which, in the case of Awards, may equal the excess, if any, of
value of the consideration to be paid in the Change of Control transaction to holders of the same number of Shares subject to such Awards
(or, if no consideration is paid in any such transaction, the Fair Market Value of the Shares subject to such Awards) over the aggregate
exercise price of such Awards, (B) provide for the issuance of substitute Awards that will substantially preserve the otherwise applicable
terms of any affected Awards previously granted hereunder as determined by the Committee in its sole discretion or (C) provide that for
a period of at least 10 days prior to the Change of Control, such Awards shall be exercisable as to all shares subject thereto and that
upon the occurrence of the Change of Control, such Awards shall terminate and be of no further force or effect. For the avoidance of
doubt, pursuant to (A) above, the Committee may cancel Awards for no consideration if the aggregate Fair Market Value of the Shares subject
to such Awards is less than or equal to the aggregate Award Price of such Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.
NO RIGHT TO EMPLOYMENT OR AWARDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
granting of an Award under the Plan shall impose no obligation on the Company or any of its Affiliates to continue the Employment of
a Participant and shall not lessen or affect the Company&rsquo;s or any Affiliate&rsquo;s right to terminate the Employment of such Participant.
No Participant or other Person shall have any claim to be granted any Award and there is no obligation for uniformity of treatment of
Participants, holders or beneficiaries of Awards. The terms and conditions of Awards and the Committee&rsquo;s determinations and interpretations
with respect thereto need not be the same with respect to each Participant (whether or not such Participants are similarly situated).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11.
SUCCESSORS AND ASSIGNS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan shall be binding on all successors and assigns of the Company and the Participants, including, without limitation, the estate of
each such Participant and the executor, administrator or trustee of such estate, and any receiver or trustee in bankruptcy or any other
representative of the Participant&rsquo;s creditors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12.
NONTRANSFERABILITY OF AWARDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise determined by the Committee, an Award shall not be transferable or assignable by the Participant otherwise than by will or
by the laws of descent and distribution. An Award exercisable after the death of a Participant may be exercised by the legatees, personal
representatives or distributees of the Participant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>13.
AMENDMENTS OR TERMINATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may amend, alter or discontinue the Plan, but no amendment, alteration or discontinuation shall be made which (a) without the
approval of the stockholders of the Company, would (except as is provided in Section 11 of the Plan) increase the total number of Shares
reserved for the purposes of the Plan or change the maximum number of Shares for which Awards may be granted to any Participant or (b)
without the consent of a Participant, would materially adversely impair any of the rights under any Award theretofore granted to such
Participant under the Plan; provided, however, that the Committee may amend the Plan in such manner as it deems necessary to permit the
granting of Awards meeting the requirements of the Code or other applicable laws (including, without limitation, to avoid adverse tax
consequences to the Company or any Participant). Except as set forth in Section 9 hereof, in no event may the Committee or any other
entity reprice any Award or substitute an outstanding Award for a new Award with a lower exercise price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
limiting the generality of the foregoing, to the extent applicable, notwithstanding anything herein to the contrary, this Plan and Awards
issued hereunder shall be interpreted in accordance with Section 409A of the Code and Department of Treasury regulations and other interpretative
guidance issued thereunder, including without limitation any such regulations or other guidance that may be issued after the Effective
Date. Notwithstanding any provision of the Plan to the contrary, in the event that the Committee determines that any amounts payable
hereunder will be taxable to a Participant under Section 409A of the Code and related Department of Treasury guidance prior to payment
to such Participant of such amount, the Company may (a) adopt such amendments to the Plan and Awards and adopt such appropriate policies
and procedures, including amendments and policies or procedures with retroactive effect, that the Committee determines necessary or appropriate
to preserve the intended tax treatment of the benefits provided by the Plan and Awards hereunder and/or (b) take such other actions as
the Committee determines necessary or appropriate to avoid the imposition of an additional tax under Section 409A of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>14.
INTERNATIONAL PARTICIPANTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to Participants who reside or work outside the United States of America, the Committee may, in its sole discretion, amend the
terms of the Plan or Awards with respect to such Participants in order to conform such terms with the requirements of local law or to
obtain more favorable tax or other treatment for a Participant, the Company or an Affiliate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>15.
CHOICE OF LAW</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan shall be governed by and construed in accordance with the laws of the State of Delaware without regard to conflicts of laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>16.
EFFECTIVENESS OF THE PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan shall be effective as of the Effective Date, subject to the approval of the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>17.
SECTION 409A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
other provisions of the Plan or any Award agreements thereunder, no Award shall be granted, deferred, accelerated, extended, paid out
or modified under this Plan in a manner that would result in the imposition of an additional tax under Section 409A of the Code upon
a Participant. In the event that it is reasonably determined by the Committee that, as a result of Section 409A of the Code, any payment
or delivery of Shares in respect of any Award under the Plan may not be made at the time contemplated by the terms of the Plan or the
relevant Award agreement, as the case may be, without causing the Participant holding such Award to be subject to taxation under Section
409A of the Code, the Company will make such payment or delivery of Shares on the first day that would not result in the Participant
incurring any tax liability under Section 409A of the Code. In the case of a Participant who is a &ldquo;specified employee&rdquo; (within
the meaning of Section 409A(a)(2)(B)(i) of the Code), any payment and/or delivery of Shares in respect of any Award subject to Section
409A of the Code that are linked to the date of the Participant&rsquo;s separation from service shall not be made prior to the date which
is six (6) months after the date of such Participant&rsquo;s separation from service from the Company and its affiliates, determined
in accordance with Section 409A of the Code and the regulations promulgated thereunder. The Company shall use commercially reasonable
efforts to implement the provisions of this Section 17 in good faith; provided that neither the Company, the Committee nor any of the
Company&rsquo;s employees, directors or representatives shall have any liability to Participants with respect to this Section 17.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 9; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4
<SEQUENCE>5
<FILENAME>ex4.htm
<DESCRIPTION>EX-4
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><B><A NAME="ex_003"></A>Exhibit 4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
PROPHASE LABS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMENDED
AND RESTATED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2022
DIRECTORS&rsquo; EQUITY COMPENSATION PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.
PURPOSE OF THE PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the Plan is to attract and retain highly qualified individuals to serve on the Board of Directors of the Company, to relate
Directors&rsquo; compensation more closely to the Company&rsquo;s performance and its stockholders&rsquo; interests, and to increase
Directors&rsquo; stock ownership in the Company. The Company expects that it will benefit from the added interest which such Directors
will have in the welfare of the Company as a result of their proprietary interest in the Company&rsquo;s success.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.
AMENDMENT AND RESTATEMENT; EFFECTIVE DATE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan, originally titled&nbsp;<I>The Quigley Corporation 2010 Directors&rsquo; Equity Compensation Plan</I>, was ratified by the Company&rsquo;s
stockholders at the Company&rsquo;s Annual Meeting of Stockholders on May 5, 2010. The Plan was subsequently amended by the Board, titled
the 2010 Directors&rsquo; Equity Compensation Plan, and ratified by the Company&rsquo;s stockholders at the Company&rsquo;s Annual Meeting
of Stockholders on May 6, 2013, May 23, 2018 and May 20, 2021. As renamed, the Amended and Restated 2022 Directors&rsquo; Equity Compensation
Plan became effective on April 11, 2022 and, as further amended and restated herein, this Amended and Restated 2022 Directors&rsquo;
Equity Compensation Plan became effective on the Effective Date, subject to the approval of the Company&rsquo;s stockholders; and amends
and restates the 2022 Directors&rsquo; Equity Compensation Plan in its entirety.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.
DEFINITIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following capitalized terms used in the Plan have the respective meanings set forth in this Section:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Affiliate</U>:
With respect to the Company, any entity directly or indirectly controlling, controlled by or under common control with, the Company or
any other entity designated by the Board in which the Company or an Affiliate has an interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Award</U>:
An Option, Restricted Stock, Restricted Stock Unit, or Other Stock Based Award granted pursuant to the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Beneficial
Owner</U>: A &ldquo;beneficial owner,&rdquo; as such term is defined in Rule 13d-3 under the Exchange Act (or any successor rule thereto).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Board</U>:
The Board of Directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Change
of Control</U>: The occurrence of any of the following events:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
A change in the ownership of the Company that occurs on the date that any one Person, or more than one Person acting as a group, acquires
ownership of the Shares that, together with the Shares held by such Person, constitutes more than 50% of the total voting power of the
Shares of the Company. No Change of Control shall have occurred in the event Ted Karkus (the &ldquo;Executive&rdquo;) or a group which
includes Executive acquires more than 50% of the voting control of the Company. The acquisition of additional Shares by any one Person,
who is considered to own more than 50% of the total voting power of the Shares of the Company will not be considered an additional Change
of Control; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
A change in the effective control of the Company that occurs on the date that a majority of members of the Board is replaced during any
12 month period by directors whose appointment or election is not endorsed by one of either the Executive or a majority of the members
of the Board prior to the date of the appointment or election; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
A change in the ownership of a &ldquo;substantial portion of the Company&rsquo;s assets&rdquo;, as defined herein. For this purpose,
a &ldquo;substantial portion of the Company&rsquo;s assets&rdquo; shall mean assets of the Company having a total gross fair market value
equal to or more than 50% of the total gross fair market value of all of the assets of the Company immediately prior to such change in
ownership. For purposes of this subsection (iii), a change in ownership of a substantial portion of the Company&rsquo;s assets occurs
on the date that any Person acquires (or has acquired during the 12 month period ending on the date of the most recent acquisition by
such Person or Persons) assets from the Company that constitute a &ldquo;substantial portion of the Company&rsquo;s assets.&rdquo; For
purposes of this subsection (iii), the following will not constitute a change in the ownership of a substantial portion of the Company&rsquo;s
assets: (a) a transfer to an entity that is controlled by the Company&rsquo;s stockholders immediately after the transfer, or (b) a transfer
of assets by the Company to: (1) a stockholder of the Company (immediately before the asset transfer) in exchange for or with respect
to the Company&rsquo;s stock, (2) an entity, 50% or more of the total value or voting power of which is owned, directly or indirectly,
by the Company, (3) a Person, that owns, directly or indirectly, 50% or more of the total value or voting power of all the outstanding
stock of the Company, or (4) an entity, at least 50% of the total value or voting power of which is owned, directly or indirectly, by
a Person described in this subsection (iii). For purposes of this subsection (iii), gross fair market value means the value of the assets
of the Company, or the value of the assets being disposed of, determined without regard to any liabilities associated with such assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this definition, persons will be considered to be acting as a group if they are owners of a corporation that enters into
a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, a transaction will not be deemed a Change of Control unless the transaction qualifies as a change in control event within
the meaning of Section 409A of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the avoidance of doubt, a transaction will not constitute a Change of Control if its primary purpose is to: (1) change the state of the
Company&rsquo;s incorporation, (2) create a holding company that will be owned in substantially the same proportions by the Persons who
hold the Company&rsquo;s securities immediately before such transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <U>Code</U>:
The Internal Revenue Code of 1986, as amended, or any successor thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) <U>Committee</U>:
The compensation committee of the Board (or a subcommittee thereof as provided under Section 5, or such other committee of the Board
(including, without limitation, the full Board) to which the Board has delegated power to act under or pursuant to the provisions of
the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) <U>Company</U>:
ProPhase Labs, Inc., a Delaware corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <U>Director</U>:
A non-employee member of the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) <U>Disability</U>:
Inability of a Participant to perform in all material respects his duties and responsibilities to the Company, or any Subsidiary of the
Company, by reason of a physical or mental disability or infirmity which inability is reasonably expected to be permanent and has continued
(i) for a period of six consecutive months or (ii) such shorter period as the Committee may reasonably determine in good faith. The Disability
determination shall be in the sole discretion of the Committee and a Participant (or his representative) shall furnish the Committee
with medical evidence documenting the Participant&rsquo;s disability or infirmity which is satisfactory to the Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) <U>Effective
Date</U>: April 23, 2023, subject to the approval of the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) <U>Exchange
Act</U>: The Securities Exchange Act of 1934, as amended, or any successor thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) <U>Fair
Market Value</U>: On a given date, (i) if there should be a public market for the Shares on such date, the closing price of the Shares
as reported on such date on the composite tape of the principal national securities exchange on which such Shares are listed or admitted
to trading, or, if no composite tape exists for such national securities exchange on such date, then the closing price on the principal
national securities exchange on which such Shares are listed or admitted to trading, or, (ii) if the Shares are not listed or admitted
on a national securities exchange, the arithmetic mean of the per Share closing bid price and per Share closing asked price on such date
as quoted on the National Association of Securities Dealers Automated Quotation System (or such other market in which such prices for
the Shares are regularly quoted), or, (iii) if there is no market on which the Shares are regularly quoted, the Fair Market Value shall
be the value established by the Committee in good faith and consistent with Section 409A of the Code;&nbsp;<U>provided</U>,&nbsp;<U>however&nbsp;</U>that
in determining the Fair Market value, the Committee shall not apply a discount for any minority interest. With respect to (i) and (ii)
above, if no sale of Shares shall have been reported on such composite tape or such national securities exchange on such date or quoted
on the National Association of Securities Dealer Automated Quotation System or other applicable market on such date, then the immediately
preceding date on which sales of the Shares have been so reported or quoted shall be used.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n) <U>Option</U>:
A stock option granted pursuant to Section 7 of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o) <U>Option
Price</U>: The purchase price per Share of an Option, as determined pursuant to Section 7(a) of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p) <U>Participant</U>:
A Director of the Company or any of its Affiliates who is selected by the Committee to participate in the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q) <U>Permitted
Holders</U>: &ldquo;Permitted Holder&rdquo; means, as of the date of determination, any and all of (i) an employee benefit plan (or
trust forming a part thereof) maintained by (A) the Company, or (B) any corporation or other Person of which a majority of its
voting power of its voting equity securities or equity interest is owned, directly or indirectly, by the Company, or (ii) any
stockholder of the Company who, together with its affiliates, owns 50% or more of the total voting power of all classes of voting
stock of the Company as of the Effective Date, or any affiliate(s) of such stockholder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r) <U>Person</U>:
A &ldquo;person,&rdquo; as such term is used for purposes of Section 13(d) or 14(d) of the Act (or any successor section
thereto).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s) <U>Plan</U>:
The ProPhase Labs, Inc. Amended and Restated 2022 Directors&rsquo; Equity Compensation Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t) <U>Restricted
Stock:</U>&nbsp;An Award granted pursuant to Section 8(b) of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u) <U>Restricted
Stock Unit</U>: An Award granted pursuant to Section 8(b) of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) <U>Shares</U>:
Shares of common stock of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w) <U>Subsidiary</U>:
A subsidiary corporation, as defined in Section 424(f) of the Code (or any successor section thereto).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.
SHARES SUBJECT TO THE PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to this Section 4 and Section 9 of the Plan, the total number of Shares which may be issued under the Plan is the sum of (i) the number
of Shares available under the Plan immediately prior to stockholder approval of this Plan (as of April 23, 2023, 180,000 Shares were
available under this Plan subject to the counting adjustment and substitution provisions of the Plan) and (ii) 150,000 Shares, plus (iii)
that number of Shares that are represented by awards which previously have been granted and are outstanding under the Plan (including
those granted under the predecessor 2010 Directors&rsquo; Equity Compensation Plan) on the date the Plan, as amended and restated, is
approved by stockholders of the Company and which subsequently expire or otherwise lapse, are terminated or forfeited, are settled in
cash, or exchanged with the Committee&rsquo;s permission, prior to the issuance of Shares, for Awards not involving shares of Common
Stock, without the issuance of the underlying Shares. The Shares may consist, in whole or in part, of unissued Shares or treasury Shares.
The issuance of Shares or in consideration of the cancellation or termination of an Award shall reduce the total number of Shares available
under the Plan, as applicable. Shares which are subject to Awards which terminate, expire, forfeit, or lapse without the payment of consideration
(or Awards settled in cash in lieu of Shares) may be granted again under the Plan. If the exercise price of an Award is paid by delivering
to the Company Shares previously owned by the Participant or if Shares are delivered or withheld for purposes of satisfying a tax withholding
obligation, the number of Shares covered by the Award equal to the number of Shares so delivered or withheld shall, however, be counted
against the number of Shares granted and shall not again be available for Awards under the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.
ADMINISTRATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan shall be administered by the Committee. The Committee is authorized to interpret the Plan, to establish, amend and rescind any rules
and regulations relating to the Plan, and to make any other determinations that it deems necessary or advisable for the administration
of the Plan. The Committee may correct any defect or supply any omission or reconcile any inconsistency in the Plan in the manner and
to the extent the Committee deems necessary or advisable. Any decision of the Committee in the interpretation and administration of the
Plan, as described herein, shall lie within its sole and absolute discretion and shall be final, conclusive and binding on all parties
concerned (including, but not limited to, Participants and their beneficiaries or successors). The Committee shall have the full power
and authority to establish the terms and conditions of any Award consistent with the provisions of the Plan and to waive any such terms
and conditions at any time (including, without limitation, accelerating or waiving any vesting conditions). Determinations made by the
Committee under the Plan need not be uniform and may be made selectively among Participants, whether or not such Participants are similarly
situated. Awards may, in the discretion of the Committee, be awarded under the Plan in assumption of, or in substitution for, outstanding
Awards previously granted by the Company, any of its Affiliates or any of their respective predecessors, or any entity acquired by the
Company or with which the Company combines. The number of Shares underlying such substitute Awards shall be counted against the aggregate
number of Shares available for Awards under the Plan. The Committee shall require payment of any minimum amount it may determine to be
necessary to withhold for federal, state, local or other, taxes as a result of the exercise, vesting or grant of an Award. Unless the
Committee specifies otherwise, the Participant may elect to pay a portion or all of such withholding taxes by (a) delivery in Shares
or (b) having Shares withheld by the Company from any Shares that would have otherwise been received by the Participant. The number of
Shares so delivered or withheld shall have an aggregate Fair Market Value sufficient to satisfy the applicable withholding taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.
LIMITATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
Award may be granted under the Plan after the tenth anniversary of the Effective Date, but Awards theretofore granted may extend beyond
that date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.
TERMS AND CONDITIONS OF OPTIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
granted under the Plan shall be, as determined by the Committee, non-qualified or incentive stock options for federal income tax purposes,
as evidenced by the related Option agreements, and shall be subject to the foregoing and the following terms and conditions and to such
other terms and conditions, not inconsistent therewith, as the Committee shall determine:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Option
Price</U>. The Option Price per Share shall be determined by the Committee, but shall not be less than 100% of the Fair Market Value
of a Share on the date an Option is granted (other than in the case of Options granted in substitution of previously granted Options,
as described in Section 4).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Exercisability</U>.
Options granted under the Plan shall be exercisable at such time and upon such terms and conditions as may be determined by the Committee,
but in no event shall an Option be exercisable more than seven years after the date it is granted. Each Option agreement shall set forth
the extent to which the Participant shall have the right to exercise the Option following termination of the Participant&rsquo;s service
with the Company or its Affiliates. Such provisions shall be determined in the sole discretion of the Committee, shall be included in
the applicable Option agreements, need not be uniform among all Options issued pursuant to the Plan, and may reflect distinctions based
on the reasons for termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Exercise
of Options</U>. Except as otherwise provided in the Plan or in an Option agreement, an Option may be exercised for all, or from time
to time any part, of the Shares for which it is then exercisable. For purposes of Section 7 of the Plan, the exercise date of an Option
shall be the later of the date a notice of exercise is received by the Company and, if applicable, the date payment is received by the
Company pursuant to clauses (i), (ii), (iii) or (iv) in the following sentence. The purchase price for the Shares as to which an Option
is exercised shall be paid to the Company to the extent permitted by law, (i) in cash or its equivalent (e.g., by personal check) at
the time the Option is exercised, (ii) in Shares having a Fair Market Value equal to the aggregate Option Price for the Shares being
purchased and satisfying such other requirements as may be imposed by the Committee;&nbsp;<U>provided&nbsp;</U>that such Shares have
been held by the Participant for no less than six months (or such other period as established from time to time by the Committee in order
to avoid adverse accounting treatment applying generally accepted accounting principles), (iii) partly in cash and partly in Shares (as
described in (ii) above), (iv) if there is a public market for the Shares at such time, and provided that a sale of Shares by the Participant
is permitted at such time under the Company&rsquo;s insider trading policy then in effect, through the delivery of irrevocable instructions
to a broker to sell Shares obtained upon the exercise of the Option and to deliver promptly to the Company an amount out of the proceeds
of such Sale equal to the aggregate Option Price for the Shares being purchased or (v) to the extent the Committee shall approve in the
Option agreement or otherwise, through &ldquo;net settlement&rdquo; in Shares. In the case of a &ldquo;net settlement&rdquo; of an Option,
the Company will not require a cash payment of the Option Price of the Option set forth in the Option agreement, but will reduce the
number of Shares issued upon the exercise by the largest number of whole Shares that have a Fair Market Value that does not exceed the
aggregate Option Price set forth in the Option agreement. With respect to any remaining balance of the aggregate Option Price, the Company
shall accept a cash payment. No Participant shall have any rights to dividends or other rights of a stockholder with respect to Shares
subject to an Option until the Participant has given written notice of exercise of the Option, paid in full for such Shares and, if applicable,
has satisfied any other conditions imposed by the Committee pursuant to the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Attestation</U>.
Wherever in this Plan or in any agreement evidencing an Option a Participant is permitted to pay the exercise price of an Option or
taxes relating to the exercise of an Option by delivering Shares, the Participant may, subject to procedures satisfactory to the
Committee, satisfy such delivery requirement by presenting proof of beneficial ownership of such Shares, in which case the Company
shall, as appropriate, (i) treat the Option as exercised without further payment and/or (ii) withhold such number of Shares from the
Shares acquired by the exercise of the Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.
OTHER STOCK-BASED AWARDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Generally</U>.
The Committee, in its sole discretion, may grant or sell Awards of Shares, Awards of restricted Shares and Awards that are valued in
whole or in part by reference to, or are otherwise based on the Fair Market Value of, Shares (&ldquo;<U>Other Stock-Based Awards</U>&rdquo;).
Such Other Stock-Based Awards shall be in such form, and dependent on such conditions, as the Committee shall determine, including, without
limitation, the right to receive one or more Shares (or the equivalent cash value of such Shares) upon the completion of a specified
period of service, the occurrence of an event and/or the attainment of performance objectives. Other Stock-Based Awards may be granted
alone or in addition to any other Awards granted under the Plan. Subject to the provisions of the Plan, the Committee shall determine
to whom and when Other Stock-Based Awards will be made, the number of Shares to be awarded under (or otherwise related to) such Other
Stock-Based Awards; whether such Other Stock-Based Awards shall be settled in cash, Shares or a combination of cash and Shares; and all
other terms and conditions of such Awards (including, without limitation, the vesting provisions thereof and provisions ensuring that
all Shares so awarded and issued shall be fully paid and non-assessable).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Restricted
Stock Awards and Restricted Stock Units</U>. The Committee may grant Restricted Stock or Restricted Stock Units at any time and from
time to time prior to the expiration of the Plan to eligible Participants selected by the Committee. A Participant shall have rights
as a stockholder with respect to any Shares subject to a Restricted Stock award hereunder only to the extent specified in the
Restricted Stock agreement evidencing such Award. Awards of Restricted Stock or Restricted Stock Units shall be evidenced only by
such agreements, notices and/or terms or conditions documented in such form (including by electronic communications) as may be
approved by the Committee. Awards of Restricted Stock or Restricted Stock Units granted pursuant to the Plan need not be identical
but each must contain or be subject to the following terms and conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <I>Terms
and Conditions</I>. Each Restricted Stock agreement and each Restricted Stock Unit agreement shall contain provisions regarding (A)
the number of Shares subject to such Award or a formula for determining such, (B) the purchase price of the Shares, if any, and the
means of payment for the Shares, (C) the performance criteria, if any, and level of achievement versus these criteria that shall
determine the number of Shares granted, issued, retainable and/or vested, (D) such terms and conditions on the grant, issuance,
vesting and/or forfeiture of the Shares as may be determined from time to time by the Committee, (E) restrictions on the
transferability of the Shares and (F) such further terms and conditions as may be determined from time to time by the Committee, in
each case not inconsistent with this Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) <I>Restricted
Stock Units</I>. Except to the extent this Plan or the Committee specifies otherwise, Restricted Stock Units represent an unfunded
and unsecured obligation of the Company and do not confer any of the rights of a stockholder until Shares are issued thereunder.
Settlement of Restricted Stock Units upon expiration of the deferral or vesting period shall be made in Shares or otherwise as
determined by the Committee. Dividends or dividend equivalent rights shall be payable in cash or in additional shares with respect
to Restricted Stock Units only to the extent specifically provided for by the Committee. Until a Restricted Stock Unit is settled,
the number of Shares represented by a Restricted Stock Unit shall be subject to adjustment pursuant to Section 9. Any Restricted
Stock Units that are settled after the Participant&rsquo;s death shall be distributed to the Participant&rsquo;s designated
beneficiary(ies) or, if none was designated, the Participant&rsquo;s estate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) <I>Share
Vesting</I>. The grant, issuance, retention and/or vesting of Shares under Restricted Stock or Restricted Stock Unit Awards shall be
at such time and in such installments as determined by the Committee or under criteria established by the Committee. The Committee
shall have the right to make the timing of the grant and/or the issuance, ability to retain and/or vesting of Shares under
Restricted Stock or Restricted Stock Unit Awards subject to continued employment, passage of time and/or such performance criteria
(as described in more detail in Section 8(c) below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Performance
Based Awards</U>. Notwithstanding anything to the contrary herein, certain Other Stock Based Awards granted under this Section 8 may
be based on the attainment of written performance goals approved by the Committee for a performance period established by the Committee
(&ldquo;Performance Based Awards&rdquo;). The Committee shall determine whether, with respect to a performance period, the applicable
performance goals have been met with respect to a given participant and, if they have, shall so certify. In connection with such certification,
the Committee, or its delegate, may decide that the amount of the Performance Based Award actually paid to a given Participant may be
less than the amount determined by the applicable performance goal formula; provided that the Committee shall have the authority to waive
any applicable performance goals. In the event the applicable performance goals are not waived by the Committee, payment of a Performance
Based Award will occur only after certification and will be made as determined by the Committee in its sole discretion after the end
of the applicable performance period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.
ADJUSTMENTS UPON CERTAIN EVENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
any other provisions in the Plan to the contrary, the following provisions shall apply to all Awards granted under the Plan:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Generally</U>.
In the event of any change in the outstanding Shares after the Effective Date by reason of any Share dividend or split, reorganization,
recapitalization, merger, consolidation, spin-off, combination or exchange of Shares or other corporate exchange or change in capital
structure, any distribution or special dividend to stockholders of Shares, cash or other property (other than regular cash dividends)
or any similar event, the Committee without liability to any person shall make such substitution or adjustment, if any, as it deems to
be equitable (subject to Section 17), as to the number or kind of Shares or other securities issued or reserved for issuance as set forth
in Section 4 of the Plan or pursuant to outstanding Awards and the per share exercise price, as applicable;&nbsp;<U>provided&nbsp;</U>that
the Committee shall determine in its sole discretion the manner in which such substitution or adjustment shall be made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Change
of Control</U>. In the event of a Change of Control (or similar corporate transaction, whether or not including any Permitted Holder)
after the Effective Date, the Committee shall accelerate, vest or cause the restrictions to lapse with respect to all or any portion
of an Award. With respect to any Awards that are vested pursuant to the preceding sentence, the Committee may (A) cancel such Awards
for fair value (as determined in the sole discretion of the Committee) which, in the case of Awards, may equal the excess, if any, of
value of the consideration to be paid in the Change of Control transaction to holders of the same number of Shares subject to such Awards
(or, if no consideration is paid in any such transaction, the Fair Market Value of the Shares subject to such Awards) over the aggregate
exercise price of such Awards, (B) provide for the issuance of substitute Awards that will substantially preserve the otherwise applicable
terms of any affected Awards previously granted hereunder as determined by the Committee in its sole discretion or (C) provide that for
a period of at least 10 days prior to the Change of Control, such Awards shall be exercisable as to all shares subject thereto and that
upon the occurrence of the Change of Control, such Awards shall terminate and be of no further force or effect. For the avoidance of
doubt, pursuant to (A) above, the Committee may cancel Awards for no consideration if the aggregate Fair Market Value of the Shares subject
to such Awards is less than or equal to the aggregate Award Price of such Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.
NO RIGHT TO AWARDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
Participant or other Person shall have any claim to be granted any Award and there is no obligation for uniformity of treatment of Participants,
holders or beneficiaries of Awards. The terms and conditions of Awards and the Committee&rsquo;s determinations and interpretations with
respect thereto need not be the same with respect to each Participant (whether or not such Participants are similarly situated).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11.
SUCCESSORS AND ASSIGNS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan shall be binding on all successors and assigns of the Company and the Participants, including, without limitation, the estate of
each such Participant and the executor, administrator or trustee of such estate, and any receiver or trustee in bankruptcy or any other
representative of the Participant&rsquo;s creditors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12.
NONTRANSFERABILITY OF AWARDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise determined by the Committee, an Award shall not be transferable or assignable by the Participant otherwise than by will or
by the laws of descent and distribution. An Award exercisable after the death of a Participant may be exercised by the legatees, personal
representatives or distributees of the Participant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>13.
AMENDMENTS OR TERMINATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may amend, alter or discontinue the Plan, but no amendment, alteration or discontinuation shall be made which (a) without the
approval of the stockholders of the Company, would (except as is provided in Section 9 of the Plan) increase the total number of Shares
reserved for the purposes of the Plan or change the maximum number of Shares for which Awards may be granted to any Participant, or (b)
without the consent of a Participant, would materially adversely impair any of the rights under any Award theretofore granted to such
Participant under the Plan;&nbsp;<U>provided</U>,&nbsp;<U>however</U>, that the Committee may amend the Plan in such manner as it deems
necessary to permit the granting of Awards meeting the requirements of the Code or other applicable laws (including, without limitation,
to avoid adverse tax consequences to the Company or any Participant). Except as set forth in Section 9 hereof, in no event may the Committee
or any other entity reprice any Award or substitute an outstanding Award for a new Award with a lower exercise price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
limiting the generality of the foregoing, to the extent applicable, notwithstanding anything herein to the contrary, this Plan and Awards
issued hereunder shall be interpreted in accordance with Section 409A of the Code and Department of Treasury regulations and other interpretative
guidance issued thereunder, including without limitation any such regulations or other guidance that may be issued after the Effective
Date. Notwithstanding any provision of the Plan to the contrary, in the event that the Committee determines that any amounts payable
hereunder will be taxable to a Participant under Section 409A of the Code and related Department of Treasury guidance prior to payment
to such Participant of such amount, the Company may (a) adopt such amendments to the Plan and Awards and adopt appropriate policies and
procedures, including amendments and policies or procedures with retroactive effect, that the Committee determines necessary or appropriate
to preserve the intended tax treatment of the benefits provided by the Plan and Awards hereunder and/or (b) take such other actions as
the Committee determines necessary or appropriate to avoid the imposition of an additional tax under Section 409A of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>14.
INTERNATIONAL PARTICIPANTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to Participants who reside or work outside the United States of America, the Committee may, in its sole discretion, amend the
terms of the Plan or Awards with respect to such Participants in order to conform such terms with the requirements of local law or to
obtain more favorable tax or other treatment for a Participant, the Company or an Affiliate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>15.
CHOICE OF LAW</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan shall be governed by and construed in accordance with the laws of the State of Delaware without regard to conflicts of laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>16.
EFFECTIVENESS OF THE PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan shall be effective as of the Effective Date, subject to the approval of the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>17.
SECTION 409A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
other provisions of the Plan or any Award agreements thereunder, no Award shall be granted, deferred, accelerated, extended, paid out
or modified under this Plan in a manner that would result in the imposition of an additional tax under Section 409A of the Code upon
a Participant. In the event that it is reasonably determined by the Committee that, as a result of Section 409A of the Code, any payment
or delivery of Shares in respect of any Award under the Plan may not be made at the time contemplated by the terms of the Plan or the
relevant Award agreement, as the case may be, without causing the Participant holding such Award to be subject to taxation under Section
409A of the Code, the Company will make such payment or delivery of Shares on the first day that would not result in the Participant
incurring any tax liability under Section 409A of the Code. In the case of a Participant who is a &ldquo;specified employee&rdquo; (within
the meaning of Section 409A(a)(2)(B)(i) of the Code), any payment and/or delivery of Shares in respect of any Award subject to Section
409A of the Code that are linked to the date of the Participant&rsquo;s separation from service shall not be made prior to the date which
is six (6) months after the date of such Participant&rsquo;s separation from service from the Company and its affiliates, determined
in accordance with Section 409A of the Code and the regulations promulgated thereunder. The Company shall use commercially reasonable
efforts to implement the provisions of this Section 17 in good faith;&nbsp;<U>provided that</U>&nbsp;neither the Company, the Committee
nor any of the Company&rsquo;s employees, directors or representatives shall have any liability to Participants with respect to this
Section 17.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5
<SEQUENCE>6
<FILENAME>ex5.htm
<DESCRIPTION>EX-5
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><B><A NAME="ex_004"></A>Exhibit 5</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
PROPHASE LABS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMENDED
AND RESTATED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2025
DIRECTORS&rsquo; EQUITY COMPENSATION PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.
PURPOSE OF THE PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the Plan is to attract and retain highly qualified individuals to serve on the Board of Directors of the Company, to relate
Directors&rsquo; compensation more closely to the Company&rsquo;s performance and its stockholders&rsquo; interests, and to increase
Directors&rsquo; stock ownership in the Company. The Company expects that it will benefit from the added interest which such Directors
will have in the welfare of the Company as a result of their proprietary interest in the Company&rsquo;s success.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.
AMENDMENT AND RESTATEMENT; EFFECTIVE DATE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan, originally titled&nbsp;<I>The Quigley Corporation 2010 Directors&rsquo; Equity Compensation Plan</I>, was ratified by the Company&rsquo;s
stockholders at the Company&rsquo;s Annual Meeting of Stockholders on May 5, 2010. The Plan was subsequently amended by the Board, titled
the 2010 Directors&rsquo; Equity Compensation Plan, and ratified by the Company&rsquo;s stockholders at the Company&rsquo;s Annual Meeting
of Stockholders on May 6, 2013, May 23, 2018, May 20, 2021, and June 16, 2023 (the &ldquo;Amended and Restated 2022 Directors&rsquo;
Equity Compensation Plan&rdquo;). As renamed, the Amended and Restated 2025 Directors&rsquo; Equity Compensation Plan became
effective immediately upon stockholder approval at the August 29, 2025, Special Meeting; and amends and restates the Amended and
Restated 2022 Directors&rsquo; Equity Compensation Plan in its entirety.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.
DEFINITIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following capitalized terms used in the Plan have the respective meanings set forth in this Section:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Affiliate</U>: With respect to the Company, any entity directly or indirectly controlling, controlled by or under common control with,
the Company or any other entity designated by the Board in which the Company or an Affiliate has an interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Award</U>: An Option, Restricted Stock, Restricted Stock Unit, or Other Stock Based Award granted pursuant to the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Beneficial Owner</U>: A &ldquo;beneficial owner,&rdquo; as such term is defined in Rule 13d-3 under the Exchange Act (or any successor
rule thereto).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Board</U>: The Board of Directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Change of Control</U>: The occurrence of any of the following events:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
A change in the ownership of the Company that occurs on the date that any one Person, or more than one Person acting as a group, acquires
ownership of the Shares that, together with the Shares held by such Person, constitutes more than 50% of the total voting power of the
Shares of the Company. No Change of Control shall have occurred in the event Ted Karkus (the &ldquo;Executive&rdquo;) or a group which
includes Executive acquires more than 50% of the voting control of the Company. The acquisition of additional Shares by any one Person,
who is considered to own more than 50% of the total voting power of the Shares of the Company will not be considered an additional Change
of Control; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
A change in the effective control of the Company that occurs on the date that a majority of members of the Board is replaced during any
12 month period by directors whose appointment or election is not endorsed by one of either the Executive or a majority of the members
of the Board prior to the date of the appointment or election; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
A change in the ownership of a &ldquo;substantial portion of the Company&rsquo;s assets&rdquo;, as defined herein. For this purpose,
a &ldquo;substantial portion of the Company&rsquo;s assets&rdquo; shall mean assets of the Company having a total gross fair market value
equal to or more than 50% of the total gross fair market value of all of the assets of the Company immediately prior to such change in
ownership. For purposes of this subsection (iii), a change in ownership of a substantial portion of the Company&rsquo;s assets occurs
on the date that any Person acquires (or has acquired during the 12 month period ending on the date of the most recent acquisition by
such Person or Persons) assets from the Company that constitute a &ldquo;substantial portion of the Company&rsquo;s assets.&rdquo; For
purposes of this subsection (iii), the following will not constitute a change in the ownership of a substantial portion of the Company&rsquo;s
assets: (a) a transfer to an entity that is controlled by the Company&rsquo;s stockholders immediately after the transfer, or (b) a transfer
of assets by the Company to: (1) a stockholder of the Company (immediately before the asset transfer) in exchange for or with respect
to the Company&rsquo;s stock, (2) an entity, 50% or more of the total value or voting power of which is owned, directly or indirectly,
by the Company, (3) a Person, that owns, directly or indirectly, 50% or more of the total value or voting power of all the outstanding
stock of the Company, or (4) an entity, at least 50% of the total value or voting power of which is owned, directly or indirectly, by
a Person described in this subsection (iii). For purposes of this subsection (iii), gross fair market value means the value of the assets
of the Company, or the value of the assets being disposed of, determined without regard to any liabilities associated with such assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this definition, persons will be considered to be acting as a group if they are owners of a corporation that enters into
a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, a transaction will not be deemed a Change of Control unless the transaction qualifies as a change in control event within
the meaning of Section 409A of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the avoidance of doubt, a transaction will not constitute a Change of Control if its primary purpose is to: (1) change the state of the
Company&rsquo;s incorporation, (2) create a holding company that will be owned in substantially the same proportions by the Persons who
hold the Company&rsquo;s securities immediately before such transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Code</U>: The Internal Revenue Code of 1986, as amended, or any successor thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Committee</U>: The compensation committee of the Board (or a subcommittee thereof as provided under Section 5, or such other committee
of the Board (including, without limitation, the full Board) to which the Board has delegated power to act under or pursuant to the provisions
of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Company</U>: ProPhase Labs, Inc., a Delaware corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Director</U>: A non-employee member of the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Disability</U>: Inability of a Participant to perform in all material respects his duties and responsibilities to the Company, or
any Subsidiary of the Company, by reason of a physical or mental disability or infirmity which inability is reasonably expected to be
permanent and has continued (i) for a period of six consecutive months or (ii) such shorter period as the Committee may reasonably determine
in good faith. The Disability determination shall be in the sole discretion of the Committee and a Participant (or his representative)
shall furnish the Committee with medical evidence documenting the Participant&rsquo;s disability or infirmity which is satisfactory to
the Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Effective Date</U>: August 29, 2025, subject to the approval of the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Exchange Act</U>: The Securities Exchange Act of 1934, as amended, or any successor thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Fair Market Value</U>: On a given date, (i) if there should be a public market for the Shares on such date, the closing price of the
Shares as reported on such date on the composite tape of the principal national securities exchange on which such Shares are listed or
admitted to trading, or, if no composite tape exists for such national securities exchange on such date, then the closing price on the
principal national securities exchange on which such Shares are listed or admitted to trading, or, (ii) if the Shares are not listed
or admitted on a national securities exchange, the arithmetic mean of the per Share closing bid price and per Share closing asked price
on such date as quoted on the National Association of Securities Dealers Automated Quotation System (or such other market in which such
prices for the Shares are regularly quoted), or, (iii) if there is no market on which the Shares are regularly quoted, the Fair Market
Value shall be the value established by the Committee in good faith and consistent with Section 409A of the Code;&nbsp;<U>provided</U>,&nbsp;<U>however&nbsp;</U>that
in determining the Fair Market value, the Committee shall not apply a discount for any minority interest. With respect to (i) and (ii)
above, if no sale of Shares shall have been reported on such composite tape or such national securities exchange on such date or quoted
on the National Association of Securities Dealer Automated Quotation System or other applicable market on such date, then the immediately
preceding date on which sales of the Shares have been so reported or quoted shall be used.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Option</U>: A stock option granted pursuant to Section 7 of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Option Price</U>: The purchase price per Share of an Option, as determined pursuant to Section 7(a) of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
<U>Participant</U>: A Director of the Company or any of its Affiliates who is selected by the Committee to participate in the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
<U>Permitted Holders</U>: &ldquo;Permitted Holder&rdquo; means, as of the date of determination, any and all of (i) an employee benefit
plan (or trust forming a part thereof) maintained by (A) the Company, or (B) any corporation or other Person of which a majority of its
voting power of its voting equity securities or equity interest is owned, directly or indirectly, by the Company, or (ii) any stockholder
of the Company who, together with its affiliates, owns 50% or more of the total voting power of all classes of voting stock of the Company
as of the Effective Date, or any affiliate(s) of such stockholder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
<U>Person</U>: A &ldquo;person,&rdquo; as such term is used for purposes of Section 13(d) or 14(d) of the Act (or any successor section
thereto).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
<U>Plan</U>: The ProPhase Labs, Inc. Amended and Restated 2025 Directors&rsquo; Equity Compensation Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
<U>Restricted Stock:</U>&nbsp;An Award granted pursuant to Section 8(b) of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
<U>Restricted Stock Unit</U>: An Award granted pursuant to Section 8(b) of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>Shares</U>: Shares of common stock of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
<U>Subsidiary</U>: A subsidiary corporation, as defined in Section 424(f) of the Code (or any successor section thereto).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.
SHARES SUBJECT TO THE PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to this Section 4 and Section 9 of the Plan, the total number of Shares which may be issued under the Plan is the sum of (i) the number
of Shares available under the Plan immediately prior to stockholder approval of this Plan (as of July 25, 2025, 100,000 Shares
were available under this Plan subject to the counting adjustment and substitution provisions of the Plan) and (ii) 500,000 Shares,
plus (iii) that number of Shares that are represented by awards which previously have been granted and are outstanding under the Plan
(including those granted under the predecessor Equity Compensation Plans) on the date the Plan, as amended and restated, is approved
by stockholders of the Company and which subsequently expire or otherwise lapse, are terminated or forfeited, are settled in cash, or
exchanged with the Committee&rsquo;s permission, prior to the issuance of Shares, for Awards not involving shares of Common Stock, without
the issuance of the underlying Shares. The Shares may consist, in whole or in part, of unissued Shares or treasury Shares. The issuance
of Shares or in consideration of the cancellation or termination of an Award shall reduce the total number of Shares available under
the Plan, as applicable. Shares which are subject to Awards which terminate, expire, forfeit, or lapse without the payment of consideration
(or Awards settled in cash in lieu of Shares) may be granted again under the Plan. If the exercise price of an Award is paid by delivering
to the Company Shares previously owned by the Participant or if Shares are delivered or withheld for purposes of satisfying a tax withholding
obligation, the number of Shares covered by the Award equal to the number of Shares so delivered or withheld shall, however, be counted
against the number of Shares granted and shall not again be available for Awards under the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.
ADMINISTRATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan shall be administered by the Committee. The Committee is authorized to interpret the Plan, to establish, amend and rescind any rules
and regulations relating to the Plan, and to make any other determinations that it deems necessary or advisable for the administration
of the Plan. The Committee may correct any defect or supply any omission or reconcile any inconsistency in the Plan in the manner and
to the extent the Committee deems necessary or advisable. Any decision of the Committee in the interpretation and administration of the
Plan, as described herein, shall lie within its sole and absolute discretion and shall be final, conclusive and binding on all parties
concerned (including, but not limited to, Participants and their beneficiaries or successors). The Committee shall have the full power
and authority to establish the terms and conditions of any Award consistent with the provisions of the Plan and to waive any such terms
and conditions at any time (including, without limitation, accelerating or waiving any vesting conditions). Determinations made by the
Committee under the Plan need not be uniform and may be made selectively among Participants, whether or not such Participants are similarly
situated. Awards may, in the discretion of the Committee, be awarded under the Plan in assumption of, or in substitution for, outstanding
Awards previously granted by the Company, any of its Affiliates or any of their respective predecessors, or any entity acquired by the
Company or with which the Company combines. The number of Shares underlying such substitute Awards shall be counted against the aggregate
number of Shares available for Awards under the Plan. The Committee shall require payment of any minimum amount it may determine to be
necessary to withhold for federal, state, local or other, taxes as a result of the exercise, vesting or grant of an Award. Unless the
Committee specifies otherwise, the Participant may elect to pay a portion or all of such withholding taxes by (a) delivery in Shares
or (b) having Shares withheld by the Company from any Shares that would have otherwise been received by the Participant. The number of
Shares so delivered or withheld shall have an aggregate Fair Market Value sufficient to satisfy the applicable withholding taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.
LIMITATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
Award may be granted under the Plan after the tenth anniversary of the Effective Date, but Awards theretofore granted may extend beyond
that date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.
TERMS AND CONDITIONS OF OPTIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
granted under the Plan shall be, as determined by the Committee, non-qualified or incentive stock options for federal income tax purposes,
as evidenced by the related Option agreements, and shall be subject to the foregoing and the following terms and conditions and to such
other terms and conditions, not inconsistent therewith, as the Committee shall determine:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Option Price</U>. The Option Price per Share shall be determined by the Committee, but shall not be less than 100% of the Fair Market
Value of a Share on the date an Option is granted (other than in the case of Options granted in substitution of previously granted Options,
as described in Section 4).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Exercisability</U>. Options granted under the Plan shall be exercisable at such time and upon such terms and conditions as may be
determined by the Committee, but in no event shall an Option be exercisable more than seven years after the date it is granted. Each
Option agreement shall set forth the extent to which the Participant shall have the right to exercise the Option following termination
of the Participant&rsquo;s service with the Company or its Affiliates. Such provisions shall be determined in the sole discretion of
the Committee, shall be included in the applicable Option agreements, need not be uniform among all Options issued pursuant to the Plan,
and may reflect distinctions based on the reasons for termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Exercise of Options</U>. Except as otherwise provided in the Plan or in an Option agreement, an Option may be exercised for all, or
from time to time any part, of the Shares for which it is then exercisable. For purposes of Section 7 of the Plan, the exercise date
of an Option shall be the later of the date a notice of exercise is received by the Company and, if applicable, the date payment is received
by the Company pursuant to clauses (i), (ii), (iii) or (iv) in the following sentence. The purchase price for the Shares as to which
an Option is exercised shall be paid to the Company to the extent permitted by law, (i) in cash or its equivalent (e.g., by personal
check) at the time the Option is exercised, (ii) in Shares having a Fair Market Value equal to the aggregate Option Price for the Shares
being purchased and satisfying such other requirements as may be imposed by the Committee;&nbsp;<U>provided&nbsp;</U>that such Shares
have been held by the Participant for no less than six months (or such other period as established from time to time by the Committee
in order to avoid adverse accounting treatment applying generally accepted accounting principles), (iii) partly in cash and partly in
Shares (as described in (ii) above), (iv) if there is a public market for the Shares at such time, and provided that a sale of Shares
by the Participant is permitted at such time under the Company&rsquo;s insider trading policy then in effect, through the delivery of
irrevocable instructions to a broker to sell Shares obtained upon the exercise of the Option and to deliver promptly to the Company an
amount out of the proceeds of such Sale equal to the aggregate Option Price for the Shares being purchased or (v) to the extent the Committee
shall approve in the Option agreement or otherwise, through &ldquo;net settlement&rdquo; in Shares. In the case of a &ldquo;net settlement&rdquo;
of an Option, the Company will not require a cash payment of the Option Price of the Option set forth in the Option agreement, but will
reduce the number of Shares issued upon the exercise by the largest number of whole Shares that have a Fair Market Value that does not
exceed the aggregate Option Price set forth in the Option agreement. With respect to any remaining balance of the aggregate Option Price,
the Company shall accept a cash payment. No Participant shall have any rights to dividends or other rights of a stockholder with respect
to Shares subject to an Option until the Participant has given written notice of exercise of the Option, paid in full for such Shares
and, if applicable, has satisfied any other conditions imposed by the Committee pursuant to the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Attestation</U>. Wherever in this Plan or in any agreement evidencing an Option a Participant is permitted to pay the exercise price
of an Option or taxes relating to the exercise of an Option by delivering Shares, the Participant may, subject to procedures satisfactory
to the Committee, satisfy such delivery requirement by presenting proof of beneficial ownership of such Shares, in which case the Company
shall, as appropriate, (i) treat the Option as exercised without further payment and/or (ii) withhold such number of Shares from the
Shares acquired by the exercise of the Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.
OTHER STOCK-BASED AWARDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Generally</U>. The Committee, in its sole discretion, may grant or sell Awards of Shares, Awards of restricted Shares and Awards that
are valued in whole or in part by reference to, or are otherwise based on the Fair Market Value of, Shares (&ldquo;<U>Other Stock-Based
Awards</U>&rdquo;). Such Other Stock-Based Awards shall be in such form, and dependent on such conditions, as the Committee shall determine,
including, without limitation, the right to receive one or more Shares (or the equivalent cash value of such Shares) upon the completion
of a specified period of service, the occurrence of an event and/or the attainment of performance objectives. Other Stock-Based Awards
may be granted alone or in addition to any other Awards granted under the Plan. Subject to the provisions of the Plan, the Committee
shall determine to whom and when Other Stock-Based Awards will be made, the number of Shares to be awarded under (or otherwise related
to) such Other Stock-Based Awards; whether such Other Stock-Based Awards shall be settled in cash, Shares or a combination of cash and
Shares; and all other terms and conditions of such Awards (including, without limitation, the vesting provisions thereof and provisions
ensuring that all Shares so awarded and issued shall be fully paid and non-assessable).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Restricted Stock Awards and Restricted Stock Units</U>. The Committee may grant Restricted Stock or Restricted Stock Units at any
time and from time to time prior to the expiration of the Plan to eligible Participants selected by the Committee. A Participant shall
have rights as a stockholder with respect to any Shares subject to a Restricted Stock award hereunder only to the extent specified in
the Restricted Stock agreement evidencing such Award. Awards of Restricted Stock or Restricted Stock Units shall be evidenced only by
such agreements, notices and/or terms or conditions documented in such form (including by electronic communications) as may be approved
by the Committee. Awards of Restricted Stock or Restricted Stock Units granted pursuant to the Plan need not be identical but each must
contain or be subject to the following terms and conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<I>Terms and Conditions</I>. Each Restricted Stock agreement and each Restricted Stock Unit agreement shall contain provisions regarding
(A) the number of Shares subject to such Award or a formula for determining such, (B) the purchase price of the Shares, if any, and the
means of payment for the Shares, (C) the performance criteria, if any, and level of achievement versus these criteria that shall determine
the number of Shares granted, issued, retainable and/or vested, (D) such terms and conditions on the grant, issuance, vesting and/or
forfeiture of the Shares as may be determined from time to time by the Committee, (E) restrictions on the transferability of the Shares
and (F) such further terms and conditions as may be determined from time to time by the Committee, in each case not inconsistent with
this Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<I>Restricted Stock Units</I>. Except to the extent this Plan or the Committee specifies otherwise, Restricted Stock Units represent
an unfunded and unsecured obligation of the Company and do not confer any of the rights of a stockholder until Shares are issued thereunder.
Settlement of Restricted Stock Units upon expiration of the deferral or vesting period shall be made in Shares or otherwise as determined
by the Committee. Dividends or dividend equivalent rights shall be payable in cash or in additional shares with respect to Restricted
Stock Units only to the extent specifically provided for by the Committee. Until a Restricted Stock Unit is settled, the number of Shares
represented by a Restricted Stock Unit shall be subject to adjustment pursuant to Section 9. Any Restricted Stock Units that are settled
after the Participant&rsquo;s death shall be distributed to the Participant&rsquo;s designated beneficiary(ies) or, if none was designated,
the Participant&rsquo;s estate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
<I>Share Vesting</I>. The grant, issuance, retention and/or vesting of Shares under Restricted Stock or Restricted Stock Unit Awards
shall be at such time and in such installments as determined by the Committee or under criteria established by the Committee. The Committee
shall have the right to make the timing of the grant and/or the issuance, ability to retain and/or vesting of Shares under Restricted
Stock or Restricted Stock Unit Awards subject to continued employment, passage of time and/or such performance criteria (as described
in more detail in Section 8(c) below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Performance Based Awards</U>. Notwithstanding anything to the contrary herein, certain Other Stock Based Awards granted under this
Section 8 may be based on the attainment of written performance goals approved by the Committee for a performance period established
by the Committee (&ldquo;Performance Based Awards&rdquo;). The Committee shall determine whether, with respect to a performance period,
the applicable performance goals have been met with respect to a given participant and, if they have, shall so certify. In connection
with such certification, the Committee, or its delegate, may decide that the amount of the Performance Based Award actually paid to a
given Participant may be less than the amount determined by the applicable performance goal formula; provided that the Committee shall
have the authority to waive any applicable performance goals. In the event the applicable performance goals are not waived by the Committee,
payment of a Performance Based Award will occur only after certification and will be made as determined by the Committee in its sole
discretion after the end of the applicable performance period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.
ADJUSTMENTS UPON CERTAIN EVENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
any other provisions in the Plan to the contrary, the following provisions shall apply to all Awards granted under the Plan:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Generally</U>. In the event of any change in the outstanding Shares after the Effective Date by reason of any Share dividend or split,
reorganization, recapitalization, merger, consolidation, spin-off, combination or exchange of Shares or other corporate exchange or change
in capital structure, any distribution or special dividend to stockholders of Shares, cash or other property (other than regular cash
dividends) or any similar event, the Committee without liability to any person shall make such substitution or adjustment, if any, as
it deems to be equitable (subject to Section 17), as to the number or kind of Shares or other securities issued or reserved for issuance
as set forth in Section 4 of the Plan or pursuant to outstanding Awards and the per share exercise price, as applicable;&nbsp;<U>provided&nbsp;</U>that
the Committee shall determine in its sole discretion the manner in which such substitution or adjustment shall be made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Change of Control</U>. In the event of a Change of Control (or similar corporate transaction, whether or not including any Permitted
Holder) after the Effective Date, the Committee shall accelerate, vest or cause the restrictions to lapse with respect to all or any
portion of an Award. With respect to any Awards that are vested pursuant to the preceding sentence, the Committee may (A) cancel such
Awards for fair value (as determined in the sole discretion of the Committee) which, in the case of Awards, may equal the excess, if
any, of value of the consideration to be paid in the Change of Control transaction to holders of the same number of Shares subject to
such Awards (or, if no consideration is paid in any such transaction, the Fair Market Value of the Shares subject to such Awards) over
the aggregate exercise price of such Awards, (B) provide for the issuance of substitute Awards that will substantially preserve the otherwise
applicable terms of any affected Awards previously granted hereunder as determined by the Committee in its sole discretion or (C) provide
that for a period of at least 10 days prior to the Change of Control, such Awards shall be exercisable as to all shares subject thereto
and that upon the occurrence of the Change of Control, such Awards shall terminate and be of no further force or effect. For the avoidance
of doubt, pursuant to (A) above, the Committee may cancel Awards for no consideration if the aggregate Fair Market Value of the Shares
subject to such Awards is less than or equal to the aggregate Award Price of such Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.
NO RIGHT TO AWARDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
Participant or other Person shall have any claim to be granted any Award and there is no obligation for uniformity of treatment of Participants,
holders or beneficiaries of Awards. The terms and conditions of Awards and the Committee&rsquo;s determinations and interpretations with
respect thereto need not be the same with respect to each Participant (whether or not such Participants are similarly situated).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11.
SUCCESSORS AND ASSIGNS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan shall be binding on all successors and assigns of the Company and the Participants, including, without limitation, the estate of
each such Participant and the executor, administrator or trustee of such estate, and any receiver or trustee in bankruptcy or any other
representative of the Participant&rsquo;s creditors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12.
NONTRANSFERABILITY OF AWARDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise determined by the Committee, an Award shall not be transferable or assignable by the Participant otherwise than by will or
by the laws of descent and distribution. An Award exercisable after the death of a Participant may be exercised by the legatees, personal
representatives or distributees of the Participant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>13.
AMENDMENTS OR TERMINATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may amend, alter or discontinue the Plan, but no amendment, alteration or discontinuation shall be made which (a) without the
approval of the stockholders of the Company, would (except as is provided in Section 9 of the Plan) increase the total number of Shares
reserved for the purposes of the Plan or change the maximum number of Shares for which Awards may be granted to any Participant, or (b)
without the consent of a Participant, would materially adversely impair any of the rights under any Award theretofore granted to such
Participant under the Plan;&nbsp;<U>provided</U>,&nbsp;<U>however</U>, that the Committee may amend the Plan in such manner as it deems
necessary to permit the granting of Awards meeting the requirements of the Code or other applicable laws (including, without limitation,
to avoid adverse tax consequences to the Company or any Participant). Except as set forth in Section 9 hereof, in no event may the Committee
or any other entity reprice any Award or substitute an outstanding Award for a new Award with a lower exercise price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
limiting the generality of the foregoing, to the extent applicable, notwithstanding anything herein to the contrary, this Plan and Awards
issued hereunder shall be interpreted in accordance with Section 409A of the Code and Department of Treasury regulations and other interpretative
guidance issued thereunder, including without limitation any such regulations or other guidance that may be issued after the Effective
Date. Notwithstanding any provision of the Plan to the contrary, in the event that the Committee determines that any amounts payable
hereunder will be taxable to a Participant under Section 409A of the Code and related Department of Treasury guidance prior to payment
to such Participant of such amount, the Company may (a) adopt such amendments to the Plan and Awards and adopt appropriate policies and
procedures, including amendments and policies or procedures with retroactive effect, that the Committee determines necessary or appropriate
to preserve the intended tax treatment of the benefits provided by the Plan and Awards hereunder and/or (b) take such other actions as
the Committee determines necessary or appropriate to avoid the imposition of an additional tax under Section 409A of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>14.
INTERNATIONAL PARTICIPANTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to Participants who reside or work outside the United States of America, the Committee may, in its sole discretion, amend the
terms of the Plan or Awards with respect to such Participants in order to conform such terms with the requirements of local law or to
obtain more favorable tax or other treatment for a Participant, the Company or an Affiliate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>15.
CHOICE OF LAW</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan shall be governed by and construed in accordance with the laws of the State of Delaware without regard to conflicts of laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>16.
EFFECTIVENESS OF THE PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan shall be effective as of the Effective Date, subject to the approval of the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>17.
SECTION 409A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
other provisions of the Plan or any Award agreements thereunder, no Award shall be granted, deferred, accelerated, extended, paid out
or modified under this Plan in a manner that would result in the imposition of an additional tax under Section 409A of the Code upon
a Participant. In the event that it is reasonably determined by the Committee that, as a result of Section 409A of the Code, any payment
or delivery of Shares in respect of any Award under the Plan may not be made at the time contemplated by the terms of the Plan or the
relevant Award agreement, as the case may be, without causing the Participant holding such Award to be subject to taxation under Section
409A of the Code, the Company will make such payment or delivery of Shares on the first day that would not result in the Participant
incurring any tax liability under Section 409A of the Code. In the case of a Participant who is a &ldquo;specified employee&rdquo; (within
the meaning of Section 409A(a)(2)(B)(i) of the Code), any payment and/or delivery of Shares in respect of any Award subject to Section
409A of the Code that are linked to the date of the Participant&rsquo;s separation from service shall not be made prior to the date which
is six (6) months after the date of such Participant&rsquo;s separation from service from the Company and its affiliates, determined
in accordance with Section 409A of the Code and the regulations promulgated thereunder. The Company shall use commercially reasonable
efforts to implement the provisions of this Section 17 in good faith;&nbsp;<U>provided that</U>&nbsp;neither the Company, the Committee
nor any of the Company&rsquo;s employees, directors or representatives shall have any liability to Participants with respect to this
Section 17.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>7
<FILENAME>ex6.htm
<DESCRIPTION>EX-6
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>
<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="ex_005"></A>Exhibit
6</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CERTIFICATE
OF AMENDMENT OF CERTIFICATE OF INCORPORATION</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OF</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROPHASE
LABS, INC.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>NAME</U>. The name of the Corporation is PROPHASE LABS, INC. (the &ldquo;<U>Corporation</U>&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. <U>ADDRESS</U>.
The address of the Corporation&rsquo;s registered office in the State of Delaware is 874 Walker Road, Suite C, Dover, Kent County,
DE 19904. The name of its registered agent at such address is United Corporate Services, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. <U>PURPOSE</U>.
The nature of the business of the Corporation and the objects or purposes to be transacted, promoted or carried on by it are as
follows: To engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of the
State of Delaware,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<U>CAPITAL STOCK</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A. <U>Authorized
Shares</U>. The total number of shares of all classes of stock that the Corporation is authorized to issue is 1,001,000,000 defined
as follows: 1,000,000,000 shares of Common Stock, with a par value of $.0005 per share, and 1,000,000 shares of Preferred Stock,
with a par value of $.0005 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B. <U>Blank-Check
Preferred Stock</U>. &lsquo;The Board of Directors is hereby expressly authorized to provide, out of the unissued shares of
Preferred Stock, for one or more series of Preferred Stock and, with respect to each such series, to fix the number of shares
constituting such series and the designation of such series, the voting powers, if any, of the shares of such series, and the
preferences and relative, participating, optional or other special rights, if any, and any qualifications, limitations or
restrictions thereof, of the shares of such series. The powers, preferences and relative, participating, optional and other special
rights of each series of Preferred Stock, and the qualifications, limitations or restrictions thereof, if any, may differ from those
of any and all other series at any time outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<U>BOARD OF DIRECTORS</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A. <U>Number</U>.
The number of directors of the Corporation shall be fixed from time to time by the Bylaws and the number may be increased or
decreased as therein provided. In case of any increase in the number of directors, the additional directors shall be elected as
provided by the Bylaws by the directors or by the stockholders at an annual or special meeting. In case of any vacancy in the Board
of Directors for any cause, the remaining Directors, by affirmative vote of a majority of the whole Board of Directors, may elect a
successor to hold office for the unexpired term of the Director whose place is vacant and until the election of his
successor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
<U>Powers</U>. The Board of Directors is expressly authorized to make, alter or repeal the Bylaws of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C. <U>Elections</U>.
Elections of directors need not be by written ballot unless the Bylaws of the Corporation shall so provide.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6. <U>AMENDMENTS</U>.
The Corporation reserves the right to amend, alter, change or repeal any provision contained in this Certificate of Incorporation,
in the manner now or hereafier prescribed by statute, and all rights conferred upon stockholders herein are granted subject to
this reservation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<U>LIABILITY OF DIRECTORS</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
A director of the Corporation shall not be personally liable to the Corporation or its stockholders for monetary damages for breach
of fiduciary duty as a director, notwithstanding any provision of law imposing such liability, except for liability (i) for any
breach of the director&rsquo;s duty of loyalty to the Corporation or its stockholders, (ii) for acts or omissions not in good faith
or which involve intentional misconduct or a knowing violation of law, (iii) under Section 174 of the Delaware General Corporation
Law, as the same exists or hereafter may be amended, or (iv) for any transaction from which the director derived an improper
personal benefit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
If the Delaware General Corporation Law is hereafter amended or supplemented to authorize corporate action further limiting or
eliminating the personal liability of directors, then the liability of a director to the Corporation or its stockholders shall be
limited or eliminated to the fullest extent permitted by the Delaware General Corporation Law, as so amended or supplemented from
time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
Any repeal or modification of this Article shall be prospective only, and shall not adversely affect any limitation on the personal liability
of a director of the Corporation existing at the time of such repeal or modification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<U>INDEMNIFICATION</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
The Corporation shall, to the fullest extent permitted by the Delaware General Corporation Law, as the same may be amended or
supplemented from time to time, indemnify any and all past, present and future directors and officers of the Corporation, and any
other persons to which the DGCL permits this Corporation to provide indemnification (&ldquo;<U>Indemnified Persons</U>&rdquo;), from
and against any and all costs, expenses (including attorneys&rsquo; fees), damages, judgments, penalties, fines, punitive damages,
excise taxes assessed with respect to an employee benefit plan and amounts paid in settlement in connection with any action, suit or
proceeding, whether by or in the right of the Corporation, a class of its security holders or otherwise, in which the director or
officer may be involved as a party or otherwise, by reason of the fact that such person was serving as a director, officer, employee
or agent of the Corporation, including service with respect to an employee benefit plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
The Corporation is authorized to provide for the advancement of expenses to such Indemnified Persons as set forth in the Bylaws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
The right of indemnification provided in this Article shall not be exclusive, and shall be in addition to any rights to which any
person may otherwise be entitled by law, under the Bylaws of the Corporation, or under any agreement, vote of stockholders or
directors, or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.
Any repeal or modification of this Article shall be prospective only, and shall not adversely affect the rights of any person
referred to in this Article for or with respect to acts or omissions occurring prior to such repeal or modification,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<U>INCORPORATOR</U>. The name and mailing address of the sole incorporator is as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mailing
    Address</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    Me Cuddy </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">621
    N. Shady Retreat Road,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Doylestown,
    PA 18901</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10. <U>EFFECTIVE
DATE</U>. This Certificate of Incorporation shall be effective as of June 18, 2015 at 5:00 PM eastern standard time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
the undersigned, being the sole incorporator herein before named, for the purpose of forming a corporation pursuant to the General
Corporation Law of the State of Delaware, do make this certificate, hereby declaring and certifying that this is my act and deed and
the facts herein stated are true, and, accordingly, have hereunto set my hands this 16th day of June, 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><B>&nbsp;</B></P>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-7
<SEQUENCE>8
<FILENAME>ex7.htm
<DESCRIPTION>EX-7
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"> <B><A NAME="ex_006"></A>Exhibit 7</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>BYLAWS
OF</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>PROPHASE
LABS, INC.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(This
amendment shall become effective upon approval by the Company&rsquo;s shareholders at the 2025 Special Meeting of Shareholders.)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
I &ndash; OFFICES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1. The registered office of Prophase Labs, Inc. (the &ldquo;Corporation&rdquo;) in the State of Delaware is 874 Walker Road, Suite C,
Dover, DE 19904. The name of its registered agent at such address is United Corporate Services, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2. The Corporation may have such offices within or without the State of Delaware as the Board of Directors may designate or as the business
of the Corporation may require from time to time. The Corporation&rsquo;s principal place of business is 626 RXR Plaza, 6<SUP>th</SUP>
Floor, Uniondale, New York 11556, effective as of the date of shareholder approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
II &ndash; STOCKHOLDERS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1. ANNUAL MEETING: The annual meeting of stockholders shall be held each year on a date and a time designated by the Board of Directors.
At each annual meeting directors shall be elected and any other proper business may be transacted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2. SPECIAL MEETINGS: In addition to the rights of the holders of any series of Preferred Stock, special meetings of the stockholders
may be called at any time by (a) the Chairman or (b) the Board of Directors pursuant to a resolution approved by a majority of the whole
Board of Directors. Business transacted at any special meeting of stockholders shall be limited to the purposes stated in the notice
to stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
3. PLACE OF MEETING: The Board of Directors may designate any place, either within or without the State of Delaware, as the place of
meeting for any annual meeting or for any special meeting called by the Board of Directors. The Board of Directors may, in its sole discretion,
determine that the meeting shall not be held at any place, but may instead be held solely by means of remote communication as provided
under the Delaware General Corporation Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4. NOTICE OF MEETING: Whenever stockholders are required or permitted to take any action at a meeting, a written notice of any such meeting
shall be given which notice shall state the place, date and hour of the meeting, and, in the case of a special meeting, the purpose or
purposes for which the meeting is called. The notice shall, unless otherwise prescribed by statute, be delivered not less than ten (10)
nor more than sixty (60) days before the date of the meeting, either personally or by mail, by or at the direction of the Chairman, to
each stockholder of record entitled to vote at such meeting. If mailed, such notice shall be deemed to be delivered when deposited in
the United States mail, addressed to the stockholder at his address as it appears on the stock transfer books of the Corporation, with
postage thereon prepaid. Notice of any meeting of the stockholders shall not be required to be given to any stockholder who shall attend
such meeting in person or by proxy without protesting, prior to or at the commencement of the meeting, the lack of proper notice to such
stockholder, or who shall waive notice thereof as provided in Article XI of these Bylaws. Notice of adjournment of a meeting of the stockholders
need not be given if the date, time and place, if any, to which it is adjourned, and any means of remote communication for such adjourned
meeting, are (i) announced at the meeting at which the adjournment is taken, (ii) displayed during the time scheduled for such meeting
on the same electronic network used to enable stockholders and proxy holders to participate in such meeting by means of remote communication
or (iii) set forth in the notice of such meeting given in accordance with the provisions of this Article 2.4; <I>provided, however</I>,
that if the adjournment is for more than 30 days or, after adjournment, a new record date is fixed for the adjourned meeting, then a
notice of the adjourned meeting shall be given to each stockholder of record entitled to vote at the meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 85; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5. NOTICE BY ELECTRONIC TRANSMISSION: Any notice to stockholder given by the Corporation pursuant to any provision of these Bylaws, the
Exchange Act (as defined in Article 2.15(b) below) or the Certificate of Incorporation shall be effective if given by a form of electronic
transmission consented to by the stockholder to whom the notice is given. The consent is revocable by the stockholder by written notice
to the Corporation. The consent is revoked if:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) The
Corporation is unable to deliver by electronic transmission two consecutive notices given by the Corporation in accordance with the consent;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) The
inability to deliver by electronic transmission becomes known to the secretary, assistant secretary, transfer agent or other agent of
the Corporation responsible for the giving of notice. However, the inadvertent failure to treat the inability to deliver notice by electronic
transmission as a revocation does not invalidate any meeting or other action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice
given pursuant to this Article 1.5 shall be deemed given if:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) By
facsimile machine, when directed to a number at which the stockholder has consented to receive notice;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) By
electronic mail, when directed to an electronic mail address at which the stockholder has consented to receive notice;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) By
posting on an electronic network together with separate notice to the stockholder of the specific posting, upon the later of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
                                            posting; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -15.65pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            giving of the separate notice; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -15.65pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By any other form of electronic transmission, when directed to the stockholder.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -15.65pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
used in this Article 1.5, &ldquo;electronic transmission&rdquo; means any form of communication not directly involving the physical transmission
of paper that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Creates
a record that may be retained, retrieved and reviewed by the recipient of the communication; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
May be directly reproduced in paper form by the recipient through an automated process.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 86; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6. CLOSING OF TRANSFER BOOKS OR FIXING OF RECORD DATE: For the purpose of determining stockholders entitled to notice of or to vote
at any meeting of stockholders or any adjournment thereof, or stockholders entitled to receive payment of any dividend, or in order
to make a determination of stockholders for any other proper purpose, the Board of Directors of the Corporation may provide that the
stock transfer books shall be closed for a stated period but not to exceed, in any case, sixty (60) days. In lieu of closing the
stock transfer books, the Board of Directors may fix in advance a date as the record date for any such determination of
stockholders, such date in any case to be not more than sixty (60) days, and, in case of a meeting of stockholders, not less than
ten (10) days prior to the date on which the particular action, requiring such determination of stockholders, is to be taken. If the
stock transfer books are not closed and no record date is fixed for the determination of stockholders entitled to notice of or to
vote at a meeting of stockholders, or stockholders entitled to receive payment of a dividend, the date on which notice of the
meeting is mailed or the date on which the resolution of the board of directors declaring such dividend is adopted, as the case may
be, shall be the record date for such determination of stockholders. But payment or allotment of dividends may not be made more than
sixty days after the date on which the resolution is adopted. When a determination of stockholders entitled to vote at any meeting
of stockholders has been made as provided in this Article 2.6, such determination shall apply to any adjournment thereof regardless
of its length except where the determination has been made through the closing of the stock transfer books and the stated period of
closing has expired.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
7. BOOKS AND ACCOUNTS: This Corporation shall keep and maintain at its principal office in this State:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A certified copy of its Certificate of Incorporation, and all amendments thereto.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -15.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A certified copy of its Bylaws, and all amendments thereto.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -15.65pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) A
stock ledger or a duplicate stock ledger, revised annually, containing the names, alphabetically arranged, of all persons who are stockholders
of the Corporation, showing their places of residence, if known, and the number of shares held by them respectively; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) In
lieu of the stock ledger or duplication stock ledger specified in paragraph (c), a statement setting out the name of the custodian of
the stock ledger or duplicate stock ledger, and the present and complete post office address, including street and number, if any, where
such stock ledger or duplicate stock ledger specified in this Article 1.7 is kept.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
8. QUORUM: A majority of the outstanding shares of the Corporation entitled to vote, represented in person or by proxy, shall constitute
a quorum at a meeting of stockholders; provided, however, that in the case of any vote to be taken by classes or series, the holders
of a majority of the votes entitled to be cast by the stockholders of a particular class or series, present in person or by proxy, shall
constitute a quorum of such class or series.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
9. ADJOURNMENTS; POSTPONEMENTS: In the absence of a quorum, holders of stock representing a majority of the voting power of all shares
present in person or represented by proxy at the meeting, or the chairman of the meeting, may adjourn any meeting of stockholders (including
an adjournment to address a technical failure to convene), from time to time, to reconvene at the same or some other place, and notice
need not be given of any such adjourned meeting if the time and place thereof are announced at the meeting at which the adjournment is
taken. Furthermore, after the meeting has been duly organized, the chairman of the meeting may adjourn any meeting of stockholders, from
time to time, to reconvene at the same or some other place, and notice need not be given of any such adjourned meeting if the date, time
and place, if any, thereof, and any means of remote communication for such meeting, are (i) announced at the meeting at which the adjournment
is taken, (ii) displayed during the time scheduled for such meeting on the same electronic network used to enable stockholders and proxy
holders to participate in such meeting by means of remote communication, or (iii) set forth in the notice of such meeting given in accordance
with the provisions of Article 2.4. At the adjourned meeting, the Corporation may transact any business which might have been transacted
at the original meeting. If the adjournment is for more than thirty (30) days, or if after the adjournment a new record date is fixed
for the adjourned meeting, a notice of the adjourned meeting shall be given to each stockholder of record entitled to vote at the meeting.
Any previously scheduled meeting of stockholders may be postponed by the Board of Directors prior to the date previously scheduled for
such meeting and the Corporation shall publicly announce such postponement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 87; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
10. PROXIES: At any meeting of stockholders, a stockholder may vote in person or by proxy executed in writing by the stockholder or by
his duly authorized attorney in fact. Proxies for use at any meeting of stockholders shall be in writing and filed with the Secretary,
or such other officer as the Board of Directors may from time to time determine by resolution, before or at the time of the meeting.
All proxies shall be received and taken charge of and all ballots shall be received and canvassed by the secretary of the meeting who
shall decide all questions touching upon the qualification of voters, the validity of the proxies and the acceptance or rejection of
votes, unless an inspector or inspectors shall have been appointed by the Chairman, in which event such inspector or inspectors shall
decide all such questions. Any stockholder directly or indirectly soliciting proxies from other stockholders must use a proxy card color
other than white, which shall be reserved for the exclusive use by the Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
proxy shall not be valid after six months from the date of its execution, unless coupled with an interest, but no proxy shall be valid
after seven years from the date of its execution, unless renewed or extended at any time before its expiration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
11. LIST OF STOCKHOLDERS ENTITLED TO VOTE: A complete list of stockholders entitled to vote at any meeting of stockholders, arranged
in alphabetical order and showing the address of each stockholder and the number of shares registered in the name of each stockholder,
shall be open to he examination of any stockholder, for any purpose germane to the meeting, for a period of ten (10) days ending on the
day before the meeting date, (i) on a reasonably accessible electronic network, provided that the information required to gain access
to such list is provided with the notice of the meeting, or (ii) during ordinary business hours, at the principal place of business of
the Corporation. In the event that the Corporation determines to make the list available on an electronic network, the Corporation may
take reasonable steps to ensure that such information is available only to the stockholders of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
12. VOTING AND ELECTIONS: Each stockholder of record of any series of Preferred Stock shall be entitled at each meeting of the stockholders
to such number of votes, if any, for each share of such stock as may be fixed in the Certificate of Incorporation or in the resolution
or resolutions adopted by the Board of Directors provide for the issuance of such Preferred Stock, and each stockholder of record of
Common Stock shall be entitled at each meeting of the stockholders to one vote for each share of such stock, in each case, registered
in such stockholder&rsquo;s name on the books of the Corporation: (i) on the date fixed pursuant to Section 6 of Article II of these
Bylaws as the record date for the determination of stockholders entitled to notice of and to vote at such meeting; or (ii) if no such
record date shall have been so fixed, then at the close of business on the day next preceding the day on which notice of such meeting
is given, or, if notice is waived, at the close of business on the day next preceding the day on which the meeting is held.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
each meeting of the stockholders, all corporate actions to be taken by vote of the stockholders (other than the election of directors)
shall be authorized by a majority of the votes cast by the stockholders entitled to vote thereon who are present in person or represented
by proxy, and where a separate vote by class or series is required, a majority of the votes cast by the stockholders of such class or
series who are present in person or represented by proxy shall be the act of such class or series. Directors shall be elected by a plurality
of the votes cast at a meeting of the stockholders by the holders of stock entitled to vote in the election of directors, provided a
quorum is present.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
13. VOTING OF SHARES BY CERTAIN HOLDERS: Shares standing in the name of another corporation may be voted by such officer, agent or proxy
as the bylaws or a resolution of the board of directors of such corporation may prescribe, and a certified copy of the by-law or resolution
is presented at the meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 88; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
held by an administrator, executor, guardian or conservator may be voted by him, either in person or by proxy, without a transfer of
shares into his name. A stockholder whose shares are pledged shall be entitled to vote such shares until the shares have been transferred
into the name of the pledgee, and thereafter the pledgee shall be entitled to vote the shares so transferred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
treasury shares of its own stock held by the Corporation, nor shares held by another corporation if a majority of the shares entitled
to vote for the election of directors of such other corporation are held by the corporation, shall be voted at any meeting or counted
in determining the total number of outstanding shares at any given time for purposes of any meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
14. VOTING TRUST: A stockholder, by agreement in writing, may transfer his stock to a voting trustee or trustees for the purpose of conferring
the right to vote thereon for a period not exceeding 15 years upon the terms and conditions therein stated. The certificates of stock
so transferred shall be surrendered and canceled and new certificates therefor issued to such trustee or trustees in which it shall appear
that they are issued pursuant to such agreement, and in the entry of such ownership in the proper books of such corporation that fact
shall also be noted, and thereupon such trustee or trustees may vote upon the stock so transferred during the terms of such agreement.
A duplicate of every such agreement shall be filed in the principal office of the corporation and at all times during such terms be open
to inspection by any stockholder or his attorney.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
15. NOMINATION OF DIRECTORS:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) In
addition to the rights of the holders of any series of Preferred Stock, nominations of any person for election to the Board of Directors
at an annual meeting or at a special meeting (but only if the election of directors is a matter specified in the notice of meeting given
by or at the direction of the person calling such special meeting) may be made at such meeting only (i) by or at the direction of the
Board of Directors, including by any committee or persons appointed by the Board of Directors, or (ii) by a stockholder who (A) was a
stockholder of record (and, with respect to any beneficial owner, if different, on whose behalf such nomination is proposed to be made,
only if such beneficial owner was the beneficial owner of shares of the Corporation) both at the time of giving the notice provided for
in this Article 2.15 and at the time of the meeting, (B) is entitled to vote at the meeting for the election of directors, and (C) has
complied with this Article 2.15 as to such nomination. The foregoing clause (ii) shall be the exclusive means for a stockholder to make
any nomination of a person or persons for election to the Board of Directors at an annual meeting or special meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Without
qualification, in addition to such stockholder complying with the provisions of Rule 14a-19 under the Securities Exchange Act of 1934,
as amended, and the rules and regulations thereunder (as so amended and inclusive of such rules and regulations, the &ldquo;Exchange
Act&rdquo;), for a stockholder to make any nomination of a person or persons for election to the Board of Directors at an annual meeting,
the stockholder must (i) provide Timely Notice (as defined in Article 2.16) thereof in writing and in proper form to the Secretary of
the Corporation either by personal delivery or by United States mail, postage prepaid, and (ii) provide any updates or supplements to
such notice at the times and in the forms required by this Article 2.15. Without qualification, if the election of directors is a matter
specified in the notice of meeting given by or at the direction of the person calling such special meeting, then for a stockholder to
make any nomination of a person or persons for election to the Board of Directors at a special meeting, the stockholder must (i) provide
timely notice thereof in writing and in proper form to the Secretary of the Corporation at the principal executive offices of the Corporation
either by personal delivery or by United States mail, postage prepaid, and (ii) provide any updates or supplements to such notice at
the times and in the forms required by this Article 2.15.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 89; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
be timely, a stockholder&rsquo;s notice for nominations to be made at a special meeting must be delivered to, or mailed and received
at, the principal executive offices of the Corporation not earlier than the one hundred twentieth (120th) day prior to such special meeting
and not later than the ninetieth (90th) day prior to such special meeting or, if such special meeting is announced later than the ninetieth
day prior to the date of such special meeting, the tenth (10th) day following the day on which public disclosure (as defined in Article
2.15) of the date of such special meeting was first made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
no event shall any adjournment of an annual meeting or special meeting or the announcement thereof commence a new time period for the
giving of a stockholder&rsquo;s notice as described above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) To
be in proper form for purposes of this Article 2.15, a stockholder&rsquo;s notice to the Secretary shall set forth:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) As
to each Nominating Person (as defined below), the Stockholder Information (as defined in Article 2.16(c)(i), except that for purposes
of this Article 2.15 the term &ldquo;Nominating Person&rdquo; shall be substituted for the term &ldquo;Proposing Person&rdquo; in all
places it appears in Article 2.16(c)(i));</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) As
to each Nominating Person, any Disclosable Interests (as defined in Article 2.16(c)(ii), except that for purposes of this Article 2.15
the term &ldquo;Nominating Person&rdquo; shall be substituted for the term &ldquo;Proposing Person&rdquo; in all places it appears in
Article 2.16(c)(ii) and the disclosure in clause (L) of Article 2.16(c)(ii) shall be made with respect to the election of directors at
the meeting);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) A
representation that the Nominating Person is a holder or record or beneficial owner of shares of the Corporation entitled to vote at
the meeting and intends to appear in person or by proxy at the meeting to nominate the person or persons specified in the notice;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv) A
representation as to whether the Nominating Person intends to solicit proxies in support of such person&rsquo;s nominee(s) in accordance
with Rule 14a-19 under the Exchange Act;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
A representation as to whether the Nominating Person intends or is part of a group that intends (x) to deliver a proxy statement
and/or a form of proxy to holders of at least the percentage of the Corporation&rsquo;s outstanding stock reasonably believed by the
Nominating Person to be sufficient to elect the nominee or nominees proposed to be nominating by the Nominating Person; (vi) As to
each person whom a Nominating Person proposes to nominate for election as a director, (A) all information with respect to such
proposed nominee that would be required to be set forth in a stockholder&rsquo;s notice pursuant to this Article 2.15 if such
proposed nominee were a Nominating Person, (B) all information relating to such proposed nominee that is required to be disclosed in
a proxy statement or other filings required to be made in connection with solicitations of proxies for election of directors in a
contested election pursuant to Article 14(a) under the Exchange Act (including such proposed nominee&rsquo;s written consent to
being named in the proxy statement as a nominee and to serving as a director if elected), (C) a description of all direct and
indirect compensation and other material monetary agreements, arrangements and understandings during the past three years, and any
other material relationships, between or among any Nominating Person, on the one hand, and each proposed nominee, his or her
respective affiliates and associates and any other persons with whom such proposed nominee (or any of his or her respective
affiliates and associates) is Acting in Concert (as defined in Article 2.16(c)), on the other hand, including, without limitation,
all information that would be required to be disclosed pursuant to Item 404 under Regulation S-K if such Nominating Person were the
&ldquo;registrant&rdquo; for purposes of such rule and the proposed nominee were a director or executive officer of such registrant,
and (D) a completed and signed questionnaire, representation and agreement as provided in Article 2.15(f); and (vi) The Corporation
may require any proposed nominee to furnish such other information (A) as may reasonably be required by the Corporation to determine
the eligibility of such proposed nominee to serve as an independent director of the Corporation in accordance with the
Corporation&rsquo;s corporate governance guidelines or (B) that could be material to a reasonable stockholder&rsquo;s understanding
of the independence or lack of independence of such proposed nominee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 90; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this Article 2.15, the term &ldquo;Nominating Person&rdquo; shall mean (i) the stockholder providing the notice of the nomination
proposed to be made at the meeting, (ii) the beneficial owner or beneficial owners, if different, on whose behalf the notice of the nomination
proposed to be made at the meeting is made, (iii) any affiliate or associate of such stockholder or beneficial owner, and (iv) any other
person with whom such stockholder or such beneficial owner (or any of their respective affiliates or associates) is Acting in Concert.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) A
stockholder providing notice of any nomination proposed to be made at a meeting shall further update and supplement such notice, if necessary,
so that the information provided or required to be provided in such notice pursuant to this Article 2.15 shall be true and correct as
of the record date for the meeting and as of the date that is ten (10) business days prior to the meeting or any adjournment or postponement
thereof, and such update and supplement shall be delivered to, or mailed and received by, the Secretary at the principal executive offices
of the Corporation not later than five (5) business days after the record date for the meeting (in the case of the update and supplement
required to be made as of the record date), and not later than eight (8) business days prior to the date for the meeting, if practicable
(or, if not practicable, on the first practicable date prior to) any adjournment or postponement thereof (in the case of the update and
supplement required to be made as of ten (10) business days prior to the meeting or any adjournment or postponement thereof).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) Notwithstanding
anything in these Bylaws to the contrary, no person shall be eligible for election as a director of the Corporation unless nominated
in accordance with this Article 2.15. The presiding officer at the meeting shall, if the facts warrant, determine that a nomination was
not properly made in accordance with this Article 2.15, and if he or she should so determine, he or she shall so declare such determination
to the meeting and the defective nomination shall be disregarded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) To
be eligible to be a nominee for election as a director of the Corporation, the proposed nominee must deliver (in accordance with the
time periods prescribed for delivery of notice under this Article 2.15) to the Secretary at the principal executive offices of the Corporation
a written questionnaire with respect to the background and qualification of such proposed nominee (which questionnaire shall be provided
by the Secretary upon written request) and a written representation and agreement (in form provided by the Secretary upon written request)
that such proposed nominee (i) is not and will not become a party to (A) any agreement, arrangement or understanding with, and has not
given any commitment or assurance to, any person or entity as to how such proposed nominee, if elected as a director of the Corporation,
will act or vote on any issue or question (a &ldquo;Voting Commitment&rdquo;) that has not been disclosed to the Corporation or (B) any
Voting Commitment that could limit or interfere with such proposed nominee&rsquo;s ability to comply, if elected as a director of the
Corporation, with such proposed nominee&rsquo;s fiduciary duties under applicable law, (ii) is not, and will not become a party to, any
agreement, arrangement or understanding with any person or entity other than the Corporation with respect to any direct or indirect compensation,
reimbursement or indemnification in connection with service or action as a director that has not been disclosed to the Corporation and
(iii) in such proposed nominee&rsquo;s individual capacity and on behalf of the stockholder (or the beneficial owner, if different) on
whose behalf the nomination is made, would be in compliance, if elected as a director of the Corporation, and will comply with applicable
publicly disclosed corporate governance, conflict of interest, confidentiality and stock ownership and trading policies and guidelines
of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 91; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) In
addition to the requirements of this Article 2.15 with respect to any nomination proposed to be made at a meeting, each Nominating Person
shall comply with all applicable requirements of the Exchange Act with respect to any such nominations. Unless otherwise required by
law, (i) no Nominating Person shall solicit proxies in support of director nominees other than the Corporation&rsquo;s nominees unless
such stockholder has complied with Rule 14a-19 under the Exchange Act in connection with the solicitation of such proxies, including
the provision to the Corporation of notices required thereunder in a timely manner, and (ii) if such stockholder (1) provides notice
pursuant to Rule 14a-19(b) under the Exchange Act and (2) subsequently fails to comply with all applicable requirements of Section 10
and this Article 2.15 and Rules 14a-19(a)(2) and 14a-19(a)(3) under the Exchange Act, then the Corporation shall disregard any proxies
or votes solicited for such Nominating Person&rsquo;s director nominees. Upon request by the Corporation, if any such Nominating Person
provides notice pursuant to Rule 14a- 19(b) under the Exchange Act, such Nominating Person shall deliver to the Corporation, no later
than five</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)
business days prior to the applicable meeting, reasonable evidence that it has met the requirements of Rule 14a-19(a)(3) under the Exchange
Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
16. NOTICE OF BUSINESS AT ANNUAL MEETINGS:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) At
an annual meeting of the stockholders, only such business shall be conducted as shall have been properly brought before the meeting.
To be properly brought before an annual meeting, business must be (i) brought before the meeting by the Corporation and specified in
the notice of meeting given by or at the direction of the Board of Directors, (ii) brought before the meeting by or at the direction
of the Board of Directors, or (iii) otherwise properly brought before the meeting by a stockholder who (A) was a stockholder of record
(and, with respect to any beneficial owner, if different, on whose behalf such business is proposed, only if such beneficial owner was
the beneficial owner of shares of the Corporation) both at the time of giving the notice provided for in this Article 2.16 and at the
time of the meeting, (B) is entitled to vote at the meeting, and (C) has complied with this Article 2.16 as to such business. Except
for proposals properly made in accordance with Rule 14a-8 under the Exchange Act, and included in the notice of meeting given by or at
the direction of the Board of Directors, the foregoing clause (iii) shall be the exclusive means for a stockholder to propose business
to be brought before an annual meeting of the stockholders. Stockholders shall not be permitted to propose business to be brought before
a special meeting of the stockholders, and the only matters that may be brought before a special meeting are the matters specified in
the notice of meeting given by or at the direction of the person calling the meeting. Stockholders seeking to nominate persons for election
to the Board must comply with Article 2.15 and this Article 2.16 shall not be applicable to nominations except as expressly provided
in Article 2.15.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Without
qualification, for business to be properly brought before an annual meeting by a stockholder, the stockholder must (i) provide Timely
Notice (as defined below) thereof in writing and in proper form to the Secretary of the Corporation either by personal delivery or by
United States mail, postage prepaid, and (ii) provide any updates or supplements to such notice at the times and in the forms required
by this Article 2.16. To be timely, a stockholder&rsquo;s notice must be delivered to, or mailed and received at, the principal executive
offices of the Corporation not less than ninety (90) days nor more than one hundred twenty (120) days prior to the one-year anniversary
of the preceding year&rsquo;s annual meeting; provided, however, that if the date of the annual meeting is more than thirty (30) days
before or more than sixty (60) days after such anniversary date, notice by the stockholder to be timely must be so delivered, or mailed
and received, not later than the ninetieth (90th) day prior to such annual meeting or, if such annual meeting is announced later than
the ninetieth day prior to the date of such annual meeting, the tenth (10th) day following the day on which public disclosure of the
date of such annual meeting was first made (such notice within such time periods, &ldquo;Timely Notice&rdquo;). In no event shall any
adjournment of an annual meeting or the announcement thereof commence a new time period for the giving of Timely Notice as described
above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 92; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) To
be in proper form for purposes of this Article 2.16, a stockholder&rsquo;s notice to the Secretary shall set forth:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) As
to each Proposing Person (as defined below), (A) the name and address of such Proposing Person (including, if applicable, the name and
address that appear on the Corporation&rsquo;s books and records); and (B) the class or series and number of shares of the Corporation
that are, directly or indirectly, owned of record or beneficially owned (within the meaning of Rule 13d-3 under the Exchange Act) by
such Proposing Persons, except that such Proposing Person shall in all events be deemed to beneficially own any shares of any class or
series of the Corporation as to which such Proposing Person has a right to acquire beneficial ownership at any time in the future (the
disclosures to be made pursuant to the foregoing clauses (i) and (ii) are referred to as &ldquo;Stockholder Information&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
As to each Proposing Person, (A) any derivative, swap or other transaction or series of transactions engaged in, directly or
indirectly, by such Proposing Person, the purpose or effect of which is to give such Proposing Person economic risk similar to
ownership of shares of any class or series of the Corporation, including due to the fact that the value of such derivative, swap or
other transactions are determined by reference to the price, value or volatility of any shares of any class or series of the
Corporation, or which derivative, swap or other transactions provide, directly or indirectly, the opportunity to profit from any
increase in the price or value of shares of any class or series of the Corporation (&ldquo;Synthetic Equity Interests&rdquo;), which
Synthetic Equity Interests shall be disclosed without regard to whether (x) the derivative, swap or other transactions convey any
voting rights in such shares to such Proposing Person, (y) the derivative, swap or other transactions are required to be, or are
capable of being, settled through delivery of such shares or (z) such Proposing Person may have entered into other transactions that
hedge or mitigate the economic effect of such derivative, swap or other transactions (B) any proxy (other than a revocable proxy or
consent given in response to a solicitation made pursuant to, and in accordance with, Article 14(a) of the Exchange Act by way of a
solicitation statement filed on Schedule 14A), agreement, arrangement, understanding or relationship pursuant to which such
Proposing Person has or shares a right to vote any shares of any class or series of the Corporation, (C) any agreement, arrangement,
understanding or relationship, including any repurchase or similar so-called &ldquo;stock borrowing&rdquo; agreement or arrangement,
engaged in, directly or indirectly, by such Proposing Person, the purpose or effect of which is to mitigate loss to, reduce the
economic risk (of ownership or otherwise) of shares of any class or series of the Corporation by, manage the risk of share price
changes for, or increase or decrease the voting power of, such Proposing Person with respect to the shares of any class or series of
the Corporation, or which provides, directly or indirectly, the opportunity to profit from any decrease in the price or value of the
shares of any class or series of the Corporation (&ldquo;Short Interests&rdquo;), (D) any rights to dividends on the shares of any
class or series of the Corporation owned beneficially by such Proposing Person that are separated or separable from the underlying
shares of the Corporation, (E) any performance related fees (other than an asset based fee) that such Proposing Person is entitled
to based on any increase or decrease in the price or value of shares of any class or series of the Corporation, or any Synthetic
Equity Interests or Short Interests, if any, (F)(x) if such Proposing Person is not a natural person, the identity of the natural
person or persons associated with such Proposing Person responsible for the formulation of and decision to propose the business to
be brought before the meeting (such person or persons, the &ldquo;Responsible Person&rdquo;), the manner in which such Responsible
Person was selected, any fiduciary duties owed by such Responsible Person to the equity holders or other beneficiaries of such
Proposing Person, the qualifications and background of such Responsible Person and any material interests or relationships of such
Responsible Person that are not shared generally by any other record or beneficial holder of the shares of any class or series of
the Corporation and that reasonably could have influenced the decision of such Proposing Person to propose such business to be
brought before the meeting, and (y) if such Proposing Person is a natural person, the qualifications and background of such natural
person and any material interests or relationships of such natural person that are not shared generally by any other record or
beneficial holder of the shares of any class or series of the Corporation and that reasonably could have influenced the decision of
such Proposing Person to propose such business to be brought before the meeting, (G) any significant equity interests or any
Synthetic Equity Interests or Short Interests in any principal competitor of the Corporation held by such Proposing Persons (H) any
direct or indirect interest of such Proposing Person in any contract with the Corporation, any affiliate of the Corporation or any
principal competitor of the Corporation (including, in any such case, any employment agreement, collective bargaining agreement or
consulting agreement), (I) any pending or threatened litigation in which such Proposing Person is a party or material participant
involving the Corporation or any of its officers or directors, or any affiliate of the Corporation, (J) any material transaction
occurring during the prior twelve months between such Proposing Person, on the one hand, and the Corporation, any affiliate of the
Corporation or any principal competitor of the Corporation, on the other hand, (K) a summary of any material discussions regarding
the business proposed to be brought before the meeting (x) between or among any of the Proposing Persons or (y) between or among any
Proposing Person and any other record or beneficial holder of the shares of any class or series of the Corporation (including their
names), and (L) any other information relating to such Proposing Person that would be required to be disclosed in a proxy statement
or other filing required to be made in connection with solicitations of proxies or consents by such Proposing Person in support of
the business proposed to be brought before the meeting pursuant to Article 14(a) of the Exchange Act (the disclosures to be made
pursuant to the foregoing clauses (A) through (L) are referred to as &ldquo;Disclosable Interests&rdquo;); provided, however, that
Disclosable Interests shall not include any such disclosures with respect to the ordinary course business activities of any broker,
dealer, commercial bank, trust company or other nominee who is a Proposing Person solely as a result of being the stockholder
directed to prepare and submit the notice required by these Bylaws on behalf of a beneficial owner;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 93; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) As
to each item of business that the stockholder proposes to bring before the annual meeting, (A) a reasonably brief description of the
business desired to be brought before the annual meeting, the reasons for conducting such business at the annual meeting and any material
interest in such business of each Proposing Person, (B) the text of the proposal or business (including the text of any resolutions proposed
for consideration), and (C) a reasonably detailed description of all agreements, arrangements and understandings (x) between or among
any of the Proposing Persons or (y) between or among any Proposing Person and any other record or beneficial holder of the shares of
any class or series of the Corporation (including their names) in connection with the proposal of such business by such stockholder;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv) A
representation that the Proposing Person is a holder or record or beneficial owner of shares of the Corporation entitled to vote at the
meeting and intends to appear in person or by proxy at the meeting to propose the business specified in the notice; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) A
representation as to whether the Proposing Person intends to solicit proxies in support of such person&rsquo;s proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this Article 2.16, the term &ldquo;Proposing Person&rdquo; shall mean (i) the stockholder providing the notice of business
proposed to be brought before an annual meeting, (ii) the beneficial owner or beneficial owners, if different, on whose behalf the notice
of the business proposed to be brought before the annual meeting is made, (iii) any affiliate or associate (each within the meaning of
Rule 12b-2 under the Exchange Act for purposes of these Bylaws) of such stockholder or beneficial owner, and (iv) any other person with
whom such stockholder or beneficial owner (or any of their respective affiliates or associates) is Acting in Concert (as defined below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 94; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
person shall be deemed to be &ldquo;Acting in Concert&rdquo; with another person for purposes of these Bylaws if such person
knowingly acts (whether or not pursuant to an express agreement, arrangement or understanding) in concert with, or towards a common
goal relating to the management, governance or control of the Corporation in parallel with, such other person where (A) each person
is conscious of the other person&rsquo;s conduct or intent and this awareness is an element in their decision-making processes and
(B) at least one additional factor suggests that such persons intend to act in concert or in parallel, which such additional factors
may include, without limitation, exchanging information (whether publicly or privately), attending meetings, conducting discussions,
or making or soliciting invitations to act in concert or in parallel; provided, that a person shall not be deemed to be Acting in
Concert with any other person solely as a result of the solicitation or receipt of revocable proxies or consents from such other
person in response to a solicitation made pursuant to, and in accordance with, Article 14(a) of the Exchange Act by way of a proxy
or consent solicitation statement filed on Schedule 14A. A person Acting in Concert with another person shall be deemed to be Acting
in Concert with any third party who is also Acting in Concert with such other person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) A
stockholder providing notice of business proposed to be brought before an annual meeting shall further update and supplement such notice,
if necessary, so that the information provided or required to be provided in such notice pursuant to this Article 2.16 shall be true
and correct as of the record date for the meeting and as of the date that is ten (10) business days prior to the meeting or any adjournment
or postponement thereof, and such update and supplement shall be delivered to, or mailed and received by, the Secretary at the principal
executive offices of the Corporation not later than five (5) business days after the record date for the meeting (in the case of the
update and supplement required to be made as of the record date), and not later than eight (8) business days prior to the date for the
meeting, if practicable (or, if not practicable, on the first practicable date prior to) any adjournment or postponement thereof (in
the case of the update and supplement required to be made as of ten (10) business days prior to the meeting or any adjournment or postponement
thereof).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) Notwithstanding
anything in these Bylaws to the contrary, no business shall be conducted at an annual meeting except in accordance with this Article
2.16. The presiding officer of the meeting shall, if the facts warrant, determine that the business was not properly brought before the
meeting in accordance with this Article 2.16, and if he or she should so determine, he or she shall so declare to the meeting and any
such business not properly brought before the meeting shall not be transacted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) This
Article 2.16 is expressly intended to apply to any business proposed to be brought before an annual meeting of stockholders other than
any proposal made pursuant to Rule 14a-8 under the Exchange Act. In addition to the requirements of this Article 2.16 with respect to
any business proposed to be brought before an annual meeting, each Proposing Person shall comply with all applicable requirements of
the Exchange Act with respect to any such business. Nothing in this Article 2.16 shall be deemed to affect the rights of stockholders
to request inclusion of proposals in the Corporation&rsquo;s proxy statement pursuant to Rule 14a-8 under the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) For
purposes of these Bylaws, &ldquo;public disclosure&rdquo; shall mean disclosure in a press release reported by a national news service
or in a document publicly filed by the Corporation with the Securities and Exchange Commission pursuant to Articles 13, 14 or 15(d) of
the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
17. CONDUCT OF MEETINGS:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Meetings
of stockholders shall be presided over by the Chairman or in the Chairman&rsquo;s absence by the Chief Executive Officer, or in the Chief
Executive Officer&rsquo;s absence by the President (if the President shall be a different individual than the Chief Executive Officer),
or in the President&rsquo;s absence by a Vice President, or in the absence of all of the foregoing persons by a chairman designated by
the Board of Directors, or in the absence of such designation by a chairman chosen by vote of the stockholders at the meeting. The Secretary
shall act as secretary of the meeting, but in the Secretary&rsquo;s absence the chairman of the meeting may appoint any person to act
as secretary of the meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 95; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Board of Directors of the Corporation may adopt by resolution such rules, regulations and procedures for the conduct of any
meeting of stockholders of the Corporation as it shall deem appropriate including, without limitation, such guidelines and
procedures as it may deem appropriate regarding the participation by means of remote communication of stockholders and proxyholders
not physically present at a meeting. Except to the extent inconsistent with such rules, regulations and procedures as adopted by the
Board of Directors, the chairman of any meeting of stockholders shall have the right and authority to prescribe such rules,
regulations and procedures and to do all such acts as, in the judgment of such chairman, are appropriate for the proper conduct of
the meeting. Such rules, regulations or procedures, whether adopted by the Board of Directors or prescribed by the chairman of the
meeting, may include, without limitation, the following: (i) the establishment of an agenda or order of business for the meeting;
(ii) rules and procedures for maintaining order at the meeting and the safety of those present; (iii) limitations on attendance at
or participation in the meeting to stockholders of record of the Corporation, their duly authorized and constituted proxies or such
other persons as shall be determined; (iv) restrictions on entry to the meeting after the time fixed for the commencement thereof;
and (v) limitations on the time allotted to questions or comments by participants. Unless and to the extent determined by the Board
of Directors or the chairman of the meeting, meetings of stockholders shall not be required to be held in accordance with the rules
of parliamentary procedure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) The
chairman of the meeting shall announce at the meeting when the polls for each matter to be voted upon at the meeting will be opened and
closed. If no announcement is made, the polls shall be deemed to have opened when the meeting is convened and closed upon the final adjournment
of the meeting. After the polls close, no ballots, proxies or votes or any revocations or changes thereto may be accepted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) In
advance of any meeting of stockholders, the Board of Directors, the Chairman or the Chief Executive Officer shall appoint one or more
inspectors of election to act at the meeting and make a written report thereof. One or more other persons may be designated as alternate
inspectors to replace any inspector who fails to act. If no inspector or alternate is present, ready and willing to act at a meeting
of stockholders, the chairman of the meeting shall appoint one or more inspectors to act at the meeting. Unless otherwise required by
law, inspectors may be officers, employees or agents of the Corporation. Each inspector, before entering upon the discharge of such inspector&rsquo;s
duties, shall take and sign an oath faithfully to execute the duties of inspector with strict impartiality and according to the best
of such inspector&rsquo;s ability. The inspector shall have the duties prescribed by law and shall take charge of the polls and, when
the vote is completed, shall make a certificate of the result of the vote taken and of such other facts as may be required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
III &ndash; DIRECTORS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1. NUMBER AND TERM. The business of this Corporation shall be managed by a Board of Directors which shall consist of not less than three
(3) directors nor more than nine (9) directors, who need not be residents of the State of Delaware or stockholders of the Corporation.
The exact number of directors within the minimum and maximum limitations specified in the preceding sentence shall be fixed from time
to time by the Board of Directors pursuant to a resolution adopted by a majority of the entire Board of Directors, which number shall
initially be six (6). Except as otherwise provided in the Certificate of Incorporation, each director shall serve for a term ending on
the date of the annual meeting of stockholders next following the annual meeting at which such director was elected. Notwithstanding
the foregoing, each director shall hold office until such director&rsquo;s successor shall have been duly elected and qualified or until
such director&rsquo;s earlier death, resignation or removal. Directors need not be stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 96; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2. REGULAR MEETINGS: Each newly elected Board of Directors may hold its first meeting for the purpose of organization and the transaction
of business, if a quorum is present, immediately after and at the same place as the annual meeting of the stockholders. Notice of such
meeting shall not be required. At the first meeting of the Board of Directors in each year at which a quorum shall be present, held next
after the annual meeting of stockholders, the Board of Directors shall proceed to the election of the officers of the Corporation. Regular
meetings of the Board of Directors shall be held at such times and places as shall be designated from time to time by resolution of the
Board of Directors. Notice of such regular meetings shall not be required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
3. SPECIAL MEETINGS: Special meetings of the Board of Directors may be called by the Chairman of the Board, or on the written request
of any two directors, by the Secretary, in each case on at least twenty-four (24) hours personal, written, telegraphic, cable or wireless
notice to each director. Such notice, or any waiver thereof pursuant to Article 3.4 hereof, shall state the time and place of the special
meeting, but need not state the purpose or purposes of such meeting, except as may otherwise be required by law or provided for in the
Certificate of Incorporation or these Bylaws. If the day or date, time and place of a meeting of the Board of Directors has been announced
at a previous meeting of the board, no notice is required. Notice of an adjourned meeting of the Board of Directors need not be given
other than by announcement at the meeting at which adjournment is taken.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4. NOTICE WAIVER: Notice of any meeting of the Board of Directors may be waived by any director either before, at or after such meeting
orally or in a writing signed by such director. A director, by his or her attendance at any meeting of the Board of Directors, shall
be deemed to have waived notice of such meeting, except where the director objects at the beginning of the meeting to the transaction
of business because the meeting is not lawfully called or convened and does not participate thereafter in the meeting. Neither the business
to be transacted at, nor the purpose of, any regular or special meeting of the Board of Directors need be specified in the notice or
waiver of notice of such meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5. QUORUM AND MANNER OF ACTING: Unless otherwise provided in the Certificate of Incorporation, a majority of the total number of directors
then in office shall constitute a quorum for the transaction of business of the Board of Directors and the vote of a majority of the
directors present at a meeting at which a quorum is present shall be the act of the Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6. RESIGNATION. Any director may resign at any time by giving notice in writing or by electronic transmission to the Board of Directors
or to the Secretary of the Corporation. The resignation of any director shall take effect upon receipt of notice thereof or at such later
time as shall be specified in such notice; and unless otherwise specified therein, the acceptance of such resignation shall not be necessary
to make it effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
7. NEWLY CREATED DIRECTORSHIPS. A directorship to be filled by reason of any increase in the number of directors may be filled (i) by
election at an annual or special meeting of stockholders called for that purpose or (ii) by the Board of Directors for a term of office
continuing only until the next election of one or more directors by the stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
8. VACANCIES IN THE BOARD OF DIRECTORS. Any vacancies in the Board of Directors resulting from death, resignation, retirement, disqualification,
removal from office or other cause shall be filled by a majority vote of the directors then in office, and directors so chosen shall
hold office for a term expiring at the annual meeting of stockholders at which the term of the class to which they have been elected
expires. No decrease in the number of directors constituting the Board of Directors shall shorten the term of any incumbent director.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 97; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
9. REMOVAL OF DIRECTORS. Except as may otherwise be provided by law, any director or the entire Board of Directors may be removed, with
or without cause, at an annual meeting or at a special meeting called for that purpose, by the affirmative vote of the holders of a majority
of the shares then entitled to vote at an election of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
10. ACTION WITHOUT A MEETING; TELEPHONE CONFERENCE MEETING:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise restricted by the Certificate of Incorporation, any action required or permitted to be taken at any meeting of the Board of
Directors, or any committee designated by the Board of Directors, may be taken without a meeting if all members of the Board of Directors
or committee, as the case may be, either originally or in counterparts, consent thereto in writing. Such consent shall have the same
force and effect as a unanimous vote at a meeting, and may be stated as such in any document or instrument filed with the Secretary of
State of Delaware.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise restricted by the Certificate of Incorporation, subject to the requirement for notice of meetings, members of the Board of
Directors, or members of any committee designated by the Board of Directors, may participate in a meeting of such Board of Directors
or committee, as the case may be, by means of a conference telephone or similar communications equipment by means of which all persons
participating in the meeting can hear each other, and participation in such a meeting shall constitute presence in person at such meeting,
except where a person participates in the meeting for the express purpose of objecting to the transaction of any business on the grounds
that the meeting is not lawfully called or convened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
10. EXECUTIVE AND OTHER COMMITTEES:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) The
Board of Directors, by resolution adopted by a majority of the number of directors then in office may designate from among its members
an executive committee and one or more other committees, each consisting of two or more directors, and each of which, to the extent provided
in the resolution or in the charter or these Bylaws shall have and may exercise all of the authority of the Board of Directors except
the power to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Declare dividends or distributions on stock;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -13.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue stock other than as provided in subsection (b) of this Article.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) Recommend
to the stockholders any action which requires stockholder approving, including, but not limited to, adopting an agreement of merger or
consolidation, the sale, lease or exchange of all or substantially all of the Corporation&rsquo;s property and assets, a dissolution
of the Corporation or a revocation of a dissolution of the Corporation; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amend the Certificate of Incorporation or the Bylaws.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -18.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) If
the Board of Directors has given general authorization for the issuance of stock, a committee of the Board, in accordance with a general
formula or method specified by the board by resolution or by adoption of a stock option or other plan, may fix the terms of stock subject
to classification or reclassification and the terms on which any stock may be issued, including all terms and conditions required or
permitted to be established or authorized by the Board of Directors under the Delaware General Corporation Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 98; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) The
appointment of any committee, the delegation of authority to it or action by it under that authority does not constitute of itself, compliance
by any director not a member of the committee, with the standard provided by statute for the performance of duties of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) Any
committee designated pursuant to this Article 3.10 shall choose its own chairman, shall keep regular minutes of its proceedings and report
the same to the Board of Directors when requested, shall fix its own rules or procedures, and shall meet at such times and at such place
or places as may be provided by such rules, or by resolution of such committee or resolution of the Board of Directors. At every meeting
of any such committee, the presence of a majority of all the members thereof shall constitute a quorum and the affirmative vote of a
majority of the members present shall be necessary for the adoption by it of any resolution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) The
Board of Directors may designate one or more directors as alternate members of any committee, who may replace any absent or disqualified
member at any meeting of such committee. In the absence or disqualification of a member of a committee, the member or members present
at any meeting and not disqualified from voting, whether or not constituting a quorum, may unanimously appoint another member of the
Board of Directors to act at the meeting in the place of the absent or disqualified member.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
11. CHAIRMAN OF THE BOARD: The Board shall elect from its members a Chairman, which Chairman shall preside at all meetings of the stockholders
and the directors. The Chairman shall serve in such capacity until his or her successor is elected by the Board or until his or her earlier
resignation or removal from the Board. He or she shall also perform such other duties the Board may assign to him or her from time to
time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
12. COMPENSATION: By resolution of the Board of Directors, each director may be paid his expenses, if any, of attendance at each meeting
of the Board of Directors, and may be paid a stated salary as director or a fixed sum for attendance at each meeting of the Board of
Directors or both. No such payment shall preclude any director from serving the Corporation in any other capacity and receiving compensation
therefor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
13. PRESUMPTION OF ASSENT: A director of the Corporation who is present at a meeting of the board of Directors at which action on any
corporate matter is taken unless he shall announce his dissent at the meeting and his dissent is entered in the minutes and he shall
forward such dissent by registered mail to the secretary of the corporation immediately after the adjournment of the meeting. Such right
to dissent shall not apply to a director who voted in favor of such action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
IV &ndash; OFFICERS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1. NUMBER, TITLES, AND TERM OF OFFICE: The officers of the Corporation shall be chosen by the Board of Directors and shall include a
Chief Executive Officer, President, Chief Operating Officer, Chief Financial Officer, President, one or more Vice Presidents (any one
or more of whom may be designated Executive Vice President or Senior Vice President), a Treasurer, a Secretary, and such other officers
as the Board of Directors may from time to time elect or appoint. Each officer shall hold office until his successor shall be duly elected
and shall qualify or until his death or until he shall resign or shall have been removed in the manner hereinafter provided. Any number
of offices may be held by the same person, unless the Certificate of Incorporation provides otherwise. Except for the Chairman of the
Board, if any, no officers need be a director.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2. SALARIES: The salaries or other compensation of the officers and agents of the Corporation shall be fixed from time to time by the
Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 99; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
3. REMOVAL: Any officer or agent elected or appointed by the Board of Directors may be removed, either with or without cause, by the
vote of a majority of the whole Board of Directors at a special meeting called for the purpose, or at any regular meeting of the Board
of Directors, provided the notice for such meeting shall specify that the matter of any such proposed removal will be considered at the
meeting but such removal shall be without prejudice to the contract rights, if any, of the person so removed. Election or appointment
of an officer or agent shall not of itself create contract rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4. VACANCIES: Any vacancy occurring in any office of the Corporation may be filled by the Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5. CHIEF EXECUTIVE OFFICER: The Chief Executive Officer shall, in the absence of the Chairman, preside at all meetings of the stockholders.
Subject to the control of the Board of Directors and the executive committee (if any), the Chief Executive Officer shall have general
executive charge, management and control of the properties, business and operations of the Corporation with all such powers as may be
reasonably incident to such responsibilities; he may agree upon and execute all leases, contracts, evidences of indebtedness and other
obligations in the name of the Corporation and may sign all certificates for shares of capital stock of the Corporation and shall have
such other powers and duties as designated in accordance with these Bylaws and as from time to time may be assigned to him by the Board
of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6. PRESIDENT: Subject to such supervisory powers, if any, as may be given by the Board to the Chief Executive Officer, the President
shall have general supervision, direction, and control of the business and other officers of the corporation. The President shall have
the general powers and duties of management usually vested in the office of President of a corporation and shall have such other powers
and duties as may be prescribed by the Board or these Bylaws. If, for any reason, the Corporation does not have a Chairman or Chief Executive
Officer, or such officers are unable to act, the President shall assume the duties of those officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
7. CHIEF OPERATING OFFICER: The Chief Operating Officer shall supervise the operation of the Corporation, subject to the policies and
directions of the Board. He or she shall provide for the proper operation of the Corporation and oversee the internal interrelationship
amongst any and all departments of the Corporation. He or she shall submit to the Chief Executive Officer, the President, the Chairman
and the Board timely reports on the operations of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
8. CHIEF FINANCIAL OFFICER: The Chief Financial Officer shall have general supervision, direction and control of the financial affairs
of the Corporation. He or she shall provide for the establishment of internal controls and see that adequate audits are currently and
regularly made. He or she shall submit to the Chief Executive Officer, the President, the Chief Operating Officer, the Chairman and the
Board timely statements of the accounts of the Corporation and the financial results of the operations thereof. The Chief Financial Officer
shall perform such other duties and have such other powers as may be prescribed by the Board or these Bylaws, all in accordance with
basic policies as established by and subject to the oversight of the Board and the Chief Executive Officer. In the absence of a named
Treasurer, the Chief Financial Officer shall also have the powers and duties of the Treasurer as hereinafter set forth and shall be authorized
and empowered to sign as Treasurer in any case where such officer&rsquo;s signature is required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
9. VICE PRESIDENTS: In the absence of the President, or in the event of his inability or refusal to act, a Vice President designated
by the Board of Directors shall perform the duties of the President, and when so acting shall have all the powers of and be subject to
all the restrictions of the President. In the absence of a designation by the Board of Directors of a Vice President to perform the duties
of the President, or in the event of his absence or inability or refusal to act, the Vice President who is present and who is senior
in terms of time as a Vice President of the Corporation shall so act. The Vice Presidents shall perform such other duties and have such
other powers as the chief executive officer or the Board of Directors may from time to time prescribe.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 100; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
10. TREASURER: The Treasurer shall have responsibility for the custody and control of all the funds and securities of the Corporation,
and he shall have such other powers and duties as designated in these Bylaws and as from time to time may be assigned to him by the Board
of Directors. He shall perform all acts incident to the position of Treasurer, subject to the control of the chief executive officer
and the Board of Directors; and he shall, if required by the Board of Directors, give such bond for the faithful discharge of his duties
in such form as the Board of Directors may require.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
11. ASSISTANT TREASURERS: Each Assistant Treasurer shall have the usual powers and duties pertaining to his office, together with such
other powers and duties as designated in these Bylaws and as from time to time may be assigned to him by the chief executive officer
or the Board of Directors. The Assistant Treasurers shall exercise the powers of the Treasurer during that officer&rsquo;s absence or
inability or refusal to act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
12. SECRETARY: The Secretary shall keep the minutes of all meetings of the Board of Directors, committees of directors and the stockholders,
in books provided for that purpose; he shall attend to the giving and serving of all notices; he may in the name of the Corporation affix
the seal of the Corporation to all contracts of the Corporation and attest the affixation of the seal of the Corporation thereto; he
may sign with the other appointed officers all certificates for shares of capital stock of the Corporation; he shall have charge of the
certificate books, transfer books and stock ledgers, and such other books and papers as the Board of Directors may direct, all of which
shall at all reasonable times be open to inspection of any director upon application at the office of the Corporation during business
hours; he shall have such other powers and duties as designated in these Bylaws and as from time to time may be assigned to him by the
Board of Directors; and he shall in general perform all acts incident to the office of Secretary, subject to the control of the chief
executive officer and the Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
13. ASSISTANT SECRETARIES: Each Assistant Secretary shall have the usual powers and duties pertaining to his office, together with such
other powers and duties as designated in these Bylaws and as from time to time may be assigned to him by the chief executive officer
or the Board of Directors. The Assistant Secretaries shall exercise the powers of the Secretary during that officer&rsquo;s absence or
inability or refusal to act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
V &ndash; INDEMNIFICATION OF OFFICERS, DIRECTORS, EMPLOYEES AND AGENTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1. INDEMNIFICATION: The Corporation shall indemnify and hold harmless, to the fullest extent authorized by the Delaware General
Corporation Law, as the same exists or may hereafter be amended (but, in the case of any such amendment, only to the extent that
such amendment permits the Corporation to provide broader indemnification rights than such law permitted the Corporation to provide
prior to such amendment), any person who was or is a party or threatened to be made a party to any threatened, pending or completed
action, suit or proceeding, whether civil, criminal, administrative or investigative (other than action by or in the right of the
Corporation) by reason of the fact that he is or was a director, officer, employee or agent of the Corporation, or is or was serving
at the request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint venture,
trust or other enterprise (an &ldquo;indemnitee&rdquo;), against expenses (including attorneys&rsquo; fees), judgments, fines and
amounts paid in settlement actually and reasonably incurred by an indemnitee in connection with such action, suit or proceeding if
such indemnitee acted in good faith and in a manner such indemnitee reasonably believed to be in or not opposed to the best
interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe such
conduct was unlawful; provided, however, that, except as provided in Article 5.3 with respect to proceedings to enforce rights to
indemnification, the Corporation shall indemnify any such indemnitee in connection with a proceeding (or part thereof) initiated by
such indemnitee only if such proceeding (or part thereof) was authorized by the Board of Directors of the Corporation. The
termination of any action, suit or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its
equivalent, shall not, of itself, create a presumption that the indemnitee did not act in good faith and in a manner which such
indemnitee reasonably believed to be in or not opposed to the best interests of the Corporation, and, with respect to any criminal
action or proceeding, had reasonable cause to believe that such conduct was unlawful. The right to indemnification conferred by this
Article 5.1 shall vest at the time an individual becomes an indemnitee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 101; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2. RIGHT TO ADVANCEMENT OF EXPENSES: The right to indemnification conferred in Article 5.1 shall include the right to be paid by the
Corporation the expenses incurred in defending any such proceeding in advance of its final disposition (hereinafter an &ldquo;advancement
of expenses&rdquo;); provided, however, that, if the Delaware General Corporation Law requires, an advancement of expenses incurred by
an indemnitee in his or her capacity as a director or officer (and not in any other capacity in which service was or is rendered by such
indemnitee, including, without limitation, service to an employee benefit plan) shall be made only upon delivery to the Corporation of
an undertaking (hereinafter an &ldquo;undertaking&rdquo;), by or on behalf of such indemnitee, to repay all amounts so advanced if it
shall ultimately be determined by final judicial decision from which there is no further right to appeal (hereinafter a &ldquo;final
adjudication&rdquo;) that such indemnitee is not entitled to be indemnified for such expenses under this Article 5.2 or otherwise. The
rights to indemnification and to the advancement of expenses conferred in Articles 5.1 and 5.2 shall be contract rights and such rights
shall continue as to an indemnitee who has ceased to be a director, officer, employee, or agent and shall inure to the benefit of the
indemnitee&rsquo;s heirs, executors, and administrators.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
3. RIGHT OF INDEMNITEE TO BRING SUIT: If a claim under Article 5.1 or 5.2 is not paid in full by the Corporation within sixty (60) days
after a written claim has been received by the corporation, except in the case of a claim for an advancement of expenses, in which case
the applicable period shall be twenty (20) days, the indemnitee may at any time thereafter bring suit against the Corporation to recover
the unpaid amount of the claim. If successful in whole or in part in any such suit, or in a suit brought by the Corporation to recover
an advancement of expenses pursuant to the terms of an undertaking, the indemnitee shall be entitled to be paid also the expense of prosecuting
or defending such suit. In (i) any suit brought by the indemnitee to enforce a right to indemnification hereunder (but not in a suit
brought by the indemnitee to enforce a right to an advancement of expenses) it shall be a defense that, and (ii) in any suit brought
by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the Corporation shall be entitled to
recover such expenses upon a final adjudication that, the indemnitee has not met any applicable standard for indemnification set forth
in the Delaware General Corporation Law. Neither the failure of the Corporation (including its Board of Directors, independent legal
counsel, or its stockholders) to have made a determination prior to the commencement of such suit that indemnification of the indemnitee
is proper in the circumstances because the indemnitee has met the applicable standard of conduct set forth in the Delaware General Corporation
Law, nor an actual determination by the Corporation (including its Board of Directors, independent legal counsel, or its stockholders)
that the indemnitee has not met such applicable standard of conduct, shall create a presumption that the indemnitee has not met the applicable
standard of conduct or, in the case of such a suit brought by the indemnitee, be a defense to such suit. In any suit brought by the indemnitee
to enforce a right to indemnification or to an advancement of expenses hereunder, or brought by the Corporation to recover an advancement
of expenses pursuant to the terms of an undertaking, the burden of proving that the indemnitee is not entitled to indemnification, or
to such advancement of expenses, under this Article 5 or otherwise shall be on the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4. NON-EXCLUSIVITY OF RIGHTS: The rights to indemnification and to the advancement of expenses conferred in this Article 5 shall not
be exclusive of any other right which any person may have or hereafter acquire under any statute, the corporation&rsquo;s Certificate
of Incorporation, Bylaws, agreement, vote of stockholders, or disinterested directors or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 102; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5. INSURANCE: The Corporation may maintain insurance, at its expense, to protect itself and any director, officer, employee, or agent
of the Corporation or another corporation, partnership, joint venture, trust, or other enterprise against any expense, liability or loss,
whether or not the Corporation would have the power to indemnify such person against such expense, liability or loss under the Delaware
General Corporation Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6. INDEMNIFICATION OF EMPLOYEES AND AGENTS OF THE CORPORATION:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Corporation may, to the extent authorized from time to time by the Board of Directors, grant rights to indemnification and to the advancement
of expenses to any employee or agent of the Corporation to the fullest extent of the provisions of this Article 5 with respect to the
indemnification and advancement of expenses of directors and officers of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
7. AMENDMENT OR MODIFICATION: This Article 5 may be altered or amended at any time as provided in these Bylaws, but no such amendment
shall have the effect of diminishing the rights of any person who is or was an officer or director as to any acts or omissions taken
or omitted to be taken prior to the effective date of such amendment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VI &ndash; CONTRACTS, LOANS, CHECKS AND DEPOSITS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1. CONTRACTS: The Board of Directors may authorize any officer or officers, agent or agents, to enter into any contract or execute and
deliver any instrument in the name of on behalf of the corporation, and such authority may be general or confined to specific instances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2. LOANS: No loans shall be contracted on behalf of the Corporation and no evidences of indebtedness shall be issued in its name unless
authorized by a resolution of the Board of Directors. Such authority may be general or confined to specific instances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
3. CHECKS, DRAFTS, ETC.: All checks, drafts, or other orders for the payment of money, notes or other evidences of indebtedness issued
in the name of the corporation, shall be signed by such officer or officers, agent or agents of the Corporation and in such manner as
shall from time to time be determined by resolution of the Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4. DEPOSITS: All funds of the Corporation not otherwise employed shall be deposited from time to time to the credit of the Corporation
in such banks, trust companies or other depositories as the Board of Directors may select.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VII CERTIFICATES FOR SHARES AND THEIR TRANSFER</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1. CERTIFICATES FOR SHARES: Notwithstanding any other provision in these Bylaws, any or all classes and series of shares of the Corporation,
or any part thereof, may be represented by uncertificated shares, except that shares represented by a certificate that is issued and
outstanding shall continue to be represented thereby until the certificate is surrendered to the corporation. Within a reasonable time
after the issuance or transfer of uncertificated shares, the Corporation shall send to the registered owner thereof, a written notice
containing the information required to be set forth or stated on certificates. The rights and obligations of the holders of shares represented
by certificates and the rights and obligations of the holders of uncertificated shares of the same class or series shall be identical.
If certificates for the shares of the Corporation are issued, each will be in such form as shall be determined by the Board of Directors.
Such certificates shall be signed by the president or vice president and countersigned by the secretary or an assistant secretary and
sealed with the Corporation seal or a facsimile thereof. The signatures of such officers upon a certificate may be facsimile signatures
if the certificate is manually signed on behalf of a transfer agent or a registrar other than the Corporation or an employee of the Corporation.
Each certificate for shares shall be consecutively numbered or otherwise identified. The name and address of the person to whom the shares
represented thereby are issued, with the number of shares and date of issue, shall be entered on the stock transfer books of the Corporation.
All certificates surrendered to the Corporation for transfer shall be cancelled and no new certificates shall be issued until the former
certificates for a like number of shares shall have been surrendered and cancelled, except that in case of a lost, destroyed or mutilated
certificate, a new one may be issued therefor upon such terms and indemnity to the Corporation as the Board of Directors may prescribe.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 103; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2. TRANSFER OF SHARES: Transfer of shares of the Corporation shall be made only on the stock transfer books of the Corporation by the
holder of record thereof or by his legal representative, who shall furnish proper evidence of authority to transfer, or by his attorney
thereunto authorized by power of attorney duly executed and filed with the secretary of the corporation, and on surrender for cancellation
of the certificate for such shares. The person in whose name shares stand on the books of the Corporation shall be deemed by the Corporation
to be the owner thereof for all purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VIII &ndash; FISCAL YEAR</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1. The fiscal year of the Corporation shall be determined by the Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
IX &ndash; DIVIDENDS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1. The Board of Directors may, from time to time, declare and the Corporation may pay dividends on its outstanding shares in the manner,
and upon the terms and conditions provided by law and its Certificate of Incorporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
X &ndash; CORPORATE SEAL</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1. The Board of Directors shall provide a corporate seal which shall be circular in form and shall have inscribed thereon the name of
the Corporation, the year of its incorporation and the words, &ldquo;Corporate Seal,&rdquo; and &ldquo;Delaware.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
XI &ndash; WAIVER OF NOTICE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1. Whenever notice is required to be given by law, the Certificate of Incorporation or under any of the provisions of these Bylaws, a
written waiver thereof, signed by the person entitled to notice, whether before or after the time stated therein, shall be deemed equivalent
to notice. Attendance of a person at a meeting shall constitute a waiver of notice of such meeting, except when the person attends a
meeting for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting
is not lawfully called or convened. Neither the business to be transacted at, nor the purpose of, any regular or special meeting of the
stockholders, directors, or members of a committee of directors need be specified in any written waiver of notice unless so required
by the Certificate of Incorporation or the Bylaws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
XII &ndash; FORUM FOR ADJUDICATION OF DISPUTES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1. Unless the Corporation consents in writing to the selection of an alternative forum, the sole and exclusive forum for (i) any derivative
action or proceeding brought on behalf of the Corporation,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of the Corporation to the
Corporation or the Corporation&rsquo;s stockholders, (iii) any action asserting a claim arising pursuant to any provision of the Delaware
General Corporation Law or the Certificate of Incorporation or Bylaws (as either may be amended from time to time), or (iv) any action
asserting a claim governed by the internal affairs doctrine shall be the Court of Chancery in the State of Delaware (or, if the Court
of Chancery does not have jurisdiction, the federal district court for the District of Delaware). If any action the subject matter of
which is within the scope of the preceding sentence is filed in a court other than a court located within the State of Delaware (a &ldquo;Foreign
Action&rdquo;) in the name of any stockholder, such stockholder shall be deemed to have consented to (i) the personal jurisdiction of
the state and federal courts located within the State of Delaware in connection with any action brought in any such court to enforce
the preceding sentence and (ii) having service of process made upon such stockholder in any such action by service upon such stockholder&rsquo;s
counsel in the Foreign Action as agent for such stockholder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
XIII &ndash; AMENDMENTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1. Stockholders of the Corporation holding at least 66 2/3% of the Corporation&rsquo;s outstanding voting stock shall have the power
to adopt, amend or repeal the Bylaws. To the extent provided in the Corporation&rsquo;s Certificate of Incorporation, the Board of Directors
of the Corporation shall also have the power to adopt, amend or repeal the Bylaws of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 104; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>formpre14a_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 formpre14a_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !5 2P# 2(  A$! Q$!_\0
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M",[EG-%1E\4X-71<M,?24W=B@/FBZ&.JM>7B6=N\S_=7K4V_-96OC=I%R/\
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M(RN3Q534]+O-/UD:C:IYB$Y***P49)(RU2.DM](LH(QB(,?5^:YA J^-E"C
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A !1110 4444 %%%% !1110 E&*** "BBB@!:*** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>proxy_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 proxy_001.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP"$  8&!@8'!@<(" <*"PH+"@\.# P.
M#Q80$1 1$!8B%1D5%1D5(AXD'AP>)!XV*B8F*C8^-#(T/DQ$1$Q?6E]\?*<!
M!@8&!@<&!P@(!PH+"@L*#PX,# X/%A 1$!$0%B(5&145&14B'B0>'!XD'C8J
M)B8J-CXT,C0^3$1$3%]:7WQ\I__  !$(")@&I ,!(0 "$0$#$0'_Q "D  $
M @,! 0$!            !08#! <"" $)$  !! ("  ,#!@@)"P$% !,!  (#
M! 41!A(3(3$'%$$5%R)1<906(S)58723LP@8-3=45H'2TR0S-D)25V)R=9&R
M<R4T0T:A4X*2HK$F=H.$H[3"PR=CT41DX@$! 0$                   $"
M$0$! 0$! 0$              1$A44$Q_]H # ,!  (1 Q$ /P#ZI1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 50R7M$X5C+<E.YFX631G3V-!?H_4>J#6^=SV??GR/]F]/
MG<]GWY\C_9O0/G<]GWY\C_9O3YW/9]^?(_V;T#YW/9]^?(_V;T^=SV??GR/]
MF]!*8CVA\-S-QE.CF(9)W_D1D%A=]G961 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
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M"+Z^MT1!$!$'RA[6?YUL?]E-?5Z B B B B B B B B B B B B B B B B
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M+/J"$B@4^,>TWD$8N15<K98_S$LLI;V_2#(0L[W>U/AKVSR'+5&#XN)D@/\
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MCZ##_P #%U! 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
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ML9FQ.3<:_P!8V;V.J"=]LO%/EKBK[E=F[>-W/'KU,?\ KA0?L2XZ^O@[V>O
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MZUOVHXZ6O.R5FJ8[L(</)R^MT!$ M:[6P#H[&_@40$0$#6@D@ $^I0"UKM;
M.CL(@(@(@(@(@(@(@(@+\(!!! (0  T    ? +]0 QK22&@$^J(! *_  T
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M&:,5SP*=\TY1X;>_BCZAV4C<YY@*7%ZO(OQ\E*?IUZ-!?MYUH@E!&9SVH8?
MW)*MS#YD!D_@MF%7\5(_ZHW$CLD_M+Q%'#,R=K%9>%C[PJ,AEK=)7/+.X(:2
M@W*7/\=+C\I<EP^8JQ4:YGE-FKX7=H^#-GS*C,5[5^-7+5"N^OD*?OKFMK2V
M:Y9'*7>FG()N'GF DY7/Q8.GCOQCU>T"-YZA^FG:#FF%98Y- 66"_"0":W]
M:+2PO^@@B,-[2L;E)*[:V$SO28;9.:FHB -_E[6@_P!K>&CM15#@,^)W@O9
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M0;>-R3<CB<?>;&6>]58I@S>^@E:':65 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 <YK&N<X@- V2?( !:6/S4M_K+'B[3*KVET5AYC >
M/@>G;N [X;"#7K9]C)Y8+M&:D65'V@Z9T9!BC(#R3&YVNNUGQEZQ>(+\5:@A
M>SLR64QCL/AM@<7-)0:F0S_R=9GB;CI[/@5!9L&(QCPXG%P!T]S=GZ!6V<_C
MX99(YG&&-M)MMDK_ ":^(G1(_2TZV/TA!HS<HDCZ!F&N2.]U-F2,&-CXXNQ
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M>-L6(YR;'61XKN(<Z%H80?(;\R$'Y8R>>',,16JPUGT9\?8E\[#F%[0^$%Y
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M<<>A)OK(P,:/(Z('FIM 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1!6A3S^'OY1^/J5KE:[8-D-DG,#X97-#7 _1
M<"PZ6.'#9"CAIJ\V.JY26Y9FGNQ.?TCW,>VF![3MH05X\'NBMA[%JE0ORU#;
M8:-EWB1,@LO#V,8^1I^E%H %7C!4H*%-[(<-2QO>0ET57KU/Z7%K6#L@\<CQ
MURQ5I/I,9)+5OP6?#>_H'B,^8[:.CHK'3I76<CR&2E8QC;&.I0] [L6R1.E<
M_P#\T%5L<+LR5*9FIT+DM;+9"R*ECSBEAN2O?K9!T\ @JV\?Q\-""QX>"HXP
MR/&V5NI[@#R+RUK!M!ESN,LWY\&^'KJIDV6)=G7T&QO:=?6=N4='@[S,!R.D
M>GBW9LB^+S\M62XLV@3XO*P93CUZO!%-[K0FJ6(S)T($IB/=IT=Z\-5ZIPJ&
MG-8K2<5PE^)]J22.Y,&"4,E?WU+N-Q);M!=<9C9ZN7SUJ3KX=N>%\6C\&0MC
M._[0H)_'<@>$7\./#]YF%OKY_0_'3.>-G["@TLGQ-K\_?R1X]B\I'=$1(M!@
MEA?&P1^1<Q^V$!2UW$WH'\=LX_&U![D)&R4V/$4;1,S1\,]=::4%B5.L\?R5
MB/D^/>R-E>]8-FO;#]EDG2/JUT>O@YB#;?1Y#EK&*9D*E6K!3M,LRNBF,IFD
MC!Z-8.K>K=G9)5F04@<>S7R/D\48(>IRAM03^+^6Q]SWD@MUY$!;V?P5NUEL
M;=&/K9&O#!*PU)W]&-E>01, 6N!( T@TL=QC*0T*T4C*K'MY![\61>4;8B2>
MK58+5#(,SLF2K0Q2M;C# V-S^G:0R=];T=!!4W<8RDM?/>'4K8^*XRN(J3)N
M[/%CD[OF.@ TN5OGQ5E_)<5D6EG@UZ5R*3Z^T[HBW_P*"(/'LB7N(\/_ $C%
M[\K_ ."&@*3I4LE4Y'EYC7C?4NNBE$PDT]CHXA&6ENOCU02M^I6MT+=6PT&&
M>%\<@/Q:\:*YUQ[ 7LMPNR^U:9[[??%.RQHEO^2EH@=]A\,.06"6KG\I>Q3L
MC5K58*4_O#A%,9C-*UA:T#Z+=,';:A;V"Y1^#^3X_6@J&*:2R8;;IB"8YI#*
M&%G7\KSZH+;!0L0\HRF1/0PST*D#//S[0OE<[_S"E$%2PW%+%;(Y3WMT;J8B
MF@H-:=N9#9>990?[2&A:C\'R:Q@(^-3Q5?=1$RM+?$I[/K,\O*+KY2.:@G_D
M_(U^637XH(Y:MJE7@D/?HZ)T#Y';U\01(HS#<?OT!Q0S&/\ R"C9AGT[?TI>
MFNO_ &0,EQNW8ESTPGBA?-=HVJ<CCL"2J&:#_P!!<U:@FS-KF^$%V*K$8*5M
MY@@E,_4/Z-[O<6LUL^30@N62JNL8Z]681XLU:6-F_0%S2 HC&8>Y4R5&S+TZ
M0X6*H[1V?$8X%!K#&Y"I3R\9QE:\RYDYI7022AC3#(!Z]FD$['HHZ'CN;KX&
ME$QD+IZV6%R*H9G%D<(>2(&R.'P!067&4+L>:RE^=C&"U6IM# [L6OB#^_\
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M689CX*LL%ZP9XYI)2PUY'M#7=FAI[C8V$%=@X/8KT^.26,3CLG)3Q8I6:UD
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M# .WVH(WBT-F#!7/DAE".V,QD6R>,PZZ-M2:!Z:*RRQ%_*L/%GA5<?DV8UP
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M-@TUC0UH^H! 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1!1[63S^1QN?MT?<VTJS[==L#V/,LXK[9([N'
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M=CO3JYA'8'S]-+2_"C#^X7;4<DCO=0/$B,,K)&EP^B"QS>P!^O2#%C>58F?
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M@JV4LR^ZMDZAX>UX#7N!=H$@;0;KN38*&&K(^R_=ACGQ,$,KI7-:=%WAAI>
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MZDM<8WAK]'1$;B-//Z&H)+'YC'9"&1].8N\)_21CF.C>QVMZ>QX#@LJ B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
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MLF%L\*FR-.9D<<.7<?H%WNC+$K'1A^O30/54;M^&7*XKVB7*,$CH+F/\*M]
MM,[XH'!SV J1R7(_'GQ;(,H^EC)JTKGW(X/$<Z9A:!""]K@PZ)/F$$/B8YW5
M<6YPM.URZ:3O.SI(6.CD(>\ - VIB&I_^*7-8S >TUG+GKU\W[+@$%L]VANX
M%E*RSLRQ1$4H/U/9HKGF'@R^=HYUTVV7*6*EPT#R-;LAI\64?H<>J@V[N1J9
M3CV+PU&M,V^):317,3F.J&"1KG.?L::&!JVQDX,5-RRG9CE%FQ<DFJQAA)G;
M+ QHZ$?I!!0>.-TS\I<2EDA=N+B@;LC\AQ,2F>;U?'PE>(1%[3E,=V9K>V^]
M1DDH(7."S2YA-<GRL]&M8QL$4,[(6RL[Q2/+XW%[7=2>P(6!E*OAG<:R#)K-
MO'13WWRS.A.XI+A["4L: 0P'85$EDLE1ERN S43G38ZLZU#-*R-SA%),UO20
MCZAHC:@.0@9B+E]^E#(ZF_"Q5>_0@6)0]SCT^L-#M;06C.=,;G^/9&=I%&O#
M;@>YK"6POF#.CCU]!IA"KT4F$R%_EMJT)ZU*27'.BM!CHW&2$'K,S['!06?C
M&3OWZUUL\YL0P6?#K7?",1LQ] >Q;]8)(V/(JB<LR>2O8GED$^0NQ6(_>HJV
M,KUP>\3/)DCW.8XD.'TM@A!T+&0C\,.13^%^73H-;)KU \0D JGT ['UN,9"
MS#(*M6[E62GH3X)FE>(WD#S#4$]QJU#=Y=RFY7@D$$M7'!DQ86B8L\4%S=K<
MR%J&ES/&36"61SXR>"-^B6F4RQD,V/B4%6K7ZM#B.0P5NK,_(];<)J"%Q=9D
MF<XA[?+1:_MLN5KS.*R<W!K.-C/B7#BQ$?/7=[6 $;_XD&CD,]B<GQC+U:?<
M3_)%G54Q/9)'J(CH00M#/59JT'#[,4L]:K3!9++#")3!WAZ,>6.#O+X$H,$E
MF2A2OY/&YB:TZY>JQ6[CZP(@C:.IE:QC6AV@F&$EG/<A?%<N7HY,+ QEF>-C
M!(\/E\H^C(P6CLJ(XV/'P_"+D%JQ##0C$-R2.#Q'UI75PP%['M/H?(E73C4-
M7OE+\&7FO/M/C$DCXVQCM$W0Z]6M!\D%2Y#DKTXY/3L9&Y6,;9(J="M7:YUE
MAB&GN>]C]AQ/P( 5AP4#OPBKS/B.QQJFSN1\3(\D()#B@=#5RP,98#F+Q:"-
M>3I2508Z8]VSF%RN=N5#9O7.\+:S'^-'8D+FOC>6$GR*"0Y!CLA*.5,KB9Q9
M/B93T9V?)' 0^3J""''02WCAG:^4EH<CLW+PPUNM"TPMA:!.!Y.+6-\]M073
M Y_#6H:U6#M#.V$!U5\;F/BZ#1:01Y:5(H&&UQCB5+H7RT\K399B+#N-\9=^
M4"H+'-;@PW+LE<R <R"Y2K,KV>KG,!A+^\1(!ZD]MA5^O4FF=1M&K(VM:Y=[
MW7C>PM+8O < \M/IV<WL@E.202.R/*',B<?$XHYH(&^S@9=!*EJ'"YZ2WDFN
MC@MXJE'7LEKG,88>W>)Q /4GL"@NEB.CFL5- ?QE:Y7<P^1&V2#7Q7+ZU'-Y
M_#YXR,>R]5P\F)@+@6=[&MS/:3\'D-02N2R=3-8[#XW&03-N-NTG^$8GL-1M
M>1KWE^P.NF@M6^9XH,_RJM)MDMJI"^NTM/XP,A<'=51K<>JGY4XK)) =Q<5#
M=D?DN)B6C9JV0,G9%662*KRQEJ6)C"YSHFPLVYK?CU)[*"0K9"KE.?UI*L<O
MAMP5EAG?&Y@>?'A/4=P"=*4R;'GF6*>&$L&&R+2[X F2#005B*G+'[-.)Q,@
M<'L?A7%G4]FN$\1<I!UZ&AR*.+#79)C;R.KV.=$YS6=ORYVNT"S_ ,2@C,M,
MT83VD8W3_>Y/>YHXNIV^-]9@#FJQ\B8RF.)W!&15H9!IF+&EWA1NKR0@D#X
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M ^+&E7S.9*/"X3(9.2(RMJP.E,8.BX-0<[A]K<$-2G=R?&\G1Q]H Q7=-EB
M?Z$]58>4\]9@[."KU<7+D7Y42&L(7M;OH&GX_7V08;G/+F-XQDLWD^-VZ@JR
M1-$#Y&%T@D<&;!"L^3ST5#C4^;= Y[(J7O)B!T2.O;6T%6QWM"IV,GQJF_'2
MPMS5'WBO,7@@$ DQE35[EL-;E=#CT=5TL\]5]B20. ;#&W>BY!4<![3,GG8:
M]BAPR^^K)-T,XECZM6?(^TR>MF\SC*O&+UWY-ZFQ) ]ODUS>V](/9]J>(%#C
MV2;2G^3<E.8'620/=I0=:E"G9^5P1<KH\>KU'V+$L!GG>UP#:\7P<]!(Y_/8
M[ 8FSD[[RRO"!O0VYQ/D&M'Q)5%^=*>E%5MY;B62H8V=S0VX\M?KOZ%[!YA!
M-\DYZ<-E\5BZ>&GR,]^!\L @D:-ABLV&REW(8]MBWBYL?,7N:8)7!S@!\=M0
M4F;VCWWYO,8O&\5NWGXZ81S/BE8!MRL>/Y='<Y5:X^:,D4T&/CMO>7 CZ?4=
M/M'9!IS<U<W.Y["U,1/9LXVI%. QX!F\3J>K=_:JU![4<M8RES&1<(R+[E5K
M'3PB:/; \ A!<L%RZ',9[/8AM-\4F,,0>\N!#S*%$2>T6JR/F+_D^4_(+V"0
M=Q^.[[01F/\ :K'-:PT60X_?H190L%*R_J^)YDUU6>W[1[HS^6P^.XO<OR4'
M,$KXI6#\L;!TY!?Z5F:S1K3S5GUI)(FN?"\@NC)'FTD?$+E;?;%$(KEN3C60
M&/JW'5I[D99(UCP@ELE[2C!G3BL;@+>3?[C'<#H'M&X9/CHJ4Q/M$P&1XQ<S
M[_&K04WO99CE;J1DC/\ 405D>U.Q6IQY.WP_*08F0C5TEATUWH\L5JSO.J.&
MGP3Y8#)CLF]K&7V/'AQN?YM[A 9RYL_(\EAL=CGVY*-7Q;$PD#(VR$;;#_S%
M:>.]I&%M\4OYZ2)]<4G2,LUGD>(R5IT&?:Y!;L%DILKB*5^6D^JZQ&)!"]VW
M-:?3:HF!]IN/R?+;?'?D^6"2*:S$V=SP62/K'S 0><W[3*&'Y;5X_P#)\T\L
MDU:)\[7@,B?9/D"IGFG,J?$:%:U-5DLOFF\.*",Z<= N)0>K/+;$V$P^5Q."
MLY-ER,/Z0O:TQ CT=V4%QKVDW.1-CLU^*W&4CXH-LRL+&&,;0>>/>TG)YZ.G
M/3X;>-.:8,]Y$L?1H[=7.6.Y[39:V6SE*MQB]<;BGZM30O:>H()[:02DGM+Q
M1H<6NU:TLL.:NMJQ[(88GE_0]UL<VYO3XA3J3S4Y;+[$CFQPQD Z8WLY_P!@
M03%KE%*/B;^11L,U84?>FQ@Z+AU[:6YB<Y!DN/5,R8S##/4%@M<=]&D=O-!3
M..^T"]GIZSZ/%;QQDTYC;?<]@&@=%Y8K^@(@(@(@(@(@(@(@(@(@(@(@(@(@
M(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@
M(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@
M(@(@(@(@(@^<*8@//>>>-S,X+_+(?22*/Q_VBM'),CCZ7M-X!<L9*#W9N-L;
MMR2-$;@Z)P#^R#6]K&3Q>4_ J>EFJX@^6PPW896/; 1K;^WH"Q;&?H2Y'V><
MHJ8SECL_.!#*=2,D<QC'AQ9J+ZPU!;N'<VXC8XWB>F5IP/BJPPOK22-C?&]H
M#2WJ5#>T+_3WV8_KEO\ _!&@B?:%2NWO:;PVM2R+J,[Z=OI9:P/+-,=\"JSA
MZ-FWP[VD8A\1?R&.<^^2[+GV6L=V:45><1S[AT/LYK&3(56.AQ8@?3[@2^(R
M/H6=%S>'%6J7$O957O1$&7D3)/"?\(Y9=A R3+."Y9Q?BD_<P4^206L=(?C5
MG?\ D;_X"I*Q0NW['MIJU&%\[W5"UC?5W0O>0B.E\%YQQ)_$\/%\J4ZLE:I%
M#-7ED$;V/C;U/D5,^T%@'!N3?6,?*@Y-D.7<;9[(*.'%R"U?L8R&O'4A(ED$
MI^L-4?RBA8QP]DE*]D3C98:TS);79H,!ZQ_%R*L/-75OFHY$R'E'RX19KDV.
M['EFY8],^@K#G<_@+WLZRM6IF*,]EN".X8IV/>-1_4"B*CFZ,[?93PS/5&[M
M85E2TW_D\@X*R^SV8<ASW+.7$.\*>1M*CL>D,(04+V3&FS$XU\O//<"V\2<6
M9H6"33_0AWG]-9,CB^0W^8^TTX;+2U)88(7OB8P'W@>'^1M!?^,8WCG)?9/#
M2@JB*L^J\/8#V,=AAV7 GX]EK>Q#'QOXU-FII'S7;TQ9+-)YGI!]!C$&Y[:J
MEF;BE6S'$Z6*EDH+-F,?&)H(*T?:'S3BV0X+=@IY&O;GOQQQ5:T3@^4O<X>K
M$%9RN$R9Y;[,L2<C/3N1X1\3[,6B]CHH3M=XPV/M8W'QUK63GO/:YQ,\P >[
M9V =(.(8'!9++\^]H7N>?N8WPKD'?P T^)V#];[*8]_J8+VR6GY.TR"&Y@XX
MX9YB&,>]A:@S<.O5LK[4>:9.E()J8JUH!.SS8]X 6SQO^>/G?ZG2_=,01W'L
MKCL'[4>=0Y2W#4][%:6!\[Q&Q[6M^!<JC%/'?P/MBRE<]ZEJ=H@E^#^A*#%C
M*EO%Y/V9VL]>??Q5JM#[DQXZ-I3F-O0::MP-@/M)YOXO,/D+Z=?3Q+%'XWT/
M3\:BOHK'/B?CZCH[@M,\!FK <'"4:_+V/([7S;PGB.8Y/B>24QGS3Q3\].+-
M9D =)*6]3Y2%!(Y/!96;VGY#'8#*OQTU?C48A>&A_9D98T1J%]V9D_8E?BQU
M,LN5;_?)Q;+GODC<.[SM!T7E//.(6_9W>%?)59'V\>8(*C7 RB1[.H;T]1U4
M!GQ)2]F/&N)S5!/E\G###!7=ZQ'?;N?JZ(B7]E#A@+^=XE?8QN3AG-D3_P!,
MB?Z/4+R/BF.D]KF*I%[VTLFSWZY6!U'+-6#T'>5\M-BDJ'DW(X6DRX;FLLS]
M?&"1_20($L4ES\'>1S,(DS/-(IF?H@B=TC"M^?R.5S/M+DDH8!^7JX*N8'0B
M9D+1/8![$EZ*EO8W?N4FYOBU^N^O8Q\YFA@>X.+89_/6PGL;_FRG_P#5MH*G
M[)339B<,^7G8J.%IW_LDS0M#_I^FB>WTUH7L7R&]GO:K+A\K)6-=T;YJ[&@^
M\LZOVSL@W[UC$V,![(GXR!L,'RW #$#OI()!W4CE[^5SGM'R%FCQY^8I8>L^
MAT$S(6B6<$2';T$9Q[(W(/9OSGC.0B?#;Q5>;K"\@N$,P[+IG!,_QB?AN"QD
MF7H/G.,9'+5\=ADT&?3!8@YM#='"\S@JW%N51Y3&7[K8SB^[9G1-E/FYI:OH
MM$$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$00F2XYPN3WK(9##XGXOGLSP
M1?VE[G!9)L+Q/+U:4CL5C;<,<(96<Z".1K(QZ-9L>009).*\5]T;3. QI@;(
M9&Q&M'T:]PT7 :UM9<=AL/B_%^3L94I^+KN((F1=NOIVZ@;0>)>)\7GN>^S8
M+'OL=NWBNKL+M_7O2V[%#'6)ZT\]."6:LXF"5\;7/B+O4L)\V[0>I<?0GNP7
MIJ<#[$ (AF=&TR1APT0UWJ-KW#C,=#<GNQT:S+<S0)IV1M;(\#T#G ;*"+DX
MMQ:2Y[\<'0=8WV\8P,+]J4O4<9/X$MNI7E-9_BPNE8UWA/;Y]V[]"/K0:4M#
M"Y*2E=?3J67PZDJV7,9(YN_I!T;EMTJN'9;R$]*"JVP^4-N21-:'ND:.P$I;
MYEP#OB@A9L%PN_<]ZFQ>*FG,[H_%=%$Y[I6>K?TN&E,AF-R-*9C_  +5=Y?%
M(WRD82TECF$>8)!&B$&M3P''L<\24,/0K/'^O#79&?\ NT+)E,'@\F(AD,73
MMF+?0SPLEZ=O778%!J,XYQV.G/2BPM".I,X.E@;7C$<A:=@N;K1(7B/BO%8#
M+X''\9'XD9C>658F]F.]6G0\P4$HZACQ1- 4X/=?"\/W?HWPNGIUZ^FE^4<=
M0QU9L%6I!7A!);#$P1L!/F=-:@A)>*\(I%DQP&'@ZO9J4UH6=7N< W1UZDJ=
M@QV.K6;-N*E!%/8UXTK(VM?)U].[AYG2#Q6QV+Q\,E>C0K5XWN+GLAB;&TN/
MJ2&@ DKU3H4,=6;6HU(*T+22(X6"-@)\SY-0>G-#@6N ((T05%,X[Q'$S^_L
MQ6-J3.D:T3B*.,]Y'=0 ?K<2@DIL?CIKD%V2G ^S '"*=T;3(P.&B&N/F 5D
M0>8,?CJEBU9@IP136"#/(R-K7REOH7D>I&UXRN&PV5B:S)8ZM:8SS:)HVOU]
MFT&2AC<?C:XKT:<%:$'8CA8&-_[-6..ACX;EBY'3@9:G $T[8VB1X:- /</,
MZ08,O@\'E3'\HXNI;+!]$S1->6_9M9/DW"PT&T9*5-E2340K&-@B._1G3T*!
M:P^&GIUJ<V,J2P5^O@1/A8YD70:!8"-#06G?XMQ:Y8DL6L!C9YY/-\LE:-[S
M]I(02=>"O5@C@@A9%%&T-9&QH:UK1Z  >@2EC<?CV2,I4X*[9)#(\11M8'/=
MZN/76R4'X,?CVWGWQ3@%MT?ANL"-OBEGKU+_ %TE;&8NDZQ+7H5H'6'E\QCB
M:PR./^L_J!LH(D\:XI3LOR#,-CH9F;>^P(6-+->9=M;\]?!^+'F;$-(21Q_0
MN/:SNV-WU2'X':#+-C<8^_%?DHUGVXF]8[#HVF5@^IKR-A>9Z&/ENPW74X'6
M8FEL<YC:9&M/J&N]0$&98#A\-'!<@;C*@CMN<^TP1-ZS.=ZF0:^D2@2X?"^!
M2A=C*ACJ/#ZL9A9UA<WT+!K32$JX['47V'4Z4$!GD,DQC8UA>\^KG:]2@R''
M8UE]]]M&N+;F='61&WQ2S_9[^NE^T\;C,=5]UITJ]> DGP8HVL8>WK]%J"';
MQ#B%>9DD'',6R6-P<U[:L0+2/,$'2F*^,QU>Q;LPT:\4UD@SR,C:U\NO0O(]
M4$>,!QZ*."&'#4&1P3^-"UM>,".7_;8 /)RW:F.QU 3-I4H*XED,DOA1M9W>
M?5SNOJ4'[-@\+//9L2XNF^6Q%X4\CH6%TL?^P\D;<U1U?BG%:<PFK8#&0RMV
M!)'6C:X=AHZ("#W2XUQG&639HX2C7G/^O% QCAO]("DFRQ.>]K9&ES" YH.R
MTD;&T!$!$'Y+:JPB7Q9XV".+Q7]G =6#_6=]0\D9/!(XM9*QS@QK] @GJ[T/
MV'2#]1 1 1 1 1 1 1SFL:YSG!K6@DDG0 " US7M:YK@6D;!!V""CIX&310N
ME8)9 XL82 YP9K9 ^.MH"("("("("("("("("("("("("("("("("("("("(
M"("("("("("("("("("("("("("("("("("("("("("("("("("("("("("(
M"("("("("("("("("("("("("("("("("(.2909 X;,BM) UCN71-E$C2XG=
MJ'KK1"Z1FLG?Q.$%^1D,CH'1.MZ!:WPNP$KV_P#*-E!%Y7D[\;;R(CKMFBIT
MX7.T=%]BU)X<,0*S_*N>QU[&1Y6.E)#=F\ /K![3#,6E[6N[D]FGJ1M!B/)+
M9X><T8(O%UOP_/IY2]%*YC)38OY,E\-A@EO15YR[>V-FVQCA_P#;D!!'U>1R
MOY/8QA@8VH&2,AL?%\\#6/D:?T 2+1I\GS&5-&"A!59+:AFMB64.=''4$G2$
M]007/D0)N59&K!<ALUH/?:N3HUI.A/A/BNRL8)&?$>3E*9O*S0Y"+&"-GAV,
M5?G<_P"(,'1H _:((/$93*FCQK$XQM82_(=>S--.'/8QG4,: UA:27%;O"I+
M<DW*C:B8R89QP>UAVW;:T(VU!$XJZ*L].(UHI/>>59.+N\;,6A,_LSZC]'2\
M\.R]B6.SC<=$Q[X<QD779G[Z0,=;D(;^F1R#)D><RQ.S$\%K%-AQ\TL9JS3:
MLV#!^7T\P&?4U2?,[-P<)R]W'6&Q.^3I91(=APC,1.V%I&G(,[LIGA:I8F 4
MC=?6?8GG<Q_@QQ!W1NF=MN<XJ3PF5MVI\E1O0QLMTI&!YB),<C)6]F/;OS&_
M0A!79>5Y.!_(;<M>LS'8B:6.3U\6<MB#P&>>AYN&R5CJ\S?%>IPWKV)G;9BF
M=JE+W? ^&,REKMD]QH'Z2"*SN2Y'=XU0NV:U1M6Y=QKQ"SMXT#'V8W,+W$Z<
MKUB\M):MYZN^-@%"ZV"/7JX&".79_M>@K^-Y3E\Q7PD5&"K':M8J*]9DE[.B
MA9+Y-#6@@N)*R9'DMZG>JXJ6_B:]OW4V+%B<ED.B\L8(V%X))U]:"9P&;DSF
M&DLQ> VPR2: EKO$A\6)Q;V!'JP^JYG)9S;N'RS6Y8K+V\E8(6CN'ET>4UU)
M>3]'X-07R+-9'&Y-]3+^ZECL?/<9+7:]NA6+0]A#R=^3P05$4.;SRS8A\]K$
MOBR$S(Q5@E[V*YE&V=_,AWU.06C,9:Y#D,?B\?'"ZY:9++WFWX<4,.@YY#?,
MG;@ %H6,KR"*W3Q+?<9+\L4L\D_1[8(X(R&@].Q)<2[0'9!'W.5Y2C7RE>Q7
MK"[3FK!\S>Y@$%DZ%AS?-P#='86#.6>1?)F&EKY+'/$N4JCQH&2=) ^1O7T>
M?H_6@DWYO,'/?)7CXZN]D,3M3,?VM%PV\P?2&@U2^>N"K\D@UXI?&R4$7XQN
M^G??TV_4X(*U)R+DKZ6<R,%>B*^-LVV&)X>9)V57'9:X'3#I2C\QDKN1-##L
MK-,56*>Q8L-<]K?'WT8UC"W9(!)\T&YCLK?ES=S%VF0=J^/J3N?&" Y\[I&N
M !)\AT5=DY9EG5L=[K4KF:WG+N/ <7=6MKF4!Y_9;*#<9FL_\L6:#V46Q4*U
M:Q<L=7Z+9.W9L;>WK]%1=+G<DQQ-F6UBC7OV(HFU(INUJ$3G49?YD$[([#0T
M@97,Y_)<>Y!>JUZGN$;+D+(G=_'E9#VC?(';T/,'35N<D?T]G$S@TN(QL)T/
MCH-0;IRO(:%S&19"&EX5^1\$1B[[@GZ&1K7DD]VGJ1L:2KRFQ;Q_'G1P1BY>
MM>!/%YD1&#?O'_W'0@(-S*9._'DZ6+QT<'O,T,D[Y9]F.&*,ANRUI!<27: 4
M1/RO)4Q;JVJ]<W:U['Q.+.WA20WIA$) #Y@H)^[EYZ^>H8YL3.D]&W.7'U!K
MNC 'V'NM'B66R^6Q%/*7H:L,5JK%)##%V+QV&R7$G6B@\T\IG<Q-9FQWN4-*
M&W) UTS7R23&%W21PZEH:-@@+5;GN17:=S)X^M2-.&280P2]_&L-@<6N<' Z
M9L@]1HH/3.197*9&M6Q#:K8)\3!?;8G:]^A,YP#>K2U:%?E7(9,4S,2TZ<=1
MEH5YH/IF5VIA7?(Q^] !VR 0@WX\QR;(9#.UJ$-"-F/M"%KIP\F8F)DG4=2.
MNNWJO3N2NGP&+R<5['8UEB/<AO'8:X>18-.9L@H(^OS')WZF#]Q@J23W;MNH
M]_8F$&MWW*TCU8>FUL6.39C'PY@7(:LDN-?5EGDB#V,?4G/TWAI)+7, *"=@
MRKY,]/1C8TPUZ<<LS_B))G'HP?V-)*@<KR2SCGYY]:A7?+!DL?7'^J9O>1&W
M;S]8[Z""5HY3,0YV+%Y/W1YGIRV(9*[7L ,+F->QP>7;_+!!6*]DLS\OQ8K'
MQU6]J)LNGG#GAFG]-=6ENR4$'!RCD/R79RKZE)E:G;?6L1?3,DIAE\&1\;MZ
M: =]005*<ESUC#%[F97#0!L/=L%IQ$LSAL]1IS>J".S&89?H9P,JQM$O$S:$
MNOQNIA)IA/U!)^0R8R#.RQ4ZYDQ_'*MMLA'TI"1+ICS]0Z():/,9RMD,.S(Q
M4Q!DI'Q,$0>)()!$Z8!SB2'[#""0 H.[RODHXY>Y%5K8]U.-DLD-9_?QG1,.
MA(7@Z_3UT@M?)<M/AL--=KUQ-(R:O&V,G7?QIFQG_P EK093.5,S0HY1E-[+
MS)?!DKA[>DD3>Y8X/)WL>CD$!0Y5R"7#8Z^^G3#LC)%7HP O!\5VRY\CMGZ&
MFEV@IL93.UL@W&W6TGS6:LTM*Q&U[8_$AUN.1A)/Q!!!01+>89>[4O2T,8WQ
M<=5>Z]%+O8M,]:\>M;.@3M61N=%G*XRK4#7PST'W)93_ *L1T(M?I>2@C[&4
MSDG(KF(QT=-C8*->R9YVO?YRN>WIU:6^O11=3E.?DQ=',S5*D5*2W#7DKCLZ
M8>)**YD:_8&@\[ UZ(-GE7*9\$;4WREAV-@A,K:<SB+,X:-D-/<:)^'D5^,G
MS3N:,#+-?W,XQLHC+'[Z&3_FUW01<7M!+X8,C[WBC3ELLC%02[MB*23PQ)ZZ
MW\2S2EF9S-6QR&0UJ8HX]]N$M>'.?.8F;'QT&_ H,MW.35<9BIVY+#8]DM2-
MX;;WHN+0>L8#V:"B1G7Y&WQ3+1UNTC\3D9O 8=[<!']%I06+C68O92I[U-<Q
M\S'-'T*S'A\,GQCD[N/F%.("("("("("("("("("("("("("("("("("("("
M("("("("("("("("("("("("("("("("("("("("("("("("("("("("("("
M("("("("("("("("("("("("("("("("("(*Q-Q:S)0OUQ9C!GSL5\'1T&1S
MLEZ_:>BLN1./CH6A>DCCJOC<R9\C@UO5XT024%"XSQF2[PI\%RU)[Q?Z3^.6
M_3;X745W$'XAL;2I]N(SE^]C9<M9J>#1E\9D==KQXLW4L#G=_0#9.D$18XIR
M!^'FPD5^HVCXSGQR]'>-T,GBB-WP_02KEG,:,KB+U'OT,T1:R3_8?ZM?_84%
M4N\/O6..5*4=]D>1CGDG?;#3HOL]Q,1]HD.E*W,%<@O4+V(D@CEKU#4=#,#X
M4D.P6C;?-I:0@CY>)W;='+/LW8OE&Y9KV!(QA\*)U1S7PL )V6@M1^$S5G+Q
MY&_9J-+<=:J-@A#RT>.6'OMW_(@R1<<RE 8>>A8K&S6QD=&PR8.\.5C """W
MS!!6]QW$7L4S+.N6XYYKM]UHN8TM#>T;&=0#]71!HLXS8AL4)C8CU7SEN_K1
M\VV&2-#/M'B+#2XA:QW6W2MQQWQ<LR/=H^%/!8G=-X4H_1W\G? H,L7'\K0M
M7_<1CI*UFR^P!9C<7Q/E\W@%OY3258<YBFY7"9/&]_#%JG+ 'ZWT\1I;M!!G
M#Y_WFGDXYJ3+\5=U:>+3S!-$2'#S]6N!6]B,9:I39&W<L1RW+LC72F-I;&QD
M;>K(V H,#^,"QC^24;$WT,G9ED#F>L8?&U@_M!:O-+'Y8-,&2CQCXS Z-\D$
M;F22=AUWH^3=H(2SQCD<V*H8B7)5/=:<]5[)0QPEF96D:]K'_ '35+38?,U\
MAF)<=:JL@R#V23>(UQDAD$8B+F:\G;#0@T:7%\GAJ^$EH6ZYM5,9'0G9*UWA
M3QQ^;2"WS:6E;EO!9=]^MEF''FY[K[O:AD:\PO8'%["UWJ"W:"?I-G958R=L
M#9/,O$+2V/U\M JJ#BN3-*>A[Q6]W&8;?@?IW?1N"VYCD$SE,(RYEZEE[QX+
M,=<JRQ_%PM&/^XM;"X?-8YM.K.<;-!7:&"P(G-G>U@TTD>@=]90;N9PURQ?Q
M^3Q\\45RHV6,"4$QRQ3:[,=KS'FT$%:<^)STMNEE634H\A#'+"^/Z9@E@D(=
MU)]0X$;!0*N(S==^1R FI39&X^(/:X/; R&$$-C:1L_$G:C(>)9"/%661SU&
M6GY>+(,C8UPK,=&YI,;1Z@.Z^90;F=PF?S==M.?Y-CA+HGF8"1TT+FD$F+>A
MVV/HN4YE\4Z]\F^&]K/=[\-AV_B(]^2"/;@)X\'GJ!G9VO2WGM?KR;[T21O[
M-K"<%EJ-YE[%V*QD?2AKVH9P[I)X&^CVEOF"-E FQ6>BR8RM6:C[Q-1BKVXY
M _P]Q.<]KV$?\Y\EHT.*6Z<.$$MUDKJ>7N7GOZZ\061+_BH+#'B.N4S5N9[7
M17:U>+I\0(@\'_OW43A,'F,6RG2<<;-5K:8R<QN%@QL\F@_#N!\4&C:XQGFX
M[+8BA?JQT;CK#F/>QYFA%DE[V#X'S)T5,Y7 37^*S8<6 R1]1D(E^#2T ;0:
M[,/F[5_&2Y:W5?#CWF9@A:YIEEZ&,/?LZ: '$Z43QNA!8Y9G\E7LB:E&_I5Z
M^;!-8:Q]CH?M:$%BRN'NR9&GD\=+"RS!#) Z.8$QRQ2$.T2WS!!:""HB?B5V
MY6RLUJ[",C;EJRL>QA\*'W)XDA8 3LC?J@SQX;-2YVME<A9J#PJ-BLV" .('
MC%CN^W?\BDL#CI,7@L3CGR->ZI3B@+P-!QC:&DH-&EA\WB;%J/'34GT9[4DX
M9.'A\)F=WD#2WR<"22%K#CV?J5;F-Q]ZJRE/),Z.21CC-7;.XN>UGP=HD]4$
MMC./,QN2CF@>!6BQ5>E''\0('.(/_8K1_!FQ^#$F)]XC[NM/F#]'KIUHV$$)
MBH.0_+','XRQ4#),KT(L-<?#>VM%]-O5;L/$;F,L8B?&S5IG5,>:G^5M=\7=
MS*TL]'./J$&;%<5O4Y<9)/>CF?7R-ZU(X-+>YMA_]]2,^.IU;>>O9"S"RG<J
M5X'B0] !&'AW8GZ^Z"/]GN.GJ\>AL6I'R6+9$SI'C3S&UHCBW^GHT+)D.+V+
M4V4>VQ&!9R>.MC8/DVF8R6G[>B"5MXM[L_C<FV1H;7IVH"SXN,[HW _V>&L_
MR9)^$/RGXC>GN'N_3X[[]]H(-_&9QQK*8LV8^]JY:G:_1T!/8,P"P6N-Y=E[
M/RU+501Y0@OGE8XSP@1B+HSX%OEL('X)V13LPFU%N3CD>,WHZ#V!X[_9])><
MEQ.Q9@SS!:C:;^"AQ[/(_0=$)-O/[1!/Y+#R6[6 E9(UON-TSOW_ *X\!\6A
M_:]<OST3H^.9' 8[/T)H9GR5Z]>,=[G9[_\ ,>3O1A]3KR:@OG/XWR\8GB9(
M8W/N4 V0#9:3;C&UZAQ>9GRU*[E+%0^Y1R"".NUPV^4=3(\O_1Y (,;.*V&<
M;PU!EMC+F-?'+!/U[,\6/8\QY'JX$@KV</R"Q=.1LV*;;4%26&C'&'F*-\VN
MTKR?-Q\AH(/&/XW%@+,5J"XQM=U<LR1F.O'?OL)R?0/V3M:/L]Q;:U3(7&R^
M)%-9=#2?K6J5=Q;" @L<>-DAY%D<EXC>EBE5@#/B# Z1Q/\ ;W46.+V/P9K8
MDV(^\5N&;OHZU':%A!&W>)YE\/)*=6U29#EGS/?8<QQL-$S.IC4X_%9"#,8^
M_!+7+6415LL?V!ZAP=VC(01^*P.3P[(:47R;-2AE_%/DC=X[8M[Z'7D2!Y!R
ME8,%-%CL]5,S";\]J1A^#1.W0!00\'&LQ0OBW2GHN>_'5JKGSL>70^ "-QZ]
M0[>RU>\=QF]CH<%UMQ/EQU.Y%V>#I[YRTM)U]GF@TYZ6?HSYC/"M4?>./\"&
MM48\B63MMKY3Y$J[0B411^*6F3J.Y:--+OCK?P0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$08FY/&#'>_
M^\QFM_\ 9?A^5TU_W\E'7\[QRM+)3N7JXD'7Q \=FLWZ=SZ-_M02K;=9UIU9
MLK3,(FREGQZ.) =]A(2K9KV&R&&5K^DKXWD?![#HM_L*#5EY'A8[_N)NL-CN
MV,L:"_J]_HUQ:" 2L<?(,&Z\*7OK/',CHPP@@&1OJP.UHN&O1!XL\IX[1DDA
MGR,3'1.+90=GIKXOT/HC])4EV;U[=AUUO?PT@T,?R'"793#5O,E>&N<2 >A:
MWU(?KJ0$H<DP%V=M>KD89)' E@V1X@;ZEA/DX#]"#'+RGCE>8POR4+7MD+'^
MNFN#BS3SZ-\QKS6S9SV&H6VTY[C&SD-)8 7$!QT"[J#U!^&T"[R/"4;7NMG(
M11S::2T_Z@?Y-+R/)H/PVL=K/87'3.AM7&,F#6.,6BY_5^]'JT$Z/4H(_+<Q
MP]"'%S"Q'-%=EC$;VDEO1_K)L [TI',9REA\+/DW_2C9 9&#S'<AI<UOH=;0
M8V<GPIQE>]+<9'',0UOKLOULM:-;)4ACLA0R%?QJ5EDL8<6DM/HX>H</@4&@
MS.887_<3>C]Y\0L,(V7!P:'GM]7DX%9:'(L+D;/N]2_%+)U+@T$_3#3HEGP<
M!]808HL_A'7O<A=8^QXGAEC07 /_ -DN (#EE@Y)@[%WW.'(0OG[.8&@^3G,
M]6M=Z$CX@(&/RE:2Q)5?D89IW36?#:UO0AD+^I9^DLV 2L,N1K>_U((LE Q[
M;AAFC+>Q>[P3+X33\':TY!X'*N.1R-A.3A[F0QD^?5KP\Q]7'T:>PUYK+?SN
M'QDK(KEQD<CF%XCT7.#!Y=B&[T/TE!O4\A3O5F6:D[)H7%X;(P[:2QQ:=']!
M"T:_(<)+<%-EUAL.>YC&D$!SV>K6N(T2-(*]%GLF[W/<P^GR:S2=]$><$?B:
M;_\ >K9Y?G68JO2@;<]VFM6H8_$Z=S'$7?3> 01M!8Z5VH]@@9;\::*")SR0
M XB0?1>X-  [:4'D^7X?&LH2>,V46;7@@C>F@.+'N\@=]2$$[6O4YW2,AF#W
ML:PO:/4"0=F_]PM27D."JU8;4V0B;%*'^&_X.Z'J=(,<O)<!5EBBFR,3'O8Q
M^COZ+9/R2_\ V=_#:D;5JM4@?-8E;'$T@%Y]!V/4(-'&YW"9&=U>I>BEE#.X
M8-CLT'79N]=F_I"_(>3\>>RR8\E 6UX?%F<3IK&?6YQ\@@S4^1X6Z+!KW6/,
M$?B2MT0]K/\ :ZD Z7[8S^&@KP3R7XA%- ^>-X.PZ)C>SGC7P 09I+=2%]5L
MDS ZP_I"/]MW4OT/[ 2M2[F\-C9V0W+C62N9W$>BXAOIV<&@Z"#4;RK&2<BD
MPG;\8R%KNWGYO<YS>FM?#JMJGG^/RV64:UN(/VX1QAI:UQ;YD,.@"0@TL)R[
M%Y6[DZD+@TU)NH)W]-@C9(7^8&M%^E(4N18+)/?%5OQ2N#"_0V.S!_K-WKLW
M](0:T7+^,/ZAF5K]3$9&O)TPM#>YTX^6P/,A;=3-XR_#,^G;8YL)U+OZ!C\M
M[<':(&D"AR+"Y)TC:=Z.5S(_$(&QMG^V-^K?TA8:W*^.VIZ\$&2A>^?7A:WU
M>7-[ !WH3KX(-*ER[$V\IDL>R9K#5:T^(=@.'4N>?,#752^,SF+RO?W*R)>H
M!/T7#R/H1L#809)YZU2"Q8E<V.*-CI9I#Y -:-EQ_L"TZ?(\#9M^YU[\3ICV
MZM\QWZ>O4GR=KXZ0?D.?PCK4E5N0B\:,2%[?]@1$M<7GT&B$J9_CV6>:\%N&
M=Q9W$9'Y;1_K-#A](?I"#*,YAXZ5:V;T7@SEPB>-GN6@D@?8&G:VG9&B(JDQ
ML,\.RYC8'?"1T@VT!!COY+'XR%LMVRR%CG!K>WJ]Q^#0/,E:S^38-E6&R;GX
MN5SFQ_0>7$L\G?1UOR0'9_!04JUV3(P""QV\*7?T7]6EY ^P-*QS<JX]!X'B
MY&-OBQ"5H(=L1GT>X:^BW])01>)Y13&$HV<K<8)K$M@,TW9>(I7-\FL'H K*
M+=<U1:\5O@&+Q?$/D.FNW9!K4.08?(22QUKC7OC9W<PAS7=/3L X#86E4Y%Q
M:Q<@;7NU73V WPWM&O$+F]@T/UHG7P09,GR+!UI9J<UZ$6 T'H?I!KCYL[?!
MI/PVLG&[\U[C.&OVG@RSX^":5V@ 7/C#G% H<@P=Z<P5+S7R]"\-T6E[1ZN;
MV [#[%X@Y9QVQ/!!%DHG/F+1'K?5Q>-AO;T[$?!!XO<@X[3=-7NW8@]GE+$0
M7]1U#_I  ^6G DJ4;>H]ZD3)HR;$9? UIV'L8!LMU\!L(,)R./A%TRV6-%3K
MX^_]3L X;^T%5_-\HK/XWR&YBKC38HT)90"P@L<&$M+F/""RSW(*U0V;,@CB
M8P.>\^@48WDO'VUO>CD8S'XY@:1L]I -EK !MW]B#:?R/!,J5[;LE ()BX1R
M=O)Q8"2/M&EFH9O%9&*>6K<C>V$ZE]6F/RW],.T6H-6ER3"9*85Z61BDE<PN
M8!L=VCU<S8^D/TA:UGF& A99ZWXWOA8]SV-#CKH\QD'0.CV&D&*ES+"6,30O
MRV6Q"RUNH].<[OU#RP #;NNU-UYX;$$<T+P^-[0YCOK!0?J("("("("("("(
M"("("("("("("("("("("("("("("("("("("("("("("("("("("("("("(
M"("("("("("("("("("("("("("("("("("("("("("("("("("("("("(.;
MFO*.3GC?A'W3W_Y9WU^CX/Y73[PLV-RN+P^.SF.R_P#[X^]=>^!S27VV3R%S
M#&/]?;"&JC#A)CQNUA_EVP("[C=6N9I3IAF@>2Z,N^O3E8^%61-C\G,8Y&"7
M+W7L#V]7=72$C84&AQ/+8W&TF8B].VMDQ<F;)#)]%\\DLI(D9O\ +#]JHV<Y
M=RM3#RV<J3;.:H.FQ<4#0*H%IHU,2"\:077$U8Q'S<F$;FR,X>2/R@*[ %B?
M6OW?9FRK6:\V7X*%K6@Z<\F$;:@QY7+8S.<5R6-PL[#;=CGAE(;CF8 /.,L]
M6'X+!E,MB,TSC]3$/#[$61JS>&UA#JL41W)X@_U/H;9HH$-6+\$><-,(W-:S
M!<->;_-P6G?RD&(EBMX_*,.3EAJ"QBGCN;7T  6#\IK]'U'D@TY.D%SE-#)9
MUF/%RY*[PY:['>\0RL :6.=YNT!UTK/A:;*W+[^RZ0PX'&PMG</-VGS;05Z)
M[*?'Z4TY\."MRVRY[G>38XO>Y0"?J:KWG6>]\7S!KZE\?&3^#T\^W>(ZT@J4
M66Q;<KQ[,266/QS<7+6%D'<=>P>A(>?]38!"E\!*RUG.1Y&G_P"XV!49%( 0
MV66)KA)(SZQHANT$-+C;=FK[3V4F$6[,QBA</(NU2CT O.*]URMG"&+DH?/3
MV^&F*[8I(MQ&,LD \V@ H-KBV4HUN-4\$^RRMEXZSH)*\FVRFSH@O'Q<''S[
M*#X]%!:H<=QMCD/@V*<M9YQQKL9-'+7]6'XZ.B"Y!N$&E0ES71^\=R2[)* -
MDUYIG1R?]@[LL\%.Q$.$3SQN%BUF9[EG_A?/5F=H_P#+L-0:_NH'LUYB!">\
MDN<?^DN\:3J5,5[U3#\AS$^2[L%R"H^M+T<\/;&SJZ,%H/T@[9ZH,OL_.N*1
MF.JZ/5J^1%Z$#WJ0ABJ S=O+,XY-8RYDM.RM1\^.A@:&U"7^;9207@MWI!,P
M,?\ ^S_H'RYG;/[Y6KE0+A@=#>LU501TF4H8;EF8?D9VUV6Z5,UWO])#$9 Y
MC?K<-CR5;JV!#Q+ V[+3!%%R!\LQD&O"8;,GF]!/0YS%8SD6:FN6FQQ78*<U
M1YV1.T,+2(M?E._0%"<?@\8<"?-7(+'9)_5X\V.\U1KR=(+G*:&2SK,>+ER5
MWARUV.]XAE8 TL<[S=H#KI6;F==L' ;59P?8$<%5A!_*E D8/^[D&*;)8[-\
MBXP<3*)33EGELN8TZAA,#H_#?]1+B/HJ$KU/!X/@GBJY\,&59:MQ,9V+HVSN
M<YQ;\>ITY!,VLSB[_(\7?HSLE@Q]2V^[:9YQLC>T 1EWQ)(WU45QBC[IDYFY
M&B8Z^8KRBA&XDBM$7%[JI^HN![H,_$C:M95E>V'G\'J[Z(<?]>9[M!_[)K3_
M &K:Y7D*N(OV<A1RT<65]U8#0>.XNMCVYC P?2#MD@.:H-NSD6T^6R2S 1RV
M<)"VM$XZ,LK)7N,33\7>:J<68LY27BDTV9-BP<E!)8I0P-9'5)8=AY(+P1OK
MYE!O9 2R0^T7$P/_ ,OLR>-7@!U)-%[I$TEGVZ(6[C74<I>QD[.2MLR4XIG,
MJ-KMB>P/B+"R0#S:@TZ-&(\%]GL+JXT+.,>YA;Z.UV)6;EE.Y:O<KCJP/<^7
MC]+;&C9D#)YBYH'Q):@V<:ZGD\E3MLY+'<EJUYNL#(&Q.:R5H:X2:\V_85'P
M5S#[,N(MCA+7LDPK_P!(<;$1<4$S+/B69[EM'*3MCCN5(3T<>IDA$+FR%J8#
MD4<,F2A?EXK^*HTQ.,B&@>&!L&*1S/HO( WL()SEDS)N&<@E8=L?A[3F_#8,
M)52?D<7DZ_%,?C1NW7NU)'P!I#ZL<#?I^)_L>7T4&.7'32\3Y4RO5<]\F<LR
MRQM&W31QV@7M_3V8TA2>0RV*S.2XX,5,V:2K=-B>5@(%> 1.:\2'_5+M@=2J
M(C#-$/(V9B:H68S*331T&'>H))-;E+?@+/59>.0S.SL&&F8? XYXQ82/)_C^
M5;7_ "1$A!/YV>+'<IQ&2O[%%M*Q")R"8X)WN8[L_P"KLT$=EI97E3)LC2BK
MYN"ECI:SY!>#&R>-*U_7PHW/VU!6L1 9X>+"5LLC1RS(2[EC#':Z6'M>YH #
M59X<E0PO(^3'+2B$W'P2UB\$B6)L(9X;/K(<#MJ"KXEV,H\:P%HY9F'OPPVV
M5FS %IC?.287QGU\VCT\U>K&?RS>%C+MH=+QI,E-<ASA&Y^MDCR.F[WI05:E
M;%OEF+ECS;\FT8N\U\S8HV0L+C$>C2P+S!7,7LSXBV.(M<Q^%?H#S#C8B+B@
MVV9#%XR'EF/R0_RJS<M2,@+27VHYFCIX8_U_+Z*EL79N4/9KC+-:JZ>S7P$#
MXX/B][( 0U! 4;YN\EXO(,\<D?\ *?%\*%C((7.A/EL#8)^HE(*K8_9?BF-A
MT0ZE)K7F'^\L=M5%KPE=@Y+RZ0PC;YZK2[7JT5V*H8BQ#C*' [MQW@U8:-J!
M\K_)D9>&E@<?@#T17MW(+$3^59''#4<N2H1BU)&YS&0NC8Q\_7XM"A<O.;<?
M,'Q927),=Q65K;'AL:QQ!<>D9C [(.B<TC\7A.9CZD]J1&@H;DK74.1X6U[\
M*%*.A/ VR8A)%#(7,(#M^3.S6^14$!=;CJ$W'+QR'O\ !-R.>U),V+36.-5X
M+@&_!I'<E;6;'R_-R6UAF&S </!!(^+\FR]LID,;#Z/(8J)G(9;%YRWQN#$2
M-FG@R,<[NC2#6A8P]_$].FP>O59^*5>O',RUD)$DV1RQ/UN)L2-"@@J^2P$G
M'N-6F\B@H7J= 0Q2.TX!_AL$L,C'+H?'[MB_A*%RU6\"::%KWQZ(T?L=Y@%!
MM(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@C:>+=7OW+T]LV+$[61AQ:&-9$PDM8T#])))6_7N5IKENHQQ
M,E;IXHUZ>(.S4'M$!KV/:'-<'-/H0=A$!?D\\5>O-/*2(XV.>\@$Z:T;/D-D
MH#'M>QKV^C@"/L*_4&*2Y7@N4ZLKB);/?PFZ]?#'8[3'Y"K>IQ6JSBZ.0'J2
M->AT@RH@\U;,%J 30O)87.:"6EOFQQ:?)P'Q"]("("("U1F\8UU-C97;M6Y:
MT1+'#<L(>7 [ \AT*#:1 4/F66XXKEN'.FK7KP.=.QD#)7,Z O+@3YAVD$EA
MZ-2EBZ=>L7>[LC!87';G=OI=G'ZR3LK,@6K5:I ^>Q*V.)FNSW'0&SI$!SV-
MUV<!L@#9ULE$!$!:V9QD&0QSZDL_A"1\7T_TM>' #?UD(-E1M_D> Q,OAY#(
MPUW].^GG7T3\4&]C<UB\HV5]&W',V,@/+?AM>Y6R.BD;&_H\M(:_7;J?@=(-
M7%8QN,KS,=.Z:6:=\\\S@&F21_QT/0   !;%:Y!;@9- XNC?O1+2WT.O1VB@
M]H@(@+%D+]3&4W6[1<(PYC0UK2YSGR.#&M:!ZDDZ 0>X)O&@CD#'L[M!ZO'5
MS=_ CX%>D!8<A1J9"E/2LQ]X96]9!LC8WO2#!**?)..3L@E<VOD*4D;9.NB&
M2M+-Z*W8F".)C-[ZM W]B Y[&#LYP:/K)TB X.+7!IT2#H^NBH_%8PT!;?)8
M=/9M3>+/,6AO8AH8T #T  T @WI[4$#H&2.(\641LTTG;B"[7EZ>07I 7EMV
ML+YQX>?'%<3D:\NA=UWM!Z6K1RV-MQT9(I''WKQ/!^@X;\+R=]B#:1 1 1 Q
MM^I?KOFK.)C;-+"21H]X7F-__P!6H@(@+7OY:KCYJ=9S)GS62X1QQ,+W$,UV
M=Y>C1L;*!DL;';NXFRZ4M-&=\K6C_6+XG1:/V=UELYBC6L3UY7N#XJ;K3P&D
MZB:=$H/VO-'8KPSQ'<<L;7M.M$APV%Z0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0<NGY7E;,65OT[&
M3,U>U8CJ4(<;++!,*[RSJ^41.VZ3KZAPZK<R6;FQ-KE=R%KA-))BX8MQNDZ.
ML 1[+&^;NO;T0#RB_B?E"8ORM^G#BK%I\EN@^J8YH-$,#C%$")%::F)SA@9-
M:Y+;\>6+Z;8HJXB8YVC^+#HW'R_22@I>(DS./X3Q@4\I(9;EJM"#+'$X11R
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ML9.W3=3,HLW*+ZKF2L> 6;,40<' ["P9.A9?[0,&]F5M1M..NO$;6PEK0Q\
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MX:[L%6)FPJ/0P^1HU.*6;<.5CBCP$52P*8<9H96:=I[&@N(*#H_'*E2G0F?
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M$WV._CM;M2G'1@,,<T\FW%Q?-*Z5VS^EQ*#%:Q%27)09(OFCL1QB/<<A:U[
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M#"OQZ',O_!QG^1RR1QM([O\ I;E!"[EQQDD6&KF;!PXF0]R^C$]CVQGL?C&
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MG$(E8^"0,FAE8Z.1CB.PVUWP(65 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
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MW+0KQ]0-!Q8Z3;OT:8D]@0.KCPI7^+*(QT;V#=@GL_ZF^2#]1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
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MR6Y)<M!D%:K*[O.\LTX2D]A]3?@@BJV3G9EN.V:D>:;5OVS$^6[,#%.Q\+Y
M61%Y<P[:"#U"U;?RC9X3FN0C-7H+HBO2PB.4MAA;"YS6Q]/3T:@D+60NW<W+
M2='EGP5:%5X;0>V(NEGV2^1Q>PG770"EZ&=S]/$8]M[C^4MVBV02.B$&P&/+
M6%^Y&CLYH!0:\-6SEN0<IAGRUZ*&K8KLKQ03&+H7UF/)/5:%7-_*&&PM>T<E
M9OR,G)BH/\!TK:\AB,KW=HPUI0,;ELHZGAXY9K+',Y-+4>)7M=*8F,D(9(YA
M(=I:<\%S*<4Y%F),M:BG'RB(HQ*1!%'7<^(1OC]#L,\R4'3,+_(^,_5(?_ +
ME,62Y!?HV\E3K9F2Z+<WNS8WQBITAE+!$6%XWL-TXD;06F*C:RV?Y+%-E+T4
M%>:!M>."9T71SX&.)VU:&)SUUC.-Y'(VB:][%213D^3!8@'B]P/@7M#D$<<I
MF)/P?IV/E-YR$-O(6&57M9,&]V&. .);U:P2>>BMCOEC#0AO0VV1Q\EK"FZT
M6F8PN9OZ9:7;ZNV$$CCH+F>I93)29>[6F%VW#6;%+TCKBM(8F]F>CR>NSV4?
MBKU_DM_#&>]9K06..PVYH()'1%TKGZV'-T0$&G8SF7KL?AA8NSZY"ZB+$9:;
M+H!6]ZZASM#O_J;5NXP[+,R&1@EK9%E#PX7UG77MDE$AV)&=@YY+?($;0;&7
MORXO/XNQ-8<VC8@G@E:2>C)6#QF/_M:UP5/J9S.4\?F&VIY'7+]:"WCFO._#
M?>=X+81^B-Q" ^UDK>3S5/><D&.,56N^I(QH#Q QYEE[/:7N)?\ '872,'-D
M9\/CI<C#X5QU>,V(_+Z,NOI#R09$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0:GR!C33RU5\9,.0DDDL-)
M^,K0PZ^KR"\Q8#&MI8JHQCQ%CY8Y(/I>?:,%H+C\?5!%6>%8:6*U"^:X*L\K
MY34;,1$)'N[EP'VG:GHZ->M<NVX^WBVO#\4[\OQ8ZC2");Q[%LK8^*-DC'4I
M"^M*U^I&=B2X;^+7?$+;Q-.]5FRLUNV939NODC;W<YL40 8QC0?3R&SKXH-G
M)XHWS$1D;M;H"#[O)T[!WU[!6I4P&,HOK&K"[_)Z3JK&EW8>&]P>0=^I)""C
MLX\+EG#PUL/E*L%2[#8U;G!AKB!PDZ0L#W[)(T/@ NCP8JI W(-8':N3/EFV
M?]9[0PZ_L"#S1IPTJ56K$"(:\+(HP3L]6#J%7[_#,-:BR$#Y;8K7'2/FJLF+
M82^7S<_2"R5\;6@O6[C.WBV&1,D)/EJ'?7_R48_BV,=1KU&F:/P+,D\$S']9
M8I)7.<XM=^GL4'[BL!C\59O6X'SR3VVQ"Q-+(7N?X7;K_P"2V\QBJF2B@$QE
M9)#+XD$T3NDD;]:VT_8=$((IG#,(R/*B7QYCD(XFVI)927O,))8[?P([++6X
MY2J9&'(.LV[%J*)\399Y>Y#'Z):@_!Q'%>ZW*;W67U9YC,(C*=0R%YE[0D:+
M3V.U)X[%^XF1SK]RP7 #\?+W#=?4  $$'S"C-?PL^+AJRRON@1"9N@ROIP/B
M.)(.V^H4K9P&,MT*=,L>QE,L-62-Q8^(QCJ"QP_1Y(,=/C>.@9?$OBV7W8_"
MLRV'F1\D8! 9\--\SY!:M;B&.ALX^P^U=G?1?NKXTQ>(AT+-#[04$I0HU<;7
M?7J]@QT\TQV=GO/(9'?_ %<H/DV#.4O<;9X<AAAO2RS21NZ.BU7D#'@_6'D(
M-IO$\8ZEE()WV9W9&#P;4\TG:5T>BT-!^ &SH!;^5P]*_#7;+XC)(']X)HGE
MDD3M:VUP0:(XCBC7MPS/LSFT^,VI)92Y\PC]&//^Q_PA9KE6M2M6LI!3L33O
MKLAEA@T?%#3]';7$#8V@P<-P7R%QZG2=&UDOTI)6@]@U\AWU!^(9^2%)9?$4
M<G%"+'B-?#*)()HGF.6-^M;8X((R?C561M8OR%\V:[I#%:\;4S1* ',WK74]
M1Y+Q'Q7$0U;%<"<MGOPW9.TA<XSPEA#R3]9C!*"0R."K9&Q!;,MFM9C86":"
M3H\L<=EA]00F(PV.P5>:"DUX$L[IG]W%Y+W@ DDH,&1X_2M7GW19M03OA;%*
M8)3'XD;"2UK_ +-G162EQK%TH\7' Q[64))GUQV]#,'!W_D@V)\'C)Y,F^>'
MQ!>@CAL,<?HN9'VU_P"2BHN*8ZM>H7I+-VS8IE_NSIYB_H'L,9'_ &<@F,G0
MJY#'V*,X)AF86OZG1T5XRN%JY,UGROFBFKO+H)X7F.2,N&CH_4?B"@UK&$J3
M8J?&V+-J=DI#G222[D#@0X$'X:(V%XL\:KV#4D-V\RS7C?&VTR4-E<QYV6O.
MM$(%7BN(J5XH(FR]&7Q=&WEQ,P^))]=K>DI0'(QW].$[:SX!Y^08]P>?[=M0
M9:>/K4GW7PAV[5@SR[._IEH9Y?V-6.6C7^4H[_GX[:SH =^71[@\^7U[:@\8
MC#5\2R:*M-.87O+V1/?V;%V)<0SX@;*]V<73FN&Y)V\3W22MY'R\.0AQ_MV$
M&"3"T/DW'T2'^%3?7=".WGNL06;/]BVT$.SB>-;#-7\6T:[KC+383)MD<C)O
M'^A]0+U)6L=3ER%>\]I,T,$T+?/Z/2<M+@1^GH$$=1XY4Q;X15N7FP1;\*J9
MR86 _  ^>A\ 3H+US"E9O<5S=.K"9)IJ,K(XQZN<X: 0>*O&<=4LU;'BVYO=
M@[W2*:4OCK]AU^@/L\@2L4W#\1.;+.]MM6Q*9)Z;)BVO*YQV[;?J=\0/(H-G
M)\<IWY2;-RZ:[BSM3;+U@=TUH%H&]>7F%GL<>HV<C-><^<&>N(+$0?J*=C>P
M >W]'<H(V'B6,KS8^1UF[.:+PZJ)IB\1::6:"JO(, ,A%EL?3P^3B=;?*"7S
M-;1#I/(V.H?_ &ZUYE!=+_'Z4UF"S'/:KV8X!#XT$G1SHQYAKP=@A2D$(KP1
MPB21_4:[/<7//Z22@J47%G6<]R6W+-=J^\680R2"7P_&B;7C:0?L<"IF7BF+
M(H^[/L4W5(#!$^M(6'P3HEAWO8V$'JIQ7$U(:\4+90V&^;K-O+CXSFEI))\S
MO:TLAQ#$6O?F/FMM@MN+[%5DQ;#(]WJXM03\$+*\$4,>^L;&L;OZFC040>.4
MH;<TU:W=KB:8S2P0S%L3I"=EVOAOXZ02T%*K4M7K,8/BVWL?*-[&V,#!K^P*
M'N<6PUC!0826.1U6'KT'?3OH_I0264PE3)>ZN>^6&6NXN@FA>8Y(^PT0"/@?
MB"O(P58P58IK%F<P6FV6/ED[.[L]/[$&C;XEC;,UMPGN0QVG=K,$,Q9%,3Y$
MN ^OXZ4;<XR+7)XIV">K#!BF0P3UW^&6$2'<8_1I!+?@IB?DP4-3=18]X$PD
M=XWC[WXO?U[K=HT!2;(#=M6.Q&W3R=SY?4   @\9[#8[-8]U&\QSHG/:[37%
MIVTI?P6,N7\9?GB/BT"\P:.A]/X$?$; (08;?'*MB]+=BM7*L\K6MF=7EZ"4
M,].XT1L? J0C8(XV,!<0UH&W$DG7UDH"("("("("("("("("("("("("("("
M("("("("("("("("("("("("("("("("("("("("("("("("("("("("("("
M("("("("("("("("("("("("("("("("("("("("("(*'C>0V*/X2O&,MVX:
MN5M.GE86@1L !TT/(+B!YZ"N%G)6XHJSZ&,ENB:/Q.['QQM#3K7F\CS*#6QW
M):5V;%Q,AF8+M666)SP!IT+@U\3OJ>-K _E=8[97ISV)G7I:M>)G4&5T'^<>
M"2 &,/D24$KB,Q'DFVFFO+7L5IO"L02:[,=H.'FTD$$$$%:>:S<&&@JS2P32
M^/99!''$ 7N>\'J "@UX^3]9+T%S&SU;->FZV(GN8\20L]2QS"02#Y$+!%S%
MCZ->V<7;#;<D;*$>V>):+VE^VCM]$ #>W($W,8JD5_W['6:T]2)DTD+BQVX'
M.ZF5CFD@M9\5N93+U:\DE-\4SR['V;+S$=%D40 WOX%Q/T4&L.0QQ#&U*%"U
M<L348['AA[ 8X?0.D>\@;)4)A.1114LQ:?!9?)/GI8(*NAXQEZ-_%CL=#6B@
ML#.54X*V4??K2U)<?$R2>%W61Q9)OHYG0GMV(T%!V\U=L\CXA!8QEJB9+EAX
M$CF.#V"I+L$QD@$(+J2 "20 !LE5F+F$(K17SC+;<9*]K6WSTZ=7G0D+.W81
MGZT&\WD!.<GQ<&.L2O@,1L2@L;'$R4;#B7$$_8%,N=U:X_4-H*O2YO#;Q,64
M&*N-KV!"*>^G>S+-_J,;OX?65M2<EM&#)Q#%3QWZL#936<^,]HW[U(UW;J0"
M"@PX;DT[\9QIU^G+'/DBR)IVP@DUS.9/H$Z:>I6UDN24\:[,MEKRO^3L:R]+
MK7TF/+QH?LT&.;EGN]"&[/B;;(Y[;(*S/H&282CZ#PT'R[?45OXW.NM7IZ-J
MA-3LQPMFZ2.8\/C>2T.:YA(\B-$(-O,RP5L+DY9A)X4=29\GANZOZM82>I^#
ME5CG\K%R3#8Z#'3/J3XZ64N+XMNZF(!^R[>F=SM!;7$AKB&EQ .A]:JF'Y3:
M=5SMO+TY*U>E9G'B.,;NK8]?B]1DDN025?DK_>:,-[$6J3+CNE>24QN:Y^NP
M8_HX]'$*8GC,T$L8D<SNQS0]ITYNQK8_2$%:QG(98.'S7[Y+[5".6&TWXOGK
M$L/[0@$+'C\OD*44&-]SM9/(P58Y+[V.8QK'R^?7M(X>?U-"#7R/++)IX6SB
MJ$TS+-]D,P)C:YKFN+7PN#R-/V%-6N1S1VI:U7$6K<T$#);3(C&/![C89MS@
M'//U!!*8^_5O4:URM)WAGB;(P^GDX;50SLT1Y34J6<U/0JC%R3;9.( 9!*UN
MR2@U\3RV>"A1;+#8R,]NW;AHRL#&.LQUW?0>=]6C;?BI^3DDK[$\%3#6K<M5
MK/>Q&^(")[VA_A O< YX!09'\JH&EBY:4,]N2^#[K78 UYZ?EE_<@-#/];:3
M\ALP,J0R8B<7[+Y!%4;)&YQ;'KM(7[ZA@V@U?PMKM@B9'1L&\^\ZF:9+ \3-
M892'.)Z]>@[ K;M<@L0'&P?)%AUVV)G-J^)$"UL)'9SG]NOQ" _)01Y6(S5K
M,5GY)FG,1>"UK6/;MI#207_45I4>8MM,Q=EV*MQ4K[XV5[3RS1=*-MVT'L ?
M0%![FY$1;OQ5L3:MQTB&VI8BP-8XM[EK0X@O< =D!36%RE;*8>CDH6/9%:@9
M*QKOR@'C8!09U!T,_+=F#Z>*L34_',7OG>-C#U/4N8UQ#G-""+=GW193,WY'
MV'U89HL;4K1>9GL^K^H) [;<&[/IHJ=Q^<\7(?)UO'S4K3H3-$R1S'ME8T@.
M+7,)!+21L()',RR0XC)2QO+7LJ3.:X>H(82"N7\=S;)[7&F8OD<^2GG8TY.L
MZ5L[(HS"2YY/JPAZ"Z,Y=7?-E.U*9E3'OG9<N/+!'&81O0&]NV$J\D(GHBYB
M+=.*X\,KSR]""]PVUCPQQ+"Y!L9//SXZ222?$6?<HI&-?:#X] .('<,[=BT$
MK%/R%\61LTZF*LW'UF,=9,18T1]QL-'<CL\CST$%:P7)XZO'<$P5;%R;(26_
M=V,T'.+)7. )>1I6(YVA2L9RU:98B=5IU9;+2[NT=P[3(V@D=MC100]O-7;/
M(^(06,9:HF2Y8>!(YC@]@J2[!,9(!"RV^;LJ8^[E1A[LN-KF0>],,>G^&>I+
M6%W;IORV@F[F<?6NRT:>-L7IXH6RV!$6,$;7[Z@F0MVYVCH*6QN0K9*A6NUG
M$Q31A[-C1&_@1\"$!<RP%^A8>SY2Y'DHKK\E:8V%TKXXCUL/$;!L=3MH""R<
MX=EZV,99HY#W:**:#Q0QOXR0OF8SKV/HW15I04GF]G,U+&!^3)Y&R^-/*^)G
MI.*\1E\(_P#-I3V8S'? P3XV4&7(^%%2?_Q6/1__ -HW;D$%@>0SQ\<X\R5M
MB_?MQ/Z1@M[R",_2>]SB  %*3<RIPT?'DI61,V^*,M4!IE9.X;:WR.CVV-(,
M[^26!+#3CPUB3(.A$TU5LD7XAA):#(_MU^EKR 7N?D4[)Z]2'$V)KKX!/+6:
M^,>"PG0[O+NOF1H:08#RVI)4QSZE2>S8NOE9%5;U:]KH#J42%QTWH?(J%Q_(
MXH,IRR[=AL0"NRBQ]=VG/$C@X!K-$@EY(UI!-1<HBK>]LR5"Q1DAHR7.CRR3
MO#%^66F,GS;\0I3#Y"W=C+YL3-486-?&Y\D;^X=_R..B@CN53V<=C:^0AE<T
M5+L$E@ Z#X"[I(#]@=V4'RO+Y*MFZ;ZMA[*N-9#8R#&^CV69A$ [_E:'.03,
MURV>2F"#Q7PT<8^>>&/6Y99W:B9YD#8#'+S-RQ]47FW<19AF@I/MMB#XY#+%
M&0']2PGZ3=H)=^8JLN8JI$#(Z\R22-S?01QM#B\_H\P%LH"("("("("("("(
M"("("("("("("("("("("("("("("("("("("("("("("("("("("("("("(
M"("("("("("("("("("("("("("("("("("("("("("("("("("("("("(*]
M4Q5Z/%\GA=!J2W;N/A'9OTVRMTTJO2X?*MLX]M_%6[]2/$UH8J\$[&,BLLWX
MAF!>P'?EHH/<6!SM+B6(]WHL.5QMN2>*N)&@.#Y'M<P.)UHL>OV_Q.>"IQA[
M:LMWY/BFCM0Q3>!+*; #GR,/9@)[MWHE!:N/4:=."U-%BK-)TT@[MGE\61_4
M:#B0^11O.'6F0X%]6)LLS<U7<R,GJ'Z:X]=H-*Q1RV:OW+[\9-4;%AK5.O%,
M^/Q)9;.B2>CG -'0 +;MXK)PTN+6ZU82V<6&^+5[-!>Q\)B>&.)UV"!!C;68
MS,]Z]CI*M08R6BR"9S#+*)W!TCG",N 'T0 H_"X+.MQ.;.2BW=?1%"M]-I[P
MP1EK'[!T#(YQ*#/7HY;#7Z5]F,EMMDPU:G8BA?&)(I*Y+FD>(YH+3W(*@I.,
MYRW4=;M8[\?'R"6][FRP&&2&6+PNK9&D:> 4$K)QJ.[B,L*6'LT;<L<(C=<G
M\0RF!_BL:=/ETW:VICGLKG^,V'8.:I6I6)WV732PEW9]=\8Z"-SMMV4%OM0-
ML5IX'$@21N82/4!PTJ!+1Y#:XLSB\N(>Q_N\=.6]WC]W\%FF&5FG=^Q;Z-T@
MM>/HSU<[GK4D76*Q[J(7;![>&S3E*2 ECP/4M*"@2<8R+^$\4INJ=K>,%226
MJ)O#+S%$8WL$C#ZZ<IG%8FKTR,T.&N499*QA#[<XE<\'9T-22Z *"*BIYDX3
MBLOR/8;:PT\7BUB^+<S6UW0/,1[:_P!?8VM7)XKD&7',I_DI\/O^!94IQ/DC
M[N>SQO)^G$ DO07#-XZW:BPC8(NQKY*O+)Y@=6,!V5[=3LCE0OF/_)_DLP]]
MC\OQ>VM(-OD%6>Y@<O5@9WFFHSQQMV!M[V$ ;*@+%/)5<UQN\RA+8CAQT]2<
M1.9VC=*8G!Q[N;MHZ(+,J1-A<I:H\IQ)JOB-BW):JVG%A@>26/8TZ/;U&CY(
M-VP,UG+6'BFP\U&*K<CLV9)9(G F'9#(O#<XG9^)TK4@IE_ 9%_)M,B:<3:L
M07;9V/*>J" SK\>Y#"MXQY/#YW,6X<7/>KY PR#P'QA\<L<8B+7"5S!U(:""
M$$8<)F*V&JSNJ^-;^7?E*>M"YNP))"2QA>0"6@K!:PT@SN2OS82_;AOL@E#:
M]H1202,C$9CD;XK&_#U!*"]8RM!2QM2M7KFO%'&-0EW8LWYEN]G>E"W<3[SR
MRO=GI12UF8N2+M(&NZRF5K@-%!NY#'V9<]Q^S%$##6%GQ7; Z=XPUJB81E\'
M?S7A8B:]7NVC:@?"^)I8]S&L<R7Q7-T-MV"$$53X]F,*,#D(ZPMSUX[K+M:)
MX!U>E$[C"9.H/1P67-XVYE+V)S+L+=+(([%>:EX[(;'24M<)6F.0-.BST+D&
M9V*QT>*F:>(WI&6;/>6$S1R3AS&@,F+GR^1\M#3MA:;:5]V J5LO@[]^42SO
M@?%-%[Q6;W/A RE[#WZG1<U!MT<1R$OHS7P)9AQ^Q6FE[M.YGO:6M/UG0\RM
MM^&R)XSQ>F(/Q]2;%F=G9OT!7<PO0> S-X.;."#'BS!:L/M0V#*QC(2]@#A,
M'$'0(WMH*UN&9/W3"<+Q)@>Z:SB!,X^GA1Q,;YN^TN 0714O%2Y_CV%&)& L
MVWU(GLK6(9(3%*P;+"[N]K@[ZT&1_&[]3CV 96:V>[CKC+DK"X,\>5P<)O/Z
MW>(2%N5HLCD^04<A/CI:-:A6G8QL[HS++)/U!\HG/ :T-03^3K26,5D886=I
M)*LK&>8&W.:0 J-4Q^:NQ<8AGP;J)QKX'RVII87/(ACZ%D8A<\Z>@D7\=NVL
M#RFA)J!]Z[9D@<XAPT_18X]4N_+><^2JUC#2TFU[L%FW-)+&6;KN[AL/1Q+N
MS@@JN4X]F[M/,P3X:S;R,MJ5\-Q]EGNXA[[C$;2_;2&>6NJMXCRV&S6:GK8B
M:[!D7Q3QF*2-ACE9$V$LD\1S=-TP$$(-# 8',UH^)^]UF!]0WS:ZN:6L,Y/7
M2S9;CN2O2\G\)C&^\UJ!JO<X=7RU7.?HZV0$'J8Y_*Y_C-@X.:I6I6)WV732
M0EVWUWQCH(W.VW958ST&<QG <IA?DP/8RO+%'=\5GAOB>X]/H[[]SO2">RN"
MECY'?OR8FW?K7(H=>ZV?!?%)$.I#FF2,%I"G:-NKC)\)A*^.DA,\$\QB[]_=
MVL()[G9WMST$VJ;G/EK-TIL2./SUF22QB2W-+"8VL8\.[QACW.+O+R\@@G>6
M8^U>P%BK4B[RF:NX-V&^3)FO<=NU\ I5!%Y6A;L9[CEF*+<-66R9G; ZA\)8
M%"X3 9.KG'ML,:,;CS,[&:<"7&T=NV/AX0VP(*_'Q3(P4>,6+&.FL.I5;->U
M4AL"*4"9X>'L<'M!UT\QM3@P.Z]!]+#SU3\M06;#)YA)(61-Z^(X]WH)"S#E
M,7R*[DH,=+=JW:T#)60N8)HI(.VB!(YH+'!RALGAK$N=;F9L+=L0VJ$,,M>&
MR(IZ\D3G.&^LC&N![H,_R--C9\'D\;A9@*[;;+%+QF/FU;<UY>"]Y:7=F;([
M*+O<>S^:;R2>:@*SK$N.FIPOF&W^YN[ECW1$]2Y!-XS&U8Y)KC>+9"*>*K(U
MHL663%_?7:)FYGCZ6DXU2MULE?,&/M8_%.A8(ZD[V.U-L]G1-8Y_1FD%HOTZ
M]_'VZ<XW%9@DB?\ 8]O4JI<;P&2GP.5BS\(;;OQ^!.WL'@1LA$ T1]>BY!'T
ML-RW\%<L^9ABS-N2'N&2M#O"@#(B&/!T"]K20?@2L^%P<K.3P78\#+3HG%6:
M\IL3,DE?(^2)P[@/?Y$-01."GFP=?-9&VQT[,6]N(Q[&N\Y6,ET/[27M85U$
M;UYH"("("("("("("("("("("("("("("("("("("("("("("("("("("("(
M"("("("("("("("("("("("("("("("("("("("("("("("("("("("("("(
M"("("("("("("("(*\SE%F:Y<K4^/7[+*UHUWSLDKL9W: 3H/E:[XJPH,&#R
MARN,AN&+PN[Y6]-]O\V\L]?[%G0%^6*-6R:YFB#S#,)8_,CJ]H(!0?J("2O\
M.-[];ZM)U]B#QA,B<IAL9D3%X?O=2&?P]]NGBL#^NU%\ASU7C^-]_M0SR1>-
M'&1$WL[<AZH-RYEJ5*O0L_2ECM6*\,3H]$;LN#6N^SS7O&9>&_/?KB.2*>G/
MX<T3P =$;8\?6UP]$#%YBODZ\T]:)X@;.^**1P ;+T.B]G_#OR!6EDN28_%Y
M#'X^1DLEBU-&S4;=B,2GJUTA^ )0;&8S-+!T'7+0D=ZB.*-O>1[M%W5H61^5
MF?B*V0J8ZQ9\:..1L#'1,?UD&_,R.:U!&T.1SVLTS&V<'=IS&L^<.E? ]O1K
M@WS\&1Z]X[DE"[F[6+@9*Z2&%SS,6ZB)8_HYK3\2"@\7\[D<>ZSKC5^:"$$F
MPR:JUA:!LNT^5I4QC<DS(8VG>;#)$+$#)6QR ![0\; < @]H@(@(@(@(@(@(
M@(@(@(@(@T;O&L+D+$D]JL^0R:[M,L@C?H:^E&'=2MX11M<'!C00WJ"!Z#ZD
M!$!$!$!$!$!$!1+N.8,6Q9]U<]XE,H#Y9'QB3>^P8YQ:"@EDZ,[]^H[:UVUY
MZ0$0$0$0$0$0$0$0$0$G@9/#)"_MT>TM/5Q8='ZBT@A!BKT*-.K%4KP-9#$>
MS6_E?2WV[;=LD[\]K*@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@HV I9>;)<DDK9<5X1FY>T7@-DWIC-
M_2*S18RAF>2<F^58Q(:DE>*JUSB/!A= '^(SZG%Q/TD%5P$4%^EPJA:E,U">
M/)2N['Z-B6.7Z ?]?DXN7C).;B3S.OB7EL0LXF%S&REH@9._K*&N\^@T51.M
MXMDWR78(\=7QM&SC9H)F0V3)N<D&*4#JW3F^>RHRUEKF7KT\TQSV'!U(+%E@
M^,SWZL,('Q8QA0;5V5]USK9G>RGDL]!0<]KBW_)*[7MUV'PDE!"V<U$..Y-[
M<#%X3Y<+?FDJL\X^]=H,4G7X$N.D&.YC<9C>.8G,8YY-]TU(QV@\NDM.G>T.
M;(?]</!*RQX[&Y&'EF1R3O\ *JUVS&R8N(=5CA:.G3_9\OI(+3PIP;PSC._S
M55_=!:_--&KA@?SYCOWX4%.RN\1/C\ __,?+5"QC3\/!-AO>'_\ -$J?YMCG
MNL8NQ5LOK36[,>-LO9ZOK3G9'Z'-_P!4JBXUX(*T$->O&V.*)C6,8WR#6M&@
M H+E_P"3Q_\ Z[34$UGOY#RWZE/_ .!6'CA XYAB3H#'U_W800_$=WW9+/O'
M\HRZK?HJ0;;%_P#=>;UD/^GS/^A._?A!@Y7_ )9\G8!A^GDIC[Q_PU(=.EW_
M ,WDQ68    : 0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$01-GB7')[$UJ;',,LK^\C@YX[./Q\BMG)8+
M!Y&<3VZ,<LH9T+CL;9_LOUKL/T%!IY3$0C&UZ5/!U+==DI=X$DGA="=N[1GJ
M[SV5K8#C,=6+*FY2J,;>+6FG$.\3(F#0820.Q))+B@F:&#Q&*>Y]2MX;BWIO
MNYQZ_4.Q.@MBOB,96BNQ05(F,MRR2V&@>4CY?)SG?:@P_)&)CQ;<6*4)IMB\
M,0%NV!J8_!XG&&5]2HV-T@ >\DO>X-] 7.).@@U(.-X"G;;9@QL+)6/<]FM]
M8R[U+&^C2?T+U?X]@;EMUJS0CDG(;W<=@/Z>G<#R=KX;0(^/58LKC+<9#8:%
M!]6K6 ^C'W+=N!^Q@"W[-2K;;&)X@]L<K)6;^#XSV:X?84'C(8W'7G5'6JL<
MKZT[9H'.'G'(WT<U>K-2M9$/C1-?X4K98]_ZKV^C@@]+\M5:UGP?'B:_PI6R
MLW_JO9Z.0?LL4<T4D4C0YCVEKFGX@C1"_#4JBE[GX0\#P?!\/X=-==($,,4$
M,<,3 R.-@8QH\@UK1H (:E46Q;,3?'\+PO$^/3?;J@_#4JBY[YX+?>/!\+Q/
MCTWVZ_9M)Z5.>>I9EA:Z6LY[H'GU87M+'$?:"@](@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@J?,+'),72M9&CE*S(8S"UM=]7N?IO;&3W[A9<CD,Y
MA,=N:U#D+MJU%6I,;#[NTRR?!Q[/^B "XE!KY&QS#!4CE+%ZK?@@'>Y696,)
M$0\WNA<'.\V_45;P\35^\$@^G'N-^MCS'D4$;Q?+SY/"PSVPQEJ)TD%MH\@V
M>!Q8]5B'E.6FQE%]."!]O+WIFXX/!Z,JLV1-+KU'4=D&Y>N\FX\*]V_>KWZ!
ME9';ZP>!) )#U$K-%P+03Y@K'R.?E="U0-?,U1%=R;*S&.I]C$V0./KW'8C2
M#)DK')ZMS 8UF7K&>[+9\2R:GD&Q1]P SNK)CH\E7A>R[?CM/+]A\</@ -UZ
M:[.0;*I7#>49#)93,4<@(ATL632+!U[0P3N@<#];FD!!ZY)R*]CLW@Z%$1$2
M6JXNEXWUBGE$3&M^HN\U,<EOY"C4K5\8(SDKLXAJB0$L;H%[WN ^#6@H,<.?
M?;X7+FH6AD[,=-(6'_4FB8>S#]C@HBOE^247<=GO7J=N#*2Q1&)D!@EC=+&7
MAS3W<' (-Z?E@HY7/P6OILK.J,IP1MW--).PNZ-'Q)4[B79DU#)E#$V>1Q=X
M,7Y,+3Z,[?ZSA\2@A<G<ST_*&8K'WZ]6,8SWESI*_CDN\7IK\MBBG\LRHXQ>
MMEM?WRGE&4GR1@F&3_*&1%[0?K#T%RR>0KXG&7<C9WX-:%TCM>IZCT"K<,'/
M9:+;OOM"&P6]V8YT!<P?'PWR]@>WUN0>I>8NEP.(MT:?>[DI? KUI#H,F;OQ
M/$(^$?0[4G1H<JCG@EN9VK,S>YH64^C=?4QW<D((N;EWN>2Y#7LM\4U[-:"C
M6B;N:=\L DZ!,EE^08K"5);DE-EZY>B@[$'W>H)SY=CL%_7^S903N/KY> S"
M_E([8=UZ=8!"6D;WO3CL**Y/?RM.QQ^IC[$4,E^^Z!\LD7BAK1"^3R;MOQ:@
MPX_-YB.[GL7?DKSST:<=F.S#&8PX2A^FO82[3AT3BK^49+&X;*V\S6=%:JPS
MR5V4^I_&L[=0_N@F./9.SD!E_'Z_Y/E+%>/0U]"/6E%R9'.Y?,7Z>*L0U*E%
MXBGM/B,SY)RT/,<8)  :"-E!HR9GDM5N;Q4QK29*#'/N4+#&$1V&-\M/82=.
M:= J0RW(;3^+T+^)\,VLC[JRGW\V=[!!V?T-&R4&*?D]@\(@R]=C1<L00LAC
M>-@6IB(@TC]#RK1?GEJXRY,UP,L-9[P2/(N:W:#G.2YIF*+.&6O!CD@N8Z2W
MDP&GL(V-BV^/_D\0E6_)YB>#+\8KUW,,&0GG;(?7;&5WRM+3]H0>^7Y.YB^.
M7[M0L$\89T+QV +WAJC8,AGL=R#&XS(VZER.]%.8WQ0F"2)T(!/8=G@M*"5X
M]D[.0&7\?K_D^4L5X]#7T(]:6+!96U>R?)*\W7I2OM@AT-'H862>?]KD$+EN
M2Y*I%SET7A[Q5)DU;;?B83(>RFL1!R$>!9O9FO/"^(.,+*GA';A_M=W(,F>R
MPP^+DM,@\:9TD<->$'7BS2N#&-4%;_#?&8]^1-VE=="PR3T&5S&"P>;FPR=B
M>P^&T&7)9?(6KG&8<-=A@BR=>>?QI(?&VQC&O9H=F^O92'',IDK-K,4+[Z\L
M]">-AG@:6,D;(P/&VDNZN"#2SES,LSF"QN/MPUO>X;<DDDD/C:\ ,T .S?\
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MC99KB]C0!HFJYY9I_P#QCR)09)<EFLGGLOCZ60KT68_P0>T/C2S&5@?W +@
MSX*U1-E;#&V5X?(& /<!U#G?$@;.D%0H3\HR]W-FOF*M:&KDI*T<9J>*2UC6
MNV7=V_6MJ?)YO*YJ[CL1/!5KT>C;5M\?C.=+(WN(HV[ \@022@RXK*Y:#-R8
M7+N@EE=7-BI:B88Q-&UP:\.;LZ>S86[Q'*6LOQK$Y"UU\:Q7#W]1INR@Q\5R
MUC)8N:S:Z=VW[D(ZC7T8)W1M_P#H%%MNY_,93(P8NS!3IT9? ?8?%XTDTX +
MFL!( :S>B4&G8SW(Z=7D%"=E>3*4J7OE65C"(K4/_(2>K]C1"E.0Y^XSCU*S
MAA&^WD'P,I=_-I,H[DD#ZF H/%OD<IXA2R=$-]YO,JLK-<-ZFLN#-$?\.U@@
MNY_,9+,P4LI6HLH61 (W0>-*\] _Q'[<W3#OR06SWZG7MU*,L[1:GC>^-FCM
MXBUW(^S:_4!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$%<]H'^B=[_U:O[]BQ<RAE@@PV49"^5N,
MR3+,[&#L[P2QT3R!\2T/V@TN0\LP=C 6*N+O5[US(0/@J00/$CWOE'79 V0U
MN]DE7/'UO<\=3K$[\&"./?U]&@(.;\A?9QF6RF(J]F_A&(S6</\ 4F\H;+O[
M(]/4UR-D6$M\9R@A(H8[Q:T_4%W@0S,#6R$#X-+1M!J\MSF*S6*^0\5=@N6\
MD61M9 \2=(BX%\KRS?5K0I?F'^=XO_U^O_X/01/.&XEV<XF,K89!4\6WWD=.
M:X!\'R^F"U6#%WN*T,1:GHY.!U*%Y=-,+1LAA/UO+GD()D$$ KE&/:^K@Y,W
M$#WQ?(LG+)^FL^R]DP_L;])!GG:^UC<9F)F$/RG)J$[ ?A7$@;"W_P"X&U+O
M^7,GRJU=Q@I&#&1FE&;/< S/T^9S>G]C4$-O(XJ'FN)R K@W,=:R-80D]/I,
M+)FCM]3M.7JKBJ/&Y>+9R%CC!/%#5N&5[IO"-A@#)6&0DL'?R("#+8PURSS3
MD64QKV#(T14\%DG^:E9)$>\3_J[:\G+H&"SM7,U7RQ,?%-$_P[-:3RE@E'JQ
MX04+DL?&7<T8,[:A@@&#^@9+)K GQOK#FJ&EE9%P+,MC.L5!F*HQTSQTW6%B
M$D_#;0[>G(+KG;6-Y)QW,4,/DZ-JV:Q?'%%.R0[80X;#2= E9H.?<6.*%V7)
M10N8W4E1QU9;)\8O"_*[H*I6HY'#X?C&9L4Y-UK]NW>@:"Y\460[DD-'QC[C
M:O\ 2Y+QJX:[:N9HS23.U$QD['.<=;T @H3L1<DYCRK,8TM^4*4]9K(Y#J.>
M*2M'WB/^R3KR<KDSD?&<IAG27Y8(8))#6L5[G5G2;XPRA_Q01'$YJ\6<R6.Q
M-]UO$0UHWL/?QF5YW..X8Y/B->>O@L'/V8LVN(MR,S(JGRJ_Q7OE,( ]VD]7
M@A!H8 8R*YR.' 3>-B#CS(^4$RL][/8$,E.R_P"BL/L_;PQF*XT^+*P')&A7
M'@_*#G'Q3$ 6^"7H);C?(<!0EY'#=R]&O+\N6W=)9V1NT=?!Q63&92C@\WG<
M;D[,586[INTYY7=(YHY6#LT./EV:0@S8ZW7SW,SD:+Q+2QV/EJ^\M\XY9YY&
MN+6'T<&!B@>,QO?R*' N'XOCT]R7^RQ_[M_VCD<@4XW?A:SCFB(:63GRWZ/!
MD8','[64KI>;_D7*?J<W_@4'.\8QK[_LV:YH(/'+8(/Q!CKJ/C$N+YEQ3 2A
MQBKW+<U!Y^-5]60=/MB/D@N/M%Z?@;EO$(#-1=B3KR\5JK./;QZ#EV*/%K++
M)E$K,F8YC:8R ,):3(2_H>^M!!)<;Y#@*$O(X;N7HUY?ERV[I+.R-VCKX.*]
MXO)X_"\FY/7R5N&K[Y9BMU7RO$;)8S R,]'.T"6EB"!R,[,A@?:;E:^W4[%(
MQUYOA*(*Q#GL^MJLG&!PF*2J<;E8);A@ \)N0=.X^6SJ-SW()+FL%IV)KW*T
M)F?0OU[AB;YND9"_;PWZSU6GE><\=.%DFHY""W//$65:L+@^:65PT&=/4(*[
M/QJ!LWL^PMWN\08ZU$_I*^(]XXF Z=&058>&-9B[&7XZYH#J<_CP.T Z6M8\
MVO<0!V<""TE!&<T9@SR;BK<Q9C@J>[9';Y)S7&_Q6OI@M4-5%5G%N?P8IYDP
MS*$QIR^H<]\#C,&O/F]J"UU.7\8@PK)?EBE,^O0#S!'.Q\A\./9 :"H*'C7,
M;/&;>.L#%M-_Q)IWN,WBMFG/??VL0>CF+,]+BO(YZ[WFA)8K91C 7.A>X>%(
M_J/@U[%?*G)N.W7UXZF:HS/GWX3(YV/<_0['0!0<WJXJ_P#A1RW-8L-??JY)
ML9@>?H6('5HBZ/\ X'?45TW#YNCEZ MUG. #BR6)XZR12-]8WM^#@@YKR?\
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M?4R%J#1XC2L5,,+-QNKMZ5URU^A\WF&?_:-TU:$$GRKS"U:]:V(C-:'ZC:F
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MB;67PLUJ*UCXC.\.L2RMLLB'9[)1(7 [ 47R#(<;=RF!^:OOKTWX..6$"S+
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M/FGFE(+Y97^KCH ! Q.+CQ4=UC)G/$]ZQ:)(UHSO+RW[ MM 1 1 1 1 1 1
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M0IU9Z,,\A8ZW/X, ZD]GAI?KR_0TH,?RYBV4LC;$KS#1DE99+8WN<UT/F_R
MV=+<-RJ*?OGCL]W\+Q?%W]#IKMVW]6D'FE;@N4X+<)<8IHP]A<TL):[S'DX
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MMR"#QG-.(7[S*=3.TY[+SID;'[+C^A3UJS!5K36)Y&QQ1,+Y'N.FM:T;)/Z
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M<DM14VRR&-CX8A89'MP#M -077B\EBWG<[D,DUL&1B;!3DJ1^;(XF;E8\/\
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M+E:/>WM+&KH?L]Y#[.LQ;<["8NO0R38"Q\'@MAE\/8WYM\GHBU^T+_0;DO\
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M_P!G-F7%8TX.'&YNLT,:980)'RANCJ1=QF@BGAEAE:'1R,+'M/Q:X:(0</\
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MGST>SG\\O^[3_P!Q##YZ/9S^>7_=I_[B?/1[.?SR_P"[3_W$,/GH]G/YY?\
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M:[RC &]N0:,'/N&6;$,$'(*+Y)7AC&"0$N<XZ "GY98X8I)97AD;&ESW'T
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M^MT/W4:^R$6B(@B B B B B B B B B B B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
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M:?,=S_\ HE7]NU/F.Y__ $2K^W:AI\QW/_Z)5_;M3YCN?_T2K^W:AI\QW/\
M^B5?V[53Z.&O8GG&-Q=MK19ARE:-X!V.Q>U!]](C(B N!_PB?Y)P'ZU*A%Y]
MCCP/9O@_ML_OWKH: B B B B B B#XW]I?\ /#;_ %NA^ZC7V0BT1$$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0%\:\D_GJ/_ %ZI_P";$6/LI$01 7 _X1/\DX#]:E0B\^QQX'LWP?VV?W[U
MT- 1 1 1 1 1 1!\;^TO^>&W^MT/W4:^R$6B(@B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B OC7DG\]1_Z]4_\
MV(/LI$!$!<#_ (1/\DX#]:E0B\^QQX'LWP?VV?W[UT- 1 1 1 1 1 1!\;^T
MO^>&W^MT/W4:^R$6B(@B B B B B B B B B B B B B B B B B B B B B
M B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
M B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
M B B B B B B B B B B B B B OC7DG\]1_Z]4_\V(/LI$!$!<#_A$_R3@/
MUJ5"+S[''@>S?!_;9_?O70T!$!$!$!$!$!$'QO[2_P">&W^MT/W4:^R$6B(@
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
MB B B B OC7DG\]1_P"O5/\ S8@^RD0$0%P/^$3_ "3@/UJ5"+S[''@>S?!_
M;9_?O70T!$!$!$!$!$!$'QO[2_YX;?ZW0_=1K[(1:(B"("("("("("("("("
M("("("("("("("("("("("("("("("("("("("("("("("("("("("("("("
M("("("("("("("("("("("("("("("("("("("("("("("("("("("("("("
M("("("("("("("("("("("("("("("("("("("("("("("("("("^->2?SU'
M_KU3_P V(/LI$!$!<#_A$_R3@/UJ5"+S[''@>S?!_;9_?O70T!$!$!$!$!$!
M$'QO[2_YX;?ZW0_=1K[(1:(B"("("("("("("("("("("("("("("("("("(
M"("("("("("("("("("("("("("("("("("("("("("("("("("("("("("(
M"("("("("("("("("("("("("("("("("("("("("("("("("("("("("("(
M"("("("("("("("("("("("("("("("("^->2?SU'_KU3_S8@^RD0$0%P/\
MA$_R3@/UJ5"+S[''@>S?!_;9_?O70T!$!$!$!$!$!$'QO[2_YX;?ZW0_=1K[
M(1:(B"("("("("("("("("("("("("("("("("("("("("("("("("("("("
M("("("("("("("("("("("("("("("("("("("("("("("("("("("("("("
M("("("("("("("("("("("("("("("("("("("("("("("("("("("("("("
M("("("("("("("^->2?SU'_KU3_S8@^RD0$0%P/^$3_). _6I4(O/L<>![-\
M']MG]^]=#0$0$0$0$0$0$0?&_M+_ )X;?ZW0_=1K[(1:(B"("("("("("("(
M"("("("("("("("("("("("("("("("("("("("("("("("("("("("("("(
M"("("("("("("("("("("("("("("("("("("("("("("("("("("("("("(
M"("("("("("("("("("("("("("("("("("("("("("("("("("("("^->2?
MSU'_ *]4_P#-B#[*1 1 7 _X1/\ ). _6I4(O/L<>![-\']MG]^]=#0$0$0$
M0$0$0$0?&_M+_GAM_K=#]U&OLA%HB((@(@(@(@(@(@(@(@(@(@(@(@(@(@(@
M(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@
M(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@
M(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@+XUY)_/4?^O5/_ #8@^RD0
M$0%P/^$3_). _6I4(O/L<>![-\']MG]^]=#0$0$0$0$0$0$0?&_M+_GAM_K=
M#]U&OLA%HB((@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(8*Y=W,+"[>]]1M 1 1 7 _X1/\DX#]:E0B\^QQX'
MLWP?VV?W[UT- 1 1 1 1 1 1!\;^TO\ GAM_K=#]U&OLA%HB((@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@+@?\ ")_DG ?K4J$7GV./ ]F^#^VS^_>NAH"("("("("("(/C?VE_SPV_
MUNA^ZC7V0BT1$$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0%P/\ A$_R3@/UJ5"+S[''@>S?!_;9_?O7
M0T!$!$!$!$!$!$'QO[2_YX;?ZW0_=1K[(1:(B"("("("("("("("("("("("
M("("("("("("("("("("("("("("("("("("("("("("("("("("("("("("
M("("("("("("("("("("("("("("("("("("("("("("("("("("("("("("
M("("("("("("("("("("("("("("("("("("("("("("("("("("X'_")_DG
M ?K4J$7GV./ ]F^#^VS^_>NAH"("("("("("(/C?VE_SPV_UNA^ZC7V0BT1$
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0%P/^$3_). _6I4(O/L<>![-\']MG]^]=#0$0$0$0$0$0$0
M?&_M+_GAM_K=#]U&OLA%HB((@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@+@?\(G^2<!^M2H1>?8X\#V;
MX/[;/[]ZZ&@(@(@(@(@(@(@^-_:7_/#;_6Z'[J-?9"+1$01 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
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MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
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M3=8BL&M"9XVEL<I8"]@/P:[U"#TVI3BL2V8ZT+9Y !)*& /<!Z!Q]2M1^ P
M\?6(H;F(,I]W9]/X_2\O-!GM8'!VY636<52FD8 &/D@8]S0/31(64    : 0
M<[CXCG\AS"GG,_/CC#CO%%""JU^SW/DZ4O70K-:K9A=!8@CFB=^5'(T/:?M!
M0>:M&A1A\&G4@KQ;WTB8V-O_ &:L3\+A#-/,<73[S B9Y@9VD!^#CKS0;$44
M<,;(HF-8QC0UC&C0:!Y  !?D]&A/-#/-4@DEB\XI'L:YS/\ E)]$"S6JV870
M6((YHG?E1R-#VG[05YJT:%&'P:=2"O%O?2)C8V_]FH/SY,Q4=QUV*A5;:<-.
MLMB:)2/J[ZVL<F#P0M^^'$TC9WOQO 9XF_K[:V@V2 000O%:I4I1>#5KQ0Q[
M)Z1L#&[/Z @_,AC<7D6!EZA6M,'H)HFR ?9V!7JM5J4X6PU:\4,;?2.-@8T?
MV!!^1T,?6AEA@IP1QRDF1C(VM:XN&CV 'GM*U6I4B$-:O%#&"2(XV!C1O] 0
M+V-Q5Q\4ENA6L21'<;I8FO+/L+AY+U#1I0NL.BJPL,[BZ8M8 9"?B_7J4"*A
M0@JNJQU(&5SL&%L;6L\_7;1Y+#4P^&Q[GOI8VI6+ORC#"R,N^WJ @SSUX+,+
MX9X62QN&G,>T.:?M!0UJQK^[F&/P>G3PNHZ=0-==>FD"CBL9C@\4J%:MW.W>
M#$V/?V]0%C?B\4([$7R?5Z3N[3M\)NI';WMXUYE!ZL4:$U45IZD$D   A>QK
MF:'H.I\DJTJ5&$0U*L->(>?2)@8W_LU!^,HT8+$MB&I R>7_ #DK6-#W?\Q'
MF5^0T*%62:2M3@B?*=RNCC:PO/KMQ'J@'&8EL$\'R=5\.9W>:/PF]'N]=N&O
M,KW+CZ$S(&2TX'MA(,371M(C+?0M!]-(*5RK$<WN9%LN).!? &-#/?H7.EA?
M\7L+05L\'XI^"^&EJ2VO>;-BR^Q:G T'RO08<YQ*?(<YP><<^LZI3J3P30/V
M7/\ %:YJM\&,QE.M+5K4:T,#P0^*.)K&$'R.P  =H/<%>O6A;#!"R*)OY+&-
M#6C[ %JQ8C#U;+[%7&5(9G>LL<+&//VN 053\"R_GF5SMT5)Z-O&,K"L]O<]
MFEAV0X:U]%7:M4JU86PUZ\4431IL<;0QH^P!!@K8C#TIWSU,;4@E=OM)%"QC
MW?:0%ZDP6$EN"Y)BJ3K(.Q.8&&3?U]B-H%G&8JW+%/9QU662+_-R21->]G_*
M2-A>9,7B'5Y*[L;4,3Y3(^,Q,+'2?%Y&M$_I0>[6"PMRPVQ:Q=.><:U+) Q[
MQKZB0LDE&E+/#/)5A?+$-12.8"YG_*3YA 1 1 1 1 1 1 1 1 1 1 1 1 1
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M(@(@(@(@(@(@(@(@(@(@(0"-% @HTJSG.@JPQ.=^46,#2?MTB B B B B B
MB B B N!_P (G^2<!^M2H1>?8X\#V;X/[;/[]ZZ&@(@(@(@(@(@(@^-_:7_/
M#;_6Z'[J-?9"+1$01 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 7 _P"$3_). _6I4(O/L<>![-\']MG]
M^]=#0$0$0$0$0$0$0?&_M+_GAM_K=#]U&OLA%HB((@/>UC'/>X-:T$DDZ  6
MGA\WB\O6DM8^R)XF3.B[@$#LSUUOU"#<1 1 6D_-XJOEZN*FLAMRQ$Z2*/1\
MVMW\?3X%!NH@(@(@(@+#3R,$^1R-%K'B2F(N[CKJ?%;V'5!F1 1 ?8@9-%"Z
M5@ED#BQA([.#-=B!\0-H@_*]BO989()F2,#WL[,(<.S#U</+X@C17Z@+0M9R
MA2H4[H=X\-FU7@C?$0X$V)!$T@_5LH-]$!0USE6'I77T]V;%EFN\-6O)9='L
M;'?P@>J"7HW:]RI%9A$@9("0)(W1O&CH@M> 0O2 B B B O&-O4K\<TE63NV
M*>2!SM$#O$[JX#?KHC6T'M8,QG<5A8:\N0LB%DT[88SHG;W?8@SH@(@(@Q4,
MM!?]]\)CVFM;DKN[?%T>MD:^'FLJ#!E<G7P]-EB9CWM?9@@TS6^T\@B!\_@"
MY9T!$!8(\C",P,86/\7W3WCMY=>O?IK[4#+9>AAJ$ERX]S86.8UQ8QTCMR.#
M&@-8"222M?%<FP^5G?7K2RMG8SN89X9*\G3T[!LH:2$&^B R>N^:6%DK#+&&
MF1@(+FA^^I(^&](@-L5W3R5VRL,K&->^,$=FM>2&DCX Z.D0%BQ&6@RU:2Q
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M->+,VYZEN6RV>*PX/<71P.>"' !>\7E<A-PG+W9+#C/$[*])?B!#-*UG_8!
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MAOYNFR;*>",.;4/O[=2LD:2TEA/GU*E,CE;\7!L3=98<+$HQ?>7XDS31-?\
M]P4&"OBWCVB79#DKIUBJTW3N.IW/+]#T_(5>P]'*#B>8R,.8M0/K6\K+5CCT
M(AX5B1WXQI![[*"TRWK^;S&.Q\=R:G7.)9>G,&A)(9CT8P.(/5HT25!Y?+YK
M$T^6XYE^2>6E3KVJ=E^O$#9WEO1Y &]%B"<M-R.)?QR,Y6U8?;S;667R$:+3
M7D<6-  TS;5HY2G>?F*^-QF=R8G+A/;<96F.M!OTUU_*?Z,"#1LYJUD,GG ;
MF:@%2RZM4;2J22Q QM&WR%K'!Y)/HMRE>SF?OXRC:GM8TLPL5RY%$/"E=/*\
MQ]-N&PUO0H-_A\-N#.<PALV38?'<K 2D .<SW=A;VU\4YQCW69>/O%ZU#O+5
MX^L3P!Y[/?S!^D@R=+^4S][&#*6J]3&UJP)B<&S3RS GL]^O0 *O9',Y^K0R
M6.COEUNEG<?6BMN W)%;=&0) - D!^B@Z+1J/I56UW7;-H@DF6=P<\D_8 -*
MJWKF?FGYE7QTKW30&F*S 6]FA[ Z3IW\NQ&];0:0LV9\%>&#R&4GL1V(1:@G
M(%R!G;<@8) -/+?1?DN7BBP567%Y>[*3G*$$PLG\="))V,?"\. (V"@M.3NV
M8N2\>K,E+89F7#*SX.Z,:0J)DL^(NF2Q>2S-H#(PM=(Z/_(71R3B-S!MK1H
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MQE\>4L9*[D9+<T],U9 Y@8SIV[::UOH%$.X1/)0J8R;.V)*522!]:+PV!S1
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M/3N6HB[PZLUB*4D:/:LXL?\ _4**;E\<;M">*:Z]\V)EM15F-VV6+;#V+?\
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M6&44S"^&+HYA<^O(V?6Y -N>6I;RU?DMS 5,?%8=X5^*W;<^%\0KL@'8,?W
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M+0_L8@W$0%%T\4^#)V\C9N&S/*QL3'= P11-)<&- ^LGS*"41 1 1 1 1 1
M1 6#)8AE^WB+#I2PT+9L- &^Y,3XM'^QZ#.B!D8;<U1[*MSW:4ZU+X8DT/L*
M\8VA6Q.-JT:^^D$88TN.W'ZW./UD^90>T0$0%BO8IEO(XFX92TT999&M WW,
MD9BT?L[(,J("("("("("("(,>2H4LC R"W%W8V:.4,V0.T3@]N]?#8!TLB B
M B#2QN-;0]_ZREPLW9+)V-:,FO)9[>,CFRN-R+I2#4CG8&:\G>/U_NH,R("(
M"("(-7.XVQDJ+ZK+[ZT4@+)RQ@<]\;AHM:3^23]:VH8HX8HXHV!K&-#6-'H
MT: 0$0$0$0$0$0$0$0$0$0$0$0%KUL?3J3WIX(NLEN82S.))+G!H8/L #4&P
MB B B B B B B B B B B B B B B N!_P (G^2<!^M2H1>?8X\#V;X/[;/[
M]ZZ&@(@(@(@(@(@(@^-_:7_/#;_6Z'[J-?9"+1$01 1 1 1!YM0>/7EA$\L1
M<->)&>KV_82"N7862]B^$8GW.],;&1N15(WRD/;7\25P+V!!9[#;_'\I@RW*
M6[=:];]TGBLN#R'NC<]LC" /BW1"F.3MRS<._P"2Q+XOBQ&3P>OC&'N/$\+O
MY=^OH@JDN7BBP567%Y>[*3G*$$PLG\="))V,?"\. (V"K1D;4\')..UHY2V*
M=EPRL^#^C&ENT%*QL?(+O$Y\R[D%IEV-EF2!K>I@ @>[JV1I'TNW7S66YR>;
M)9*A6=)DZ]<XBO>D%"!\LCWV2>K2YC7%K6AJ##)D^23X["UQ;N5I).0NI"S-
M 899JI@D>'ECP/I*0S(MXN]7;?RF6CQ$=1H9<A>'%L_=W=UH@$ZUK1UU0>,K
MFY)\_)C?>\JVI5HUY>]"!\SYI)^VB]\3':: U8JV5Y!?BPF)EL6ZK[%ZVR2V
M^'P+$M:J.S"&O ZN?L E <;6!Y1EIY;4MN*MQN2Q#XIW* R0DL+@M.AE\N!A
M;<4^=MV9[$'OL4E&5E4Q3'3S'M@#!'O8*"^Y]F6=A;QQ8=[WU;X?7KV([#MT
M[^7;KOKM0-++X:'"9.9V>R48C+8Y_>O.U6D=Y!H8YF^SO@@UL!E;#.4PT&2Y
M9U6SCIIM7V:<)(9&#;-@'1#UHXS*9?*8O@U(Y*>)^1I26;=EFO%<(&MVUI(T
M"XO02N&J6Z?/,C!-=DLL&%KF%\NC(&&9_P!%Y"N-Z]4H5)[-B9L4$+"^21QT
M  @H BR0XYS7D#X706,A3EFK0'R?''!7+(N__&5L\C@KP>SF,5V, KUJ3ZVO
M@^-["PA!8N1Y@8NHR*O$)\A:)BIU_P#;D(]3]3&^KBLV$QU;CG&:-*>RWPJ-
M1HEF<=-^@-N<@A.,QS7LEEN1R1/A9?9!%4C<-/-:#?61X^MY<O7/))XZF#?#
M!XTC<Y3+(^P;W/;TV4$'R"AE[6.Y5F<C5BJ!O&[E6&NR7Q7D%ID+WD !2F4O
M42<;2-_*^\BDR3W7'M)=U/D))"&G7Z-E!!0YK.W\!Q?I?FAL3YV>C/,6M$CX
MHA.S9'IWTP%6O&>^8[D\F,=D+-FM-CO>6"P0]\;V2=#IP^!!061$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!<#_A$_P DX#]:E0B\^QQX'LWP?VV?W[UT
M- 1 1 1 1 1 1!\;^TO^>&W^MT/W4:^R$6B(@B B B B JU!PUHQ$^*GR,LE
M42B2F0P,EK/;(96N#_B6E!N5^.V7Y&I=R>5?=?4[&LSPF1,8]XZF0AOJ_2E[
MU:Y+6Z4[ONTO8'Q/#$@T/@04%</#8YZ>49;R,TUN[/#,^TUK8S')7T8BQHV!
MTZK8K\:M_+-'*W\O):GJQRQQ@1-B8&RC1TT(*EQGBUZWQAE4YBS7I6G3FQ6$
M;>^GR.#VL>?-@>KA>X]VMU+^/NNH68:WNWT6"2-\(.PQ[#]1]$&Q)@Y[+,0;
MF1?/-1O>]"3PVL[GH^/KIOH 'KQF\5E+XFCBS;JU::'PY(A Q[M'R<6.=Z$H
M-:3BO@SU+.*OOI30TV5">@E9+#%^0'M.MEOP*RW\#-:IX\S927Y0IS&6"ZV-
MC3V=L$%GH6%IT0@U:O%VQ96YD;]^2[/9I>ZRM>P,C\/>]-:WT"RXW!Y3%^ZU
MX\_-)2KZ#(9(6.DZ#T8Z1!-W*]J>J]E:T:TI(ZR]!)UT=^;7>NU59^%-L-NS
MW<I++?L359&V6QL8(C3=WB#6>8T"3O:"2I<:GBS=?+V\K)9L159:_7PVQQ])
M7-=Y-'H06K6'$8J^)P=6OD)8;.*9UK6@UI.NO1P<T^1#@@VL3QI]+,W,O8R,
MMJU9K1PR%S QH$9)'5H] G)>-S9U^.+<F^NRK,9?"$;9622#\DO#O7H@WJ./
MR,+++,EE#>CD9U#70LBT#L$?0]=JO0\-=%%2J3YFU/C:DK)(*;VL]8CN-KW@
M;>QB#/8XIDGYZWEX,_)%++&V-C75XY1#&/\ 49V] 3YE9<UQ>[F<91IV,W)N
M&;Q97^ SK.6G;0]GIH()+'4LK4D?[YF'7&EFFL,#(@T_7MBV<OB8\F* ?*YG
MNUZ&T-#?8Q'8:@]93&,R>)R%![RQMJK+ 7#U:)6EA*A9>,6(\B^]C\M)5DEJ
MPU['XIDH>V#?1S>WY+AV0>*/#JU.IBJS+DSVT<K->8YX!<XR^)MKOVJEY<;&
M,RS)"5P>VDZMT^&G/#]_;Y(,]&&Q4IQ0SVWVI6[[3/:&EVSOS#=!>T!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!<#_ (1/\DX#]:E0B\^QQX'LWP?VV?W[
MUT- 1 1 1 1 1 1!\;^TO^>&W^MT/W4:^R$6B(@B B B B B B B B B B B
M B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
M B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
M B B B B B B B B B B B B B B B B B B B B B B B B B B N!_PB?Y
M)P'ZU*A%Y]CCP/9O@_ML_OWKH: B B B B B B#XW]I?\\-O];H?NHU]D(M$
M1!$!$!$!$!$!$!$!$!$!(YX9'2LCE8YT;NL@!!+':!T[ZCHH"("("("("_'3
M0LDCB=(QLDF^C"0'.Z^NA\=(/U$!$!$!$!$!$!$!$!$!$!))(XHWR2/:QC&E
MSG..@T#S))* US7-#FD$$;!'F"$0?AFA$PA,K/%+"\1['8M!T3KZME?J B D
M,T,[!)#*R1FR.S2'#;3HC8^HA 1 1 1 1!^230Q!AED8P.>UC2X@;<XZ &_B
M5^H"("("(".>QA:'/:"YVF[.MGUT$!$!$!$!$!$!$'YW9WZ=QWUOKOSU]:_4
M!$!$!$!$!$!$!.[.X9V'<@D-WYZ'Q0$0$0?DDT,1C$DK&&1_1@<0.SM$]1]9
MT%^H"("("_ ]CG.:'@N;KL ?,;^M!^H@(@(@(@+\BFAF:XQ2L>&O<QQ:00'-
M.B#KX@H/U$!$!$!?D,T,S"Z*5CVASFDM((#F'1'E\01HH/U$!$'FS:J4J[[%
MNQ%!"P;=)(X,8W[25^Q2Q311RQ2-?&]H<Q[3MKFGS!!'J"@_4AFAGA9+#*R2
M-X!:]A#FN!^((0$0$0$0$0?CYH6211OE8U\A(C:2 7:&SH?'2_4!$!CV2-[,
M<'#9&P=C8.BB DL\,+ ^65D;2YK07$-&W'0'G\23H("_(,CCIK,]2"Y!)/!K
MQH62-<^/?IW:/,(/U$!$!$!<:K9WVA\RR>6EX[>I8[&T;;ZS'S1B1\KV?:'(
M-V?$^VNM!),SDV+LF-O80^[@=]?#?173@?*6<GXS4RIA$4KRZ.9@]!(PZ.D%
MD1 1 1!S_GO*LY2R6%X]@&0_*62+R)IAMD4<:C?D'VT?UPQGW5O^&@S\5Y-R
MJKRV;BO)W5I[#JGO-6W .H>Q=+0$0$0%%\@RL6$P>1RDK"YE:!TG0>KB/0(.
M6XOYX<[C:V5BSV+H06XQ+#6\ /(C?YCU85XS63]JO#:@S.4RF/R="*5@LPLB
M$;PUYZ[!#6H.T5K$=FO#/&?H2QM>W['#87Z@(@+@?\(G^2<!^M2H1>?8X\#V
M;X/[;/[]ZZ&@(@(@(@(@(@(@^-_:7_/#;_6Z'[J-?9"+1$01 R.,IY.M[M;C
M+XBX.+ ]S0=? ]2-A4KC=.I4Y?FH<.PQ8V"I#'/&TGP1<[$Z8/@0S7=!=40$
M0%R[*6+#K]KED4KS7Q%UE9K ?HOJQ[CM/_[O_P#O$%YSV>M4+6(JTJ3;4F0?
M(R+<G1H+&=^Q(!^BO>(S-Z;)7\9D:L,-JM%%.'0O+XY(IBX!P+@T@@L(*"5R
M<N1BK T8())>P!\:0QL:WXN):UQ*J$G,IZV'Y!8LTX39Q19XC8)3)'*R0!P<
MQV@4'JQR7D=2Y0JSX2OXN1#Q3:RP3T>P=BV<]/+3=G;5LLY7-4JYPY2FUD^-
M\,O9 \R-F$PW'T+@T[<?+109JV=R\&2Q]/+X^M![\'BN^"<R]9&-[F.3LUOG
MU!((4(SF6=DPMC.,PT H5?&,P,[A,]D#RV1\8Z:T-()J[GKQRK,9B:D$TPJ-
MM32SRF.**-Y+6#Z+7$N?I5'&<AL8VMSK*S4")H<O )*P=OS\&&(]2@L$W(>1
MU+]+'386J9[['FKTLDL88]%XG)9\ =[:LWX735:>5]_H@7:5J&N(8']VSOL]
M?"Z%P&NW9!N4\UEF96MC<M2KPR68)):\E>4RL)BUWC=V:T@C:@*?-,W-@:7(
M),-79CI&Q&5OCDSM:\AI>!UT0"@W)[W)1SJ"K%'5-0X][^AGD&V"5@+RWIKN
M%9<D;[,?8DI,A=,UI+1*\QM_3YM:XH*7@N29>MPO 6;U=EJY>BJPTV-F)?8?
M+'V[2N>T=?B7*PT\UDX,M5QF5HP1/M1O=6FKRF2-QC\WQN[M:0[7F$&MSV]E
MJG&<C-C3&U[(]OD,CHWL'ULZ@[*BLS8S,&<XB30KOO/%]@BCE<81MK?-SRP'
M0""5AY/)2AS@RU6.*;&0QS2> \R-ECE!Z%FPT[):1I98,]F(+V,AR^-@KQY!
M[HX'13F4QRAAD$<NVM\R&GS"#/RC(V,7Q[(W*P;XS6!D)<-@22.#&D_H!*T(
MN!<:9 PWJ3;]LC\9;LDR3/?\7!Q\VH)#(9F['E8L1BZD4]HU_>)GS2&.*&(G
MJW?4.)+B#H*+L<RL4\7FI;>-Z7<9) V>NR3NU[9R U\;M#8(*!-R'D=2_2QT
MV%JF>^QYJ]+)+&&/1>)R6? '>VI8Y?;HXC/SW:#!;Q4C!+'$\O9(V0-<US#H
M'T<@SMSN9I6\8W*8J"&M?G$,;XIS))#*X%S&S M \]:V%YSN<S&#BMWY:=$T
M:X[.!L.$[XQ^4YK>FMCZD&2[G\H,\_$8ZA!(\4(;7CS2ED8;(]["#U:3OZ"Q
M0<NL>%1?9Q[8B<L['7-2]A#+H]'-.AV:\Z09,C/9RDN?PE0B(QT&,=;)WTEL
M@_1#?K:SS6/#Y:_/:FJ4:E)M''V?<G!]APL 0_1[] PC[ 2@M"Y='9G9E*G,
MC*_W6U?=2+=GJ*+R(HI/V@[?8Y!<LKG+]/-T,32HQ336JLTPDDD+&1B)S0>V
M@3KZ2BJ_)^16&Y*.MA:OBXQ[F7.]EP8]X'<-A(9Y[:0=E!*2<GGMMP\6(JLF
MGR%(7&^,\QQPP$ ]GD!QV2[0"T;/-9ZN,M2RXW=RIDX*5BLR38[3EO5T;B!L
M.#P0@DJ>9S$>8JX_*T:\1MP22UY*\SI&[BUVC?V:P[TY57-\DS.0XCG,E#BH
M3BI*=ID;_&/O#HNI9XW3KKJ@G8LWD-T<7BZD$T\6.@GL/GD,<<3)!IC?HM<2
MYW4H>8S24*7@8[MDK-Z2D*;I-,9-!LR%SP#]!H;O:#2HV,E)SZ&&_4BAFCP<
MY#H7E\3VNGCT6EP!!5RN&\RL]U."*6?8#&2O,;/,^9) <?((*Y#RF['\N07*
MM4V:%#WQIKS%\4K"'Z&R 6N!8L47)\RV/$7K>+@CH7YX(F$3$SQFSY1N>WJ!
MHDH-Q^>S-K)9*OB<;7FAH2"*>6:8Q&27J'F.(!KO0'U*Q>SV43<3IR]'-[V+
MCNKO(C=F0Z*"F9V?BL/-<\_D,1?&S&T3"?#D?T),O;1C'T58L5DLGA>,8>">
M!]B_;L214H99?/H2Z2/Q9!V_(B'TB@V[/+K>,AS#,G0C;:I5&66B&4NBFB>2
MS?9P!;U(^DO>1O\ *1QS*6? Q@D%5TD,D-J0CKT)<X'P_5OP0;>*M<C?QRC*
MZK3?;=%$1VL/Z="P'N]Q9OLHT9_+ST,_6BKTFWZ,;27,G<871R,+@]K@PD.&
MCY(,.,Y#EZO&L"ZU5AL9"\R"*HQL[B)-P^(7S/<P=?($N4@[EDN/;F&9FJR&
M:C2%O<#S(R:$[&V=@T]@1K2"OYZ_R%\/'1DL5!!%/FL?T\&8ROB<)@[K*"UJ
MZ+-$R:*2)^^KVEIT2TZ(UY$>80<^N8;%XSE7&Z^#K^!;,SY;O1Q(-,,()F^O
M;M=25L5L3CN1Y;D5G*P^.RM>]SJQEQU"R*-I<]@^#W.=ZH-CCU6OG.-,J9;O
M9]QOV:SBYYW*:LKXFE^M=MA8N)5*\>=Y/%C-LP[#!"QC2?#%EH/C>%]0&P"@
MTLO@L1BLQQJ'"P&')RWV/>YCWN>^I'_GC,23V:NAH.;<3XC@<AQ:E:FKOCM2
M>*3:AD?%,'"0@$.:5NXO.RRX_C\>2@9:MLST] S.T")*XE G'Z2UBHDHN67Y
M+>9>:,,6.Q4\[+EI\I[$1,[_ (I@;YE9(.29F-^+FR6)A@J9"9L419.7RPOE
M&XQ*WJ!]+]!.BH%?-9K)2VGXC'U'U*\[X?'LS.C,SXCU?X88QVF@^6RM+&W>
M1GG&7JRLJ^Z1TZC^OCO/1CWRZ>UO37=VOI($7)\S-C),U4PT,N,;V>S<Y%F:
M%GK(QG7K^EK25LV.27Y<I4H8>C!9-G'1W8YYI#'&V)[M$G37%!M4,_E<CDKK
M*U6D*E6Z^M+WG<+'T#HOZ!A 'Q:"5*XK%/HVLQ;FF\26[;\7?P;&Q@8QG]@"
M"G\[.)^6.*C*Q&2H9;?=G1\FR(O+Z+ 2MZ'*<>PN FN8:@XL?;9#%7;&^$RV
M)2V-HU( @SLY!G*V:PV,R6,K--]TW2>O.Z1C?"C+RT]FM/9;E+D;K7'+^6-8
M-=6-X>%V\G>Z2/C]?T]$&"+*NLY6J(,?![Y-@S9CE>\C6WM_%$@$]=E5G <D
MS]7"B[DX89:YS4U>283O>^-KK3XMD%@^@PZ 07:/*D\@DQK(06PTFSSR[_(=
M(XM8S7UD-)41R;WJS=PF%BLR5V7Y9G69(R6R>! SLYC'#T+B0-H-^GQ/C&,L
MQ6:6)KPV6;U,UNI/I#1[.]2M-F=S5V7('#8NM-6J3O@,D]@Q.GEB\GMC#6.
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MC&\WXP<=6A@DD@O=H(FB-C^D8ZO+6JB-Q>'P=[V?NRMZ*,WI:<MJS?<-3QV
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MK R#$<XQE)Y91KW*(@:ST@DE,;GLC^H ^>E1:,MP^O"[&S8K%4)XJ?C=\=,
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MF9OUZR-#@OU 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
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M!$!$!$!$!$!$!$!$!$!<#_A$_P DX#]:E0B\^QQX'LWP?VV?W[UT- 1 1 1
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M+.TGVZC)FQMGDA(E9T?VC.CY%!GRV5IXBA+<M.(C86@  N<YSSU:UH'JXDZ
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MF>%__@^\^+O_ (^G72#.B#3RL>,@N8[*7)W1NKN->'_9+K;FL ( ^)  1N1
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M^[_5_P#&\-!=+V_G P8BWOY(O^/_ ,G>'HL7M&H5[/$,FZ3Q-PQ=F=)'Q_\
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MHDK"D0:<E=WAO@ZMZ?0/U:0>L;QS'T8KS"9K+[O_ +U-8=XCYAUZ .]!H#R
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M++-L^?:5H8>J\/P-)]'%TR9/#HR5WP^8V37_ ">R"/GXM +5NS4R>0H^\O\
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ML@>^6/QHP&]HV@N036?^5!@<F<2-W_=7^[?\^O+6_BN>P8YLN=XK8I8_-O\
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MG;7\'Q;YL:Z.=V+6"P?K"S\C@N0Y7!9B"K+9CIFQ'/%$-R".PT#NQOQZEJ"
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M("#I&#_D7%_J</\ X!5:N[,9O*9EE?*RT*M"R*S/!CB>^64,;(]SS*U_T1W
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M<&Z)#U-O;GSF*F!;GYQJG)<M7?"A$S@9.C(V#H6-"!Q9EZ#D7+8[U@3R,=3
MF#0TR-\(D%P'D'*8Y-DKE)F*IT7MCLY"\VLR9S>XB'1TCWZ^)#6G2"->_,XO
M,XW'39B:U!DF6(XYI8XA-!/'&9 YO1C6EI /D0L/ J5R&+,OERD]AORO>9T>
MR(#LV8[?MC0=E!O<U_\ =L%_U_'?O@L'/X(F8:+)-:UMRE<JR5I?]<$S-86
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M)T]X$4IT@B:G(LSF*/$ZL-L5;.2@L2V;+(AV:RKIKNC)-@%[BH^SD,AQW/\
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MRP('3!FI2SN&ECP_S;MN_11T& R+\E2OYC+MMNIE[JT,5<5XFO>WH7D%SR2
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MY!;K&).5N<\HL/65XIF%_P#LRLA#V._L<%FX3>=G9[_(IHW1^)'#3@C=ZM$
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MK9:&M&@  @!K020!L^I7X6@D$@;'H@$ @@@$%',8YO4M!'U$(/W0T@    T
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@+@?\ ")_DG ?K4J$7GV./ ]F^#^VS
M^_>NAH"("("("("("(/C?VE_SPV_UNA^ZC7V0BT1$$0$0$0$0>+,$TU>6.*R
M^![A]&5@:YS?T@/#@N68V?,XCV;P7*N1?-,ZQ6;"R5D?1G>V(W-^BT>3@4%O
MR;GXO&5X<CRNRR::P2)F01.GE\MF.*,,?Y#["56F\IRXX]R5\%N::?'W*\=:
M>S7->1[)O#.I8W,9]9&^J"Q%^9P^<P45G,RW8<C+-#*R2*)@CD9$Z8.BZ-!
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MO"C@BV3IC7%^R2=DE /'LS8OX6YD<S7D..G=)'%!5,3'AT3HCVV]WG])3%#
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M("("("("("("("("("("("("("("("("("("("("X'_")_DG ?K4J$7GV./
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MREE;!6[C6Q]W/C?$T?\ *T/<"7((VQS.@V/!NJU;-HY6!\E-D0 +N@:[1[D
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M(?X?@Z!T7=EL8K."Q=EH6J$]*VR$3".4L>'Q;Z]FNC+@='R*"21 1 1 1 1
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M;09T05Z7E-9MR>M2QM_)2P.Z3^ZL9TC=_LE\KF-[*?IVG6JL4YKS0%P.XI@
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M\^QQX'LWP?VV?W[UT- 1 1 1 1 1 1!\;^TO^>&W^MT/W4:^R$6B(@B B B
MB#1Y%?EQ''<Q?A9WEK4IIF#X=F,)"I&7QK\)Q@9VMDKLF0KQ13OF?.][;))!
M>QS">G5^]  ()&M1]^YEGI+5JRZ&E+3?6@;,]C!(8@22&D;6US**=[^,5HK<
M\ L9EL<SHGEA=&:\I<W801$6$@/+;^*-J[\F1XZ"V*OO,NO&E>^/?;MVUIGH
MM"E<OVZ^%PLE^PV&3,9.M+.)")GP47OZ1]_4$@#;D%C@@^1.68ZA4L3.IY"E
M9>^O),^7PGURS3V%Y) (?HA4BA[[2X+@LB+>0L9#*>YUI91,72"*1WI$'N#
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M5EYK93C['S[<>C;-6/QBX#X=V$JV\5]]&"JSW'O-FV7VI0\[,?CGN(Q]08"
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MAL8G@64N4W$B*?MT#P/B!U*R?.Q=HSUCG^'9'%U)9 SWIY[L83]?DU!U0$.
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M!,W,14M5J4,I?TJSPS1Z(V70G;=K7DPD#,R<K%;LQ2R1LCFB8YOA3"+?7N'
MGR[? A!GS.&@RT$$<D\\+X+#9X9H2 ^.1@(!'8.'H5@K8NO6OV;S9)7S3UH(
M)'O(/85^W4Z 'F>YV@U+7%,9+ ]HELQ/&0?>CGC>!)%-)L$L)!&M'6BL^-XY
M3QM^QD?>;4]J:!L4LLSPXO#"2/(  (,F&PT&"K.K5[=F2#?XF&4M+86[)ZLT
M =?:L]>A6J7,E:A+^]V5DDVSL=F1MB'7^QJ#1;QG&MP%3#GQ15K"OX>W#O\
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MF4QL<V02AVIO&:_Q/&[#_7[>:#=Q&%K8L6G,FGGFLR"2>>9P=)(X-#1O0
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M< <V*S7<&R!K_5A[!P<TZ]"$&M6XYCZE/(P^+/-)>#A9L2O[2R;;T\SZ#0]
M!H*2JUXZE:"O&26Q1-C;OUTP:"#2& K?*ES(Q6[3/>F 6(&EOA2%K/##B"TD
M$#ZBAXYCSQ^O@]R^ZPPP1,/8=^L&BW_Q08,CQVO-?DOU[]VE:EC:R9]9[0)6
ML].[9&O&PI6M#X$$47BR2=&AO>0]GNU\7'ZT$#;XI3]\L6J.0OX^6<]IA5D
M9([_ &G,D:]NU)6>/U+>,@HV;%J4PR"2.RZ34[9&G8>'MUHA!K4L!6IWG7I;
M=JY:\+PFS67M<61D[+6A@:T K*.-8\8%F%[2^ZMZZ/8=_HO$@\T&Q8Q]:6]0
MN$N\:JV4,T=-_'  [_[*A<;X9">-8^M=GR$4<D8=:QQ?TA<_>SW!'8 _$ @%
M!<KG&8+&0?>AO7*<TD3(IC6>UHE9'OJ'!P=HC9T0L%;BV'HUL?5@\8,I7Y+L
M(+]ZDE[[!)]6_C"@D+52HR^_*D3.DAIOA+8VE^V=A(0UK027;"@>(8EM:?/9
M=]62!V2O.E9%(.KV1,\AL'T+R2_2"6S& ^4C*7YC(P0R1])8('L:QX_M87#^
MPA2'N52.BVEX+3 (/!$7JWP]=>OV:01V,XVS&OB$.5R#ZT32V.I+(U\36D:U
MLM[D#X;*CCPK%L@%7WR\<>']FXXRCW?R/;KZ=NG_  [T@G8\94ARES(Q]_%L
M0PQ2>?T>L!<6Z'_VY6F_C.,^0+N%)E]UL^\>(>P[_P"4O=(_1^UR#>./KQY:
M;) N\>6K'7?Y_1Z1N<\?V[>5JNX[CAB,KC"9? OOMNF^D.V[9+G]3]KD&.[Q
MFK8LPVH+=NG9C@$!GKN <^(>8:\/#FE8/P;Q+<4_'#QBR6U'9FE<_M+)-'(V
M4/>X^I):$$M;H5K5VA<>7^)3=(8M'R)D9T.TRF,EOB+P\I=IEF_.N6#L#]8D
M:\((B3B>,;B(<='+9C\.U[TRPUX,WC]R\RES@0225GM<9@GG@M,R%V"Y'7$#
MK<3V"26,>>I 6EA0!Q+#'$3XU\<LD<TWC2RND)F=-OL)>_KW!"\.XNR:G9J6
M\MD;44OA^4SX]L\-X>.O1C4&\[$4HLN<I$9(K#XO#F:PZ9,!Z&0?$M^!3*X*
MIDC5>Z2:">LXN@L0.Z2,[#3@"000?B"@P4.-XZLR^9'S6Y;T899GL.[/D8 0
M&>0 #1OT 4=%PFBTT/&R.1L,I3125(YI6EL)B.QK303]6W;*"3GX]!)EI<E%
M=MP230-BG9$]H9*&=NI<'-)!;V^"U:7'HJM^&_9R%Z[8BC>R#WE["(FOUVT(
MVL&SKU*#6DX9C/ N0&W<$$UHVF1![0()S)XWB0D-V#V6>IQNK6RD63?=NV;<
M=>2#QIWM.XY"TD:8&@:+4&P>-XUG'(\#VF]T;7;"/,=^K4RF!K7+K+T=RU4M
MMB\)TU9[6E\>^W5X>' @(-&'A^'IT7TXC8+'Y**^XND[.,\18[9)^LL!*FJ]
M"M4N9*U"7][LK))MG8[,C;$.O]C4$!E,)B*.%IUGP9"2."TZ2"6JUTEB&1Y<
M\R#PQOXD*,XUBW,S]_*MANLC?39 V6[L3S.[%SG%IT6L T $%Y1 1 7)?8LX
M-PO(S\3G[/\ X,0=9(!!!&P?4+E7L+>!P*/]=G0=61 1 1!RCD_\\?!?U.W^
M[>NKH.3W]#VYXCX;P#O_ #D76$!$!$!4WVF@C@'(OU5!)\*=UX5Q@-_--3]T
M%7/;-U^;G-_;6_?L07;"2'Y#Q(']!@V?_M MQ 1 7 _X1/\ ). _6I4(O/L<
M>![-\']MG]^]=#0$0$0$0$0$0$0?&_M+_GAM_K=#]U&OLA%HB((@(@(@(@*$
MK\CF9=HUKV%MTFW'F.O+(Z)X,@:7]'B-SNI(!0>\=R27(V-U\1:-(S21"X71
M!A,1+2>A=VZ[&EO9;+5<33%B9DDG>5D4,,0[232O.FL8$$=6Y&_WLT;.(M5;
MCX'S5X7NB<+ C]6L>UQ;V'Q!4#P7M:NYV_/AGP67W[4;K<CHGNZ,DZB#;'$Z
M9I!OY7/9BGRK$XZOBIY:TT%ESBU\(\4LZ>8[N! 9V45B<U;JYGF,%;$V[SV9
M;Q'B(L:&,-:+0!D+=DH+-)RJB,?BK%.">V_(MW4KQ@"1XUV<7=R T-^.UMX?
M*Q9(VHC6FK6*LH99K2Z+FDCLT[:2"T@[!"##DN0FODAC*>.L7K8@$TK(G,8(
MHR2 7ND+1MQ!T% <4RKI:O*KL%.S,?EN3K6T&R]O"B:6'N0 04$U7Y%//+=J
M2X6U'>@A9,*I?$?&C>2T%C^W7R(\P5#<?Y98/%QE<O3GC=L-:X>&39>^0L:R
M-D9*"?Q_(/>;QH7,=8I6C 9XXY7,<)(P0"6F-SAMI(V%[RF:AQDE.NVK-:N6
MBX05HNO<AGFYQ+R UK?B2@TF<GEEBR$+,3:;D*C&/DI.=$'EC_21CB_HYJAO
M9PU@XK1L'&FO/:KPRSSN+"ZT]S-F4EA*"4LY[&8RUGYC!9?+#-3CD:';\66<
M!L38@3H;VMF?DEBI2$US"VH9WV(X(*_>%[IGR>@:YK]#]/9!D=GI8(*\M[&6
M*[YKT51D3GQO\Y= /VQQ'5;+\E!%EZ&/>QQDM0SRL(UU @Z;W]O=!&S\CGHS
M,-O#6X:CK3*_O9=$6ASW^&UQ8UQ<&$I-RN0Y+)X^CA;EN>B]@GZ&-C0'QME:
M07N&R>R#V>58QF(H9*-D\WOK@RK68P>-)(=[8 2 "-':3\BGJTG3Y#$6J[S,
MR*"N'12OL22>C6='$(-S%YSWRY/1LT9Z=R*)LIBE+'=XWG0>QS"X$;&BM]!"
MY;DL^+]YGGPMOW&N1XML/BT&_%X9V[%H4=>Y#FH>94,;%BYY*LE*>0D.A'?J
M^("0%S@0&=B"$%JMS/@K22LK23N:-B*/KV>?J'8@*/QN=DM9"7'VL=/3LL@$
MS62.8\/C)Z[:Z,D>1]0@PYG/5\//CH'U)[$UU[V011 $N>P=M?2(6*'E41;E
MF6Z%FK;H539DKO+'%\.B0^-S"00>J"-EY'5R&.K7;.,O14Y,A0%27NUAF=-*
M QX#7;# =;WZA2$_(9!?LTL=BK-^6MKW@QNCC9$YP[!A=*YNWZ.]!!EM\DDC
MM&G5Q-NW89 R:Q'&8V^ '^C7.>X#N?@ IC&9.ME,=!>J]C'*TEK7#JX$'1:X
M'T((T4%$H<@S.29S"O<QD\459TK(W.=#J$"LQ_0]'$DDNVLG'>5^%@^.F;&6
MV4I8:E9EYQ9T,CVA@);OOT+O(.063)Y:]1?+X6"MVHHH^[Y(WQ-&O4AH>X%Q
M"@,SRS(LM\6?C*$UBID9.W=CH1XS'0/D#!XC@6D:!06_)Y*/'XB]D9H7F.K5
MDGDC;HN(C:7EH57=S6*LVH^?#7V0W3UI2:C)L/(VU@;VVTN'F.R":Q6=][GO
M4YJ$]6W48R1\#RQY='+OJYA82""6D+6K<CF;=J4[N&M4S:#Q6=(^)P>^-O<L
M/AN=U=H(/0Y71/'H,R(INDKV1M@\O%\5\GA>%]78.6CSN05N*W)WDM:R:JXG
MZ@+#$&W6Y-J_4IW,3;H^^=A5EF,9$CF@NZ.Z.):_0V 5IOYA7@%JR,=:DQ]:
M5T<]]O3PV%AZO(:7=G,8?)S@$%ARFOD;(N']#E(/_P!H56\;G/=,-QJE#2GN
MW)\7#(((BT:C9&T&1[GD !!MNYC5-*"2*C9?;ENNI"D>C96V&-+W-<2[J &C
M>]K/9Y'8KQT8WX6U[[:E>R*IWAWJ,=G/+^_7J@F*4TT]6.2:K)6>=]H9"QSF
MZ.O,L+@J7B<]F+V0Y-4L8J>&&#JUCG.AU%NN'Z=T<22XG:#0XERHUN*<8?/B
M[GN7NE.N^\>G02.:(]EN^_3MY=E=\GE<A3E+*V"MW&MC[N?&^)H_Y6A[@2Y!
M'3\QHB'"25:MFT<K"Z2HR( %W5H=H]R /(J1P^<&1FNUI:<U2U4+/&@D+7>4
M@VUS7,)!!T@@<SG<Q0Y'AZ5;%SS03"<O+7P 2]& ^7=P(Z*/I9BW5Y/S&"MB
M[5V06ZSW-C<Q@8PU(_C(6C906.7E=#Y)QU^"*>9UYP95KL $SWZ)+=.( ZZ/
M8E;>)S;;]BW5EJ2U;E8,,L$I:2&R;ZO:6$@M.D&OD,^*5^+&U,?/=N/A\9\<
M18T1Q;ZASW2$ ;/D%$LY]C_DO*WYJ-R%N/O0U+$;VCNV24L;\"=AID0;AY-+
M##48_"7&W;3WBO2[1>*YD>MR//;JQHVMJEGF6:5Y\6.M&W4F\*:D>GC"0Z(T
M>W71!V#M!CK\BGGENU)<+:CO00LF%4OB/C1O):"Q_;KY$>8*AN/\LL'BXRN7
MISQNV&M</#)LO?(6-9&R,E!.5.2>)9FIW<;8IV15=89%*8W>+$WR):8W.&P2
M-A.-<B^7JT=J#&V8:;X6/AGE+ )"X>8#02?)!YNY[P<B['4L=8O68XFRS,B+
M&-B:_?7NZ0M&W:\@JSRGDDEOA67M4*EOOX<U><;9%+4>!IP?MW_B@NN!J5ZF
M,BB@Q(QS-N/NOT/HG?J?#+ALJ@<:Y1+1X_,\8B]9K5+=WWJQ'TTS_*'N/5KG
M!S^H07.YR:".>E6HU9K]BU7]XCCA+0!#\)'N>6@-*QP\MQAQV2MVF3574'=;
M<$C=RQN(!:!T)#N^QU(08ZW)G,M4J]_#W* N.Z5Y)C&YKGZV&.\-SNCB%#8;
M.5\<S+QN9)/9GSUQL%:/1D?IPV1OT:WXDH+AF,HS%XNW?EAD>RO$996QZ+@T
M>NEXGRM:M:Q-=K'2R7WN$19K08QA>7G?^J@BG<BFIV8&W,-;@KSVFUV67OB(
M[R.ZL[-:XN#7%1-;+Q8S(\XNRM>^.+(TAU;Z_3K0L06BYDX*5[%5I8WEUZ=\
M,9&M-+(G2DN_L8H-_,*\ M61CK4F/K2NCGOMZ>&PL/5Y#2[LYC#Y.< @L]BU
M6J5)K4\K60Q1NDDD/H&M&R57HN8 "I/;P]ZI2M2,9#:E\/KN0Z9W:UQ<P/09
M3R5GRY/B*N-LSRP/B]XD:6-CBCE;V$A+B%MYK-UL-!5FF@FE$]IE>-D0#G%[
MP2T:/UD:01@Y?.;K\:<!=&1#!**W:+1A/EXGB!W4 $:4G5S_ +[B'7:V/LR2
M,F=#)3TQLK96/Z.82YP;Y'X[0:\7*&],NRWCK%6S0J>\R0.+'E\1#B',<TD'
M980JSFL[)E\-C[,="Q7K.S6)->:0M'CL?99LM#22 @M-;D&/F&2G =[E28XR
MW#H0DL\WM9\7=?B5AJ\K\6>C'9Q-RI'=)%.6;IJ5P;W#2&N)8YP&P"@T>,<@
MS&1RN>@N8R>&*O=\-CG/AU"/!C?X;NCB227;5B9E(6YIF+?&]LKZCK$;CKJY
MK'AC@/TC80:,6==-#<DHXVS:,%Y]4!AC;W=&/IN!>X -!\E6N0Y@7^(<DB-6
M:K:J=8YX9""6EQ#FD%A(((*"YLS$,N6OXQC'B2M!!*]_EU(G+P /V:TI.548
MJ5VTZ&<^!?=3;$T!TDTP=T#6#_B*#)BLX+%V6A:H3TK;(1,(Y2QX?%OKV:Z,
MN!T?(KQD\S'C[%2JRI-:N60\PUHNH=T9KL]Y>0&M&T&C+RF66AEFPXRTS(4V
M?CJCG1"1@>"6R ]NKF+![/H88.,4)?DLU))J\+Y7N+'/LO,8)F)83LN0,1G<
MQ8Y3EL?-B9VUH65^KRZ#478//<Z<20_2K_%^4>Y<4H2RXNV^E#MEBZ"P,8?$
M()ZEP<6M^)072_G?=K[,?4H3W;1B\9\418T1Q[T'/=(6@;(T I##96IE*#;4
M >P=GLDCD'5\<D;BUS'CZP0@BIN3ROMW*^-PUN_[J_I/)&Z*-@D V8VF5S>S
M@L<_(G"[;JT,3;OOJ:%DPF)K8W.'8,W(YO9^CO00+/-,9%C<5?A@LSLOVO=8
MHV,'<3=7GHX$C1VPM6%O+YW79,:,#=^4F,$AK=XM>"?27Q.W77P0>W<RQ\6'
MH9 5;)%BX:G@!H,K)P7-,9&_7LW2\#E\YNOQIP%T9$,$HK=HM&$^7B>('=0
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M;E<LDLVY\]DVPUX]%[@++@7'>@&-5Y0>;]F>G7#Z]":U(YX:(XRQI^UQD+0
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ML?D;-FM/7@=8;*RR\R:=TWU<TG1VLU*S8X_?SD5G&W9X;5YUNM-6@=,'>*T
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MXIDK.0XMA+=A_:>:C"Z5WUNZ^904:.C:.1Y9E:#"Z]C<Z98V#UFB-6$2P_\
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M9;Q'*C'7PE#&B;!6Y16J2]Q(^!\?1SVAD8#E$93!87YK_E?3/?IL=%/+?_\
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MQS?PDS..ASE=LL;..T[;:LHW$^><D2O<ST);H!!%9F'W.AS;$TI'1TX),:^
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M0^0/\M]"-MZ+LJ B B N4>Q+^1.1_P#7[/\ X,0=77*O83_H&S]>G0=51 1
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M4,;=,C8UC!]0:-!$!$!<#_A$_P DX#]:E0B\^QQX'LWP?VV?W[UT- 1 1 1
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M=VA(_N_&W9*?<^9,; 'Q[_3T>$$TB B B B B B B B B B B B B B B B
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M_E;U?&37JN1; \B!\8EBEA9X?F)7,!8X ((>7C69FP^5MF!@R-K,ULD*O<$
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MI21MSX))"1K["%8<I1KY'&W:-@;BLP/B?]CQI!SZGQWD%KC.5?D(6LS,I@?
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MRG[E'?\ $B]U,0;X8E([=]Z]6]5/T,-/1S\,K6$U(,'#4;*2-E\;_32"N9'
MYTU^1B*M*YEG/PV3#%,V-]FHV&)CV-=L:)+$Q''Y(<_/=I\:CQE23$3P:_$B
M5\ID:X&01DH)G&X*2?@E#!W6^$\8>*O,-[Z2"(-WMOQ:5B]G@NVL/)F;^O>\
ME()':.P(XFB)FOT$#L@D.7T,M+6I7L1 )<A1G[P1EX9W;(TQO:2[0UH[4;-Q
MZ]BH.,3XZ'WN3%12Q30]@U\S)V@2/87Z'?L-H-RC5R62Y+%F;="2E!5I2UZ\
M4KV&5[IGM<][A&7  =  J^S$YM_%I\*<5*V>OE(I62E\7AS1^_B?LP]M^3$%
MNHTK5?D>?MR1:AL14Q"[8/8Q-<'*L#CF8BJPVHJX-NER*]>A@,C0)H9WR-UO
MS )8_80>Z]C*W?:#C);6/-1D>&MZB>]CY!VEB'9YC):-J9YG0R-VICVUH);$
M$=UC[M2*01/GA#3] $EH]=$A!7,7Q:4Y'//@P,.)I7L.*L3&^$'=]OV^41$^
M9[):AY/D,1@L;\@2POI7<<^U*^:$QN;6E87>#IQ)]-H+#X%^GS*W=%"6:I=H
M58?&C+-0O@?(3W#G Z(>M*+!Y,>SW)8HU]7):E]C(NS?-TSGE@WO7GM![%/+
M8;,')08Z2[!;H5H;,,3HQ-%+6WIP$A:"TAZC;F!S=ZCF[<M,1VLADL<]E3NP
MF."I-&?INWU+M DH+9E:%N?/<<M11=HJTMDS.V!U#X2T*+Q56W5S?):]K'2O
MJ9&T)V6 6&+H8&1.8\=NP.V((7@-2Q"<K;O3 LH;Q=:7ML&O2<=O4U@??Z^)
MO92+'NGGR60-H0![8W"*0MC827_$1M!(06=$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!<#_A$_P DX#]:E0B\^QQX
M'LWP?VV?W[UT- 1 1 1 1 1 1!\;^TO^>&W^MT/W4:^R$6B(@B B B B B B
M B B B B!TC\3Q.C>_7KVUYZ^K:("("QU*-6DV=M9A8V6>2>3S)W)*>SCYH,
MB(,-NA2LRTI98^SZLYFA=LCJ\L='OR]?)Q69 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1!CAPU&')S9("5]F1G3M)*]X8PD
M$MC:XD,!(\]+(@(@(@(@(@(@(@(@(@(@(@U\CC:U^FZM9=,&/]1%*^$D?42P
M@Z/Q"V(HHX(HX8F!D<;0UC1Y!K6C0 0$0$0%BO4*U^F89S* 7!P,4KX7@M]"
M'1EI"#!C<+C<69GUF2&670EGEE?/*\#T!?(7'06X@(@(@(@+\M5F6J\D#WRL
M:\:+HWNC>/L<P@A K8ZA2Q[*,,#17:PL$;MO!#O7MVWO?Q)7Z@(@(@(@(@(@
M(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@+@?\(G
M^2<!^M2H1>?8X\#V;X/[;/[]ZZ&@(@(@(@(@(@(@^-_:7_/#;_6Z'[J-?9"+
M1$01 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 7 _X1/\DX#]:E0B\^QQX'LWP?VV?W[UT- 1 1 1 1 1
M 1!\;^TO^>&W^MT/W4:^R$6B(@B B B B B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B N!_PB?Y)P'ZU*A%Y]CCP
M/9O@_ML_OWKH: B B B B B B#XW]I?\\-O];H?NHU]D(M$1!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!<#_A$_P DX#]:E0B\^QQX'LWP?VV?W[UT- 1 1 1 1 1 1!\;^TO^>&W^
MMT/W4:^R$6B(@B B B B B B B B B B B B B B B B B B B B B B B B
M B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
M B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
M B B B B B B B B B B B B B N!_PB?Y)P'ZU*A%Y]CCP/9O@_ML_OWKH:
M B B B B B B#XW]I?\ /#;_ %NA^ZC7V0BT1$$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0%P/^$3_)
M. _6I4(O/L<>![-\']MG]^]=#0$0$0$0$0$0$0?&_M+_ )X;?ZW0_=1K[(1:
M(B"("("("("("("("("("("("("("("("("("("("("("("("("("("("("(
M"("("("("("("("("("("("("("("("("("("("("("("("("("("("("("(
M"("("("("("("("("("("("("("("("("("("("("("("("("("("("("("(
M"("("("("("("("("X'_  B?Y)P'ZU*A%Y]CCP/9O@_ML_OWKH: B B B B
MB B#XW]I?\\-O];H?NHU]D(M$1!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!<#_ (1/\DX#]:E0B\^Q
MQX'LWP?VV?W[UT- 1 1 1 1 1 1!\;^TO^>&W^MT/W4:^R$6B(@B B B B B
M B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
M B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
M B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
M B B N!_PB?Y)P'ZU*A%Y]CCP/9O@_ML_OWKH: B B B B B B#XW]I?\\-O
M];H?NHU]D(M$1!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!
M$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!
M$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!
M$!$!$!$!$!$!$!$!$!$!$!$!$!$!<#_A$_R3@/UJ5"+S[''@>S?!_;9_?O70
MT!$!$!$!$!$!$'QO[2_YX;?ZW0_=1K[(1:(B"("("("("("("("("("("("(
M"("("("("("("("("("("("("("("("("("("("("("("("("("("("("("(
M"("("("("("("("("("("("("("("("("("("("("("("("("("("("("("(
M"("("("("("("("("("("("("("("("("("("("("("("("("("X'_")_DG
M?K4J$7GV./ ]F^#^VS^_>NAH"("("("("("(/C?VE_SPV_UNA^ZC7V0BT1$$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0%P/^$3_ "3@/UJ5"+S[''@>S?!_;9_?O70T!$!$!$!$!$!$
M'QO[2_YX;?ZW0_=1K[(1:(B"("("("("("("("("("("("("("("("("("("
M("("("("("("("("("("("("("("("("("("("("("("("("("("("("("("
M("("("("("("("("("("("("("("("("("("("("("("("("("("("("("("
M("("("("("("("("("("("("("("("("("("("X'_")_DG ?K4J$7GV./ ]F
M^#^VS^_>NAH"("("("("("(/C?VE_P \-O\ 6Z'[J-?9"+1$01 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 7 _X1/\DX#]:E0B\^QQX'LWP?VV?W[UT- 1 1 1 1 1 1!\;^TO\ GAM_
MK=#]U&OLA%HB((@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@+@?\ ")_DG ?K4J$7GV./ ]F^#^VS^_>N
MAH"("("("("("(/C?VE_SPV_UNA^ZC7V0BT1$$00W*,I=P^-K24F0F>>_5K
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M$26[3'WIL?%8F;Y D/\ +OU"FH+-:=\[8IF/,,GARAIWT?H.ZGZCHH-*WR#
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MKOX;PXC?HD/(L%/?=0BRE5]II(,(D!=MOJ/M"#0IY)T^6R9\5L=''L$4KG:
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MAQN7Q&1CDDH7H;'AG3O#>'=2?K 4)S?DL.#Q;0V_!6M6)X(HC(1MK9)6L?(
M[UZ!VT$YBKM1]>K S+"Y*Z#Q6RDL[RQ[UWTP *.Y/FG4\/DI:-EGO-66NQX&
MG&,RO9Y.!^MKD&?'W[<_(\]3DDW#6CJ&)NAY&5KBY:6=Y7B,%:QL%RQ"Q]J<
M,ZOD##'&6N/BG?PVW2#;GSE.I+D+-C+5?=8ZU>1L>PTQ^*7:>YQ/I)Z-4"SF
M<64PN R&-GC:;5^C'8B!$AC$Y!=&Y!8[N=PF/GB@NY*M7D>-M9)(&G1.MK?0
M1[N18".][B_*519[B/PC(-]SZ,/Z5[N<@P.,LLJW,G6AG< 1&]X!T?($H-U1
M^/Y%Q^Z^=E7*59GQ1ND>&2 Z8TZ+OL"#>=>I1U([;[,8@?X?24N'0^*0&:/_
M !$C2PY'.83$&-E_(UZ[I 2ULCP'. ]2 @KSN44ZG(;$=G(P1X\XFI/"XD /
MDGDD&VGX[#59Z=RG;K1V:MB.:&0;9)&X.:X?H(0>E'4,I+-GLYCG,8(J<55[
M'C?8^.'$]OLZH/W'\BX_=M&M5RM26?Z6HV2M)(;ZZ66/)0Q3Y1]C)5S##/$T
M, #3!W8W3'GZW$["#SC\_@;L\L%3*5IIF N>UD@<= Z)'UA1^!YGA<W?R-.K
M:@=)7GZ,#90\S,Z->9&@? %VD$ZB B B B B B B B B B B B B B B N!_
MPB?Y)P'ZU*A%Y]CCP/9O@_ML_OWKH: B B B B B B#XW]I?\\-O];H?NHU]
MD(M$1!$%0]H,'?#XV)LKXW/S>-;W9KLW=AHV-K)D>.U<?A\_==:MV[;\58B\
M>S)W<(PPNZ-   ""KP/R;.3XGP;E" NXW6%1UN)T@)V3*(^KV:=Z;6^R:_@*
MM2G!;QL\^5S4YCGZ%E2J2PR.'7N23MIT-H-&I59E,[S/'W\Q#*V7'8\2V(&"
M%K7]Y->1+P2%AY+F,O-AN08BS)5GEIMHRS6X6DQOJR3Z>)8P?(AK3V *"TTJ
M%^WG,-D)\QB)!7AF$;*D#HW2Q2MUK9E?] '14WG\7'>K5&^_"K8AM,GJS$-<
MT3,!T"UVNPT2@IC\U/E(L0VQ'")Z?*(JTCX"70RN9&7=XR?M4AA;N'H6>8LR
MDT$4[LC)).)B 7UG1@1'S]6=4%:XU5JS4/9HQT)\-DMYS(W_  Z,>6[5ZJ,;
M'S[+!@UXF%I/>!\7":9NT$5S+WJ'-<2>R>I#&+%@>+:C,D(G,8\/8#F:.M]5
MA?3@HP\IOYN]1MU[=>&.>K5A+ 7M!8/(O>3))L ((3#9*UQS#\BER\!GS4-6
M&9XE>"):V@R(=M?DL.P]2)GR!Y?Q(7,K0L2O-L^%5A+!&PP$_E%[R051+<#L
MT8^/F&66)EYMJ9M]KR!)[R9#LOVM_#R1CEW*XR\!Y-(AOQ(\)043&VHL'Q7@
MW(Y/*"O0%6Y_Z$[=M/\ 9(T+H7$ZL]/ UW61JW;+[=G]$M@]R/[-Z05Z_FK]
MZ?DL++N.H5*#C!*)HO&GG)B#]Z[L :>V@H_"P66\:XOF:>4K17H,! R2*T08
MI8=!VG'U8=CR<@Z%A<JW+87'9%L+H19K,E\-WJP/&]+FSVEN5?PWTB?EA>^R
M@3[P1^V'1!8>-3XZO9Y:V_+#':^5)GV/%(:37('@D]O5G15G O%:#A$TY\.H
M<EDF52_R @E$G@#^UOH@F[-VM:Y1RL0RM>(N.0Q/(\QW#YG$*S\0KUZ?%,%'
M$T-;[A [[7.8"24$>(8)?:$)BP.='@AT)^':<@JNC+R86OR]\,$+R>2Q01"4
M]86.LQ0#N_ZF@NV4&,2W!S6&*UE*EN4\>N]Q7A\(,'>,@';WK2./IGV9<*A,
M#>DL^&[CZ_'E9W_[]D%GS G'+8Q2\IG\:OB/7Q>R6+HJSA*%[*\7X]#%FL/#
M!#)4DC#*[VSLFA<'%A)E_P X2"'(+)CZ%2[B^7XJ_*8@_*6Q,_8:0RSJ1C@3
M^AP6_A,U<9E+^)R,]6PZI498%R = 8G$C4K-GH\:0;/!HY&<5Q9>TM\1CY6-
M(T0R5YD:/^Q5.SV:O9+%\M)N8ZE3K.M5'0/A,T\[F-Z>?TVZ[^C!I!DH6,>S
MEW%WW7M$K^--\![_ $\4N_\ (A0_(C3DQWM"FA'>@^[C@\Q>;7S-<P3==(+=
MG+&,LY/A8QLD+YQ?[P^"0=51"X2>GHQ5'%T<GD^,YC'2Y?$5_$M6V71-7>;$
M4SI2>[G&4#M\6%!;9\QDY<IDZ#,ACJ4>.KP"S9L1F628O9W):.[ &!5G 5X+
M='V:-F:'L9)<<&D:&XXW]?)!=:K(V<JY/!9.A9HU)6N)UN(!\;M']!6E@K5C
M#93&\==9K7:KJCS2FCTV:*.  =9FM\B/J>$&[Q8ES^26&G\58S4QB^R)C(7$
M?_;L*PT((#[0\_8<P&2/$T&,=\0'OF)04C(B>''Q")]>&K#S.?Q3,PO@C!+R
MPO:"WZ/B$*Q7L;?_ /QBR5O*8Z9[L!/ ^&K"8R0 7,>_M(]!HYVNZGQ?A3*[
MJ\-6.Y3,[YV%\(W$>CI0"W8[Z7O.8K.R5>2WV9.C/<DP4D AI1.B>[S[->=R
M/V=;#4&WR.S@YN)8V/%2PN>Z>F,2R(CN) ]I'37U#?93''ZT!Y5S><QM+W7*
ML9/Z!4C0>N$SU:O%L8R6:.(&>>"$.<&[(F>&L:K,@Y?QMIES-'CQ_(X_8N2/
M^QQZU?\ ]7*4IM<>20<8T1'2R\^3UZCW8@2QC]K*@LV @K#E7-YS&TR/MU(R
M?B6"I&=*BP.M14>"&.>I!#';R$;'VHS)"R4.<V$$!S-'0(:@DL]B[D>%YI;M
M9*E.;=6NV2*K&8@Q\9UW.WO/9P*M7(Z\%>_PML,09X>7\)FAKK&ZM*"Q!/Y_
M'U,EB;-.S9\!DA9J4$ M>UX<P_2\C](+G>:S5ZSQ_EN+O&O-8HP0$VJ_E'*V
M5WD"WSZ/'7S""?JV:5+F_('WYHH99:=0U7RD-#H& ]PPGZG^JH].+&7,(65X
M0:4W-FEC-::YCI0?^SD'1,@QK.<\=>P:<_&Y%CR/BUCH2 J1CH(9\;[-&2L#
MV?*-AVC];()GA!8,]#9.>Y$VB-6I^*N#.OJZ5KWAB@.07^-2\#P=:L^!Q$^.
M%:)A'>-[)6=MM^&AL.0=2R5H4,;=NF-T@KUY)>C?5W1I=H?I*YA;OY"S)PRQ
M;R6-)GR=>2&G5A.XVN803XA>=@;T3I!.LG?QO)5H:UNM;QV2RCP(=CQX9K#R
M]SFD;[L!]0?,*P\HRK\-@[%QE=DK^\436R>48,T@C#GGX-&]E!4JTMP<]P;+
M64IVIODV[W%: Q"-KC&0"2]Y.R%(8!S#@>4Q CQ!DLMM@.R-RN*"&?/5?@_9
MS//*QV.C?5]Z.QT#S5(A+_T=U8KDM:;G>$-)['SLHVO?3&=Z@=U\,2:^M_FU
M!48*\-;V'RB%@;WP3WN(^+G,VK?GZM>NSB#88FL$&8@CBT-=6F-[" @K%"+)
M6+/,:9OXB'Q<C.+,=JN]\IA> (R2)6;9T7O)2S\-9B,B9_>S+A_DZ25K=>/9
M@9WK'_[<]@@OW'*M;%XVEB/>8WVJ]9CIV]@7ESR2Z0CZG.VJWSEUEF0XJ]L]
M:&$7Y-R66.D@;,8B(NX:YB#%[E%3?R3*9O(4+-:>A%%:K5H2P'IV )!>\E[P
M[J%6<9!EJF$Y53LMF&>?B"^H7N[O-41%L4;#H?2C/D__ (D$QBZ%K)4N+/CS
M.%%2K-!-6;!6<R33&Z,8)E.B6[!4MPFS2@K9B*W+$S(#*6S>[N >=RGPR?\
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MM60UCW,X]4$3_J#YY5DXS/5I1\E,TT4,$6<G\WN#&-[AA_\ JXH+*YP:"YQ
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MA@BJ0,CB<'1,;&T-C(^+0!H%5KD'RDR] [W;"]99F0T[%@2/FCD>W>NH8?\
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M-KU<;5Y/=E=9+K]^JQS8R/R8*IZGJ?J[2*2M5:MN!\%F"*:)WY4<C0]I^T%
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M^2D;8)F!X_SGD7(,L63Y9D&YN:K9HP,HW;,,+'P.D,_@G8['L.H6&WS5DS<
MR*_1QQR&.;>?8N$=8HW :8P%S.SR2@U/PVR,N.E%-]&Y<@S5>B98CNO.V< M
M>-$Z]?-260RF>Q]S&8^YF:5<S1/<Z^^H1%)-WTV!H+],.OK.R@Q7F9L\SQL%
M6:NV=V"?X]ET1+&ZE;LLC[?$K)/R+*UL/R!ED5Y;F,O00&01D1RLF\-[7]"3
MH]9$&P^_R&WR'+XRE/5K5ZC*[O'?"9G.,K2>@;V:IKC.5MY*C8%R.-ENI;EJ
MV!'OHY\1_*;OS <""@@J]_EN5LYQM.Q2KQT;LL$/>$R&8M:' .^FWJ/-9W<D
M=;XSA\M\J4L4VW#')(^RWOKNW?1FW,00;>;9)^"N3UGU+=FMFZ]!LK&ED4[9
MW,T[6SU.I%)27N7PYRMA??*,C[55]D6_=W-\!D+@UXZ=SVV7CJ@Q3<PNT,-D
MC<?4-VKEFXYLSOQ,#GR!CVROV3U :_;EGP?*3+GHL3)F<;DQ/5DFCGIZ!8Z(
M@.8]H>_U[;:4'C-'*NYWBX<>Z*.23#V0^:1A>(V":,DAH(V5AL<HSF-CR\-P
MU99L5-4FGE8PL$M&P2'/#23U>P H+2W*V)^3''0=#6KT1-9?K9\29VHF@_8T
MDK0Y%DG8^2 #D6.QK7L.A8C\221_Z 7M\D$;CN66[E7ATP9 !D;5B"SU!(_$
M12G<?VNC4Q8N9%^?FQ=::&+_ -F-L1ROC,G60REGF YNQI!S@#*Q^R^.::>*
MR3<I.@C$9B((O-\G.+G[VK_#=S]#.8VID;56S%?9,&^%"Z(PR1-[Z&W.[-(0
M1U7+<KRN+ES5"2DR ]WU:<D3G.FB82 7RAPZN?\ #0T%B'(LQE[V'KX1]>"&
M_AQ>,\T9E,0[ :Z@MV?-!+5KN5N7>1TZ]BM7?3MUXXI70&3;75V2'LT/;L[<
MH!G*<W1J9_)VK-.YCZ31%!*V$UA-9+^AT2]X\-I.BY!GQG+',S6*HS9[#Y$7
MA(S_ ",@.@E8PR?![]L("B<CDN2Y/A&8S44E3W*>C9=%2\(F0UNI >9>WY>O
MI(+O/E(L3Q3Y0EC+HZV.9*X#U?U8"&A1%K)\KQ%*#*Y&6E+7[Q"W5BA<QT#)
M7!NV2%Y[EFT&A5K9T<\SW7*51K%U/6H3]!SY^C?\YZM490MYO$<4YED7VJLY
MKV\D]D9KE@,L<AVYWTSMI06ZQD<Q=S-G&XV6"LRI!%):LRQF4]IMED<;.S?@
M-DE1N4Y+:I9.MA9L[BZ<[*8L6KMAH8']W%K&11N>/,ZV4&FWF63LX:I)2]QL
M6SG!C9)&$NKR>1(D9H^GH5?J++T=.)EVRR>< ^)*R/PFN._@W;M(,B("("("
M("("("("("("("("("("("("X'_")_DG ?K4J$7GV./ ]F^#^VS^_>NAH"("
M("("("("(/C?VE_SPV_UNA^ZC7V0BT1$$01_(</-DX*;ZTS(;=.TRS6D>.S.
M[06EK@//JYKB"HV/%YJYF:.0RSZD8I,E]W@K.>\&24=#(][PWX>0"##A^+R8
MW+9:S--%)5E\1M.$ [C98>9I@[[7K5PW$;E#!YRG/;CEFM0&M!)YZ97BB\*%
MCD$MD\'/9P>(HB6,/JV:$KB=Z(J2,>[7V]5J/P>9H97)VL9'0GAORMFDAM%\
M9CF#0PN8YC7[#@T>2#=;BK0SV,R4CX!X&+GK2L9L#Q)GQOVW_A^@M#/X;/9M
M[*KX\;'59;BFCMA\CK,8C>'_ $&]0 XZUOL@L-X980,=CH:DDG?Z3+#W1M+-
M? L:]5.AP^]!# 7RU6/.>&1DAAV(8FAG4QQ()[(80V\_!=D<PUVXNU4EC\^Q
M]X?&?_P,4 >.<H?A/P??<I>XF'W9UP=_>37UUZ]-=>_7R[;024^$RU+,NR.'
M]S>V:E#6EAL/>P 0%Q8]A8UWP>00HV/B>3;B#6L789)W9^+(OD (!#9VS. "
M"1.(S]#(Y27$R4G07Y1.]EDO!@FZ!A<WH#W!Z@Z4EQ3#6,)@:N/L6!-+$^<N
ME'^MXDKI$$)B\%G\/$VA5BQ=BDR5QAEF+V31Q.=VZ%K6D/+=Z!V%D^0L]3S6
M9N8]]!PR)C)FG[^+!TC$?5H:"'M&M@;"#1I<3RV(IX&:C;KF[0I.IS-E[>%8
MB<>VM@;:X$;!4O-B\O;L\?MW/=(I*%V:9[(GO>"Q\#X@ 7-;L[>@WG8R5G(G
M9(/9X9QS:W7_ %@X2%^UI<DQN<R-:U0K5<7)4GA+'.LN?V82-=N@80[7P\P@
MU).)1O?>9=M"2I-Q^#&R/)U(?",G:0_:'JK9QF<GJX#'3Y7'SCY4HF/W?9EL
M"&4/+W@G36M:TDZ0="Q^,FI93/VW2,+;UF&5@'JT1P,B(/\ :U9./8V7$8>&
MI-(QSV/F<2S>CXDKGC_R04#C5'E,W&[-:E8I"M:MWP)I2_Q:_:P]KNK0-/4_
M+Q>SC+5*WAA4>(,;%1EKVMM:^.#SC<'M#M.""2L8C)WJ^',XIPS5LFRS*V'L
M6=&!PTTD D^:<DJ9N[#/4KU,7-4G@Z/]Z>_;7'>ST:QP<@C*_',MAI*EK%VH
M+$HQM>G;;:+V"?W??24/8':=YE?DO$\A9QV3-BU Z_?OT[$KF@B%D=25CFQL
M^QK$%BOXF6SEL);8]@CIOG<\'?9WBQ%@TJ0.'<C9QUV BFQS*XE#S:'?QI]2
M>)]-NM GXG90369XO;R,/+FQ3PM^5:,4$)._H&-CFDN49S;%MR64XY4@F:)I
MY7U[;!YEU+0EE!_M8 @O,4E[WJV)#![M]#W;H'"0#7T^^_+U]-* O\6H93.6
M;N8J5;D#:\<5.&5@>(O5TCB'#\IQ0>(^(8[%9K&Y#"U*E(,$L5R.-GAB>*0;
M'Y T7-< L>-XS:HQ\6$D\).--DRZW]/QF%HZH)?*X>6WD<!:9(P-HVY9I =[
M<'P/BTW^UZU<KQYN0R5^6P]IJV\0:+V#??Z3R24$59P7)[V+BPV0M432'1D]
MF/OX\\49WUZ$=6%VM$[*W;_%);YY*U]EK!D35? ]HV8GUFCJX@_4YJ#6LX7E
M63OX*:_-CXHL?=$[HX'2.\8]',['L!K6_1*N!S^(-NMCH\7/4DLRS0FR7LD@
M\9Q>YNFM<'@.)T@G&XN6+DEK)A[!%)C8*P8/R@8I)'D_9IZB;V&SV4RF,EMQ
M8V&&E=$[+$3GOL.:W>F %K0P.]'>903&7P\UZ?!R1R,:*>1%EX/Q:(I(]#].
MWK\9CI8N2V\H7L+)<;7K!GGV#HI)'D_8>Z"#/%,@S%/AALP"U%G)LE7<X$QG
MO.Z0,?\ :UVBLD.'Y++GX\S:DH,?'C;%6.M&Y[V!TCV/:XN(:3LM\T"IB,P_
MD<>8OLH5WQTY(.E1[Y#-W+3N5SVL_)Z_1"WN,T,GAZ!Q]KW9T4#G"O)$]Q>]
MKGEWTVD -(W\"4$?FL'G<Q8K02QXZ&M!>BGBM,>]UD-B>'Z:TM :7 :)[+S<
MXU(*.4,E^&O*[,C(5)SYLCD'4,#P=;!UHH(UCLM<YO@C:MTY'5:MM[X:FRR)
MKP&=Y'.^+SZ!33./6(^%W\$Z:(SSUKD0>-] ;!>6_P#D@GF,R,$M*(&L:C*W
M27?;Q#(- =?AU6KF,/-?R?'K<<C RA<DFD!WMP?"^+3?[7(&+Q<V.NY^Q)(Q
MPO7FSQAN]M A9%H_VL4=?PN89R4YF@*4SGTF5BRTY[#%T>7=HRP.]>WF$&UQ
MO$W,10L06[+)II;UBPZ1@(!\=Y>M&EB.1862U7QAH349;,D\;;#Y(WP&9Q>]
MHZM>'C9)"#TS$\AQ=K)_)+Z,E:Y8=8Z62]CH)9/R]= >[2?/2QT.*NQSN.EE
MELGN4UN:P\C3II+37=G ?\SD$98CS7S@Y2;&&LYS,-2;)#.YS&/#I9O/NP.(
M(6W^"%Q]"S-+=A9E9<FS(B9K"862Q ,9'H^99T'4H-MF)S%S*XZ]EC3CCH%[
MX(*[GR=YGM,?=[GAOH"=!>#Q2Q)PJU@'VHVRRMG'B $L_&2F0 CR.CO10>68
M?/S9;!7+GR=7@Q[IM5JQ>X.$D1CV"YK5XDXYF32Y9C0^I[KDVW'P2]WB1DEI
MG7J]O774(-J3"9BEDFY+%OJOEDI15K4$Y>QDG@;+'M>T.(([%:4O$\A9QV3-
MBU Z_?OT[$KF@B%D=25CFQL^QK$%COXF6SEL);8]@CIOG<\'?9WBQ%@TL.?Q
M%JX_'7:4\<5RA.9(3("8WM>TL?&_7P<$$<S#Y:WDOE++256214YJ]2O7<][&
M&?7=[GO#22>H"D\!0EQF Q..D>USZE*"![F^CC&P-)""FXT<@BY'S2;&&G(Q
MV1A8^*RY[ PBK%I[2P.6Y^!URO5P;ZLM6S:HV[%J86 YD4\UKL7O&NQ:07?1
M0)^)YNY#R<V;5039."JR-K.W2+P"Y67DV'L93$BO5DC9/%:K6(C)OH75Y6R@
M.U\#U08H<=D#FZ^5M"NQPQKZ[XHW.> ]T@?L$ANQH*+R'$IKSN0D6F1OMWJM
MNI)HN\*6K'&&]Q\1MB":Q<><;.3D*F+BC;&=.K/>][G_ %_3:WJ%JXG&9C"\
M6Q6.J^Z36JL$<3O$>]D3NHT=$-)05]O$,B8+;Y7TX);.9HWG00=O!C%5['.#
M20-O?U5NN8F6?-8:ZQ[1'3;9#VG?9QF: -(.>93!Y'&P\2IQ6H19_".W/&_1
M+/QK;$X:[^PZ*MD%#*_*SLWE_=0^K2DB@@K%\@8UY#Y'ES@TESN@ &D$I@+-
M^WA,?:R%=D%J:$221-!'3OYAOF3Y@*B<8K\I=C,Q'CIZ/@V,MD]23EX?7)LO
M:2UK00]!8(.)05+6*CC>#3J8.?'.8=]W"4Q^?_9BR8;$\CQL5&A(S%V*M<-C
M%H]VSNB9Y#<8;KOKX]D$>_C.?BCY%4IRT!#E)YY76G]_>&"<:Z%H&CU]&G:V
M\EAN0V,*S#QUL3-7=09 ]]A\FV.#.I<&!A#OK'F$ <;RV-N,MXV2I:,E&O7L
MQ7"YG=]<=6RM>P/T2#YA6ND+3*L8L,@;/HE[8=^&#OX;T4%6CP>=N9[$Y+(1
MXZO[B)=/JO>^2<2,+.CR]K-,^.EJ,XY:QN.XX8[]2+(X\S,C,I/@S-G\WQ_
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M0$&1$"&&&"/I%$R-FR>K0&C;CLG0^LE$!$!$!$!>6TJ++4MMM6%L\C0V28,
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M 1 1 1 1 1!\;^TO^>&W^MT/W4:^R$6B(@B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
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M'\0'_P NXO[K&C^'\0'_ ,NXO[K&@/X?Q ?_ "[B_NL:/X?Q ?\ R[B_NL:
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MUT- 1 1 1 1 1 1!\;^TO^>&W^MT/W4:^R$6B(@B#7G_ -(,?^H6_P!Y"MA
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MY#_L*U^._P"C^&_4*_[L(-A$!$!$!$!$!1];_2O+?]+H?O;""01 1 1 1 1
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M$!$!$"3\A_V%:_'?]'\-^H5_W80;"("("("("("CZW^E>6_Z70_>V$$@B B
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MULA8B/BQQAP?$^-[^K=D:?Y*9M\DJU;#*D5&[9L> V:2"",.="QWH9-D $_
M()*AD:F1I07*LG>&5G9AT1_80?0CXA>D!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$%%J>/F,UFJEG/W*-FO9+*]. LB/@ #K-I[29.ZMC[=&'.2Q/
ML3MECQHE<PNU (@\COK_ &T$&[GN)BK5K4E#),J3R,CKV70:CE,ATW7GL _
MN 4E:Y74AR5O'0T;MJS6Z&6.",.ZM>T.#B7$!!MPYRG-AX<G3@LV8I==&11[
ME)WU(+3K1!\CM1\7)(7ULBYF/O"W3#/%JOC;XH$F^KAIQ!:@U..\N-S 8*Y?
MJSQ37O=XM] &/EF9W[,\S]!6=^4JLRU?&'OX\U:6PSR^CTB<UCMGZ]O""N4>
M:X:S3GO-BMMJ0Q%[K3HOQ?;8;X3=$ES]G6@I3'<BK7;ON4E2W4LF$RQQ66!A
MDC!T7,T2/+8V$&#DEJ>M0@KUW]+-^U'4A?\ %ADV7/\ M8P$A:F:LSX_*</I
MU9G,AENO@E;Z]HV5GN ._P!+4&6?EE&O+<9#1OVHZCRRS/!#WCC<T;</4%Q;
M\0T%;?RGC;.4PAAMS/-JI8EK"-WXB6,>&2YX^)'8=4$2WGF(-5]ME.^:43RR
M>T(AX4):[J>_GOR^)"\Y/DMNCR;%XZ/'V98)H)WO>R,'L6=-%A[#R'8]D%@S
M&2AP^'R&2E:3'5KOE<!ZNZ#>@J[5P')+5!ENUR6Y!D9&"3I$V/W:%Q\Q'X9:
M>S0@V<#RIM^OBX;L9BNV)+5>0,'T!/3);( ?[-A3%;D&.LYN]B(W/-FK&U\G
ME]'3@#H'XD=AM!&3\TQ,3H6-CLROFLV((&QQ]C+)5<&O#%M4.1XZ:ODGS-FI
MNHCM;CLM#'1-+>P<=$@M(^(*#'C^4T;5FK6=4NU3987U76(N@F#1V/7S.CKS
MT[16E6YIAI(KEAL-SW>H)_>+)B_%1O@<6EGZ7(-N6S9SF/N0Q4K]"=K&R5Y+
M#&L'B-/9A'1Q^(\P5OX?+-RV(HWFQ]#/"'.8?5CO1S?["@VT0$0$0$0$0$0$
M0$0$0$0$0$0%1\?3R^8N\BD'(\C5-;*R00,B\$QM8V-CAL/8[XN03."S5\Q9
MFIDF>+<Q<O21T$?^?8Y@D8]C/K(.B%L4^2026)*DF.O5[(K/GCAF8T.F9'H'
MP^KB"02/)!%\?Y<;E/,6\E7FJPT[5O<TC QC8H9"T-.B?I@#S4IC>1U+5N"K
M)3NU99XW/K^\Q=!*UOKUT3HCZCHH)=$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!
M$!$!$!$!<#_A$_R3@/UJ5"+S[''@>S?!_;9_?O70T!$!$!$!$!$!$'QO[2_Y
MX+?ZW0_=1K[(1:(B"(,>3R=+&56S6A*82\1DQQ/FUOXN# 3I<WK5XGMY:_"U
M+$6)EQ,G6,Q/BCDMD/[&"-R"0@=+ALKB\G:K6G59\#6J.?%"^8PRQ.+]/8P%
MP#^RKTSYLE4Y_(RA,PRY&AUA<PB0M:V+S<WX$A!?>1PS/SG$)(XW$1Y"<O<!
ML,!J2C97->02W\C@.2Q7I<S)E2+C(\?#'*R!D0V&:Z ![2P;V2@O>1F%'E?'
M;T[)17.+MUS(V-SP)7OB<T.Z@ZV&K2K9,8D<DQ\]2T;<V0LS58VPO<)VV!MI
M:\#K^@H,&!IV!%[-/$K2 P8B1LNV$&-W@,;IRU7UV8SD'(?E'(9:G';MMLUI
M:K7.BD:8F,+3U8_3VEJ#H.#J4\?A:-6F9O ;"#'XP(D#7_2TX$ @^:HEF*6;
MAOM#BBC<][[.4:QC1MQ):@MN$P&#Q<,4U/&006'P,$DK6 2>GIM5KA_(,;0Q
M%;'6VW([+;EH%AIV"/IV'EI[!G5!&T'\5JY/D/RSB.]AV8G>R1^,EL$QD-ZD
M/;&Y3UZKE,UR;WBI<?3@Q=<-AD=!W$LUD;>0'Z_);H(/%*GEL'RMT]JR^]#E
M*Q$LC(.G2>J-LV&[_*82%H9*[C<OEL/;P=:T,HVW#X\_NTT'6J#^-98+PT$=
M?(-*#2J'B];-\J^7,1XLTF6+X7OQLEG<7@1CR>V-ZZC&]LD;'MWU<T$;!!T?
MT%!SKDM_%YCPCBJEPYZ*=C*LHK31/A(>.WB/< /"6[<P<V6R7/*1#HA=H4XH
MIB#U[]'_ /B4"7/X&]0BH\IPTK+,6C+6FI26(C*T:[Q%K7-<%#XC'W(,=[-6
M/IS1F"Y.96&,M,33!+KL/@@R9['7L=R#%05:TLF/O9JM<^@TD5IV'\;OZF2
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M=D%J-X$,@86GON, >1(6WQZM5@X=?CR=1YKR7LB9XS$]Q='):?Y]6C9V$&#
M98TY\N8[ERS@ZE,2LL6F/#HY!OM$U\@!D: K%Q*I/2XUC8K3.DI89)(_BU\K
MC(6_V%R"81 1 1 1 1 1 1 1 1 1 1 1 5"Q&<@Q-_D\$]/(R32YF66)D%.:
M7NPQ, (<&]$&"S%R:MA^0YIE>2O=OV:Y$+&B:6M5CZQ[ZC8=(&[=I8\8R*7F
M6%GIS9:U793N-DM6_%Z=W]"&L#PU!KSUK-SCO+<-!%/[^,I:M,BZ%ADC]Y$[
M>CW#J>X4MB(<)D<KC)ADLW8LU2^:.*U&]HB<6%A[[C: =.07I$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!<#_A$_P DX#]:F07CV/DL]G&"_3[S^_>N
MB("("("("("("(/E/V\X&S2Y)5SD0/@VXF-+_JFA7>> <_Q7*\57/O$;,@R,
M"S7)T_L/5S1\6E%7-$01 1!JW\;D+#HGU<O-3+0X.:R..1K]_$B1I.PL.*Q,
M&-AF:R6262:4RSSRZ,DLA !<[J /0: ""01 1 1 6M4Q./H6;EBJV5C[,CI)
MMS2.87N.R0QSBUI/Q("#91 1 1 1 1 1 1 1 1 1 1 1 1 >P/8YA[ .!!T2
MT^?U$>87G&8JAB:\D-1CVL?*Z5Y?*^5SGO\ 5Q=(7$DH/2("("("("("("("
M("("("("("("("("("("("("("("("("("("("("("("_'#8(V1L>H00C>,V
M)I:IR>;M7H:\K)8X7QQ1M,C#MKY/#:"XM4X@(@(@(@_)8HYHI(I6!S'M+7M(
MV""-$%?L43(88XF;#&,#6[)<= :&R=DH"("("("("("(/-FI6M0^%.SO'W8_
M1) )8X.&]>HV%Z0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0>9YX*\3YIYF11,&W/>X-:T?625\?>UOF<7+\_
M2H8GM-6JDQPEH_S\TI ):BQ]7<.PCL#Q?#XQ^N\%9HD_YW?2>I5$$0$0$0$0
M$0$0:V<P>+S6*GQV0@$M>4>8^(/P<T_ A?+N>]@O):5DRX.U%;AWM@<\0S-1
M8KY]F7M=_H5K[]%_B)\V?M=_H-K[]%_B(O#YL_:[_0;7WZ+_ !$^;/VN_P!!
MM??HO\1#A\V?M=_H-K[]%_B)\V?M=_H-K[]%_B(</FS]KO\ 0;7WZ+_$3YL_
M:[_0;7WZ+_$0X?-G[7?Z#:^_1?XB?-G[7?Z#:^_1?XB'#YL_:[_0;7WZ+_$3
MYL_:[_0;7WZ+_$0X?-G[7?Z#:^_1?XB?-G[7?Z#:^_1?XB'#YL_:[_0;7WZ+
M_$3YL_:[_0;7WZ+_ !$.'S9^UW^@VOOT7^(GS9^UW^@VOOT7^(AP^;/VN_T&
MU]^B_P 1/FS]KO\ 0;7WZ+_$0X?-G[7?Z#:^_1?XB?-G[7?Z#:^_1?XB'#YL
M_:[_ $&U]^B_Q$^;/VN_T&U]^B_Q$.'S9^UW^@VOOT7^(GS9^UW^@VOOT7^(
MAP^;/VN_T&U]^B_Q$^;/VN_T&U]^B_Q$.'S9^UW^@VOOT7^(GS9^UW^@VOOT
M7^(AP^;/VN_T&U]^B_Q$^;/VN_T&U]^B_P 1#A\V?M=_H-K[]%_B)\V?M=_H
M-K[]%_B(</FS]KO]!M??HO\ $3YL_:[_ $&U]^B_Q$.'S9^UW^@VOOT7^(GS
M9^UW^@VOOT7^(AP^;/VN_P!!M??HO\1/FS]KO]!M??HO\1#A\V?M=_H-K[]%
M_B)\V?M=_H-K[]%_B(</FS]KO]!M??HO\1/FS]KO]!M??HO\1#A\V?M=_H-K
M[]%_B)\V?M=_H-K[]%_B(</FS]KO]!M??HO\1/FS]KO]!M??HO\ $0X?-G[7
M?Z#:^_1?XB?-G[7?Z#:^_1?XB'#YL_:[_0;7WZ+_ !$^;/VN_P!!M??HO\1#
MA\V?M=_H-K[]%_B)\V?M=_H-K[]%_B(</FS]KO\ 0;7WZ+_$3YL_:[_0;7WZ
M+_$0X?-G[7?Z#:^_1?XB?-G[7?Z#:^_1?XB'#YL_:[_0;7WZ+_$3YL_:[_0;
M7WZ+_$0X?-G[7?Z#:^_1?XB?-G[7?Z#:^_1?XB'#YL_:[_0;7WZ+_$3YL_:[
M_0;7WZ+_ !$.'S9^UW^@VOOT7^(GS9^UW^@VOOT7^(AP^;/VN_T&U]^B_P 1
M/FS]KO\ 0;7WZ+_$0X?-G[7?Z#:^_1?XB?-G[7?Z#:^_1?XB'#YL_:[_ $&U
M]^B_Q$^;/VN_T&U]^B_Q$.'S9^UW^@VOOT7^(GS9^UW^@VOOT7^(AP^;/VN_
MT&U]^B_Q$^;/VN_T&U]^B_Q$.'S9^UW^@VOOT7^(GS9^UW^@VOOT7^(AP^;/
MVN_T&U]^B_Q$^;/VN_T&U]^B_P 1#A\V?M=_H-K[]%_B)\V?M=_H-K[]%_B(
M</FS]KO]!M??HO\ $3YL_:[_ $&U]^B_Q$.'S9^UW^@VOOT7^(GS9^UW^@VO
MOT7^(AP^;/VN_P!!M??HO\1/FS]KO]!M??HO\1#A\V?M=_H-K[]%_B)\V?M=
M_H-K[]%_B(</FS]KO]!M??HO\1/FS]KO]!M??HO\1#A\V?M=_H-K[]%_B)\V
M?M=_H-K[]%_B(</FS]KO]!M??HO\1/FS]KO]!M??HO\ $0X?-G[7?Z#:^_1?
MXB?-G[7?Z#:^_1?XB'#YL_:[_0;7WZ+_ !$^;/VN_P!!M??HO\1#A\V?M=_H
M-K[]%_B)\V?M=_H-K[]%_B(</FS]KO\ 0;7WZ+_$3YL_:[_0;7WZ+_$0X?-G
M[7?Z#:^_1?XB?-G[7?Z#:^_1?XB'#YL_:[_0;7WZ+_$3YL_:[_0;7WZ+_$0X
M?-G[7?Z#:^_1?XB?-G[7?Z#:^_1?XB'#YL_:[_0;7WZ+_$3YL_:[_0;7WZ+_
M !$.'S9^UW^@VOOT7^(GS9^UW^@VOOT7^(AP^;/VN_T&U]^B_P 1/FS]KO\
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MN_T&U]^B_P 1#A\V?M=_H-K[]%_B)\V?M=_H-K[]%_B(</FS]KO]!M??HO\
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M&N<NV< ]DN.XQ.R_=G;<R('T' :BA_2Q$UUQ$01 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
(1 1 1 1!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>proxy_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 proxy_002.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP"$  8&!@8'!@<(" <*"PH+"@\.# P.
M#Q80$1 1$!8B%1D5%1D5(AXD'AP>)!XV*B8F*C8^-#(T/DQ$1$Q?6E]\?*<!
M!@8&!@<&!P@(!PH+"@L*#PX,# X/%A 1$!$0%B(5&145&14B'B0>'!XD'C8J
M)B8J-CXT,C0^3$1$3%]:7WQ\I__  !$(")@&I ,!(0 "$0$#$0'_Q "?  $
M @,! 0$             !@<$!0@# @$0  $$ @$" @,*"@<& @@""P ! @,$
M!082!Q$3(10Q41<B055Q=).4L],(%1@R-3=488'2%E)6<G.2LB,S-D)UD20T
M.$-38J&QM-$E8W:"PR9$I,(GHN.C 0$!                     1$! 0$!
M 0$!              $1(4%1,?_:  P# 0 "$0,1 #\ ZI
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M<KD1%".1R(J*BHJ=T5 /T
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M(G\H$@K7ZN2Z\8:[4?S@GIMDC7]SJ;AL#)]ZZK+K5JW-%BJ*+WA8[MSX,Y.
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MG4F1[&\O5!Q+-QM1M''4:B/5S:U>.%KE3LKDC:C>X1[
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M'W?Q916[Y6O1HO2/5_O>*<_S?+UA'V
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MMN-Q<LK'KCD8O%O!/4WNX"S*-*M0IUZM>-(X88FQQL3U-:U.R(?8
M                 $)WGI['MUW#67Y)U9:#WN1J1<^?-6_RDV
M       ".[IJ<^S4ZL,&9LXZ:O-XL<\'K[]N/M:5W'T;FMWZ]O9MIN99L*^\
MA>BM3^*N<\"YFM:UJ-:B(B)V1$
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M1\WI&B*[MW[>7<#9-7DU%]J
M
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M 'CZ\\:N9S7X7,-'INJ2;'J&,R&8R^2?:FK)X#XK4D:0-;Y-<B-7S?\ "JN
M:CB;>W8&')Y_)WI)>[X*[8)WUV,2!?"67M&J<GO<TFG3W(WKVOOCNSNGFIWK
M--9G?G2)!(K4<X"4@
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MU\@)KB+[\CC:MQ].>JZ9G)8)V\9(_P!SD
M
M                               #ROIDTI2KC6UG6O+@EASFQ>OS[JQ%
M4#5:M@+.*BOV+T\<V0OVEL6I(T5&=^W%K&=_/BQ#=
M                    &AU'"V<!AWTK$D<DCK=F;NSOV[32*]#?    $>V?
M&;)DJS\?C;%*"M9B6*S/)S6>-KO)WA(WR]1OZ5.OCZ-:G69PA@A9%&WV-8G9
M /H
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MYM^G \$SG7O^RF(_SM^_"9WKW_93$_YV_?A>)AI>0ZDVKMAFS86C3JI!WA?
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M*!W=BQ=D[+Y/>;H(
M
M
M
M
M
M
M
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M&(6W8J-KRI:L0NA:_FB+!*L?K VP
M
M
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M2?2KOC8'PTCK-2I9GJ,=73C#*D#^"2,0\.G_ .@[?_6,E_\ 5/()0
M
M
M                                    'RZC16\V]Z-%Z4V%84GXIS2-
M5Y<$7V=P%JI4L.KNFA9(Z&3Q(E<G?@]$5.2?O[*?3FM>US7)W14[*@'Y5JUJ
ME>&O7A9%%$Q&1QL3LUK6^2(B"U3JW*LM:S"R6&5JMDC>G=KD7X% _3XFPN*G
MJW*LU&%\%J19+$:M[MD>O;S<G\ -76U#5:%B*U5PM2&>->\;V1HCD4V[FM<U
M6N1%14[*B@:JEJVMXRPD]+$U89FHJ->UB=V(OP,]AM;-2M9;&D\+)$CE9*SD
MG?B]B]VN3]Z*!YY#&XS(5G5;M.&S$JHJLE8CV]T]2^9\XW#8C$1/90HP5FO7
MNY(V(WDOM<!ZS4ZL[ZSYH6/=!)XD2JG?@_LK>3?W]E,7)ZW@,M(R7(8NK8D8
MWBU\D:*[C[.X&7!!!6A9#!$R.)C>S&,:C6M3V(B'S6J5:D;HZ\+(F*][U:U.
MW=SW<G+\JJH'T                !I,QMVK8%4;E,O6@?\ !$KN4GR\&]U
MBB=8^G#5_33OJT_\A]^[1TY^.7_5I_Y N'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0&'NT=.?CE_U:?^0>[1TY^.7_ %:?
M^0&'NT=.?CE_U:?^0>[1TY^.7_5I_P"0)E/=HZ<_'+_JT_\ (/=HZ<_'+_JT
M_P#(%P]VCIS\<O\ JT_\@]VCIS\<O^K3_P @3*>[1TY^.7_5I_Y![M'3GXY?
M]6G_ ) 93W:.G/QR_P"K3_R#W:.G/QR_ZM/_ " RGNT=.?CE_P!6G_D'NT=.
M?CE_U:?^0&4]VCIS\<O^K3_R#W:.G/QR_P"K3_R RGNT=.?CE_U:?^0>[1TY
M^.7_ %:?^0+A[M'3GXY?]6G_ )![M'3GXY?]6G_D!A[M'3GXY?\ 5I_Y![M'
M3GXY?]6G_D!C+J=7.GEIZ,9GHV?XL4L?^MI-JUB"S"R:"9DL3T[L>QR.:Y/:
MBH$?0           J7J[OTVK8^&ACG]LE<8JI)\,,7JYE+:9TDSVWP_C:_=6
MK5F=R;+(BRS3!5C_ ).V)^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U
M]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[
M7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U
M]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[
M7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U
M]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[
M7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U
M]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[
M7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U
M]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[
M7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U
M]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[
M7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U
M]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[
M7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U
M]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[
M7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U
M]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[
M7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U
M]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[
M7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U
M]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[
M7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U
M]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[
M7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U
M]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[
M7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U
M]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[
M7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U
M]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[
M7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U
M]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[
M7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U
M]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[
M7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U
M]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[
M7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U
M]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[
M7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U]"T&GY.V*^/[7T+1^3MBOC^U
M]"T&GY.V*^/[7T+1^3MBOC^U]"T&L*_^#O"E9ZT=@?XWLFA]X5QKFQ[-TSV=
M]"^R1*R2(EJKW[L<Q?\ UL0/UVA7GALUX9X7H^*6-KV.3U.:Y.Z* @
M   #C?JXKK_5*S4D<O!JTX&_N:]C7'8\$$5>"*&)B,CC8UC&IZFM:G9$0*_0
M$
M
M                                           .=OPB,?6;!K]U&=IN
M<T*N]K +.Z4W7V>G> <YWFV*2/\ A%*YB$[           XWZE_KAM_.Z'V4
M9V0%H @
M
M                                                !0?X1/Z)P'SJ
M4$3GHX_CTWP?RV?MWEA@          <;]2_UPV_G=#[*,[("T 0
M
M
M                                 H/\(G]$X#YU*")ST<?QZ;X/Y;/V
M[RPP          .-^I?ZX;?SNA]E&=D!: (
M
M
M                 4'^$3^B<!\ZE!$YZ./X]-\'\MG[=Y88          '&
M_4O]<-OYW0^RC.R M $
M
M
M *#_  B?T3@/G4H(G/1Q_'IO@_EL_;O+#           XWZE_KAM_.Z'V49V
M0%H @
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MHZ:%&JS@[V=G>:&Q"
M                     4'^$3^B<!\ZE!$YZ./X]-\'\MG[=Y88
M  '&_4O]<-OYW0^RC.R M $
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M$_K\.5C_ /*P"*]#Z$69W3)96]VEF@A=.W_&F?YO.K@@
M                                                 4'^$3^B<!\Z
ME!$YZ./X]-\'\MG[=Y88          '&_4O]<-OYW0^RC.R M $
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M0=P5LD;%Y*CW<$\G&5KFT8S9,4S)8_Q?!?(]B>(WBO=@1LP
M                                                  H/\(G]$X#Y
MU*")ST<?QZ;X/Y;/V[RPP          .-^I?ZX;?SNA]E&=D!: (
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M'8YB-1M=)'M_,=R3WR+R,S"X+$Z[CFT,76\"NU[G(SFY_F[UKW>JJ!E@
M                                                          !0
M?X1/Z)P'SJ4$3GHX_CTWP?RV?MWEA@          <;]2_P!<-OYW0^RC.R M
M $
M
M                                            *#_")_1. ^=2@B<]
M''\>F^#^6S]N\L,          #C?J7^N&W\[H?91G9 6@"
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M%1\[ZM=\[$;*Z)JR-3R1'*GF@0
M                *#_")_1. ^=2@B<]''\>F^#^6S]N\L,          #C?
MJ7^N&W\[H?91G9 6@"
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MN;ZVE\121RQLDC>U['M1S7-7NCD7S144(
M                       %!_A$_HG ?.I01.>CC^/3?!_+9^W>6&
M    !QOU+_7#;^=T/LHSL@+0!
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MM<[#&G#NL3T5)4_=P"N?H%M=3>J++D$#TH02Q.<JI^97A_G)K^$7_P"3UO\
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M2DPSZTV26;O--73R6+V/+XZ:LNUM"U^&VCFS)6]3O6C'.56 3(!
M                                        *#_")_1. ^=2@B<]''\>
MF^#^6S]N\L,          #C?J7^N&W\[H?91G9 6@"
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MP0^-*G!SOWH[N!J(>D'3J%_)N!;\CYYG_P"IY.L9B<7BJR5L?2@K1?U(F(Q
M-9LNL8'8ZL-?+TO28XI.<;?$?'V=V[=^\:M(G[C73?XB7ZS/_.!**FI:YC\#
M/@Z]+ACYFR))#XDB\DD_.]\J\CXP&JX#6Z\]?#T_1XIGH^5/$?)R<G]]5 Q,
M[H.H9O(ID\CC/%MHUK4E2:6-?>>KRC<T]-GT?5]D\!^5H>+)$SA&])'L<U/X
M*!H\=TFT+%V&3Q8E)96>;5FD?*B?P<3T
M                       4'^$3^B<!\ZE!$YZ./X]-\'\MG[=Y88
M    '&_4O]<-OYW0^RC.R M $
M
M
M       *#_")_1. ^=2@B<]''\>F^#^6S]N\L,          #C?J7^N&W\[H
M?91G9 6@"                                             !4?5GJ
M/D-5GQ='%-@?:G1TDJ2-Y]F>IH&XZ5[S9V_#6GW?";=K3\)6QIQ;P?YL<??5
M3:\IJ6O5+^-2%9Y+S(5\5O-.*L>X"1Z3F[>;U/$Y2YP](L1*Y_!.+>Z.5"LN
MJ_4/8-0RN-K8U*JLGJK(_P 6/GY\@+CR>6QV%Q<^2OS)%!#'S>Y?_DGM53GA
M_5W?-FORUM3P+?"9\+F>*_Y7KY,:!M*VR]<J-NK^,<%#+ ^5C9%2)K^+7?X#
MR=]5-JRNI:[5OXU(5F?>9"[Q6\DXN8]P$BTG-V\WJ>)RESAZ18B5S^"<6]T<
MJ%9=5^H>P:AE<;6QJ559/561_BQ\_/D!8&[[G6U#7ER$D7BS2/2*"+U<WJ4S
MC=SZVYRJF1Q>(@6H[OP[1L:B_2.Y*!9=K.=15T2A>KXABYU\_:>MX2HC6<G)
MWXN<5)G.J75C +73+8RG56?DL7.'U\/D>%F)-A]IZT6[F-=-@($J2RQ*^1L7
MJB>OF[\\OL(JK<MHZ@U\\_#ZO@63\(8Y'VGMY)[_ .56M0@+>K._ZSFJ]3;<
M7$D+_-_9G%_#^LQS%5K@J[-VW6GJ^O/RBM297\&5HT7MXCWIW0I"+?\ K'-B
M'[%%BZOXK9W?_ND[<&_QY\0+PT/<:NX8./(1Q>%-&]8K$/?OPD),$"FMBVWJ
MG9SN2QVMZ]&L%27AZ2]O?G_&16M T&O=6MKH;1!@]MH1Q++*R+FC.#XW/]3O
M8YI;'4+>*^G85+:Q)-9F?PK0_ YWM<%4M+U$ZN8G'U,[D,367%S*U4;P1OO7
M_([DTNEFXQ6M'DV7%UEL*E59&5E]?-ODYB]@*BN;?UR;5DR?X@B@JL;S5B0M
M5R,_>QSN98G2_J*_<J5N.U!'#>J\?$1G?@]C_4]H%>YGJ9U!7=\GK^#J4YW1
M6)&0QK'[]6L^5R$AP>;ZTS9C'1Y+ U8J3K#&V'M:SNV/Z0'%S (YYZ@]:,KB
MMBGQV";5?#53A/+(SGWF+IT_-W,SJV(R-KAX]F#G)P3BT#>E%;#U+V>YM$NM
MZ;2AFFA<YLL[^SN[F>3^W+R1K0,K3>IVP)L_]&-MHQU[CW<(I6)Q]_ZVM<3_
M *A;Q7T["I;6))K,S^%:'X'.]K@*7FZB]7<50JY[(XFLN,G5JHG!&^]?\CN3
M3H75\]1V'"4\K3[I'89YM7UL<WR<U0,^=ZQP2O;ZVL<J?P0Y;PG5CJIG)9F8
MO&4K3H6HZ1K(5_G FNF]9+=S.18+8\4VE:DE2)KV<F(DOP,>QY=X',6U=9=S
MQ>R9NA5CI+!4MRQLY0JJ\&N.AM-SZ;%K&*RJ\><\">*C?4DC?>O"JBZG]4,W
MK.?@Q>'97>YM5);"R,5Y+ND^Y9C;</?M9)(4DAM^$SPF<$X\$<$6, !6W5;<
M,QJ&'QUK&I LDUI8W^*SDG;@J@5Y1W?K=?IP7*F K2P3,1\<B0^3D_SEUZ=?
MV6Y@8Y=@J-KWUE>CHVMXHC/@ C/53=[.H8:H^FD2W+,_&)LB<DX,\WN-7TGZ
MDY':YLI2RR0,MP(V2)(V\.\?J<!;5FS#5KS3S/1L<4;GO=[&M3NJG-Z=5NH6
MTY6S7U+$1)#%[6HY_'VO<]4:!96C9?J1:ERL&S8N.#PJZ.KO2/MS?[.[7*TK
MF_O/6W'4Y[ES UH8(6\I)'0^34_S@8>%ZD]8,[6DLXO$5+,3).#GLA]3OXO)
MGN&][EKFDZ_D9ZU>')V;#H[44D?DT*C-'=^MU^G!<J8"M+!,Q'QR)#Y.3_.6
M?5S^VUNGF4RV8IQ5LI6@L2-BX=F>\\V 4_A>IW5S.0SSXO$5+3(G<9%9 O\
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M-%\O:Q(D7;BW_.!<P
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M\]!C%UV>ISCD=XSY>2)P3^X@%J (
M             %!_A$_HG ?.I01.>CC^/3?!_+9^W>6&          !QOU+_
M %PV_G=#[*,[("T 0
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MBPK+52WDN*)4?"G>5K@-IT @NQZI?DE1R02WU6#^#41Q%?PC?]]J_P#<M_\
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M5S)VV5X/$O,YN]JR'2^-ZA:3?N04J>;@EL3.XQL1']W*$28
M                                 "@_PB?T3@/G4H(G/1Q_'IO@_EL_
M;O+#           XWZE_KAM_.Z'V49V0%H @
M                    #4;%IVN;)'69EZ:SMKJY8D\:2-&J[UK[QS38U*E:
MC4KU*L21P01-CB8GJ:QJ=D0#PSF$Q&;QLE#)U$GKR.:JQJYS/-B]T7DQ44\L
M+KN$UVA)0Q=3P:[WJ]T3I'RIW<G9?]XK@(?E.D6@7;#IG8GPGN]:0ROC:;_
MZ1JNM*K\5C(XI53LLKE621?XO D9$LWTRTC-SOL7,/&DSE[NEA585=\O #5X
M_H_T]K.23\3++_C32/0L!(HTC2)&IP1O'CV\NWJ[ 5]E.D6@7;#IG8GPGN]:
M0ROC:;_ Z1JNM*K\5C(XI53LLKE621?XO V>PZW@\_193RU1)X&OYM;R<U4?
MV[=T5JH0RMT8Z>P3)+^*GR>QLD\BM L*O7KU8(X((F111M1K(V(C6M1/@1$-
M/L>EZWLZU5S-#TE:_/PO]K)'QY^O\QS0-S7@BK010Q-XQQL:QB>OLUJ=D3S
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M=,-%Q60K7Z.)6*>!_*.3QYG=G?(YX$W
M                  H/\(G]$X#YU*")ST<?QZ;X/Y;/V[RPP          .
M-^I?ZX;?SNA]E&=D!: (
M
M
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M#U89KM],3BJC+F2\N?+S9$KO4WLWS<XBTNU==Z=9<C/A(EKM3DYBPL_T,=S
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M?QZ;X/Y;/V[RPP          .-^I?ZX;?SNA]E&=D!: (
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M_P ]''R?P\*I_,\QZ\G] ^LTC%]Y2NS?P2&W_(\"_P#J!YZ+LWS"4K7\'C]
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M (' =(:3U.UW;')6K\Z]U&=UK2^M?WL4G 0
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M@M?O9N3*WXZS98(DC5YB;_G,;M&_8N75VO=.G@Q).UBL669'^3POJP?PB_\
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M*]_U# Z17JY++1PSLFG<L7![G>;@>*[W?9[O4K8L=B\)4E6M"KFP-=ZW*_\
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M  B?T3@/G4H(G/1Q_'IO@_EL_;O+#           XWZE_KAM_.Z'V49V0%H
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M]                          %!_A$_HG ?.I01.>CC^/3?!_+9^W>6&
M        !QOU+_7#;^=T/LHSL@+0!
M
M
M           "@_PB?T3@/G4H(G/1Q_'IO@_EL_;O+#           XWZE_KA
MM_.Z'V49V0%H @
M
M                                                       !0?X1
M/Z)P'SJ4$3GHX_CTWP?RV?MWEA@          <;]2_UPV_G=#[*,[("T 0
M
M
M                                        H/\ ")_1. ^=2@B<]''\
M>F^#^6S]N\L,          #C?J7^N&W\[H?91G9 6@"
M
M
M                         %!_A$_HG ?.I01.>CC^/3?!_+9^W>6&
M      !QOU+_ %PV_G=#[*,[("T 0
M
M
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M[J $4T,S><4C'M[]N[514  QKN2HT/1?2ITC](LQUX>Z*O*63R:WR R0
M   'C7R6/ER4^/;.BVH8F2R1=E\F/7LBGLYS6M5SE1$1.ZJH!CV/:US'(YJI
MW147NBH      !\ONT87K'):A8_X6N>B*!^M<UR(K5147U*@KWZ,\MJ&"Q&]
M]=Z,G:U>ZL>J=T1P'Z           /FS<I4D@6S.R+QIF0Q<E[<I'_FL;^]3
MZ ^+F3H49J,%B=(WVYO!@3LJ\W]N7%.Q]@     :3*[3@L1<KT[EIS;$S>38
MHXI)GHSOVYN2-'=FF[ 'S!DJ#LC/C63HMN*%DTD79?)CU[-4#Z
M    !\T;M*[&Z6K89,QLCHW.8O=$>Q>SF_*A]       !YY+(4,50FO7YDAK
M1=ED>J*O;NO%/)IZ    'PV]2=<EI-L,6Q%&V1\*+[Y&.\D<J>Q3[ \J&1H7
M+%Z""='RU)$CG9V5.#W)R1/,]0  \J.0HY#TM*DZ/]&LOKS]D5.,L?;DWS/4
M                    #S==I1W(*;[#&V)6.?'"J^_<UGK5$_<>@      H
M/\(G]$X#YU*")ST<?QZ;X/Y;/V[RPP          .-^I?ZX;?SNA]E&=D!:
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M">SS:_/1.1?EB>?&S*Q.HNCK9_W'"\D7L2?@G8#8=24IIH6P^D<>*TW<._\
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ME^TX[-97(8UZ5:TT'"K#)&KVR^WFYQY=+8(H\-EWM8B.ESE]SU^23B!ZZO\
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MVM;0Q[O8^C_M55ORRGO2RS-OSFF</.&KCURMEOLG>G@QM_@[D!N,?^M'/?\
M1:?VCQJ/_%V__/ZOV" >>EPQ)M>_S<4YNR4#%=^YL*'K#Y=6+O[]:A5?K#@)
MJ0C0U[7=Y[_VCG^S8 Z>P1,L[M,C??OV:VUR_N8UIY8_Q6]0]S2'\]V+HJG[
MWHCT0"*=.8=UDT[%OQN1PS($27RFK2OE1_->?-6R)W<3_4,#DL%!EVW;=>:6
M[D)+:^ QS&,65$Y(B.50--U=6M_16NMGMX'XTI^+W]7#F3?85J)KN76QP]']
M GY]_P WAP4"F*C968WHYZ=Y0>+[[GZDE6%? +6W!*;=2SZW.*0?BZ?DCO[@
M%>V66\?J_3K89^238U*K+2KZTKVV)$_D9%_$OVMN^7(_6UK:&/=['T?]JJM^
M64#WI99FWYS3.'G#5QZY6RWV3O3P8V_P=R-9@&[6_8]Y3&7<7"Y,POBMLPR2
M2\.">'YL>WWH$RU[6\_5V3(9K*WJ,K[5*.!T=:)\:=XW=T<O-SC!Z511P:+C
MUC\G2SVWO^G>@$](3H:]KN\]_P"T<_V; /#I/P_HQ.C^WI:92[Z9[?&\51[U
M>KO_ (;X-=7TSZ;WG("4;+FHM>P&1RTL:R-K1<N">7)RKQ:A ]@@WF;4\S>R
MF;QU2)<;,Z2G!463WKHU]XLCW@:S9%JKIO2YUSS@_&>(67Z$L+>&UFZ5LBVN
MW#\6V/\ -P7B!7^8XMJ](DR7;DEBNDG+_P!KX'\Q+>IS($T'/K/V[+71&(O]
M?FG #4JDC>HVI^G?V=F2#E^T]V\_X\39=6_!_H)E$?\ [U70)6_K^-XB<. "
M]XGND:IXOY_XGN\_E[L&EQ1IM6_R\$YNR4#57]R0H!]P^75FYV^'6H5=]8<,
M%^L?=/FF,_TO FP   4'^$3^B<!\ZE!$YZ./X]-\'\MG[=Y88          '
M&_4O]<-OYW0^RC.R M $  ,&G@J6/S&:RL<DJSY)8%F:Y4X-6NSPV\ /O(86
MI;RN(R<LDJ38Y9U@:U4X.6=G!W,_,]@Z6:JUX+<DK&0VX;#%C5$57PNY(B]T
M7R Q-BU3'YYU2:26Q6N57*M:Y6?PFC[GQAM;MT+GI5K8LG?>D:L;'.YB1-[_
M  \(VM\P-U+'XD4D?-S>35;R:O9R=_A1?:0N7I]Z8C(,ILF6OTFO:Y:DSXT9
M)Q\T216-1SD D6R:Y3SM&O!+/-6?6L,L5YX%1LD4D?J5O=%,.YJ=+(8.+&Y6
MY:MNCE\6.VYS66&2(O='L=&C416@:E-$BDLU7Y;.Y/*,KR))#7LO8D2/;ZG/
M1C6\U))L6LXO8:L4-Q)6OAD22">%_":%_P#68X#!Q&N7\=;;8M;-D[S&,5K(
M9EB1GG\+N#$55,K&:]C,5C;>.8CYX;$\\LK)N+NZV'<G-\D3R UB:)B_Z-7=
M>]-OK0G=W8QSVJZ!J.1_")5;Y-))9KLL59X)%5&RQN8O;UHCD[ :I=6PR:O#
MKT\3[%)E=D*)(OOU1GJ=W;V\S0.Z=1V(F5;^QYBYCV]NU.65O%R)ZFR.:U'.
M0"5Y37Z.3BQ<4JR1LH78+4#8NS4Y5_S6KW1?>F'G]5JYF>I;;:LT[U7DD%NL
MY&R-:[UM7NBHYJ@::/0:#,C0RMS)W[N0JS)(R>9[/@16\.*-[(SS-KG]1H9N
MU5O-M6J=^LBMAN57\)$:OK8O=%1S0/?"X"SC9Y;%K/9&_(YG#M8<Q(VI[6L8
MUJ=STP>$IX6I/7JR3.CDM36%6145><SN:^I$\@-9F\?9J9_$YVE ^16IZ'>C
M8G=7UY7=VO[)\,;S&R.FV[4MOOMF996L/>KZS7Q]D1_K8Q_#DUH'A;P$;KV
MPE6HL6(Q;6VI/)>,DC/*&-%7U]E[O>30#!9A*<&>N9EDDOI-BK'7>U53@C(U
M5R*B=N_?S/FW@Z=K+XG*2/D2;'LL-B1JIP<EE$:[DBI\''R U69TRG<R?XVJ
M9&YC;ZQI')/5<U/%:WU)(QZ*CC:X7#28B.=9LM>O2RJBJ^R]J\>/P,:Q&HU
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M;$D3(IT@5G&9D:]V\D>UP$C   "@_P (G]$X#YU*")ST<?QZ;X/Y;/V[RPP
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M*U:E1'>?A1.CYKQ_OJ!][G%'2VS2<G6:C;<N16E*K?7)!*Q55'&56_6MD?\
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M$_HG ?.I01.>CC^/3?!_+9^W>6&          !QOU+_7#;^=T/LHSL@+0!
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M]R-C+M6TQRQ2.B\FR(K/-' 8F-T[--VZMLF3R<$UA*LL$D43',C8UW;@R(G
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MEX2/63MV^50/L                       #6-8U&M:B(GJ1$[
M P\YKV.SD4#+GCM6%ZOBDAF?"]BKY>2QJ@&IQ>GX3%W?3F)9L6D:K&6+<[[$
MC6KZT8LBKQ)$
M .#$<KD:G)?6H           %!_A$_HG ?.I01.>CC^/3?!_+9^W>6&
M     !QOU+_7#;^=T/LHSL@+0!  >.0N1T*%JW)V[0PR2(WOQ5W!O+LAH'9Y
M<AH=G*P+X$LN&?9:UC^[HG/AYH!G:WDXUUG79;EQBSSXZJY5D>G.1[XVJJ^9
MMP/QMJLLRP)/$LJ>N/DG)/X'Z!^*J-15541$3NJJ(+-:PU5@GCD:B]EX.1W_
M ,@(AH&6?/I6+M9*_P!Y9'V46:>3S=QG>U/-Q,$5%1%10"6JB3>!Z1%XO]3F
MG+_L%<UO;NJ)W7L@'XR>&1TC62L<YB]GHBHJM7V*([-5\KX63QND9^<Q'(KD
M^5 $LT4,:R2R,8Q/6YRHU$_BHBEBE8CXI&O:OJ<U>Z*!^GY);J0O9'+8B8]W
MYK'/1%7Y$4!)*R)BO>Y$1/:O8@'3B&7(XVKL-O+7)[MUDKY('6'+ QKG^36Q
M>I.(%@$'M;'G\OE[N)UF*LQE)W"YD;**^..3U^%&QO;D\#8X_';O3O5WW-CI
M7*OGXT7H7@/[=O\ D5KU)-+-# Q7RRLC8GK<Y4:@".2.5B/C>U[5]3FKW10^
M>")CWR2L8UOYSG.1$3Y0/U;$"0^-XK/"[=^?)./;V]Q')'*QKXWM<U?4YJ]T
M4!+;JQ,YRV(V-[]N3G(B=Q+8@AC2269C&?UG.1$\_P!Z@$<US4<U45%\T5#Y
MFM5(',;-8BC5WYJ/<C>_R=P/H2VZL7#Q+$3.?YG)R)R^3N /FY:AHTK-J;OP
MAA?*_MZ^+$Y*!7V*DZ@;%CJ^7KYBAC(++$EK5$J>D+X;O5XCU<TD>=V&37\!
M#<MLCL6&K6BD:QWAH]\KDC5Z=^Z\>Z@2!KV/3NUR*GM1>X9<J23.A98B=(WU
ML1Z*Y/E0 ?C;=/QUA2S"LJ>7A\TY)_ ")ZK?N3Y[=(K%F1\=?)1,A8YW=(VK
M"U>S26HYJJJ(Y%5/6@ ^9K52!S&S6(HU=^:CW(WO\G<#Z<YK6\G.1$]JE>:C
M&[-9?+9BUEKG.OE[5:K5985L"0P>\\XT\G 6&5NW)[KD]GV6AC<E0K5\9+7:
MULU995=XL7/UHYH&]US8\M/?RV%S$$#,A1B9*DL'?P9X9/4]J/\ -"*:QD>I
M>>UREFH,MAT\=CW-KRU7I^8]6=E>UP$SU_;X<GJ\N8MQI4=6\9MQG?ND3ZZJ
MCR/8Z_OFSUFY2G=IX:A-W=4C?7])GEC^![^[FHWD!GXC9,Y1V"'7MD966>S$
M^2C=@[MCL</-S%:O?B]#QV+)[-_2['8+#W*E9L^.ELO?/ LWFQ_'VH!D8_/;
M'C=BHX38$IS)?BE=3N5FNC170IR='(QRJ9^KYV]D\GM5>RK.%#)^!!V3M[S@
MB^8'GN.:OX6#!25>"+:S52I)R3O_ +*951Q)U5&HJJJ(B)YJ!6NI[OD\AL?@
M78HF8[)13RX=Z)V<YM:3@O/Y6^^+!RV2@Q.(OY.PU5BJUWRN:WUNX)W[ 0NA
M#U'RU&OD4S>-H>/&V6.DE19FM8].Z(^17(9N[9G/XROKD&/L5X[5_)PU))9(
MN;$YL7S1H&7CL?OD=ZN^_G<=-6:[_:QQU',>Y/W.YJ28".9+.7ZV[8#$1JST
M:W4M22]V^^Y0]N/921@:/;\U-A,#8L56-?;D<R"HQ?/G/,O!B'AI&>O9?&VH
M\DC&Y*C<EJW&L3LWFQ?)S4]CF@:O<,MGZ>6U?'8FS7@DR4UACY)HEE1J1,YG
M@_.;?K^5P]?.NH7*61MMJ,LUF/ADBF>B\$<URN144#)R^9SUC8V:]@W5H)VT
MTM6K<[%D2)CG<6M8Q%3NY3?82IL]*:=,OF:U^)6IX2LK>CO1W[^SG(!MP!&]
M<SUW(9O:ZEA6>%0NQQ0=F]EXNCY$6Z:[WDM@6:IF8XF6'M?/3>Q.+9H&/6)W
M\6.:!)=BS5[&9O5:E=8^%^Z^*?DWNO%(^2=C)VG9Y<3)1H4*?IF5O.5M6OWX
MM1&^;I)%^!C0-2W$=2GL25^T8V*7]G90YQ?)S<_D3.OZ1Z/"EA6+-X;?%5B*
MC5?V\^/?X /HUNU;#%KV!OY-T23.KQ<TAY\%?Y]@-%U"R=FOHV6N4K;HIXV1
M*V2)_9S5=(TESK59DS8'3QI*OJC5R(Y?D0#]/R*U5F<YD-B)ZM_.1KD<J?+V
M T>3V&#'9C XYT;7KD)IF*_FB>$D4:R=U0WB*BHBHJ*B@:[:MABU[ W\FZ))
MG5XN:0\^"O\ /L:[=,A-#I6=N5+*QSQT7O9)&[LYC@-WC[U=*.-2>S'X\M:)
M>SWIS<JM]?F9 'Y%:JRO>R*>-[V?G-:Y%5OR]C] 221Q,<^1[6-3UN<O9$#+
M->6+Q8YXW1_UVN16@:G6]EASE>[*D;8E@O6*R,Y\E=X#N/,VDMJK7X^/8BC[
MKY<W(WO\G<#Z145$5%/B6U4K\?'L11\O5S<C>_\ W C&=OVH]PTB""T]L%EU
M_P 5C7>\DX0<F\B5*YJ*B*Y$5?4!$\+?G7<MT@GM.]%JLQRQ,>[WD7.)RN[$
MKAFAG8DD,K)&+ZG-5')_W0!-/7KLYS2LC;_6>Y&I_P#$,>R1C7L<CFJG='(O
M=% C&D7;EMVU)9L22^#L5N&+FO?A&UK.S&DF2S6\;P?'C\7MW\/DG+_L!%>G
MEZ[>PMR6U9DF>W*W6(Y[N2HQDJHUI*VVJRS+ D\2RIZX^2<D_@!^JYJ*B*J)
MW]1Y29"A6IV[DEF/PJS'OF<UR+P1B=U[@:G4I+T^(_&=^1[9+SULI$]WO8(7
M)[R-/9V;YN-T_P!$R-&S!7N^3XW1K+!+V>Q7)V[HYB^2H!I-3S4]_'30WE3T
M^A.^I;_?)'ZGI^YZ=G&\ Q<-7NU<7!#<R27IV<U?9XHQ'(KU5/)/8GD9,%JK
M8Y>!8BDX^O@]'=OE[ 1?=LS=Q6)KQXU6ID+UR&K3[IR3G([S<J>QK24/M5ZS
M8V6+4;7*B)W>YK%<H#NB)W[IV]H\>#Q&1^*SFY.36<D[N3VH@!]FK#(R.2>-
MCW_FM<Y$5WR(?H _&VJRS+ D\2RIZX^2<D_@!^JYJ*B*J)W]1^16:TCWQQSQ
MN>W\YK7(JI\J :3-;%!B+6&@=$DBWK[*OYZ-\/DU7<U-KE(+=IE!U/)I61EV
M*254:CTFB:OOH?W<@-3D]A@QV8P..=&UZY":9BOYHGA)%&LG=4,#-W;,.X:1
M7@LO2"RZ_P",QKO>2\(.3>0$KEGAA8KY9&,8GK<Y4:B?Q4_8Y&2,:]CVN:OJ
M<U>Z*!^26:T+F,EGC8Y_YK7.1%7Y.Y&,%=N3;KNE:6Q(^"NF.\&-7=VQ\XE5
MW$"4*J(BJJ]D0T^+V:'(Y;.4&QM9Z!/%$C^:+XJR,Y]P-O-/7KLYS2LC;_6>
MY&I_\0Q[)&->QR.:J=T<B]T4#]#7-<B*U45/:@!'-551%153UAERI),Z%EB)
MTC?6Q'HKD^5 -;M6PQ:]@;^3=$DSJ\7-(>?!7^?8V,4K)&(YCFKY>?9>X".S
M5?*^%D\;I&?G,1R*Y/E0_0/Q7(U%551$1.ZJH@LUIT589XY$1>RJQR.[?]@-
M):V*"IL6)Q#HVJMR&Q(LO-$2/P.WDJ>U>YO$5%1%10-5M.R1:_BWW%A29R2P
MQI'SX?[YZ,[FCW^_8IZ]#/1N/C>N2IL5\3^WD^9J*T"8>E5O'\#QX_%[=^')
M.7_8_0$-JK.KTAGCD5J]G<'([M\O8 1+8<WF&YRAKN$2O'<L5GV9;,Z*]D,+
M%X]T:G;DY5-EAJ6V4K4BY7.5;]=T2\$95]'>V3^#G(K0-V^>"-CWOE8UK?SG
M*Y$1/E$<L<K$?&]KV+ZG-7NB@?,MFM71JSSQQ\E[-YN1O?Y.Y] ?+[=.![63
M686/=ZFN>C54QYJMUV9I3Q9/A59!(V2IQ1?%<[MQ?R^#B!DS6JL"(LT\<:*O
M9.;D;W_[F!L,LL.NYB>"16N9CK#XY&KYHY(U5%0!JL\MC5\#8GE<^67&U7R/
M<O=7.=&U5535[GEK>&U;+Y*IP\>M#SCY)R;WY ?.C9^WG,0],@C&WZEA\%MC
M/)O)/-KD_<YIG;/EWX3!6[L;$?97C%4B_KSS+PC:!@=/<YE,YK<=S)+$MGTF
M>)ZQMXM_V3U:2;TJJD_@+/'XO;RCY)R_[ ?HAM59U>D,\<BM7L[@Y'=OE[ :
M+)[#!CLQ@<<Z-KUR$TS%?S1/"2*-9.ZH;6U#:GR>*GKY-(J\2S+/71J.2SS9
MV;Y_!P7S R'RQ,1[GR-:C$]\JJB(GRB*:*6-'Q2->Q?4YJHJ )[-:LQ'33QQ
M(J]D5[D:G_Q#9(W]N+VKW;R3LO?NGM ":>O79SFE9&W^L]R-3_X@&R1O8CVO
M:YJIW1R+W14*[L=\_O62I39BW7IXZG5?%'6L+ CYIE<JN<K/6!8@   4'^$3
M^B<!\ZE!$YZ./X]-\'\MG[=Y88          '&_4O]<-OYW0^RC.R M $ !H
M=TQ&+RF!O^G4HK"UZD\L7-._!Z1KV<A#<!@L10Z6R7*E&&&Q:UOE8E8WLZ1?
M  ]=0T/7;^GXF7+4(KMFUCX%?/,G)[&+&G!D:_\ (C$-)%LF2QW2&2=MIZVH
M9I*$4_FYZ(DZP(_Y6M U.0BZ;LP$T.,J7H\I%"KZU]*%I+"V&^:/=)P+PU_(
MV+VOXFY8C5EB>G$^5BIVXO5J<@(UU$QM^]C<<L-*2[5@OQS7Z4:]GV(&HO=J
M>WV\1I[]$M+/<P%.K6G:WPK,+(? E9\/&1@$-Z;ZEALAJE>YEJ<5Y\DMEL#9
MT21L$39GIQ8A)-%?!CZ6UXR6?A1Q>4GBA61_E%7<Q)./)?@:!!LTO3J?7\G^
M)-;MO?%6D?!DJM&7WDK$[M?X[B0;G-=RFF:-,R=S+5O)8M4F3UM?/'YO R=R
MI8O3=3DBPT*TG9"Y6J36(T<^7L]?.3VN?V(?FW:!7P;G:[0N5LM41):5EE&R
MV9TK/@>]6>?("6;2Q;&0U_.9C#2W\*F-59ZS&>*E>Q+V=XKXE]:(A.=3BU=V
M-6SKS*C:=B3FOHZ<6J_U>;4]2@>^QY)^'US+Y-C4<^M4EE8U?4KFM\B&:_H.
MN3X*K8R]"+(W[M=D]JU83G(KY4Y>2@8FMXRG>K[-K.6A;?KX:^BU%L>_5(Y8
M^4?\6&7TEPN'J:AA\G#1ACMV*BMFG:G9[TY@6,0#I.Y$TUDCO]^^_<=8_P 7
MQG 3\K3%XJCM^T;+=S,+;5?&W5H4JDGG"Q8VHKY%9\+G %QU;4=YP4>*9X%#
M,I/#8J-\HFS1,YLE8TP,%KF,RVX[M+E(&VJ\&1C\&M(G*))'Q-Y/5H'EA-2Q
MD^Z;'B9(N>&Q_H]F#'/\X&37&>:\?W<#?ZW3K8?>\_B*$:0T),=6MI79Y1QR
MJ]S'<$ T/3_4<-E:66MY:I%=[9:[%7CG3FR&-)5[\&^U5/C3-5Q=Z?8(<G$E
MZKBLG/0QU:Q[^.")J\_)J_WP-QJ]A,$S?:<'?T/$VG35HE7OP8Z!)5C:>6H:
M?@LKK]3+YRC#D<ADX4LS33ISXI+YM8S^JC0/O6O%Q=O=-7\9\M2C R>ES<KW
M,ALQJJQ?(TP.GVEX"_I6*MY:A#?L6*J)SG;SX1IY,9'_ % )+TWGGCP=^C)*
M^1,=E[M*%SU[N\*%_9I-98HIHI(I&HYCVJU[5]2HODJ 5BM#:=%B5V-:N6P4
M7=WH3_*W59ZU\)W_ #M0PNHM;6\]I]//PU(9G2R46P3N9[](GSIW8!M-PI5\
M/BL1@,'$W'LR^6CKR/@]XK(W)WD5O[U1IFY;IKJJ8:5F.QT5*W#$KJUR'WL[
M)6)Y.5X$<N[/ELSI.GLBLNKVL[9AJ3SL\G,;YI*YG[UXDTJ:'IM'T;T?!5$D
M@D9(RPYO*;FQ>Z.YKY@5Q!G;\&Y[3@L<]E>WDLJWA=F_W<360-Y</Z\OL:7#
M@L!CL#2\"LURN<Y7S32+REFD7UOD=\+E RLE9] QEZZYO)*]:6;C[?#:KBM]
M0T[!937JF8SM*'(W\G$EF::=.:HDOFUC._YK6@?>L8ZLF1VO3+K/3,956M/5
MCF59.,,Z<_"^1CFF+TTU[ UV9:_%C8&6H,Y?AAE1OOF1M?QX 6H5!C[NRUMZ
MWQN'PM>ZCK%+Q'2V4@X=H )EK^ RT%_+Y[-RP+?N0,A2&#NL4$,?J8BN\W*5
M1K%_J#CNF6/MXYN.6A%#*Y7,:]]QL22.YN:UW9@$FV>AC\=T9OLP\TDT$U:*
M;QW>;Y4GE:Y[W%NU/ CIUFP=O"2%B1]OZJ)Y 0#J0B>FZ*Z/RL)LE9K/\-R+
MS-=M%G+UNI>%DQ>/CNV/Q).GA/F2!.*R^OEV<!N*>&V3*;#C\UGV5*K:#)4I
MTZ[UE[/F3BZ21ZD9UY=N38]Y_$J8KPOQROB>F++RY<$]7A@>.Z?TT[:NF8;A
MTK)L=#MZ*LW/GR_]\EW4?*IC]=]$;99!9RDS*44CW(QL:2^3WJOL:T"-;I>U
MJGK>*L8?,8Y]G S035(V68U<^./WCX_XL+6C;CLWA4[M;-3O545?8^.5H%;J
MFUZ%!Y<LQK\'URI$GVC&CJ'<?>JZ)<Q,D$CI\[5DJOE[^$[G&Y6\N($PQ:[[
MZ=#^,TP?HGGXOHZS^+ZO+CS-\!!,U^M#4/\ I]\G8%;YK,8BWU"QU*YD*M>K
MA8%MO2:5L:/M3)QC3S_J-\S'AS6'H]2XGT<G4GK9VKX<S89F2<+5;\QR\?ZS
M0/O?V9)-HT%,<M=+?I-Q8UL<EB[^#Y\N!K\DFR5]BP5S<?1I*$5YB4UH=TAB
MM/\ )CIVR>^ FNS:I:O7X,SA\CZ!EH(O"25S><4T7?OX4S3YUC:KMR]/A,SC
MDHY:O"DJL:[G#/%ZO%B4"5 "":3_ ,4]0/\ JD/V)!]:PURUTUPF4QGZ4Q5N
MY8J_^^B3OYP_(]H$AS.8IYK(],LC4=WAGORN3VM7PE[M4VM;B[JYD/&_/9KT
M7H_]Q9EYJ@$]  KOJYAL39TW+WIJ44EJK6[03.;W='W>@&+O>#Q.&Z9Y^/&4
M8:S98X'O;&WBCG\V&;E.GVN+K5YT]1DN02H^5V0=_P"96=K>7B<P,ZKEL1=Z
M=XV]LD[&UK%"NMISW.3FY43V>:\E*XS=S5JJ8;(:]KERA/#DZJ-N-HOJQ21O
M?Q>QSE1.2. DNYZMKLVZ:@^7$UGK>MV_2^[/]]P@54YEHTZE:G6AK5X6101,
M1D<;4[-:U/@0"O\ JYA<39TW+7IZ43[5:MV@F<WNZ/N]#[VC!XC#].]ECQU&
M&JR2@][V1)Q17<0&/Z>ZY<UF!,A2BM7K%-CI;DB=YDD>SUL=ZVHWX$(A<V>U
M+TSTY+-N=BY2:&K;L1-<^;P(^7-6\//DY& 8&>M:12QL-K5<9:K9:E)$^LZ*
MA9C65&N3G'*Y6>:.0OYCD>QKD[]G(B@5]OV/D??P5ZWBILEAJGCK<J1IS5'N
M1.$RQ_\ .C3;X+'Z!EL+;_%-&B^A;<STF&./@U71^:(]GP*@$3Z;X' U*F8R
MC,; RQ5RV19',UOOVQ,<J<$/;2=8Q.R8=NQ9^E#?NY-SY?\ ;IXC88N2HR*-
M% ^L-874\[M6&A5[Z%;%IE*<+G*[P4\T?$T:?J>&RN$J9O.TX<ED<E"EB26P
MU)$8V3S:QC7>36M0##WN[2U#*:59KT7+6I-R7AUH?WP$MUO"+)+'L&4LPW<C
M/%WA='YUZL3O/A!_.!&JVO5,UU*W!+[/&IP18YRU7^<4DKHEXN>WX>)GX['4
M=>ZC-HXR!M>GD,.^:6M'Y1I-!(C4>UH&#KV(Q^W9#/9S-UV7$CR,U.C7F]_%
M## O'NC%\N3C+H4H=5WZGC,:GAXW+TIY/1.Z\(IZ_FKF>Q'(!K*F6GP^K]3,
MA7\IH,[D%C_<]6L1#>X?IQK7X@J,GI,?>E@;)+D?_P"*\=Z<ED;(!!<3F,C@
MNDN6G987TU<I8@\=$]4DL_!TAY9"+INS 30XRI>CRD4*OK7TH6DL+8;YH]TG
M HWFU/NY['=-GR/DK6+MR-)U3WKV>+ J2]C:[O@\3@=%OTL7395AM6ZD<_#V
M23,8Y5 W'4'%WK>*QC:]!]RG6O12W:,2]GSUV(OO4_E/73I-#LK8N:_2JUIV
MM\*S$R'P)F?#QD80>&(_V/4G:8(_S)L=1GD3V2)RC)J!2F-QV2R/23$0TH'V
M$;??):JL?P=8KLM/5\2$UTUV@W+4L^$QE:G?@C6.>#P$KV(D7X'L \?+.=25
M=ZZNOU/X+;M_RL-;E;'3:?,7V2X)V7R"O[6? ION.8OL5WFU@&%K-CQ>GFY5
M>T[8*DV5KUHK'E+'"D?)K'=_9R-AJ&"QN)U&CLL]=)\FW$I96P_S>C/![MC;
M[&HT"%8"ST^NX5EG/T[5[)WF>-;LOHV9'-=)Y\8GHSR:WX.)9O3:W<NZQ"VV
MZ=[JMF:O'),QS9)8F.]X]R/ ]>H>6LX74,C;KR+'._PX8GHG=6+,]&<RL,C'
MTXCP$T.,J7H\G%"KZU]*%I+*V6^:/=)P WVT.MY[']-GS/EK3W;D:3JWNQ[/
M$@7Q40RMUUK!X#!PYO#8V&C;Q]RJK)84X.>Q\S8W-?\ UD7D!Z=0M;P-C.:I
M9GQE=\MS-1167N;YRQI$[R<;/<Z%+&T--ITJ[(((MGH(R)GDUO=[@-1N>K:[
M-NFH/EQ-9ZWK=OTONS_?<(%5.9N<O4K4MPZ<U:T#888ER+(XV^IJ)6 B.5RN
MMW]XS,>PQ3V*N,2&"E42M-8AYO9SDE>D;7)R-CIM_&5MROU<)!9BP]G'>.Z)
MT$T,<-F-_9>"2M3MS:!]Z+K>%V/!OV/.4(+UO)S32=YVI)X42/5C(XS+Z?XY
M^+V[?**SR2LA?CTA<]W)R1+$YS&@63/7KV*\U>:-LD4L;F2,=YHYKD[*BE5Z
M=J>M,V_;E9B*R+0OU?1.S/\ <]X4=[P#[U[$8_;LAGLYFZ[+B1Y&:G1KS>_B
MAA@7CW1B^7)QF4*4.J[]3QF-3P\;EZ4\GHG=>$4]?S5S/8CD L<@&D6(L%%M
M&%L.X18>W)-%^ZG.BS, AB+DDU7%-;*^M<V[.<[,S?)\4$W=W%J_W&DXRW37
M54PTK,=CHJ5N&)75KD/O9V2L3R<KP(9LWH.S=(F[#?IPR7V8UO"96^;'<^#E
M:;_<&8_4].6'#P,Q_P",+E>O))78O-B3>3WM1OGRX@0W-.T&O@W.U['W*V6J
M(DM*RRC9;*Z5GP/>K//F7[0LOLX^G.YG!98(Y'-]2M5[>_8#2;C9U2/&Q-V)
MS%K.G:L<*HYZRR)ZFHQGF\K%EK!U=NU.?!8&YBTL69:UA74W5(;$3HU VF?U
M+6INHVOQR8BJ]MRM?FLHK/*61.*\G%KPP10010Q,1D4;$8QJ>IK6IV1$ K7J
MWA,39P27YZ$+[3+%.%L[F]W)&Z=.[#SZBX2CBM'6GAZT5-'92FYB1M\DD=*U
M.0'WMFC:Y3U'+6JU)K+].G+9BO\ _P#$K-"WGS=(8N[Y])L-IU6Y//%6RZL?
M>? Q[I'0LB21S&I'Y^_ C>5OZ?1EQ5[5,99K7ZUR'NV*C8A2>!SN,C)>[$12
M^@([M&JR9:>GDL=D'T<K31R5[*)S:YKO7'*WX6&!KVUY5V47!;#095R:0K+%
M)$O*O:C;ZW1_R@1/7==QV7VS=ILI$VU6@RO:&K(G*+Q'1MY2.:;7&4:^L]16
M8S',2''Y3&R3.JM\HXYX'>;F)\') (5A<QI67?D<MLE2>]<LVYFQM?2GL100
M,=P8R+BQS38XK9)L+I^ZR46V'5<;+WQ3[$<C%;'8]3>TOP1N FN(Z=:O%C(7
M9/'0Y"[/&C[5JRWQ9))')YKW<>=^)D/4C586,1K&8BZQK?W)P Q,_9Z=OSMI
MEO$?C;)]F-FCAJ/NOC3MV1/A:PT>M66_T5ZB48(;$%2JZVE6O.U6/@CDK\^'
M9P%G:;_PAK?_ $FI]DTTO5+]7^Q?-4_U(!JXO_P+;L-;]53.T8JL_L2W SE$
M[Y7M[M,S(=LOO%&@GG6PT/IEC]]F9.,+?X-[N AV S,^$Z2YK(P=O&AL7O#_
M '/=.K44U?@=-/Q ZLM:^_).AY+D5H6ELK9]?BI)P V&;V6S;U/1ZN6?:@;E
M']LDL4<GC.CK-]^SBQ.7OS RM_4*,N)O:KC+%6_6N0]VQ4;$+9X'.XR,E[L1
M% DNYZMKLVZ:@^7$UGK>MV_2^[/]]P@54YFYR]2M2W#IS5K0-AAB7(LCC;ZF
MHE8#45M>I9OJ1MZ9"-)ZE=E!_HK_ #B?*^'LCGM^'BB&?CL=3U_J.VAC(6UZ
M60Q#YY:S/*))H)$1)&M PM<PV,VS-[3E\S4BN^!E):%.&=.<<,5?R\FK\+CX
MP6 J83JK=JU&\*DFO>+#!W[MB[V$16L M0JO 8FAMN0SN<S5:.XD>2FITJ\W
MOXH(:Z\>Z,7RY/ RJF-K:UO5;#TF<<5FJ%ASJ?KCBF@];F>Q'-4UV#T[5TZ@
M[+ F&J)'4K4):S.'E&]W)5<T"VP   H/\(G]$X#YU*")ST<?QZ;X/Y;/V[RP
MP          .-^I?ZX;?SNA]E&=D!: ( #XR5);6,O5D5$=-6DC1R_ KVJTK
M[!0[$_2K&OV\!/6GK89]5DKI8G1SR)'P;P[. F&OUIZ>NX.G8CX3U\?7BE;W
M1>+V1HUR=T(50TG(6^G^1P5U/1;4MRS-"_DC^#O'66)WO -E5V7=XJ[*UK2Y
MY;K6\72Q684K/7^OR5>Z$W:KE:U7)V7MYH!KLO?RF-B@EIX2;(<G*DC(I6,>
MQ/:B2*G(B&&H9>]NDNQV<2N+A;CO16PO>QTUAROY<Y.'=$1H&ZT+%WL1J>/H
MWX4BGB?8YLY-=VYS.>GFTB]G3\S?P_4*EV2!V4OK+3>YZ=GM1C/7Q]2*K0/:
M]9V_,:Y:PL&K2T)7TG0/FDFB6%B<.*I%P=YF5:P&8GUG0ZK:O^WH7L7);9S9
M_LVUF]I -YN.O6<[@I*M:=L-N.:*S4>[U-FA=R;R-=6V;<>$4$NDV$L^J1Z6
M84K_ +W([EW W>:S>9QUMC*VM6K\#HD7QH)8D5K^Z^]5CU::;1L)DZ5G8<E>
MIQTER=QLT=)CD?X*-;Q[N5OER>!,,GCJ^3QMW'SM7P;,#X7]O8].RE=XJ_NV
M QT&)LZS+DI*K$AK7*\\38Y6-\F+)S5%8H&[U+7LCCZ>6M9)['Y+)V'V+*1K
M[QBJG%D;?W-0]=&QU[#Z=AL?=B\*U! K96<D=Q7DJ^MH$E(%)AMCUG+Y"]@*
ML5_'WI5GLXYTB0R1SKZWPN7R]\!N,;L.R7K\$4FHVZD"JOC3SV(>S$_<UBJK
MC3R4=@UG8<M?QN+=DL=DY&S3012-9-!.B<5<WGV1S7 >F.QN>SFT4<YEL>E"
MKCH96T*;I&R2NDF3B^63AY(;36<3D*.<VZS9@X17;\<M=W)J\V)$C0&(QUZK
MN6W7Y8.->Y%CVUW\FKS6%CT>*^*OQ;]DLJ^'M3DQ$$#)>3?.1DCG*WL T3$Y
M#%8F[!>@\*1^4N3-;R:[NR617-7WIYZEC,CC)MH6U#X?IF=GLP+R1>43V,1'
M>0'GA\':BS&ZOO0<:N2LQ>"O)J^)&D*,<:7"S;?JE!F%?KTV5@K=V4K=>:)O
M*+_E;*DBIQ5 -IKNO9B*+8LIE&1)E,M^=#&[DR&.-G".)'&QTNA<Q6I86A<B
M\.Q!5:R5G)'=G?*T#XT[&W\7'L#;D'!;.>O68O?-=RAF?W8[R)+9=.RM.Z"-
M))6QN6-BKQ1SD3R15 @<^P[S:J2TZNERU[;V*Q)I[<*UXU7_ )^[/-QAW]+O
MP=-8,#0[3VJC87Q]UX)-)',DSD S\QCLQM."BECQLN*R5"]'9HMLO8]'21>W
MPE=[UW=4,>_F=[R>/FQU?57TK4T:Q26YK$3H(>7DKV<55S@,K+:*]=1Q&+Q=
MA(KF)D@GHS/]2S0_U_W/,NALVTR2UJ]W3;<,BR-;/,V>%T#$^%Z+R[J!K8-*
M_&%K<HLM55L%[(Q3TYFO;S;PB1J2L5OFUS5)%JR[/#'/0SD*2NK+Q@R#',XV
MH_@5S._)K_:!N[,$5BO-!*WO'+&YCT]K7)V4KG"S;?JE!F%?KTV5@K=V4K=>
M:)O*+_E;*DBIQ5 -YJ.%RE*QF,QETB3)929CI(HW<V011)QCB11I>-OXREF(
M[</AOGS-VQ'YM=WBE?W:[R E9%]<P^1I;5N=VQ!PKWIZCJS^35YI%#P<!*'H
MJL<B>Q2(]/\ %7<5I.)QF1KI'/%%*V:)5:_MRD<OK:!A:SK-RKAL_K.3K*[&
M>-,RC+S:O.K/Y\?:BL,3$V=WU:G%B;&"?F*U=.%2Y6F8QZQIZFRLD ]*&&S^
M9V*GG<_5CIQ46/3'X]LB2N:^3R=+*Y/+D;>[B[[^H6-RK8.]2'$SP/DY-\I'
MO1R)V E9$]6Q61QN5V^:S!P9=RJS5W<FNYQ\$3EY -[P]_)5< RE!XGHV=I6
M9??-;QBB5>3O?'C;P$N5W)]O*4(Y,;1I)%29+PD;+-,O>216_N1.P$B=J>KN
M3LN!QW;YM&1O4Z&QX#7,EC%HI.^C/,F,Y2M1+$"KRC15\^(&%DLSN^7QUK&U
M=0EI36(G1/LV;,2PQ(].RN3@JJXQM@U;+4<%I57#T77W8;(5I9&>)'$KV0L5
M%7O(!)*6?VZ>W!%8TJ>M"]Z(^=;U=Z1I[>+5),! ]KI;#'M^O9G&85^0CJ5;
M4<K&SQ0JBR]NWG(J&\Q.:V6Q.Z*YJ4]*)L3W>*MRO+W<GJ;V8H&GUC48&XZ>
MWG\54EREZU+9M>+'',L?-?*-KO/R:T^MOTBE;P<RX3%TZ^3KOCLTGQ11Q.\6
M%W)&\@,;:JFRV,CI>7IX)UF6BZ>2U52>*-6.FBX<>3W'A?QVV[5+0JY+%P8K
M&5[<5B=JV&V)YEB7DC$X>34 DV7S6PXR]PJZO-?J+&U4G@GC:]'_  M5CU0U
M.$Q6>R6U.V3+TVT6Q4EJTZ:2)+)V>[DY\KF@;G ;'8S.9V.LVJQE3&VFUF3<
MN[I94;WD^3B;T")ZSB\AC\_N-FS!PBNWXI*SN35YL2/B.G6+R&&U"C1OP>#8
M9+85[.37>3YG/3S:!$+6E9VIO>)GQU='X1,@Z^_W[6K6FD8K)$1JKZGDSVK7
M;]RYC<QA[$<.6I(]L?BHOA3Q/_.BD Q&[7N"(D4NAVUG]K+<"P_YU4D.2N9^
MOCJ,E#$LL6GRQ-L0+,UJ1,?YO=R7LCN(&R(_N6%LYO4<SCZJ-6>Q75(D5>R*
MY%[H@$<SS-BV71<O0_H_/4N+' QD,LL/OW->USN*HXG^0K2S8N]%&WO))6E8
MQOJ\W-5$0"L;.JYY-.TIC*3)KF%EK3S4'O;VE\)G%6([S;R/K:&;?M5"I#7U
MZ6E%!?K3R-L31>++PD3R:C7=D:@$@W+'Y7\8:SEL=0=<7&VY7S5V/:Q[HYHU
MC56\R5T+,T]*&::G)6D>G=T+W-<YG[E5BJ@&FW3"VLUJ69QU9$\>>NJ1(J]D
M5R+R1#29-V>S^CYVD_ 3T[;Z2PQ12RQ+XKW)Y\5:X"9T&20XZE#(WLZ.O&UR
M?O:U$4K"II.=7IYKE)J,K9G$SMM0,>Y',\5CW+P<K._DY% D]+8]JE?! _2K
M4,BO:V>5]F'P6)\+D<BJKB7 :K-9?+8R6!M37K.0A<Q><D$L:.8[V<9%:1[4
M,3E(LYL.=O46X]N16!(Z*.:]R>"GG))P\N3@,;5:V<P^0RF)LX.9]6SE;5EE
MYDL?A>%,O/LYO?D8N&9M&FP2X>+ S93'Q2O=0GKS1M>R-Z\DBE;(J ;/ 8#)
M37<[F<]#'':R<+:[:C'\T@K,3MP5R>MRFLP3]OU&BS#2X&;*U*_=M*W6DC1Z
MQ? V5DBM[*@&ZO8[+9;.Z5DI<6L,==+RW8GR,?X*30\&M7VGEC<+F-7S"08N
M!;.!M/5SJ_-K7T'K\,?-4[Q+[ -CA\7>J[=MV0G@XUKC*"5W\FKS\&-S7GS;
MQ&0DW[&91L/>I%BIX7R\F^4CWM5&]@-'!4V+4LMEUH8=^3Q5^TZVUD,C&3UY
MI/ST[2*G)BF9A<7G<IL_](\S32DV"JZO0I<TD>Q'KW?)(K?+DH'SC-4M6,1N
MN-R,7@LRF6NR1.Y([O%,QJ-?Y&-CLIO='&08A^LNEO0PI"R\D\:5'\4XI*[S
MY@:S#Z'E).G61U_(R>#;?;GEBG547WZ2\XY%X&\J[+N\5=E:UI<\MUK>+I8K
M,*5GK_7Y*O= ,[9,1D;V2U&>O7Y-IY+QK2\VIP:L3FFUV? IF]>R>-Y<7SP*
MD;_ZLC??,7^#D TE3:,E:U[&7J^"GO3^<5Z".5D<D$T7O7^3U3O[Y# PN.S%
M[<IMEMXO\55V8Y:R12/8LTZ\N?.3AY(C0,_2V+=L9S97IY9.PU*OS2NG"-?_
M -?S<2\" :Y!G]<TK%5EP4MNU%/.DU>.:)KFLDE>_DU57BX\:]3.Y3;JNQRX
M&3'PT*$\7![XW6+;I/4WM&J]FM W.AXN[C<&^6^SCD;]J6Y=]K9)5\F?P0CN
MLLV?5*4^%_HS+=5+<\D-V.>)D4J2OYHZ7FJ.:H&1@-<V&IK&YTKT377+]N_-
M#Q>WC*MB%/-OL3D3+#8U\6HXS&78^+VXJ&M.SNB]E2)&.3N@$*P,^XZMCHL)
M/KD^3AJHL=2Y5EB;SB_Y4>V1S>*H61C)KDU&"2Y3]%G<BJ^#FDG#S]7)ODH&
MIV[74V#7;^,9+X4DK6NBE_J2QN1[%(]7V3>(JS*UK3)Y;K6HUTT5F%*[U_K\
ME7N@&PV3%Y')9+4+%>OS93R7C65Y-3@SPG-//?,3D<QJ]VE0@\6=\M96LY-;
MY,G8]?-P#>,9E)X\%<QM);4N-RD5IU='M8Z1B-<QR-5QY9VKF<_0UF=F)EKR
M09^I9G@EDCYQPPO7N]>S@&Y8_*_C#6<MCJ#KBXVW*^:NQ[6/='-&L:JWF?=V
MGELEG]*RRXV2".JMYUMCWQJZ'Q8>#._90,"]C]AP&TY',XK'+D:629%Z959(
MV.:.6%."/9S\E14)5A,ME\@^P^[@9L="QK?"6:6-\DBKZ_>QJO$"%X6/9=/B
ML8B'7YLG02Q*^A/!+&U61RNY^%*DBM[<3+T?";%0SNUY',PQL=D7U)(U8]'M
M3@QR+&G]P">$#I0Y[#;AG968.:W3RL]65EB*6-$AX,2-_B(]4 \H*FQ:EELN
MM##OR>*OVG6VLAD8R>O-)^>G:14Y,4S,+B\[E-G_ *1YFFE)L%5U>A2YI(]B
M/7N^216^7)0)J5KO>J9W)9>"7$Q-6'(U$H91_-&<($E:_G^]>/) )/M^M393
M#TX\8^."[CK,-F@KN_!'P^ICOW*AH;^9WO)X^;'5]5?2M31K%);FL1.@AY>2
MO9Q57. S\SI[_<YLZUCEY/;02&'EY<WL\S$R=#-[;J\M:7%S8F]6E@FJNG>Q
M[5GA7E_R*[WH&56V;<>$4$NDV$L^J1Z684K_ +W([EW)F!"=LQ.59L&O9ZA0
M]/;0;89)41[62=ID1/$CY^7)#69*OM>>SFK9%V$=3IT+ZO?%+-&LRH]BHLCD
M:O9$0#;;73S$&QZ[G*&,DOLJ,M0V((WL9)QG1.SF\U0F-:>66K!+-6=!*^-K
MG0N5KG1JJ>;55O=%5 ([OF'O9?5;57'QI)9;)!-#&JHWFL,K9.)IMACS^SZT
MUC,#/4G;DZCT@FEBY+'%(U[G]VN E.S4+=[6<[4K1\Y[&.LPPL[HG=\D:M1.
M[B*Y?6<Q-@=6FQZ1-RV%2"1L,B^\D5(N$D2N0#;4MEV6S8KPRZ=;K(KT2>:6
MQ#PC3X5;Q55>2@#2YW,Y_'6HDI:Y+D:SH_?R0S1L>Q_?U<'JG="/8S&;!F=K
MH9[*8],=6H5IHZ=596RS/?/Y/?(K/) (U@;6>QVU;Q<I8U^0J/RGASUXWL9*
MQ[8VJCV<^R.)1AL?FLCL\VQY6DM%L=/T6C45[7R-:YW)\DBL\N[@-?BH=GTV
M6_0@P4N4Q<EN6>I+7DC;+$DR\EC>V16DJL4KFTZUD*65Q[\=Z4Q\21+(R5[6
MJGO7JK ([C,QNV(IP4,AJL]^>NQ(X[=6>+PYD;Y(YW-S58IM[.*R=C=->RB5
M.->#&VHYUYM]Y)*K51@$>P<6R:K8S%)NMS9!EO)36H;D$L3$>DR^J;FJ*BM&
M(UW9(L?OR9"M%Z1E%DDK\'M5CG20<>#?D7WO=P$[URM8HZYA*EAG":OCZ\4K
M>Z+V>R-&JG=#7[]C+V5T_-4*4/BV)X.,;.2-[KR3X7 ?&RX"SEM3=2B[,NPQ
M12U7?U+,'9S#YT?#Y*AC;-O+1M9E,C:DLW&HJ.1BN\F1HJ*ODQJ 1_ Z;=ET
M#)8#)Q^C2VIKGPM?Q2217L=[T]\;G=WH4H*%[49[=J%B1I9KV(4@FX^7/N]4
M5H&PVW"9K*5,)DJ#(H\KC9VV60/?[Q_)O&2'D>M+9=ELV*\,NG6ZR*]$GFEL
M0\(T^%6\557@>&Y8_*_C#6<MCJ#KBXVW*^:NQ[6/='-&L:JWF+M/+9+/Z5EE
MQLD$=5;SK;'OC5T/BP\&=^R@9F'Q=ZKMVW9">#C6N,H)7?R:O/P8W->?-O$9
M"3?L9E&P]ZD6*GA?+R;Y2/>U4;V U,>/V76LWF9L7C&9+'Y*QZ4L+9V0RP6'
M^3U]_P"2M<:?769B7JC?LY1(F3OP"=Z\3N:5V.G]Y'R^%P%IE?05-BU++9=:
M&'?D\5?M.MM9#(QD]>:3\].TBIR8H&5@\3G,ELW](LQ32DV"JZO0I<TD>U)%
M[ODD5OER4V.)P]^ONVQY&2#M4LU*3().35YNB1W("3   !0?X1/Z)P'SJ4$3
MGHX_CTWP?RV?MWEA@          <;]2_UPV_G=#[*,[("T 0
M                                                   >%/&T,;%+
M#2@;$R29\TB(JKRDD7NYR]SW                                #SKT
M:E::W+!$C%L2^+-V5>SW\4;R[?(A]VZL%NK/6G:KHIHW,D:CE;W:Y.RIW;V4
M!%%'%&R.-B,8QJ-:U/)$1/)$0_0
M    U.%P;,3<SEEME9/QA=](5%;VX>\1G$VP               &BR6&V>:_
M/8Q^T+5ADX]J\E1D[6=D[+Q7NU1@]=BQ#[MF6Y-=OW'-6U;E[(Y_#R:QJ-\F
ML:!O0      *#_")_1. ^=2@B<]''\>F^#^6S]N\L,          #C?J7^N&
MW\[H?91G9 6@"  P-@SE/7\-:R=IKW1PHG9C$[ND>Y>+6I\JD<JWNI+W03/P
MF'B@>].4"VI%L,:OM7AP[@22]FJF.R.'HS,D67(RR1P\43BWPF+(Y7&<   C
M6B9F[EM5Q]^[(DEB1TZ/<C4;WX3/8WU -[R=[":EE<C2E1EF%L:QO5J.1.4C
M6^IQ)0  C.S92]C<KJ<%:5&LNY-89TXHO)GAN<28".;/F+]#+:G7K2HV.[DE
MAL)Q1>3$C<XD8   !C9[.4\%CG7K39'1I+''V8B*[E*]&-,D  (UL65O8_-Z
ME5K2HV*[>DBL)Q1>36Q*XDH  ".:UE[]_-[96L2HZ*E?CBKIQ1.+'1(X"1@#
M%SEB6C@\O:@>B3049Y(U[=^+F,54&MW+%_7<+<L/Y36,?7EE=V1.[Y(T<J@:
MW<<A;QFJ9J_3>C)J]5\D3NR.[.:;O'ROGH4Y9%[O?!&YR_O5J*!^@#"@S5-^
M>FPR,D])BILLN7LG!&/=P3^)F@)98H8I)97M9&QJN<YR]D:U/-54A.G[Q/LF
M:RU5<=X%>"&*:K(Y??RQ2JO%ZM^#D!-B$V=GSUS+W\?KF)KV?07(RU:M3+%$
MV54[^$SBBJK@-UJ^RR99U^E<HK2R5"1K+5;ES3L].['L=\+'&EL[/GKF7OX_
M7,37L^@N1EJU:F6*)LJIW\)G%%57 ;K5]EDRSK]*Y16EDJ$C66JW+FG9Z=V/
M8[X6.-X       $0V;8\UC,U@\1B<?5LSWX[#^\\JQ-3P$1?@138X:UNLMQ&
M97%8VO6X+[^"PZ1_+Y%:@&^  P?QU39GX,+PD6Q)2?:1W9.'!CT9_P!^Z@9P
M   '<D:[BB*[MY(H%9YO;-_P5.&Q;P&)X/L10-X6WJO.5>*?\A*\7;W>269N
M2QF-K1)"[@^&P^5?$^!%16IY ;K%+E$QE5,HZ!;:1IXZP=_#5_\ [O?X#W
M       *UP.V[]GL9%D:&!Q2UY'R-9XEM[7>\>K/5P+*H/NOIP.NQ1QV58BR
MLC<KV-=[&JO;N@&+EF9E*;?Q4ZNECQH^2S]^/A\O?]NWP]O490$<VS*7L4W7
MO1)$8MK.U*TWDCN44O?DTD8    GGAK033RO1D<3'/>Y?4UK4[JI#-'W>;9)
M+T%K'>AS1,AGA9R[\ZTZ=V2 3,     ^;=F.K5L69._APQ.D?V]?9B=U _<1
MDH,KBJ&1@:]L5JNR9C7^3D;(G).XLR215YI(X72O9&YS8VJB*]43NC4[^T"
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ME1*]U;WI#>*+R\&+FT"0   !0?X1/Z)P'SJ4$3GHX_CTWP?RV?MWEA@
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MEBG#P9.]D79TZ>:L3RY&;LGI.M86AB,-;LI;RN396BL6)76'PI)YO?WD]B-
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M/DHGPO>Q6I(U(6IW8 92MIU-L6_1I4K+KD423\5X<TL.7AR(;A%@U!U[$9G
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ML](KRQ)-L=N6+FQ6\XW-9V>WVM/BA3N,ZCYJTZM*E=^(JL9-P5(W/:]W=J.
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MOU+_ %PV_G=#[*,[("T 0
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MQ^;>;Y.W9H$X       UV1PE"_>Q-N?FZ3'ROEA1%[,YO;Q[N3X>WP ;$
M   +D#+52Q7>]S6S1/8KFKV<B/3MW0\<7C*>)QE/'U&*RO6B;'&B^:JC?A4#
MV                         N0,M5+%=[W-;-$]BN:O9R(].W=#QQ>,IXG
M&4\?48K*]:)L<:+YJJ-^%0/8 15VOYO([%2NY62DE''S2RTX(.;GR2.3BQ\R
MO[>;&DJ         ,*?"T),[!F'\UM0U'5XT[^\8U[N3E1/ZRF:
M   &-G\)1SN,DH7ED]'>^-TC6+QY^&Y'HU?W=T,D         %!_A$_HG ?.
MI01.>CC^/3?!_+9^W>6&          !QOU+_ %PV_G=#[*,[("T 0
M #6;)E7X37\GDXX4E6K7=+P5>R.X@>S,I;67!LCQSY(KL3GS3M7WE?M'S3E[
M>2^1F@          ?DLL<,4DLCT:QC5<YR^2(B>:JI^5+=:W5@LUI6R0S1MD
MC>WU.:Y.Z*!]        /EE^BMY]!L[%LMA25T2+[Y&*O%'*?0
M \+%ZE4?6;9L,C6Q,D4*.7S?(OFC4 ]SPO7Z6/KK/;G9#"CFM5[U[)R>O%$_
MBH&MVG./U[%QW&0-F<ZW7AXN7MY3/1G<W(      B-W/YQ^R2X?#TJ;W5JL<
M]N:S(YC6I*JHUC$8BKR EP
M
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MG;E[P"W0
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MC:<EKBBKQ@F@2-TAD]2=MP4FE9.MC[U>[/<K+P9!(DB\/6^1W'U-:@&RO?\
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M=NY&E7M(^Q1<QMF-$5%C61%5OK/4
M
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MNH!D$$<DLC(F-?)VYN1J(KNWJ[J
M
M             !0?X1/Z)P'SJ4$3GHX_CTWP?RV?MWEA@          <;]2_
MUPV_G=#[*,[("T 0
M
M                                                          H/
M\(G]$X#YU*")ST<?QZ;X/Y;/V[RPP          .-^I?ZX;?SNA]E&=D!: (
M
M
M                                          4'^$3^B<!\ZE!$YZ./
MX]-\'\MG[=Y88          '&_4O]<-OYW0^RC.R M $
M
M
M                          *#_")_1. ^=2@B<]''\>F^#^6S]N\L,
M       #C?J7^N&W\[H?91G9 6@"
M
M
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M![             !JL)L^OYNQ<K8V^V>6JO:=B->WBJJJ>?)$ VH
M    #YN7*M"G8N6Y$C@@C=)(]45>+6IW5?(Q\'F\1FJ'IV-M-L5U<YGB(US4
M[M]:=G(@&4   6;,%2M/9L2-CAAC=)(]?4UC$[JJFNI;#@;6)LY:MD(I:5=L
MCI9V=U:U(DY/ \*>VZU9PEC-09!CZ$"N22QP?V;Q]?DJ=S:8?-8S-T([^-LI
M/6>KD;(B*WNK5[+Y.1 /G*Y7&8/'RW\C92&O'Q1\BHJHG)>*>31C,I1R%""[
M2G2:"9O*.1$5$<GJ^'LH'L         #72;7K\>>9@GWVID7IW;7XO[JG'GZ
M^W;U&Q P:>Q8*?*SXF#(0OO0HY98$7W[>)G   -?FMAPFNU8K>6N-K122)&Q
MSFN=[Y45>WO44#85YHK$$,\3N4<C&O8[VM<G=%               -7D=HU[
M$9*CCKUYL5NVK4KQJUR\^;N">I ,JYL>#I92KB[.0ACNV$:L,#E]^]'JK4[&
M4       &-DLC2QE&Q=NS)%7A;RDD5%5&HJ]O/B>F'R^+R^.BOXZPV:M)RX2
MHBIRX*K5\G=@/#+9K$X"CZ=E+25X.:,YJUSO-W]U%,NG>JWJ5>Y5E22">)LD
M3^RIR:Y.Z+Y@?H    ,+';#@[]^YCZ>1AFMUE<D\3%]]&K'<%[F:   ^8[-:
M21T;)XWO;WY-:Y%5.WM0#3['NNL:SX+<MD60/D3NR-&N>]4]O%B*;G&9&ED\
M?6NTI?$KSL1\3^*MY-]O9R(H'Z        _)I8H(99I7<61L5[W>QK4[JI@Z
M]L.$S]:6SBKK;,4<GAN>UKF]G=N_;WR(!G@ :JAM&NW,Q;Q%:^R2_61RS0\7
M(K."HU?-4[ 9&.V'!W[]S'T\C#-;K*Y)XF+[Z-6.X+W,T    &+<V/!TLI5Q
M=G(0QW;"-6&!R^_>CU5J=@,H   ,#+YO$X6LRQDKD=:!TB1H]Z]D5ZHJ]@,Z
M&:*>&*:)Z/CD8CV.3U*UR=T4_0     !JK&T8"EFJV&LWVLOV$:L,'%ZJY'>
MKS1.P&U   #4YW:,#KT<#\K>;6CE<K6.5KG<E3^ZB@;9JHYJ.1?)4[H?.5S&
M,P]1;>1MQUX$<C5D?ZN[@%2Y5NU8+5:9LL,K$?&]OJ<UWJ4^@    4'^$3^B
M<!\ZE!$YZ./X]-\'\MG[=Y88          '&_4O]<-OYW0^RC.R M $ !'=P
MTG!;9%39E?'[5G/6-(G\/-YS)0T' S]6+NLO\?T")K^/9_O_ "B1X$_ZDZ=B
M-3Z;W*F,\;PILG!*[Q7\UY##=8,3@]8P59N(OVXZM&O%8LQMXQ,DX>;$50+/
MS&PZYE] O9>2*2UBY:JNDB:O"1S4=V5AJ=3V;4<3T]9EZ=::CBXGR\8I'+(_
MES UN&ZNQY.W2C@U3+)6M6&0LM\.\?=[N/=2UP*]S_5/ :WL3\->KV45L'BK
M.WBK?-G)&FIQ76G"V<O7QM[$WL<L[FI#).GE[[U<@)1M>\XS5+>%@N5Y9/QC
M*]C'LXHUG!6IW?W_ +YC:EU*PFRW<O#3@EBKT8O$=9E5&M>P",6^N6&2Q8;C
ML)D;]>#_ 'EF-O9A.L'O.+V#!6LKB(IK*UV*LE3R;,CD\^ &MUKJ?KV>Q.6O
M^_JICT5UB.;MS1GP./'%]2:U_5<GL4.$NMJ4_@<K.<J-_/5G[F@274-LH;5A
M692HQ\<:R/C>R3MR8YAK--WVCMT^391I3LAIO1BSOX\)%7U<0)81'<^H%#4+
M.,CO4K#XKBJC9V<>#.*IWY 9&Y[GC--QE>];ADG\:=(F,B[<O4KNY[8#<,5E
M]6?L,+'Q5VQS/D:_MR9X/?NB@5;NFWU]NZ29S(UZ4]>%+4$34E[=W<96&KU;
MJSC-?T[#4V8J]=6K!VM31-[11*YW?BK@+QP6U8;-Z^S-5IN%3@YTBR>]6+P_
MSD>5C)UOQ/>>6GKV5M4(7=I+C&>\ L>/<<39U:QL=1SIJ<5:2;LGD]?"3NYG
M[G%<)URPDE%DU+"Y&S*B*Z6)C47P6>U[@+"T_=\3MN+?=H(]CHW\)89/)['&
M_N6&5*=FPYJN;#$^143UJC$[@4_%UUPEFEXE3#9&Q9YO1:K&HKFL:B+S<331
MM_PFX06/0V2PV(.WC02^M$4"'S=;M:JUK[WT;?C5[/@,A][WE<2W-]2<!@L!
MC,K>\1'7JT<T%5G9TKN;$>!%<=ULPC[M>ME,1?Q;)O\ =33-]X2O<][QNG5*
M%JU5FG;:>YC/"X^78"'7.N>"J6$X8;(R4/$X-NHU&L?^]A:+]DP<.O?CUUMJ
M8]8$F\;VM4"JV=<<8G&R_7<LS'.DXI=X)P)UL&Z8K"ZU%L'%]JG*L7A^#V[N
M24#38;JM@\QLM#!4:L[GSP\WS+V1D;DC616%6])\C^+,EU%O^CR3I63Q5B9^
M>Y&/>!>>D[EC=OQ4MVE%+$D4ZQ/BD[<D4P-7WW';!FLSCJ=2?C0<K9++NW!Z
MH[@G$"8/>QC'/>Y&M:BJJJO9$1"H)^M6)2>S^+L#DK]6NO:6W$SWB 3.+?,7
M/J,VQXVM/<KQ><T+.R3,X_G=T7^J8E/JAKMK3[6R)S9# Y625W=O%23X& ;/
M%;ICK.J+L=NO+0I(UST\;MS<Q/)'=F^T@#.N.,3C9?KN69CG2<4N\$X 6A:V
MC!8_7?Q[-<9Z"L39&RM\^?/U(U"NL#U@JYC)4ZU76LGX%BRR%+2HG!JO7CW<
M!*Z^_P!";>)]4;3G2Q$WDLWEX?E&DA\9_?L=@,_A<//3GEER+HVQ/9QXLYR>
M'Y@4[U;Z@Y6&]#B\<W(T6P69&3RI[QME/+MP<7)A=]QMS 9',W*=O&UJDG&1
M+3.+U\D7NU (4SKCC$XV7Z[EF8YTG%+O!.!9N4V_!XW74S\MGE1=&U\;V>:R
M<_S6M0"E<YUAQ6:UC,U'X>_4CM4IXJUE[>43Y.'DTEW0K_@*+Y[.!:9H]QVN
M#5,0N3GIS6(6S,C>D7;NWGZE\P/B?<\9%IZ;/PD6KZ(V?AY<_?\ EP-=H^^X
MO<JUUU&":!U9[&O9+Q[^_ U*[_@L_5W6B['69:>,IV4MO[HC9F(CFJUAH\+:
MURUTDVB3 T)J=3T2_P!XI7\W<_! ANI_J'V7_$L?_P!!9G1/]7F-_P :Q]JH
M5Z=:?U=9C^_6^V85UJW5K&X#4,12CQ-ZZM6MVM31-[11*K@B\->W'!Y_!+F:
ML_"M&CO'\7WJPJQ.[D>5K)UOQ/>>6GKV5M4(7=I+C&>\ M?7LSC<[BZ^3Q\_
MB03)Y>796JGDK7)[4-7MNS0ZKAERMBG-8A9*QCTB[=V\_4[S S,=L>-MZQ'L
M#%5M1U-;*\NW)J-3NY%([@>I&$R6M7<_/!-1HUY%C5\W;N]4_J\0(8SKKB&]
MI_Z/93T#GQ6WQ0F.;WS'4]7JYK'06;\5M5CB=6;R=&O%?-R+ZN(%5=)>H>3G
ML2TLI#DLA->O,1+7Y\4)9&Q]4<5A,NN(JXZYD[[4[R0U6\N &ST_J!A]I])K
MP0SU;E7SFJ6$[/(WFNL.&Q>:FQ5/%W,E8A<K9E@3R:YOK1 *VQFPT-BZX8;)
MT^:120JBLD;Q>QS*ST<UQT^!56 O:?)U1S5>GB;,68:R5;%MTJK&].[>_9O(
M]+O6# 8W,93%34;KK%1>+."(Y9Y.Z(C& 9>J=5\3L.9=AIJ%JA=5%X1S_P#,
M6,!R_M?4[*OW+"^CU\K6IUIHUGI=N#K2QRFXZP9U,]T[PF12E8JI)ENW@SIQ
MD3@R1H5N8>M.&Q>.QD3,1D+%6&O##)<8SC%S:SLJ,Y%O?THP3-<;GEMM;CUK
MI,DJ_P!5?W>T(JQG7'&)QLOUW+,QSI.*7>"<"XL?<J7Z5>Y5E;+!/&CXWM]2
MM<!%]TW*EIN.K7[E6:=DUA(6LB[=T7BKB$7^N.!K3QK^)\C)2>_AZ9QXQN]O
M #[RG6O 47KX&+OW*?/B^[&WC%R]C5<67+M.)9K*["USY*7HOI'O&]WJP"L'
M=;:=9(YK>JYBO3>[LEE\9.-@W3%X+6X,^L<EJG,L7#PNW=Z2^:+Y@0BYUTPL
M,44]?"Y&Q6X,\:PUJ-CC>]._ GS]RP_]#9-FKI)/3;!XO%OD_P G<5:! ']<
ML)Z!#8IX7(V>S%?91C4XP?WW%CZCM&(VC$MR=!7HWFK)(Y/)T;T];7 0._UH
MQ3+UJOB\+D<G'67M-8KL]XA-]?W;"[#@I\O06160,>LL+D[2,<QO+BH%>R=>
M-;3'5K+*%MTTTSF)7[M[M:W_ )W%Q 5SMG5/"ZUEF8IE*S?O]DYQ0?\ )R*7
MV?;*&S[]HUBM!/ ^"W6BG@G;Q?&_T@*MO:KVG1=2]<KW\39FRSXX/1;3)%;'
M&BROX\FFYS_5#!X'89L1?AG9X57QW3IV5G;CW1H0Q'4W"Y'5+VQ3LDIU*]AT
M/9_9SW*B-5.W;V\B*P];L4G@S6=?RM6A,_BRZYG=@%L979,-BL(_,VK;4I)&
MU[9&^?-'_F\/:JE98'K!6S&2IUJNMY/P+%ED+;2HG!JO7CW<!7&U]3LJ_<L+
MZ/7RM:G6FC6>EVX.M+'*7E[H.(@U)NQ7X+-*%SW,;7E9VF5Z.5.*- A]3K9B
M4EJ^GX')T*EAW:*W*SO&6)LVU8C6L-^-+\JK!W1(F1]G.E<[S1&@4?M?5O&Y
M_4,O1DQ%ZDMNOVJRRM[Q2JCBR.C'ZN<+\MG[=X&MZ[?\!R?/8"+8;K!B<'K&
M"K-Q%^W'5HUXK%F-O&)DG#S8!=&.V?"6]=;GH[2-HK"LKI'^7!&>M%_>A5WN
MWXKL^RS7,M)CVOX+=X)P GF3W/$4M2=LT7.S21D3F^'Y.=XCTC^$CF+ZNX#(
MYO#8FG3L/FO,8KWJJ<85>WFC5 9WJOBL;EYL30Q5[*6H._CMJM[HPD^F[YA]
MM@L+49-#8KKVGK3)VD8!$=)N:A/O.V08K%6:V1CDL)<L/D5[)52?L[BG(\$Z
MW8%[[L,6)ORVX9O"CKL:CWR@232.I>'VZS:IQ5IZER!O)T$Q-P!SATRG\#J5
MO\W!7<$NOXI^ZR!"LKME+*=3Z>7N8"[-6CB:GXNDB1TKN$2]O>'7.!MUI\'C
MIZU):D4D#7QUE:C%B1?/BK4]0$1VOJ%A]4RN-HY&O.J6V\O&;VX1MY<55Q%X
M>M^"COP0VL/D:M:=>T5N9G%JM_K@6?LNU8;6<6N1R4_&+NC8VM]\^1R^IK$*
ML@ZZX?Q8'WL%DZM.9>T=IS>[0+CJV:UNM#9KS-DAE8CXY&KW1S7>:*AH=PW3
M#:=C8[5_Q'+*Y60PQIW?(Y -!JO41^?R45!VM9.BDL;GLGF9VC5&FQQ.^X_)
M;?D=9BJ3LGIMD5\KN/!W!40!E=_Q^-W#':S)3G=/<:Q62MX\&\U4P-PZDX+4
MYH:L\4UJY*B*RM#ZT3VN 8O<W;1@-DYX:Y0=7I/][83MSYL=YM*3Z5[]2UC6
M;]?T"Y>MRWWRI!79WXQ)&Q.;P+_TC>\/N-*>2BR2*2!R)-!+VY)R]2DJ IZ?
MK=@X\C8K4,/?OQ0KVELPM(=TSR=/)]7MER%5ZN@L4[$D:_N=+&%3[2;VH6-Y
MVR'%8JS6R+)+'IEA\BN9*J3]G<6\C%FZWZU5K9![Z-OQJ]KP&0^]Y2N")-G.
MI."P.$Q%^Q%,^?)5XI:]./WTJH]J.-;KW5?%9#+P8F_BKV+M3]O 2TWLD@$@
MW/>\'IU2%]U7OEF[^%!%YO?V-'@NJ*Y:+)R.UG)UTJT'VV\V_P"^1G_(P"GZ
M'5/+)O\ ;NS5LO-2;$]L.,1/?Q<D3S5A96>RVG2[_J?IV%MORUFK5DJSI(K6
MPH][N+7MY 2_<M]P6H10)>\26Q-YPU84[O>1C$=9\+:R4%#)XR[BY)NR1/L-
M]X!(=SW[%ZA8Q4-ZM,]MU7]GL[=F<%:BJXB+^N>!@M0I+ALE'1E=VBN.9V:]
M/ZZ- N&&2.6)DL;T<Q[4<UR>:*B^:*A7?5>SJ]+6Z;]AQL]VLM]B,CA>L;DD
MX/\ ,#99G=]>U/5L3=GCE2*>M$VI6;[Z1R<##U3J*_/9.&B_6<G126-[V3SL
M[1JC0)\53+UHP<=W*TDQ=^6W4G=!'!&U'NF<QRM7@!CX[K;K5FI:62A>BN1/
M1C*/'G),[V,-_IG5#%;1DY\7Z#9HW8F*](IOA1H'CL/4F#"9BSB:^ R>1LP-
M8LRUX^[&\V\S;:7U#P^VK<A@AGJVJOG-7G3LX"/[+U9P^#S2X>OCK>0ML\I6
M0? XJFSLU#9NK^IWZC)HTXPQ2Q2MXOCD8Y_=J@7;MO4;$:O:KT5K6+N0F3NR
MI73NY$/+4>I>(SV3DQ4M&WCLBUJN2O9;Q5X$]#EXM<O;U(!RQE.J65FWO%68
MZN7AH0HUSL9VXOE=V=Y\3:=:LHW+:CJE]M6:ND\\SO!F\GL"IA/UOP=%]=OX
MHR,E+ND:7N'&-ZIZ^!)>H.4U5^D1W\G4EOXR9\#V,A?P<[GYM<$>B;CK&M:+
MALHL4T-)]:)*=7\^7S;Y,,/6NI[\]E*5)=7RE6.UR\*S(S_9=FL5X%C   !0
M?X1/Z)P'SJ4$3GHX_CTWP?RV?MWEA@          <;]2_P!<-OYW0^RC.R M
M $  .=\1_P"D'E/[DGV" 33KM_P')\]@/..E6BZ&.C9$U&NP"S?*]S.8$*UA
M57H)G$^<FXTG6*^T=&Z^*ELK LD\KHY?7Q>R8"/PY_>>F%_#X;*S5;V+F=QA
MX?G-CY>?$Z5 YJVQU!O7?$K>X)!WK=^?JY</>&P_"'=3=%KK&]EN^)+Q_K\
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M17*UB=O/MV([KNDX+3I\WE(+=I4M(LMA9G-<UB,[O7CP:@%#;TN"Z@[]@*V
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M<3I62<H7-1W=G]Y'&1_1B@NK?T<\6?T3T'T3GW;XO#CP[]^W;D!K\!J&&P.
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M0#7XW&Z]BWOKT*=&DZ1>[HX6,C<_Y4:; #\98KND=$V9BO3UL1R<D/T
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M(]K&I\+E[(&/9(U'L<CFKZE1>Z*!^@ ?/IU!+"5EMP>-_P"Q\1O-?X ?0
M                          /Q]BNQ[6/FC:YWYK5<B*OR'Z
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M\GCH[]"Y%-5<U525J^7EZ^X$'?U:Z>5["UW9Z-7_  N9%*]G^9&DZ145$4
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MVZ!OO'2-98^6+^9ADV>&Y]9JD<:I)C\+ R3VL5S??_ZW 7Z<^VF)J77""?\
M,J9J/^'*;R^T:!6^4Q]K-XK:MZBY\X<[&M=WLB;_ /;DPG^>R,.\[[H=&'SJ
MQ5(KTZ? BR=I7- R-]_7=IO^#4^VD&;_ /2!PO\ @L^Q> S?_I X7_!9]B\Z
M# Y?Q.$Q>:ZX9R#(PLFACEGF2%_FU[VF1U$QE#7.IFI6L-!'6DGDA=)%"U&-
M[^+P \MZM7+76%(5PCLNE.M&D%!7\6O[Q<S[LX_;;NYZ]FJ6A2XA:UB-+"Q.
M:K9&<OW(P#IHYYWUBZAU4P&RL3C5O*C+/V<@1FXUO]+NM5Z[^?3P4?!GLYL\
MO]9HNG]"EM/4O:K>;A99DKNE6&&5.3&]I.'J7^H%-]H4M5ZFZK:PD+*TEAT2
MS0PIP8O*7AZD_KGWU@Q.+K;EJ"04:\:69^4_&-J>*KIF^;P-[UR9#A]/Q^/Q
MU:*K6L9#O*R%B1L7BTBN8H9K*:NS$5>E2UN+&+!<9(UTC53_ )N_!.7(#%ZF
M3YV#I[HM#),FAE7QDLLD]L'9C.1/^I>CZI1Z=3RU*%:"6BR%8+#&HCY.[D:O
M)WK=R E/1C]7.%^6S]N\P.NG_ ,_SR 'J%[I^HK7O\.B9L6F:[%T8DLKC8'6
MGXA;JV58BRI+QY^3P)/T1LR.T"JCW*O"U.QA*MYR^"PVKW+&9@=/5E[1+ WU
MRJ_U,"*%VV;)9/2+-IG3BCC<;PCD@MI+$R5C5<G%R-1&N-ELN3O,Z#X#@]_^
MW6&"7_#8KOY JR= U#5:^GX*=,73GGGJPV'SOC:]ZRN3GZU*NPN.I[-UKV%F
M:C2=E59UAAE\V+X+TC8!9'5-D&OZ!F%Q%2&FMF2)DJP,2/R>O%RKQ,3IOHVI
M6]!QS[&*JV7W8%?/,]B.DY*OP."('T@MSQ5-\Q3)G24X()'Q?+V>P\.BFGX'
M-XW)WLM52UX,Z001O5>+/+FY0K(2C4V'KM>JY:-LT%=JI% _S8J11)Q:8'5O
M 8;$[EK,V.JPUEM.8LT42(UG)DB)R M#J'LV!JYS$8I=:3-Y;BYU6N[MPC\4
MJ78W9BKONF7+FLU<+.^Y#V;!*Q_BM25J>_2,#?\ 6RFR_N^GTY/)EA&1.^22
M;B>G7+6<#B,!A+&.QL%61EOP>43$8JLX 8G6.Y9NQ:'1GG<RM9A;+,[VO=P;
MR.@L;J^MX=M;T'#U(9(&JV.5L34D\TXJJO\ 6$<KZ-DLI/EM@RB:4N?LS6/?
MOD>G^PYJJ]NSFN+#Z98C9:&\Y>W+K<^*QEZ!R^!WY1L>BHJ!5[VZD%NK8K3M
MY131.C>WVM>G94.6=1S\^GX/J-@K$G&>FU[J_P"][U]' Q]<Q;])S_3O*OY-
MCRU566>_MF=_]GM)WTZ8NQ=2MOV5WG# Y:U;_1_H8!JNFT,$_4OJ'#/$R6)[
M[C7L>G)KD6R8>O87#2];<Y0DQM1]1D4O"NZ)BQ-[-9ZF@>G6C'06MSTS'\>$
M,S(X.S/+BQ\W ]^N6LX'$8#"6,=C:]61EOP>43$8JLX =!XV9\V(QTCW=W/J
M1.=\JM1>Y3G7S'8]-6AO)3@2VZ_"Q;'!/%5O!_ER"1-<-BL72Z?-FJ4*\$L^
M 8Z9\<;6.D7P/6Y4*EZ$ZM@LCB,Q?OT(+3_2? :DS$>C6(Q' .D;UQ>S;_5K
M>4-9LJQQ_P"#(Y&D1Z<W<GX&6NLT9,_/8LKXUI[V^\[^:M[.8X*L[I%A]BQ>
MQ;"MK!6,;C[;/%A@>O)C'H_R8A=]]W_@[2?_ )#_ /2$<?=+],R>RXS,.J;-
M<QC8I&,='#RX2\D];^+VEC](+\6'V'-ZC+0K-M0*]RW8>7>?P5X^_P"05HND
M.,Q^T[)M64S<$=JVQ[',CG;S1JRN<?>:IU-7ZUX!F$B2!EM($G@B\F=IWK&\
M"69S9\9<W2]0PFDQ9O+0L2.Q/,K&LC2/X$YD1TM+M3K1-%/B8,7+-4?XU."1
M'QM[QH_RX 8M+ 4<_P!;,]2OL62JR66>6'X)."(C4<9G6:C4IV=-P%5B5L9S
MD=X;?4U9)$ W_6+3-8QVDLM4L;6JSU9XF1/C9P<]KO)6N+*Z8?\  &N_- (!
MU[O7*FJ4:\3E:RU<XS_(QO+B;E="T[W/?!_%E7]%+.MS@WQ>?A<_$Y@07ICX
M>7Z9;%!D:L-EE#TE:BS,1_A<H>7O.1M>@6,QDNMW+\U&N^U#E)$CG=&U9&)X
M3/4X"]SG?H_^L3=_[T_VX1L_P@K^/9KV,Q_=BVGW4F:GPM8QCFFGZH5K%7I!
MIL$Z*DD<M)K_ *L\*R^KWZJ]3_QJ7_TKR88#5\1KNDKFZM1'9=,)+9?:\UD=
M))$LBA/%-=.K%^'#6Y(>GJ9Q;,[TEN22-^C[.8XDVHU-MUG5^H+YL79H0NJO
MGI,?Y^$[S1>*A6ZZ):KKEK59LG<Q]:W9EM2,>Z=C9>#6>IJ<C<=:L1BH]&EL
MLQU=D\3ZT,4B1MYLC1WDQK@>F(BKX;H^N6QU*O#?7!JJV(XFME7][G&DZ,:M
MKEW4YK]W&UKEFQ:E9*^=C9>*-"-;TV1,+U8V7"4'.] [3^\]:-6-QH^EVK8K
M8=NV?\:0)8KU)GN9 Y5X+)+(J<E E'4?1,]%LF(S>&Q$61I4ZT$*47>_XM@]
M3>'PM)KTSW/!;#+D8*V"BQ>1B:STJ)C&MYHP"RD1$]2(AI]Y_P""]G_Z3;^R
M4"CNB^FX+(Z_+ELE4;9G;<6.MS5>T38NS_(CB7LA9ZJ;1;_HNN=FKS2Q1UWO
M1$A9&[@C^RHX*D>M8O:4ZF4LU%ITV'IS,=%;B8J.C\VF%A<=3V;K7L+,U&D[
M*JSK##+YL7P7I&P"R.J;(-?T#,+B*D--;,D3)5@8D?D]>+E7B8G3?1M2MZ#C
MGV,55LONP*^>9[$=)R5?@<$5]TFMSQ8[J#BF2NDIP597Q?+V>PS.A^KX')Z[
MF[60H069)+*UD65B/XL1B.]Z%:[H1KV&R4>>M9"C!:6-8HHF3,1[6\^_(W?0
MYB5]EW6G%Y0,E;Q9_<D>T%]:?HUKV(RVR[7/?I0V?1G<8V2LYM19GN/+IKK.
M&M]3MIKSTXI*U"6WX$#V\F>4_!H&XTFM!C.MVQ4J4:0U_ F1(F>3$3WCR&Z-
MDLI/EM@RB:4N?LS6/?OD>G^PYJJ]NSFN L/IEB-EH;SE[<NMSXK&7H'+X'?E
M&QZ*BH1GI]@,7F.J>VR9"O'/'4LVY&12)R9S=/Q V5>E4PO7ZO6QT#*\$T3N
M43$XL]_65QC:]0I;#UJV9<S$R=M5;*PPRIR:O@O;$P#!WO XC#=6M53&P10,
ML6:,LD,?DUK_ !^)9.\;-A6;72Q4&J-SF;9#VC8_MPB1_O\ X>0%:S_C.IU9
MU2>YKU7#3S.9RAKRL>U[7*YG->!LNL&*QE?<=/2*A6C])GY6.$36^*KIF]^8
M$TZR8^C0Z=SPTJ<%:'TV!4BA8D;2#;[D;E;H[IE:%SFQ6HH&S?O1D?+B!9"Z
M!ION=K'^+:OEBO']+X)XO/P^?B\RK-1R-RST5W"O,]SHZKU9#^YKN+N($JZ6
M:9KMWIW-;N8V">>[Z1SDD8CG,1BJQ.!I.D-"YFNG^XXB&?@Z9_"+V(Z2,#28
M:_/T_KIBMLT>":K-.[_QO!CW._CYH\ZN@LPV*\,\+N4<L;7L=[6N3NBA'Z
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M$3^B<!\ZE!$YZ./X]-\'\MG[=Y88          '&_4O]<-OYW0^RC.R M $
M!A9K7\;GL3/CLA&Y]>;@KT:Y6JO!R.3S0^\7C*6'QE;&46N;7KMXL1R\E1._
M?UJ!E     AN>Z8:GL&97*Y&O/).J,1S4E5K'(PF,,,->&."&-K(HV(QC&IV
M1K6IV1$0#]
M
M                                          H/\(G]$X#YU*")ST<?
MQZ;X/Y;/V[RPP          .-^I?ZX;?SNA]E&=D!: (
M
M
M                          4'^$3^B<!\ZE!$YZ./X]-\'\MG[=Y88
M       '&_4O]<-OYW0^RC.R M $
M
M
M          *#_")_1. ^=2@B<]''\>F^#^6S]N\L,          #C?J7^N&W
M\[H?91G9 6@"
M
M                                                      %!_A$_
MHG ?.I01.>CC^/3?!_+9^W>6&          !QOU+_7#;^=T/LHSL@+0!
M
M
M                                      "@_P (G]$X#YU*")ST<?QZ
M;X/Y;/V[RPP          .-^I?ZX;?SNA]E&=D!: (
M
M
M                        4'^$3^B<!\ZE!$YZ./X]-\'\MG[=Y88
M     '&_4O\ 7#;^=T/LHSL@+0!
M
M
M         "@_PB?T3@/G4H(G/1Q_'IO@_EL_;O+#           XWZE_KAM_
M.Z'V49V0%H @
M
M                                                     !0?X1/Z
M)P'SJ4$3GHX_CTWP?RV?MWEA@          <;]2_UPV_G=#[*,[("T 0
M
M
M                                      H/\(G]$X#YU*")ST<?QZ;X
M/Y;/V[RPP          .-^I?ZX;?SNA]E&=D!: (
M
M
M                      4'^$3^B<!\ZE!$YZ./X]-\'\MG[=Y88
M   '&_4O]<-OYW0^RC.R M $
M
M
M      *#_")_1. ^=2@B<]''\>F^#^6S]N\L,          #C?J7^N&W\[H?
M91G9 6@"
M
M                                                  %!_A$_HG ?
M.I01.>CC^/3?!_+9^W>6&          !QOU+_7#;^=T/LHSL@+0!
M
M
M                                  "@_P (G]$X#YU*")ST<?QZ;X/Y
M;/V[RPP          .-^I?ZX;?SNA]E&=D!: (
M
M
M                    4'^$3^B<!\ZE!$YZ./X]-\'\MG[=Y88
M '&_4O\ 7#;^=T/LHSL@+0!
M
M
M     "@_PB?T3@/G4H(G/1Q_'IO@_EL_;O+#           XWZE_KAM_.Z'V
M49V0%H @
M
M                                                 !0?X1/Z)P'S
MJ4$3GHX_CTWP?RV?MWEA@          <;]2_UPV_G=#[*,[("T 0
M
M
M                                  H/\(G]$X#YU*")ST<?QZ;X/Y;/
MV[RPP          .-^I?ZX;?SNA]E&=D!: (
M
M
M                  4'^$3^B<!\ZE!$YZ./X]-\'\MG[=Y88          '
M&_4O]<-OYW0^RC.R M $
M
M
M  *#_")_1. ^=2@B<]''\>F^#^6S]N\L,          #C?J7^N&W\[H?91G9
M 6@"
M
M                                              %!_A$_HG ?.I01
M.>CC^/3?!_+9^W>6&          !QOU+_7#;^=T/LHSL@+0!
M
M
M                              "@_P (G]$X#YU*")ST<?QZ;X/Y;/V[
MRPP          .-^I?ZX;?SNA]E&=D!: (
M
M
M                4'^$3^B<!\ZE!$YZ./X]-\'\MG[=Y88          '&_
M4O\ 7#;^=T/LHSL@+0!
M
M
M "@_PB?T3@/G4H(G/1Q_'IO@_EL_;O+#           XWZE_KAM_.Z'V49V0
M%H @
M
M                                             !0?X1/Z)P'SJ4$3
MGHX_CTWP?RV?MWEA@          <;]2_UPV_G=#[*,[("T 0
M
M
M                              H/\(G]$X#YU*")ST<?QZ;X/Y;/V[RP
MP          .-^I?ZX;?SNA]E&=D!: (
M
M
M              4'^$3^B<!\ZE!$YZ./X]-\'\MG[=Y88          '&_4O
M]<-OYW0^RC.R M $
M
M                                                          *#
M_")_1. ^=2@B<]''\>F^#^6S]N\L,          #C?J7^N&W\[H?91G9 6@"
M
M
M                                          %!_A$_HG ?.I01.>CC
M^/3?!_+9^W>6&          !QOU+_7#;^=T/LHSL@+0!
M
M
M                          "@_P (G]$X#YU*")ST<?QZ;X/Y;/V[RPP
M         .-^I?ZX;?SNA]E&=D!: (
M
M
M            4'^$3^B<!\ZE!$YZ./X]-\'\MG[=Y88          '&_4O\
M7#;^=T/LHSL@+0!
M
M                                                         "@_
MPB?T3@/G4H(G/1Q_'IO@_EL_;O+#           XWZE_KAM_.Z'V49V0%H @
M
M
M                                         !0?X1/Z)P'SJ4$3GHX_
MCTWP?RV?MWEA@          <;]2_UPV_G=#[*,[("T 0
M
M
M                          H/\(G]$X#YU*")ST<?QZ;X/Y;/V[RPP
M       .-^I?ZX;?SNA]E&=D!: (
M
M
M          4'^$3^B<!\ZE!$YZ./X]-\'\MG[=Y88          '&_4O]<-O
MYW0^RC.R M $
M
M                                                      *#_")_
M1. ^=2@B<]''\>F^#^6S]N\L,          #C?J7^N&W\[H?91G9 6@"
M
M
M                                      %!_A$_HG ?.I01.>CC^/3?
M!_+9^W>6&          !QOU+_7#;^=T/LHSL@+0!
M
M
M                      "@_P (G]$X#YU*")ST<?QZ;X/Y;/V[RPP
M     .-^I?ZX;?SNA]E&=D!: (
M
M
M        4'^$3^B<!\ZE!$YZ./X]-\'\MG[=Y88          '&_4O\ 7#;^
M=T/LHSL@+0!
M
M                                                     "@_PB?T
M3@/G4H(G/1Q_'IO@_EL_;O+#           XWZE_KAM_.Z'V49V0%H @
M
M
M                                     !0?X1/Z)P'SJ4$3GHX_CTWP
M?RV?MWEA@          <;]2_UPV_G=#[*,[("T 0
M
M
M                      H/\(G]$X#YU*")ST<?QZ;X/Y;/V[RPP
M   .-^I?ZX;?SNA]E&=D!: (
M
M
M      4'^$3^B<!\ZE!$YZ./X]-\'\MG[=Y88          '&_4O]<-OYW0^
MRC.R M $
M
M                                                  *#_")_1. ^
M=2@B<]''\>F^#^6S]N\L,          #C?J7^N&W\[H?91G9 6@"
M
M
M                                  %!_A$_HG ?.I01.>CC^/3?!_+9
M^W>6&          !QOU+_7#;^=T/LHSL@+0!
M
M
M                  "@_P (G]$X#YU*")ST<?QZ;X/Y;/V[RPP
M .-^I?ZX;?SNA]E&=D!: (
M
M
M    4'^$3^B<!\ZE!$YZ./X]-\'\MG[=Y88          '&_4O\ 7#;^=T/L
MHSL@+0!
M
M                                                 "@_PB?T3@/G
M4H(G/1Q_'IO@_EL_;O+#           XWZE_KAM_.Z'V49V0%H @
M
M
M                                 !0?X1/Z)P'SJ4$3GHX_CTWP?RV?
MMWEA@          <;]2_UPV_G=#[*,[("T 0
M
M
M                  H/\(G]$X#YU*")ST<?QZ;X/Y;/V[RPP          .
M-^I?ZX;?SNA]E&=D!: (
M
M
M  4'^$3^B<!\ZE!$YZ./X]-\'\MG[=Y88          '&_4O]<-OYW0^RC.R
M M $
M
M                                              *#_")_1. ^=2@B
M<]''\>F^#^6S]N\L,          #C?J7^N&W\[H?91G9 6@"
M
M
M                              %!_A$_HG ?.I01.>CC^/3?!_+9^W>6
M&          !QOU+_7#;^=T/LHSL@+0!
M
M
M              "@_P (G]$X#YU*")ST<?QZ;X/Y;/V[RPP          .-^
MI?ZX;?SNA]E&=D!: (
M
M
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M'V:2N2=KHU:C5:[@!OP
M            H/\ ")_1. ^=2@B<]''\>F^#^6S]N\L,          #C?J7^
MN&W\[H?91G9 6@"
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MKPR5[-9_"Q6E_/C4(E
M          %!_A$_HG ?.I01.>CC^/3?!_+9^W>6&          !QOU+_7#;
M^=T/LHSL@+0!
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MLCW\D<Y$ M<!
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M3,]?DO3U9H+$B]Y'UW\.:FXU?3,!JL%B'%0R,2=S5FD>]7N?P D8
M                                           %!_A$_HG ?.I01.>C
MC^/3?!_+9^W>6&          !QOU+_7#;^=T/LHSL@+0!
M
M       >=S'XZTY'6*5>5Z>ITD;7JG_<]&L:QB,8U&M1.R(B=D0
M
M          %!_A$_HG ?.I01.>CC^/3?!_+9^W>6&          !QOU+_7!;
M^=T/LHSL@+0!
M
M                                                      "@_P (
MG]$X#YU-_H G'1]59TXP7[_2?MWEB           <I]><#9I;)5SD2+X-N)C
M5?[)H2^= W_%;7BJZ^D1LR#(T2S7<O9_)/6YOM:H7Q,P$
M
M
M                          !\SSP5XGS3S,BB8G=SWN1K6I[553C[JWN<
M6WY^E0Q/*:M558X7-_\ 7S2A8ZNT[".P.KX?&/[<X*S4D_Q'>^>;4(
M    QLY@\7FL5/CLA DM>5/-/A1?:U?@<<NY[H+LM*RLN#M16X>_=B.>D,S0
ML1]>F75W]BM?7HOO![F?5W]AM?7HOO O#W,^KO[#:^O1?>#W,^KO[#:^O1?>
M X>YGU=_8;7UZ+[P>YGU=_8;7UZ+[P'#W,^KO[#:^O1?>#W,^KO[#:^O1?>
MX>YGU=_8;7UZ+[P>YGU=_8;7UZ+[P'#W,^KO[#:^O1?>#W,^KO[#:^O1?> X
M>YGU=_8;7UZ+[P>YGU=_8;7UZ+[P'#W,^KO[#:^O1?>#W,^KO[#:^O1?> X>
MYGU=_8;7UZ+[P>YGU=_8;7UZ+[P'#W,^KO[#:^O1?>#W,^KO[#:^O1?> X>Y
MGU=_8;7UZ+[P>YGU=_8;7UZ+[P'#W,^KO[#:^O1?>#W,^KO[#:^O1?> X>YG
MU=_8;7UZ+[P>YGU=_8;7UZ+[P'#W,^KO[#:^O1?>#W,^KO[#:^O1?> X>YGU
M=_8;7UZ+[P>YGU=_8;7UZ+[P'#W,^KO[#:^O1?>#W,^KO[#:^O1?> X>YGU=
M_8;7UZ+[P>YGU=_8;7UZ+[P'#W,^KO[#:^O1?>#W,^KO[#:^O1?> X>YGU=_
M8;7UZ+[P>YGU=_8;7UZ+[P'#W,^KO[#:^O1?>#W,^KO[#:^O1?> X>YGU=_8
M;7UZ+[P>YGU=_8;7UZ+[P'#W,^KO[#:^O1?>#W,^KO[#:^O1?> X>YGU=_8;
M7UZ+[P>YGU=_8;7UZ+[P'#W,^KO[#:^O1?>#W,^KO[#:^O1?> X>YGU=_8;7
MUZ+[P>YGU=_8;7UZ+[P'#W,^KO[#:^O1?>#W,^KO[#:^O1?> X>YGU=_8;7U
MZ+[P>YGU=_8;7UZ+[P'#W,^KO[#:^O1?>#W,^KO[#:^O1?> X>YGU=_8;7UZ
M+[P>YGU=_8;7UZ+[P'#W,^KO[#:^O1?>#W,^KO[#:^O1?> X>YGU=_8;7UZ+
M[P>YGU=_8;7UZ+[P'#W,^KO[#:^O1?>#W,^KO[#:^O1?> X>YGU=_8;7UZ+[
MP>YGU=_8;7UZ+[P'#W,^KO[#:^O1?>#W,^KO[#:^O1?> X>YGU=_8;7UZ+[P
M>YGU=_8;7UZ+[P'#W,^KO[#:^O1?>#W,^KO[#:^O1?> X>YGU=_8;7UZ+[P>
MYGU=_8;7UZ+[P'#W,^KO[#:^O1?>#W,^KO[#:^O1?> X>YGU=_8;7UZ+[P>Y
MGU=_8;7UZ+[P'#W,^KO[#:^O1?>#W,^KO[#:^O1?> X>YGU=_8;7UZ+[P>YG
MU=_8;7UZ+[P'#W,^KO[#:^O1?>#W,^KO[#:^O1?> X>YGU=_8;7UZ+[P>YGU
M=_8;7UZ+[P'#W,^KO[#:^O1?>#W,^KO[#:^O1?> X>YGU=_8;7UZ+[P>YGU=
M_8;7UZ+[P'#W,^KO[#:^O1?>#W,^KO[#:^O1?> X>YGU=_8;7UZ+[P>YGU=_
M8;7UZ+[P'#W,^KO[#:^O1?>#W,^KO[#:^O1?> X>YGU=_8;7UZ+[P>YGU=_8
M;7UZ+[P'#W,^KO[#:^O1?>#W,^KO[#:^O1?> X>YGU=_8;7UZ+[P>YGU=_8;
M7UZ+[P'#W,^KO[#:^O1?>#W,^KO[#:^O1?> X>YGU=_8;7UZ+[P>YGU=_8;7
MUZ+[P'#W,^KO[#:^O1?>#W,^KO[#:^O1?> X>YGU=_8;7UZ+[P>YGU=_8;7U
MZ+[P'#W,^KO[#:^O1?>#W,^KO[#:^O1?> X>YGU=_8;7UZ+[P>YGU=_8;7UZ
M+[P'#W,^KO[#:^O1?>#W,^KO[#:^O1?> X>YGU=_8;7UZ+[P>YGU=_8;7UZ+
M[P'#W,^KO[#:^O1?>#W,^KO[#:^O1?> X>YGU=_8;7UZ+[P>YGU=_8;7UZ+[
MP'#W,^KO[#:^O1?>#W,^KO[#:^O1?> X>YGU=_8;7UZ+[P>YGU=_8;7UZ+[P
M'#W,^KO[#:^O1?>#W,^KO[#:^O1?> X>YGU=_8;7UZ+[P>YGU=_8;7UZ+[P'
M#W,^KO[#:^O1?>#W,^KO[#:^O1?> X>YGU=_8;7UZ+[P>YGU=_8;7UZ+[P'#
MW,^KO[#:^O1?>#W,^KO[#:^O1?> X>YGU=_8;7UZ+[P>YGU=_8;7UZ+[P'#W
M,^KO[#:^O1?>#W,^KO[#:^O1?> X>YGU=_8;7UZ+[P>YGU=_8;7UZ+[P'#W,
M^KO[#:^O1?>#W,^KO[#:^O1?> X>YGU=_8;7UZ+[P>YGU=_8;7UZ+[P'#W,^
MKO[#:^O1?>#W,^KO[#:^O1?> X>YGU=_8;7UZ+[P>YGU=_8;7UZ+[P'#W,^K
MO[#:^O1?>#W,^KO[#:^O1?> X>YGU=_8;7UZ+[P>YGU=_8;7UZ+[P'#W,^KO
M[#:^O1?>#W,^KO[#:^O1?> X>YGU=_8;7UZ+[P>YGU=_8;7UZ+[P'#W,^KO[
M#:^O1?>#W,^KO[#:^O1?> X>YGU=_8;7UZ+[P>YGU=_8;7UZ+[P'#W,^KO[#
M:^O1?>#W,^KO[#:^O1?> X>YGU=_8;7UZ+[P>YGU=_8;7UZ+[P'#W,^KO[#:
M^O1?>#W,^KO[#:^O1?> X>YGU=_8;7UZ+[P>YGU=_8;7UZ+[P'#W,^KO[#:^
MO1?>#W,^KO[#:^O1?> X>YGU=_8;7UZ+[P>YGU=_8;7UZ+[P'#W,^KO[#:^O
M1?>#W,^KO[#:^O1?> X>YGU=_8;7UZ+[P>YGU=_8;7UZ+[P'#W,^KO[#:^O1
M?>#W,^KO[#:^O1?> X>YGU=_8;7UZ+[P>YGU=_8;7UZ+[P'#W,^KO[#:^O1?
M>#W,^KO[#:^O1?> X>YGU=_8;7UZ+[P>YGU=_8;7UZ+[P'#W,^KO[#:^O1?>
M#W,^KO[#:^O1?> X>YGU=_8;7UZ+[P>YGU=_8;7UZ+[P'#W,^KO[#:^O1?>#
MW,^KO[#:^O1?> X>YGU=_8;7UZ+[P>YGU=_8;7UZ+[P'#W,^KO[#:^O1?>#W
M,^KO[#:^O1?> X^V](NJ-Y6QVJO%GMGN,>U/\KG%V:!TEQVL3LOW9VW,BB>\
M<B=HH?WL":MP!
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
)        '__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
